0000863894-19-000007.txt : 20190515 0000863894-19-000007.hdr.sgml : 20190515 20190515132137 ACCESSION NUMBER: 0000863894-19-000007 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VERU INC. CENTRAL INDEX KEY: 0000863894 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 391144397 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13602 FILM NUMBER: 19826792 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD STREET 2: STE 888 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3125959123 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD STREET 2: SUITE 888 CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: FEMALE HEALTH CO DATE OF NAME CHANGE: 19960205 FORMER COMPANY: FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC DATE OF NAME CHANGE: 19920703 10-Q 1 veru-20190331x10q.htm 10-Q 20190331 10Q Q2



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





FORM 10-Q





(Mark One)



 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019





 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             



Commission File Number 1-13602





Veru Inc.

(Exact Name of Registrant as Specified in its Charter)





 

 

 

 

 

Wisconsin

 

39-1144397

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

4400 Biscayne Boulevard, Suite 888

Miami, FL

 

33137

(Address of Principal Executive Offices)

 

(Zip Code)



305-509-6897

(Registrant’s Telephone Number, Including Area Code)



N/A

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes       No  



Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes      No  



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.





 

 

 

 

 

 

Large accelerated filer 

 

Accelerated filer 

Non-accelerated filer 

 

Smaller reporting company



 

Emerging growth company



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      



Indicate by check mark whether the registrant is a shell company (as determined by Rule 12b-2 of the Exchange Act).    Yes      No  

Securities registered pursuant to Section 12(b) of the Act:



 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value per share

VERU

NASDAQ Capital Market



As of May 10, 2019, the registrant had 62,790,208 shares of $0.01 par value common stock outstanding.

 

 


 

VERU INC.

INDEX





 



 

                      

PAGE



 

Forward Looking Statements



 

PART I.          FINANCIAL INFORMATION

 



 

Item 1.  Financial Statements



 

Unaudited Condensed Consolidated Balance Sheets -

 

     March 31, 2019 and September 30, 2018 



 

Unaudited Condensed Consolidated Statements of Operations -

 

     Three and six months ended March 31, 2019 and 2018



 

Unaudited Condensed Consolidated Statements of Stockholders’ Equity -

 

     Six months ended March 31, 2019 and 2018



 

Unaudited Condensed Consolidated Statements of Cash Flows -

 

     Six months ended March 31, 2019 and 2018



 

Notes to Unaudited Condensed Consolidated Financial Statements



 

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations

30 



 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

38 



 

Item 4.  Controls and Procedures

38 



 

PART II.          OTHER INFORMATION

 



 

Item 1.  Legal Proceedings

39 



 

Item 1A.  Risk Factors

40 



 

Item 5.  Other Information

40 



 

Item 6.  Exhibits

41 



 



 

2


 

FORWARD LOOKING STATEMENTS



Certain statements included in this quarterly report on Form 10-Q which are not statements of historical fact are intended to be, and are hereby identified as, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, plans, objectives, expectations and intentions, costs and expenses, outcome of contingencies, financial condition, results of operations, liquidity, cost savings, objectives of management, business strategies, clinical trial timing and plans, the achievement of clinical and commercial milestones, the advancement of our technologies and our products and drug candidates, and other statements that are not historical facts.  Forward-looking statements can be identified by the use of forward-looking words or phrases such as "anticipate," "believe," "could," "expect, " "intend," "may," "opportunity," "plan," "predict," "potential," "estimate," "should, " "will," "would" or the negative of these terms or other words of similar meaning.  These statements are based upon the Company's current plans and strategies and reflect the Company's current assessment of the risks and uncertainties related to its business, and are made as of the date of this report.  These statements are inherently subject to known and unknown risks and uncertainties. You should read these statements carefully because they discuss our future expectations or state other “forward-looking” information. There may be events in the future that we are not able to accurately predict or control and our actual results may differ materially from the expectations we describe in our forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include the following:



·

potential delays in the timing of and results from clinical trials and studies and the risk that such results will not support marketing approval and commercialization;

·

potential delays in the timing of any submission to the U.S. Food and Drug Administration (the “FDA”) and in regulatory approval of products under development;

·

risks related to our ability to obtain sufficient financing on acceptable terms when needed to fund product development and our operations;

·

risks related to the development of our product portfolio, including clinical trials, regulatory approvals and time and cost to bring to market;

·

product demand and market acceptance;

·

some of our products are in early stages of development and we may fail to successfully commercialize such products;

·

risks related to intellectual property, including the uncertainty of obtaining intellectual property protections and in enforcing them, the possibility of infringing a third party’s intellectual property, and licensing risks;

·

competition from existing and new competitors including the potential for reduced sales, pressure on pricing and increased spending on marketing;

·

risks relating to compliance and regulatory matters, including costs and delays resulting from extensive government regulation and reimbursement and coverage under healthcare insurance and regulation;

·

risks inherent in doing business on an international level;

·

the disruption of production at our manufacturing facilities and/or of our ability to supply product due to raw material shortages, labor shortages, physical damage to our facilities, product testing, transportation delays or regulatory actions;

·

our reliance on major customers and risks related to delays in payment of accounts receivable by major customers;

·

risks related to our growth strategy;

·

our continued ability to attract and retain highly skilled and qualified personnel;

·

the costs and other effects of litigation, governmental investigations, legal and administrative cases and proceedings, settlements and investigations;

·

government contracting risks;

·

a governmental tender award, including our recent South Africa tender award, indicates acceptance of the bidder’s price rather than an order or guarantee of the purchase of any minimum number of units, and as a result government ministries or other public sector customers may order and purchase fewer units than the full maximum tender amount;

·

our recent South Africa tender award could be subject in the future to reallocation for potential local manufacturing initiatives, which could reduce the size of the award to us;

·

our ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives; and

·

our ability to successfully integrate acquired businesses, technologies or products.



3


 

All forward-looking statements in this report should be considered in the context of the risks and other factors described above and in Part I, Item 1A, "Risk Factors," in the Company’s Form 10-K for the year ended September 30, 2018 and Part II, Item 1A of this Form 10-Q.  The Company undertakes no obligation to make any revisions to the forward-looking statements contained in this report or to update them to reflect events or circumstances occurring after the date of this report except as required by applicable law.

4


 



PART I.FINANCIAL INFORMATION



Item 1.  Financial Statements

VERU INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS







 

 

 

 

 



 

 

 

 

 



March 31,
2019

 

September 30,
2018

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash

$

5,896,536 

 

$

3,759,509 

Accounts receivable, net

 

4,027,235 

 

 

3,972,632 

Inventory, net

 

2,998,201 

 

 

2,302,030 

Prepaid expenses and other current assets

 

1,220,908 

 

 

1,148,345 

Total current assets

 

14,142,880 

 

 

11,182,516 

Plant and equipment, net

 

320,802 

 

 

404,552 

Deferred income taxes

 

8,570,150 

 

 

8,543,758 

Intangible assets, net

 

20,323,112 

 

 

20,477,729 

Goodwill

 

6,878,932 

 

 

6,878,932 

Other assets

 

776,178 

 

 

965,152 

Total assets

$

51,012,054 

 

$

48,452,639 

Liabilities and Stockholders' Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

$

2,525,162 

 

$

3,226,036 

Accrued research and development costs

 

437,928 

 

 

981,357 

Accrued expenses and other current liabilities

 

2,472,422 

 

 

2,465,657 

Credit agreement, short-term portion  (Note 7)

 

5,836,615 

 

 

6,692,718 

Unearned revenue

 

 —

 

 

187,159 

Total current liabilities

 

11,272,127 

 

 

13,552,927 

Credit agreement, long-term portion  (Note 7)

 

2,717,934 

 

 

2,701,570 

Residual royalty agreement  (Note 7)

 

2,341,522 

 

 

1,753,805 

Deferred income taxes

 

895,860 

 

 

844,758 

Deferred rent

 

210,594 

 

 

88,161 

Other liabilities

 

30,000 

 

 

30,000 

Total liabilities

 

17,468,037 

 

 

18,971,221 



 

 

 

 

 

Commitments and contingencies  (Note 11)

 

 

 

 

 



 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

Preferred stock; no shares issued and outstanding at March 31, 2019 and

 

 

 

 

 

September 30, 2018

 

 —

 

 

 —

Common stock, par value $0.01 per share; 154,000,000 and 77,000,000 shares

 

 

 

 

 

authorized, 64,968,184 and 57,468,660 shares issued and 62,784,480 and 55,284,956

 

 

 

 

 

shares outstanding at March 31, 2019 and September 30, 2018, respectively

 

649,682 

 

 

574,687 

Additional paid-in-capital

 

105,666,943 

 

 

95,496,506 

Accumulated other comprehensive loss

 

(581,519)

 

 

(581,519)

Accumulated deficit

 

(64,384,484)

 

 

(58,201,651)

Treasury stock, 2,183,704 shares, at cost

 

(7,806,605)

 

 

(7,806,605)

Total stockholders' equity

 

33,544,017 

 

 

29,481,418 

Total liabilities and stockholders' equity

$

51,012,054 

 

$

48,452,639 



 

 

 

 

 

See notes to unaudited condensed consolidated financial statements.

 

 

 

 

 

 

5


 

VERU INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS









 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Net revenues

$

6,976,115 

 

$

2,572,872 

 

$

13,347,924 

 

$

5,159,485 

   

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

2,367,264 

 

 

1,374,936 

 

 

4,094,993 

 

 

2,647,928 

   

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

4,608,851 

 

 

1,197,936 

 

 

9,252,931 

 

 

2,511,557 

   

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

2,910,587 

 

 

2,076,794 

 

 

5,272,410 

 

 

4,035,162 

Selling, general and administrative

 

3,822,854 

 

 

3,817,692 

 

 

7,116,838 

 

 

6,845,390 

Loss on settlement of accounts receivable

 

 —

 

 

 —

 

 

 —

 

 

3,764,137 

Total operating expenses

 

6,733,441 

 

 

5,894,486 

 

 

12,389,248 

 

 

14,644,689 

   

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

(2,124,590)

 

 

(4,696,550)

 

 

(3,136,317)

 

 

(12,133,132)

   

 

 

 

 

 

 

 

 

 

 

 

Non-operating (expenses) income:

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(1,258,272)

 

 

(350,595)

 

 

(2,536,695)

 

 

(350,595)

Other income (expense), net

 

25,637 

 

 

(2,412)

 

 

52,031 

 

 

(15,580)

Change in fair value of derivative liabilities

 

(628,000)

 

 

(21,000)

 

 

(403,000)

 

 

(21,000)

Foreign currency transaction loss

 

(23,643)

 

 

(63,077)

 

 

(41,187)

 

 

(116,532)

Total non-operating expenses

 

(1,884,278)

 

 

(437,084)

 

 

(2,928,851)

 

 

(503,707)

   

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

(4,008,868)

 

 

(5,133,634)

 

 

(6,065,168)

 

 

(12,636,839)

   

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

25,167 

 

 

(1,302,416)

 

 

117,665 

 

 

(4,548,469)



 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(4,034,035)

 

$

(3,831,218)

 

$

(6,182,833)

 

$

(8,088,370)

   

 

 

 

 

 

 

 

 

 

 

 

Net loss per basic and diluted common share outstanding

$

(0.06)

 

$

(0.07)

 

$

(0.10)

 

$

(0.15)

   

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average common shares outstanding

 

62,767,258 

 

 

53,355,944 

 

 

62,659,352 

 

 

53,253,901 

   

 

 

 

 

 

 

 

 

 

 

 

See notes to unaudited condensed consolidated financial statements.



 

 

 

 

 

 

 

 

 

 

 

 



 

6


 

VERU INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

Additional

 

Other

 

 

 

 

Treasury

 

 

 

   

Preferred

 

Common Stock

 

Paid-in

 

Comprehensive

 

Accumulated

 

Stock,

 

 

 

   

Stock

 

Shares

 

Amount

 

Capital

 

Loss

 

Deficit

 

at Cost

 

Total

Balance at September 30, 2018

$

 —

 

57,468,660 

 

$

574,687 

 

$

95,496,506 

 

$

(581,519)

 

$

(58,201,651)

 

$

(7,806,605)

 

$

29,481,418 

Share-based compensation

 

 —

 

 —

 

 

 —

 

 

417,256 

 

 

 —

 

 

 —

 

 

 —

 

 

417,256 

Shares issued in connection with public offering of common stock, net of fees and costs

 

 —

 

7,142,857 

 

 

71,428 

 

 

9,060,539 

 

 

 —

 

 

 —

 

 

 —

 

 

9,131,967 

Issuance of shares pursuant to share-based awards

 

 —

 

190,000 

 

 

1,900 

 

 

(1,900)

 

 

 —

 

 

 —

 

 

 —

 

 

 —

Net loss

 

 —

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(2,148,798)

 

 

 —

 

 

(2,148,798)

Balance at December 31, 2018

 

 —

 

64,801,517 

 

 

648,015 

 

 

104,972,401 

 

 

(581,519)

 

 

(60,350,449)

 

 

(7,806,605)

 

 

36,881,843 

Share-based compensation

 

 —

 

 —

 

 

 —

 

 

496,209 

 

 

 —

 

 

 —

 

 

 —

 

 

496,209 

Issuance of shares pursuant to share-based awards

 

 —

 

166,667 

 

 

1,667 

 

 

198,333 

 

 

 —

 

 

 —

 

 

 —

 

 

200,000 

Net loss

 

 —

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(4,034,035)

 

 

 —

 

 

(4,034,035)

Balance at March 31, 2019

$

 —

 

64,968,184 

 

$

649,682 

 

$

105,666,943 

 

$

(581,519)

 

$

(64,384,484)

 

$

(7,806,605)

 

$

33,544,017 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2017

$

 —

 

55,392,193 

 

$

553,922 

 

$

90,550,669 

 

$

(581,519)

 

$

(34,263,262)

 

$

(7,806,605)

 

$

48,453,205 

Share-based compensation

 

 —

 

 —

 

 

 —

 

 

207,454 

 

 

 —

 

 

 —

 

 

 —

 

 

207,454 

Shares issued in connection with common stock purchase agreement

 

 —

 

304,457 

 

 

3,045 

 

 

344,036 

 

 

 —

 

 

 —

 

 

 —

 

 

347,081 

Net loss

 

 —

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(4,257,152)

 

 

 —

 

 

(4,257,152)

Balance at December 31, 2017

 

 —

 

55,696,650 

 

 

556,967 

 

 

91,102,159 

 

 

(581,519)

 

 

(38,520,414)

 

 

(7,806,605)

 

 

44,750,588 

Share-based compensation

 

 —

 

 —

 

 

 —

 

 

411,848 

 

 

 —

 

 

 —

 

 

 —

 

 

411,848 

Net loss

 

 —

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(3,831,218)

 

 

 —

 

 

(3,831,218)

Balance at March 31, 2018

$

 —

 

55,696,650 

 

$

556,967 

 

$

91,514,007 

 

$

(581,519)

 

$

(42,351,632)

 

$

(7,806,605)

 

$

41,331,218 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See notes to unaudited condensed consolidated financial statements.

 



 

7


 



VERU INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS







 

 

 

 

 



Six Months Ended



March 31,



2019

 

2018

OPERATING ACTIVITIES

 

 

 

 

 

Net loss

$

(6,182,833)

 

$

(8,088,370)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

84,394 

 

 

88,239 

Amortization of intangible assets

 

154,617 

 

 

137,631 

Noncash interest expense

 

2,536,695 

 

 

350,595 

Share-based compensation

 

913,465 

 

 

619,302 

Deferred income taxes

 

24,710 

 

 

(4,653,558)

Loss on settlement of accounts receivable

 

 —

 

 

3,764,137 

Change in fair value of derivative liabilities

 

403,000 

 

 

21,000 

Other

 

174,357 

 

 

(1,942)

Changes in current assets and liabilities:

 

 

 

 

 

(Increase) decrease in accounts receivable

 

(54,603)

 

 

3,250,664 

Increase in inventory

 

(748,095)

 

 

(821,133)

(Increase) decrease in prepaid expenses and other assets

 

(73,589)

 

 

62,485 

(Decrease) increase in accounts payable

 

(656,527)

 

 

853,949 

Decrease in unearned revenue

 

(187,159)

 

 

(142,147)

x(Decrease) increase in accrued expenses and other current liabilities

 

(391,011)

 

 

375,957 

Net cash used in operating activities

 

(4,002,579)

 

 

(4,183,191)



 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

 

Capital expenditures

 

(644)

 

 

(1,913)

Net cash used in investing activities

 

(644)

 

 

(1,913)



 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

 

Proceeds from sale of shares in public offering, net of fees and costs

 

9,131,967 

 

 

 —

Installment payments on SWK credit agreement

 

(3,191,717)

 

 

 —

Proceeds from stock option exercises

 

200,000 

 

 

 —

Proceeds from SWK credit agreement

 

 —

 

 

10,000,000 

Payment of debt issuance costs

 

 —

 

 

(120,000)

Net cash provided by financing activities

 

6,140,250 

 

 

9,880,000 



 

 

 

 

 

Net increase in cash

 

2,137,027 

 

 

5,694,896 

CASH AT BEGINNING OF PERIOD

 

3,759,509 

 

 

3,277,602 

CASH AT END OF PERIOD

$

5,896,536 

 

$

8,972,498 



 

 

 

 

 

Schedule of noncash investing and financing activities:

 

 

 

 

 

Shares issued in connection with common stock purchase agreement

$

 —

 

$

347,081 

Increase in deferred assets from accrued expenses

$

 —

 

$

77,840 

Debt issuance costs in accounts payable and accrued expenses

$

 —

 

$

143,943 



 

 

 

 

 

See notes to unaudited condensed consolidated financial statements.

 

 

 

 

 



8


 

VERU INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



Note 1 – Basis of Presentation



The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (“we,” “our,” “us,” “Veru” or the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018. The accompanying condensed consolidated balance sheet as of September 30, 2018 has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and six months ended March 31, 2019 and cash flows for the six months ended March 31, 2019 are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending September 30, 2019.  



The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.



In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.



Principles of consolidation and nature of operations: Veru Inc. is referred to in these notes collectively with its subsidiaries as “we,” “our,” “us,” “Veru” or the “Company.” The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (“APP”) and The Female Health Company Limited, and The Female Health Company Limited’s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the “U.K. subsidiary”), and The Female Health Company (UK) plc’s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the “Malaysia subsidiary”). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the “APP Acquisition”) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer health care product, the FC2 Female Condom/FC2 Internal Condom® (“FC2”).  The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company focused on oncology and urology with multiple drug products under clinical development.  Most of the Company’s net revenues during the three and six months ended March 31, 2019 and 2018 were derived from sales of FC2. 



Reclassifications:  Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. These reclassifications had no effect on the results of operations or financial position for any period presented.



Cash concentration: The Company’s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia.



Restricted cash: Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds.  Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life.  The Company had no restricted cash at March 31, 2019. Restricted cash was approximately $135,000 at September 30, 2018 and is included in cash on the accompanying unaudited condensed consolidated balance sheets.  

9


 



Patents and trademarks: The costs for patents and trademarks are expensed when incurred. 



Deferred financing costs: Costs incurred in connection with the common stock purchase agreement discussed in Note 8 have been included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. When shares of the Company’s common stock are sold under the common stock purchase agreement, a pro-rata portion of the deferred costs is recorded to additional paid-in-capital.



As discussed in Note 8, in connection with the common stock offering that closed on October 1, 2018, we incurred costs of approximately $190,000 through September 30, 2018. This amount was included in other assets on the accompanying unaudited condensed consolidated balance sheet at September 30, 2018. These costs were charged to additional paid-in capital in the six months ended March 31, 2019 after the common stock offering was closed.



Costs incurred in connection with the issuance of debt discussed in Note 7 are presented as a reduction of the debt on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. These issuance costs are being amortized using the effective interest method over the expected repayment period of the debt, which is currently estimated to occur in the third quarter of fiscal 2021. The amortization is included in interest expense on the accompanying unaudited condensed consolidated statements of operations.



Fair value measurements: Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 – Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to us as of the reporting dates. Accordingly, the estimates presented in the accompanying unaudited condensed consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. See Note 3 for a discussion of fair value measurements.



The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash, accounts receivable, accounts payable and other accrued liabilities approximate their fair value based on the short-term nature of these instruments. The carrying value of long-term debt, taking into consideration debt discounts and related derivative instruments, is estimated to approximate fair value.



Unearned revenue: The Company records an unearned revenue liability if a customer pays consideration before the Company transfers the product to the customer under the terms of a contract. Unearned revenue is recognized as revenue after control of the product is transferred to the customer and all revenue recognition criteria have been met.  The Company had no unearned revenue at March 31, 2019. Unearned revenue at September 30, 2018 was approximately $187,000 and was comprised of sales made to a large distributor who has the right to return product under certain conditions.



Derivative instruments: The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company reviews the terms of debt instruments it enters into to determine whether there are embedded derivative instruments, which are required to be bifurcated and accounted for separately as derivative financial instruments. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. Liabilities incurred in connection with an embedded derivative are discussed in Note 7.



Revenue recognition: Revenue is recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products.



The Company generates nearly all of its revenue from direct product sales. Revenue from direct product sales is generally recognized when the customer obtains control of the product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have significant unusual payment terms beyond 120 days in its contracts with customers. See Note 4 for additional information regarding credit terms.



10


 

The amount of consideration the Company ultimately receives varies depending upon sales discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of current contract sales terms and historical payment experience.



Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt.



Research and development costs: Research and development costs are expensed as they are incurred and include salaries and benefits, clinical trial costs and contract services. Nonrefundable advance payments made for goods or services to be used in research and development activities are deferred and capitalized until the goods have been delivered or the related services have been performed. If the goods are no longer expected to be delivered or the services are no longer expected to be performed, the Company would be required to expense the related capitalized advance payments. The Company did not have any capitalized nonrefundable advance payments as of March 31, 2019 and September 30, 2018.



The Company records estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials and contract manufacturing activities. These costs are a significant component of the Company’s research and development expenses. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed, number of patients enrolled and the rate of patient enrollments may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accruals could materially affect the Company’s results of operations.



Share-based compensation: The Company recognizes share-based compensation expense in connection with its share-based awards based on the estimated fair value of the awards on the date of grant, on a straight-line basis over the vesting period. Calculating share-based compensation expense requires the input of highly subjective judgment and assumptions, including estimates of the expected life of the share-based award, stock price volatility and risk-free interest rates.



Advertising: The Company's policy is to expense advertising costs as incurred. Advertising costs were immaterial to the Company’s results of operations for the three and six months ended March 31, 2019 and 2018.

 

Income taxes: The Company files separate income tax returns for its foreign subsidiaries. FASB ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.

 

Foreign currency translation and operations: Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency.  The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries.  Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first-generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $0.6 million as of March 31, 2019 and September 30, 2018. Assets

11


 

located outside of the U.S. totaled approximately $5.0 million and $5.2 million at March 31, 2019 and September 30, 2018, respectively.

   

Other comprehensive loss: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss.  Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss.



The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis.  Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized.  For the three and six months ended March 31, 2019 and 2018, comprehensive loss is equivalent to the reported net loss.    



Recently Issued Accounting Pronouncements



In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606).  This new accounting guidance on revenue recognition provides for a single five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation. The new guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts.  The Company adopted the new guidance on October 1, 2018 using the modified retrospective method and elected to apply the guidance only to contracts that were not completed as of the date of adoption. The adoption of this guidance did not have a material effect on our consolidated financial statements and related disclosures. See discussion above for disclosures relating to the Company's revenue recognition.



In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842),  which requires that lessees recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of key information about leasing arrangements.  ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required upon adoption.  Early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases to clarify the implementation guidance and ASU No. 2018-11, Leases (Topic 842) Targeted Improvements. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. In December 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors to address certain implementation issues facing lessors when adopting ASU 2016-02. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842): Codification Improvements to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016-02. The Company will adopt the new accounting standard on October 1, 2019 and intends to elect certain practical expedients, including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts.  We have begun to identify our significant lease contracts and are in the process of evaluating the effect of the new guidance on our consolidated financial statements and related disclosures.



In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The purpose of ASU 2016-18 is to clarify guidance and presentation related to restricted cash in the statements of cash flows as well as increased disclosure requirements. It requires beginning-of-period and end-of-period total amounts shown on the statements of cash flows to include cash and cash equivalents as well as restricted cash and restricted cash equivalents. We adopted ASU 2016-18 effective October 1, 2018. The adoption of ASU 2016-18 did not have a material effect on the presentation of our consolidated statements of cash flows or related disclosures. 



12


 

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment. The purpose of ASU 2017-04 is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the impaired fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position or results of operations.



In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The purpose of ASU 2017-09 is to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. We adopted ASU 2017-09 effective October 1, 2018. The adoption of ASU 2017-09 did not have a material effect on our financial position or results of operations. 



In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The purpose of ASU 2018-07 is to expand the scope of Topic 718, Compensation—Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 will be effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than the Company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. The adoption of ASU 2018-07 is not expected to have a material effect on our financial position or results of operations but should simplify the process by which the Company measures compensation expense for share-based payments to nonemployees. 

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Change to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 and early adoption is permitted. The adoption of ASU 2018-13 is not expected to have a material effect on our financial position or results of operations as it modifies disclosure requirements only.

 

Note 2 – Liquidity



The Company has incurred quarterly operating losses since the fourth quarter of fiscal 2016 and anticipates that it will continue to consume cash and incur substantial net losses as it develops its drug candidates. Because of the numerous risks and uncertainties associated with the development of pharmaceutical products, the Company is unable to estimate the exact amounts of capital outlays and operating expenditures necessary to fund development of its drug candidates and obtain regulatory approvals. The Company’s future capital requirements will depend on many factors.



The Company believes its current cash position and its ability to secure equity financing or other financing alternatives are adequate to fund planned operations of the Company for the next 12 months. Such financing alternatives may include debt financing, common stock offerings or financing involving convertible debt or other equity-linked securities and may include financings under the Company's effective shelf registration statement on Form S-3 (File No. 333-221120) (the “Shelf Registration Statement”).  The Company intends to be opportunistic when pursuing equity financing which could include selling common stock under its common stock purchase agreement with Aspire Capital Fund, LLC (see Note 8) and/or a marketed deal with an investment bank.

13


 

Note 3 – Fair Value Measurements



FASB ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).



The three levels of the fair value hierarchy are as follows:



Level 1 – Quoted prices for identical instruments in active markets.



Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. 



Level 3 – Instruments with primarily unobservable value drivers.



We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels of certain securities within the fair value hierarchy. There were no transfers between Level 1, Level 2 and Level 3 during the six months ended March 31, 2019 and 2018.



As of March 31, 2019 and September 30, 2018, the Company’s financial liabilities measured at fair value on a recurring basis, which consisted of embedded derivatives, were classified within Level 3 of the fair value hierarchy. 



The Company determines the fair value of hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument. The Company estimates the fair value of hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair value. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating the fair value of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Increases in fair value during a given financial quarter result in the recognition of non-cash derivative expense. Conversely, decreases in fair value during a given financial quarter would result in the recognition of non-cash derivative income. 



The following table provides a reconciliation of the beginning and ending liability balance associated with embedded derivatives measured at fair value using significant unobservable inputs (Level 3) as of March 31, 2019 and 2018:







 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018

Beginning balance

$

2,426,000 

 

$

 —

Additions

 

 —

 

 

3,319,000 

Change in fair value of derivative liabilities

 

403,000 

 

 

21,000 

Ending balance

$

2,829,000 

 

$

3,340,000 



The expense associated with the change in fair value of the embedded derivatives is included on a separate line item on our unaudited condensed consolidated statements of operations.



The liabilities associated with embedded derivatives represent the fair value of the change of control provisions in the SWK Credit Agreement and Residual Royalty Agreement. See Note 7 for additional information. There is no current observable market for these types of derivatives. The Company determined the fair value of the embedded derivatives using a Monte Carlo simulation model to value the financial liabilities at inception and on subsequent valuation dates. This valuation model incorporates transaction details such as the contractual terms, expected cash outflows, expected repayment dates, probability of a change of control, expected volatility, and risk-free interest rates. A significant acceleration of the estimated repayment date or a significant decrease in the probability of a change of control event prior to repayment of the SWK Credit Agreement, in isolation, would result in a significantly lower fair value measurement of the liabilities associated with the embedded derivatives.

14


 



The following table presents quantitative information about the inputs and valuation methodologies used to determine the fair value of the embedded derivatives classified in Level 3 of the fair value hierarchy as of March 31, 2019:





 

 

 

 



 

 

 

 

Valuation Methodology

 

Significant Unobservable Input

 

Weighted Average
(range, if applicable)



 

 

 

 

Monte Carlo Simulation

 

Estimated change of control dates

 

December 2019 to December 2021



 

Discount rate

 

15.3% to 17.3%



 

Probability of change of control

 

0% to 90%

 

Note 4 – Accounts Receivable and Concentration of Credit Risk



The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period.  As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales.  The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa.  For the order of 15 million units under the Brazil tender in 2014, the Company agreed to up to 360 days credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government.   



The components of accounts receivable consist of the following at March 31, 2019 and September 30, 2018:









 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Accounts receivable

 

$

4,076,745 

 

$

4,046,733 

Less: allowance for doubtful accounts

 

 

(36,201)

 

 

(36,201)

Less: allowance for sales and payment term discounts

 

 

(13,309)

 

 

(37,900)

Accounts receivable, net

 

$

4,027,235 

 

$

3,972,632 



On December 27, 2017, we entered into a settlement agreement with Semina, our distributor in Brazil, pursuant to which Semina made a payment of $2.2 million and was obligated to make a second payment of $1.5 million by February 28, 2018, to settle net amounts due to us totaling $7.5 million relating to the Brazil tender in 2014. The settlement was not related to our belief in the ultimate collectability of the receivables or in the creditworthiness of Semina. We elected to settle these amounts due to the uncertainty regarding the timing of payment by the Brazilian Government and, ultimately to us, on the remaining amounts due. The result of the settlement was a net loss of $3.8 million in the six months ended March 31, 2018, which is presented as a separate line item in the accompanying unaudited condensed consolidated statements of operations. Semina did not make its second payment of $1.5 million by February 28, 2018.  In July 2018, the Company agreed to accept $1.3 million as settlement of the $1.5 million that was owed, which resulted in an additional loss of $0.2 million in the third quarter of fiscal 2018



At March 31, 2019, one customer had an accounts receivable balance that represented 11% of current assets.  At September 30, 2018, one customer had an accounts receivable balance that represented 15% of current assets.



At March 31, 2019, two customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 65% of net accounts receivable in the aggregate. At September 30, 2018, three customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 74% of net accounts receivable in the aggregate. 



For the three months ended March 31, 2019, there were four customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 82% of the Company’s net revenues in the aggregate. For the three months ended March 31, 2018, there were two customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 44% of the Company’s net revenues in the aggregate.



For the six months ended March 31, 2019, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 66% of the Company’s net revenues in the aggregate.

15


 

For the six months ended March 31, 2018, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 50% of the Company’s net revenues in the aggregate.



The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable.  Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts.  Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions.  Accounts receivable are charged-off when deemed uncollectible.  The table below summarizes the change in the allowance for doubtful accounts for the six months ended March 31, 2019 and 2018.







 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018



 

 

 

 

 

Beginning balance

$

36,201 

 

$

38,103 

Charges to expense

 

 —

 

 

3,058 

Charge-offs

 

 —

 

 

(5,000)

Ending balance

$

36,201 

 

$

36,161 



Recoveries of accounts receivable previously charged-off are recorded when received.  The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies,  which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. In the U.S., the Company’s customers include telemedicine providers who sell into the prescription channel.

 

Note 5 – Balance Sheet Information



Inventory



Inventories are valued at the lower of cost or net realizable value.  The cost is determined using the first-in, first-out (“FIFO”) method.  Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date.  Write-downs of inventories establish a new cost basis which is not increased for future increases in the net realizable value of inventories or changes in estimated obsolescence.



Inventory consisted of the following at March 31, 2019 and September 30, 2018:







 

 

 

 

 



March 31,

 

September 30,



2019

 

2018

FC2

 

 

 

 

 

Raw material

$

599,772 

 

$

366,220 

Work in process

 

62,710 

 

 

77,669 

Finished goods

 

2,786,083 

 

 

2,232,864 

Inventory, gross

 

3,448,565 

 

 

2,676,753 

Less: inventory reserves

 

(451,041)

 

 

(391,861)

FC2, net

 

2,997,524 

 

 

2,284,892 

PREBOOST®

 

 

 

 

 

Finished goods

 

677 

 

 

17,138 

Inventory, net

$

2,998,201 

 

$

2,302,030 



16


 

Fixed Assets



We record equipment, furniture and fixtures, and leasehold improvements at historical cost.  Expenditures for maintenance and repairs are recorded to expense. Depreciation and amortization are primarily computed using the straight-line method.  Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows:







 



 

Manufacturing equipment

510 years

Office equipment

35 years

Furniture and fixtures

710 years



Leasehold improvements are depreciated on a straight-line basis over the lesser of the remaining lease term or the estimated useful lives of the improvements.



Plant and equipment consisted of the following at March 31, 2019 and September 30, 2018:







 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Equipment, furniture and fixtures

 

$

4,018,333 

 

$

4,018,284 

Leasehold improvements

 

 

287,686 

 

 

287,686 



 

 

4,306,019 

 

 

4,305,970 

Less: accumulated depreciation and amortization

 

 

(3,985,217)

 

 

(3,901,418)

Plant and equipment, net

 

$

320,802 

 

$

404,552 





Note 6 – Intangible Assets and Goodwill



Intangible Assets



Intangible assets acquired in the APP Acquisition included in-process research and development (“IPR&D”), developed technology consisting of PREBOOST® medicated wipes for prevention of premature ejaculation, and covenants not-to-compete. IPR&D represents incomplete research and development projects at APP as of the date of the APP Acquisition. These intangible assets are carried at cost less accumulated amortization. Intangible assets with finite lives are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. IPR&D is tested for impairment at least annually in the fourth quarter of each fiscal year until the underlying projects are completed or abandoned.  



The gross carrying amounts and net book value of intangible assets are as follows at March 31, 2019:

 



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

404,269 

 

$

1,995,731 

Covenants not-to-compete

 

500,000 

 

 

172,619 

 

 

327,381 

Total intangible assets with finite lives

 

2,900,000 

 

 

576,888 

 

 

2,323,112 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

576,888 

 

$

20,323,112 



17


 

The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2018:





 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

285,366 

 

$

2,114,634 

Covenants not-to-compete

 

500,000 

 

 

136,905 

 

 

363,095 

Total intangible assets with finite lives

 

2,900,000 

 

 

422,271 

 

 

2,477,729 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

422,271 

 

$

20,477,729 



Amortization is recorded over the projected related revenue stream for the PREBOOST® developed technology over 10 years and on a straight-line basis over seven years for the covenants not-to-compete. The amortization expense is recorded in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. The IPR&D assets will not be amortized until the underlying development projects are completed. If and when development is complete, which generally occurs when regulatory approval to market the product is obtained, the associated IPR&D assets would be accounted for as finite-lived intangible assets and amortized over the estimated period of economic benefit. If a development project is abandoned, the associated IPR&D assets would be charged to expense.



For the three months ended March 31, 2019 and 2018, amortization expense was approximately $77,000 and $69,000,  respectively. For the six months ended March 31, 2019 and 2018, amortization expense was approximately $155,000 and $138,000, respectively. 



Intangible assets are highly vulnerable to impairment charges, particularly newly acquired assets for recently launched products. These assets are initially measured at fair value and therefore any reduction in expectations used in the valuations could potentially lead to impairment. Some of the more common potential risks leading to impairment include competition, earlier than expected loss of exclusivity, pricing pressures, adverse regulatory changes or clinical trial results, delay or failure to obtain regulatory approval, additional development costs, inability to achieve expected synergies, higher operating costs, changes in tax laws and other macroeconomic changes. The complexity in estimating the fair value of intangible assets in connection with an impairment test is similar to the initial valuation. Considering the high-risk nature of research and development and the industry’s success rate of bringing developmental compounds to market, IPR&D impairment charges are likely to occur in future periods. 



Goodwill



The carrying amount of goodwill at March 31, 2019 and September 30, 2018 was $6.9 million. There was no change in the balance during the six months ended March 31, 2019 and 2018. Goodwill represents the difference between the purchase price and the estimated fair value of the net assets acquired in the APP Acquisition.  Goodwill from the APP Acquisition principally relates to intangible assets that do not qualify for separate recognition, our expectation to develop and market new products, and the deferred tax liability generated as a result of the transaction.  Goodwill is not tax deductible for income tax purposes and was assigned to Company’s sole reporting unit in the Company’s Research and Development reporting segment, which consists of multiple drug products under clinical development for oncology and urology.



Goodwill is tested for impairment at least annually in the fourth quarter of each fiscal year or when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that its fair value exceeds the carrying value. Examples of qualitative factors include our share price, our financial performance compared to budgets, long-term financial plans, and macroeconomic, industry and market conditions as well as the substantial excess of fair value over the carrying value of net assets from the annual impairment test previously performed.



18


 

The estimated fair value of a reporting unit is highly sensitive to changes in projections and assumptions; therefore, in some instances changes in these assumptions could potentially lead to impairment. We perform sensitivity analyses around our assumptions in order to assess the reasonableness of the assumptions and the results of our testing. Ultimately, future potential changes in these assumptions may impact the estimated fair value of a reporting unit and cause the fair value of the reporting unit to be below its carrying value. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value; however, if actual results are not consistent with our estimates and assumptions, we may be exposed to an impairment charge that could be material.



Note 7 – Debt



SWK Credit Agreement



On March 5, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with the financial institutions party thereto from time to time (the “Lenders”) and SWK Funding LLC, as agent for the Lenders (the “Agent”), for a synthetic royalty financing transaction. On and subject to the terms of the Credit Agreement, the Lenders agreed to provide the Company with a multi-draw term loan of up to $12.0 million, with $10.0 million advanced to the Company on the date of the Credit Agreement. The Company may draw up to an additional $1.0 million if the Company enters into an agreement to distribute at least 47.5 million units of FC2 in Brazil upon the terms described in the Credit Agreement and up to an additional $1.0 million if the Company enters into an agreement to distribute at least 30 million units of FC2 in South Africa upon the terms described in the Credit Agreement.

The Lenders will be entitled to receive quarterly payments on the term loan based on the Company’s product revenue from net sales of FC2 as provided in the Credit Agreement until the Company has paid 175% of the aggregate amount advanced to the Company under the Credit Agreement. If product revenue from net sales of FC2 for the 12-month period ended as of the last day of the respective quarterly payment period is less than $10.0 million, the quarterly payments will be 32.5% of product revenue from net sales of FC2 during the quarterly period. If product revenue from net sales of FC2 for the 12-month period ended as of the last day of the respective quarterly payment period is equal to or greater than $10.0 million, the quarterly payments are calculated as the sum of 25% of product revenue from net sales of FC2 up to and including $12.5 million in the Elapsed Period (as defined in the Credit Agreement), plus 10% of product revenue from net sales of FC2 greater than $12.5 million in the Elapsed Period.  Upon the Credit Agreement’s termination date of March 5, 2025, the Company must pay 175% of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue.

The first quarterly revenue-based payment due May 15, 2018 was approximately $0.6 million and was paid on that date. On August 10, 2018, the Company entered into an amendment (the “Credit Agreement Amendment”) to the Credit Agreement.  The Credit Agreement Amendment deferred until November 15, 2018 the due date for the quarterly revenue-based payment that would have otherwise been due on August 15, 2018. The Company made a payment of approximately $2.6 million on November 15, 2018, consisting of approximately $1.4 million for the quarterly revenue-based payment originally due on August 15, 2018 and approximately $1.2 million for the quarterly revenue-based payment due on November 15, 2018. On February 15, 2019, the Company paid approximately $0.6 million for the quarterly revenue-based payment due on that date.

Upon a change of control of the Company or sale of the FC2 business, the Company must pay off the loan by making a payment to the Lenders equal to (i) 175% of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue, plus (ii) the greater of (A) $2.0 million or (B) the product of (x) 5% of the product revenue from net sales of FC2 for the most recently completed 12-month period multiplied by (y) five. A “change of control” under the Credit Agreement includes (i) an acquisition by any person of direct or indirect ownership of more than 50% of the Company’s issued and outstanding voting equity, (ii) a change of control or similar event in the Company’s articles of incorporation or bylaws, (iii) certain Key Persons as defined in the Credit Agreement cease to serve in their current executive capacities unless replaced within 90 days by a person reasonably acceptable to the Agent, which acceptance not to be unreasonably withheld, or (iv) the sale of all or substantially all of the Company’s assets.

19


 

The Credit Agreement contains customary representations and warranties in favor of the Agent and the Lenders and certain covenants, including financial covenants addressing minimum quarterly marketing and distribution expenses for FC2 and a requirement to maintain minimum unencumbered liquid assets of $1.0 million. The Credit Agreement also restricts the payment of dividends and share repurchases. The recourse of the Lenders and the Agent for obligations under the Credit Agreement is limited to assets relating to FC2.

In connection with the Credit Agreement, the Company and the Agent also entered into a Residual Royalty Agreement, dated as of March 5, 2018 (the “Residual Royalty Agreement”), which provides for an ongoing royalty payment of 5% of product revenue from net sales of FC2 commencing upon the payment in full by the Company of the required amount pursuant to the Credit Agreement. The Residual Royalty Agreement will terminate upon (i) a change of control or sale of the FC2 business and the payment by the Company of the amount due in connection therewith pursuant to the Credit Agreement, or (ii) mutual agreement of the parties. If a change of control occurs prior to payment in full of the Credit Agreement, there will be no payment due with respect to the Residual Royalty Agreement.  If a change of control occurs after the payment in full of the Credit Agreement, the Agent will receive a payment that is the greater of (A) $2.0 million or (B) the product of (x) 5% of the product revenue from net sales of FC2 for the most recently completed 12-month period multiplied by (y) five.

Pursuant to a Guarantee and Collateral Agreement dated as of March 5, 2018 (the “Collateral Agreement”) and an Intellectual Property Security Agreement dated as of March 5, 2018 (the “IP Security Agreement”), the Company’s obligations under the Credit Agreement are secured by a lien against substantially all of the assets of the Company that relate to or arise from FC2. In addition, pursuant to a Pledge Agreement dated as of March 5, 2018 (the “Pledge Agreement”), the Company’s obligations under the Credit Agreement are secured by a pledge of up to 65% of the outstanding shares of The Female Health Company Limited, a wholly owned U.K. subsidiary.



After payment by the Company of certain fees and expenses of the Agent and the Lenders as required in the Credit Agreement, the Company received net proceeds of approximately $9.9 million from the initial $10.0 million advance under the Credit Agreement.



For accounting purposes, the initial $10.0 million advance under the Credit Agreement was allocated between the Credit Agreement and the Residual Royalty Agreement on a relative fair value basis.  A portion of the amount allocated to the Credit Agreement and a portion of the amount allocated to the Residual Royalty Agreement, in both cases equal to the fair value of the respective change of control provisions, was allocated to the embedded derivative liabilities. The derivative liabilities will be adjusted to fair market value at each subsequent reporting period.  For financial statement presentation, the embedded derivative liabilities have been included with their respective host instruments as noted in the following tables. The debt discounts are being amortized to interest expense over the expected term of the loan using the effective interest method. Additionally, the Company recorded deferred loan issuance costs of approximately $267,000 for legal fees incurred in connection with the Credit Agreement. The deferred loan issuance costs are presented as a reduction in the Credit Agreement obligation and are being amortized to interest expense over the expected term of the loan using the effective interest method.



At March 31, 2019 and September 30, 2018, the Credit Agreement consisted of the following:







 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Aggregate repayment obligation

$

17,500,000 

 

$

17,500,000 

Less: Cumulative payments

 

(3,834,202)

 

 

(642,485)

Less: Unamortized discounts

 

(6,212,466)

 

 

(8,475,874)

Less: Unamortized deferred issuance costs

 

(149,783)

 

 

(204,353)

Credit agreement, net

 

7,303,549 

 

 

8,177,288 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,251,000 

 

 

1,217,000 



 

8,554,549 

 

 

9,394,288 

Credit agreement, short-term portion

 

(5,836,615)

 

 

(6,692,718)

Credit agreement, long-term portion

$

2,717,934 

 

$

2,701,570 



 

 

 

 

 



The short-term portion of the Credit Agreement represents the aggregate of the estimated quarterly revenue-based payments payable during the 12-month periods subsequent to March 31, 2019 and September 30, 2018, respectively.

20


 

At March 31, 2019 and September 30, 2018, the Residual Royalty Agreement liability consisted of the following:







 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Residual Royalty Agreement liability, fair value at inception

$

346,000 

 

$

346,000 

Less: Unamortized discounts

 

 —

 

 

(2,420)

Add: Accretion of liability using effective interest rate

 

417,522 

 

 

201,225 

Residual Royalty Agreement liability, net

 

763,522 

 

 

544,805 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,578,000 

 

 

1,209,000 

Residual Royalty Agreement liability

$

2,341,522 

 

$

1,753,805 



 

 

 

 

 

Interest expense related to the Credit Agreement and the Residual Royalty Agreement consisted of amortization of the discounts, accretion of the liability for the Residual Royalty Agreement and amortization of the deferred issuance costs.  For the three and six months ended March 31, 2019, interest expense related to the Credit Agreement and Residual Royalty Agreement was as follows:







 

 

 

 

 

 

 

 

 

 

 



Three Months Ended
March 31,

 

Six Months Ended
March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Amortization of Credit Agreement and Residual Royalty Agreement discounts

$

1,107,622 

 

$

317,747 

 

$

2,265,828 

 

$

317,747 

Accretion of Residual Royalty Agreement liability

 

123,946 

 

 

27,278 

 

 

216,297 

 

 

27,278 

Amortization of deferred issuance costs

 

26,704 

 

 

5,570 

 

 

54,570 

 

 

5,570 



$

1,258,272 

 

$

350,595 

 

$

2,536,695 

 

$

350,595 

 

Note 8 – Stockholders’ Equity



Preferred Stock



The Company has 5,000,000 shares designated as Class A Preferred Stock with a par value of $0.01 per share. There are 1,040,000 shares of Class A Preferred Stock – Series 1 authorized; 1,500,000 shares of Class A Preferred Stock – Series 2 authorized; 700,000 shares of Class A Preferred Stock – Series 3 authorized; and 548,000 shares of Class A Preferred Stock – Series 4 (the “Series 4 Preferred Stock”) authorized.  There were no shares of Class A Preferred Stock of any series issued and outstanding at March 31, 2019 and September 30, 2018.  The Company has 15,000 shares designated as Class B Preferred Stock with a par value of $0.50 per share. There were no shares of Class B Preferred Stock issued and outstanding at March 31, 2019 and September 30, 2018. 



Common Stock



On March 27, 2019, following approval by stockholders at the Company’s annual meeting of stockholders held on March 26, 2019, the Company filed an amendment to its articles of incorporation to increase the number of authorized shares of common stock from 77,000,000 to 154,000,000 shares.



Common Stock Offering



On October 1, 2018, we completed an underwritten public offering of 7,142,857 shares of our common stock, at a public offering price of $1.40 per share. Net proceeds to the Company from this offering were $9.1 million after deducting underwriting discounts and commissions and costs paid by the Company. All of the shares sold in the offering were by the Company. The offering was made pursuant to the Shelf Registration Statement.



21


 

Common Stock Purchase Warrants



In connection with the closing of the APP Acquisition, the Company issued a warrant to purchase up to 2,585,379 shares of the Company's common stock to Torreya Capital, the Company's financial advisor (the “Financial Advisor Warrant”).  The Financial Advisor Warrant has a five-year term expiring October 31, 2021, a cashless exercise feature and a strike price equal to $1.93 per share. The Financial Advisor Warrant vested upon issuance and remains outstanding at March 31, 2019.



In May 2018, the Company issued two warrants to purchase a total of up to 750,000 shares of the Company's common stock at $2.31 per share in connection with a services agreement. The services agreement was terminated in March 2019 and the warrants were cancelled at the same time. Prior to termination of the services agreement, for measurement and recognition purposes, the Company utilized the lowest aggregate amount within the range of potential values, which was zero. Therefore, in prior periods, the Company had determined the fair value of these warrants to be zero and had not recognized any compensation expense related to these warrants.



Aspire Capital Purchase Agreement    



On December 29, 2017, the Company entered into a common stock purchase agreement (the “Purchase Agreement”) with Aspire Capital Fund, LLC (“Aspire Capital”) which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right, from time to time in its sole discretion during the 36-month term of the Purchase Agreement, to direct Aspire Capital to purchase up to $15.0 million of the Company’s common stock in the aggregate.  Concurrently with entering into the Purchase Agreement, the Company also entered into a registration rights agreement with Aspire Capital (the “Registration Rights Agreement”), in which the Company agreed to prepare and file under the Securities Act of 1933 and under the Shelf Registration Statement, a prospectus supplement for the sale or potential sale of the shares of the Company’s common stock that have been and may be issued to Aspire Capital under the Purchase Agreement.



Under the Purchase Agreement, on any trading day selected by the Company, the Company has the right, in its sole discretion, to present Aspire Capital with a purchase notice (each, a “Purchase Notice”), directing Aspire Capital (as principal) to purchase up to 200,000 shares of the Company’s common stock per business day, up to $15.0 million of the Company’s common stock in the aggregate at a per share price (the "Purchase Price") equal to the lesser of the lowest sale price of the Company’s common stock on the purchase date or the average of the three lowest closing sale prices for the Company’s common stock during the ten consecutive trading days ending on the trading day immediately preceding the purchase date.



In addition, on any date on which the Company submits a Purchase Notice to Aspire Capital in an amount equal to 200,000 shares and the closing sale price of our common stock is equal to or greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of common stock equal to up to 30% of the aggregate shares of the common stock traded on its principal market on the next trading day (the VWAP Purchase Date), subject to a maximum number of shares the Company may determine.  The purchase price per share pursuant to such VWAP Purchase Notice is generally 97% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.



In consideration for entering into the Purchase Agreement, concurrently with the execution of the Purchase Agreement, the Company issued to Aspire Capital 304,457 shares of the Company’s common stock. The shares of common stock issued as consideration were valued at approximately $347,000. This amount and related expenses of approximately $78,000, which total approximately $425,000, were recorded as deferred costs.



During fiscal 2018, we sold an aggregate of 1,717,010 shares of common stock to Aspire Capital under the Purchase Agreement resulting in proceeds to the Company of $3.0 million. As a result of these sales, we recorded approximately $85,000 of the deferred costs noted above to additional paid-in capital. The unamortized amount of deferred costs of approximately $340,000 is included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. As of March 31, 2019, the amount remaining under the Purchase Agreement was $12.0 million.



22


 

Note 9 – Share-based Compensation



We allocate share-based compensation expense to cost of sales, selling, general and administrative expense and research and development expense based on the award holder’s employment function. For the three and six months ended March 31, 2019 and 2018, we recorded share-based compensation expenses as follows:





 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,



 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

$

7,778 

 

$

1,797 

 

$

15,730 

 

$

5,061 

Selling, general and administrative

 

 

407,426 

 

 

362,006 

 

 

734,435 

 

 

537,344 

Research and development

 

 

81,005 

 

 

48,045 

 

 

163,300 

 

 

76,897 



 

$

496,209 

 

$

411,848 

 

$

913,465 

 

$

619,302 



Equity Plans



In March 2018, the Company’s stockholders approved the Company's 2018 Equity Incentive Plan (the “2018 Plan”). On March 26, 2019, the Company’s stockholders approved an increase in the number of shares that may be issued under the 2018 Plan to 6.0 million.  As of March 31, 2019, 4,117,272 shares remain available for issuance under the 2018 Plan. 



In July 2017, the Company’s stockholders approved the Company's 2017 Equity Incentive Plan (the “2017 Plan”).  A total of 4.7 million shares are authorized for issuance under the 2017 Plan. As of March 31, 2019, 190,868 shares remain available for issuance under the 2017 Plan. The 2017 Plan replaced the Company's 2008 Stock Incentive Plan (the “2008 Plan”), and no further awards will be made under the 2008 Plan.



Stock Options



Each option grants the holder the right to purchase from us one share of our common stock at a specified price, which is generally the closing price per share of our common stock on the date the option is issued. Options generally vest on a pro-rata basis on each anniversary of the issuance date within three years of the date the option is issued. Options may be exercised after they have vested and prior to the specified expiry date provided applicable exercise conditions are met, if any. The expiry date can be for periods of up to ten years from the date the option is issued. The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model based on the assumptions established at that time. The Company accounts for forfeitures as they occur and does not estimate forfeitures as of the option grant date.



The following table outlines the weighted average assumptions for options granted during the three and six months ended March 31, 2019 and 2018:





 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,

Weighted Average Assumptions:

 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

65.45% 

 

 

62.34% 

 

 

66.88% 

 

 

61.38% 

Expected dividend yield

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

Risk-free interest rate

 

 

2.27% 

 

 

2.76% 

 

 

2.59% 

 

 

2.47% 

Expected term (in years)

 

 

5.9 

 

 

6.0 

 

 

5.7 

 

 

5.8 

Fair value of options granted

 

$

0.90 

 

$

1.28 

 

$

0.85 

 

$

0.93 



During the three and six months ended March 31, 2019 and 2018, the Company used historical volatility of our common stock over a period equal to the expected life of the options to estimate their fair value.  The dividend yield assumption is based on the Company’s recent history and expectation of future dividend payouts on the common stock.  The risk-free interest rate is based on the implied yield available on U.S. treasury zero-coupon issues with an equivalent remaining term.



23


 

The following table summarizes the stock options outstanding and exercisable at March 31, 2019: 





 

 

 

 

 

 

 

 

 



 

 

Weighted Average

 

 

 



 

 

 

 

 

Remaining

 

Aggregate



Number of

 

Exercise Price

 

Contractual Term

 

Intrinsic



Shares

 

Per Share

 

(years)

 

Value



 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2018

5,645,312 

 

$

1.59 

 

 

 

 

 

Granted

880,882 

 

 

1.42 

 

 

 

 

 

Exercised

(166,667)

 

 

1.20 

 

 

 

 

 

Forfeited

(301,834)

 

 

1.52 

 

 

 

 

 

Outstanding at March 31, 2019

6,057,693 

 

$

1.57 

 

7.83 

 

$

785,435 

Exercisable at March 31, 2019

2,042,285 

 

$

1.46 

 

6.51 

 

$

436,840 



The aggregate intrinsic values in the table above are before income taxes and represent the number of in-the-money options outstanding or exercisable multiplied by the closing price per share of the Company’s common stock on the last trading day of the quarter ended March 31, 2019 of $1.46, less the respective weighted average exercise price per share at period end



The total intrinsic value of options exercised during the six months ended March 31, 2019 was approximately $48,000. Cash received from options exercised during the six months ended March 31, 2019 was approximately $200,000.  No stock options were exercised during the six months ended March 31, 2018.



As of March 31, 2019, the Company had unrecognized compensation expense of approximately $2.7 million related to unvested stock options. This expense is expected to be recognized over approximately three years.



Restricted Stock



The Company has issued restricted stock to employees, directors and consultants. Such issuances had vesting periods that ranged from one to three years. All such shares of restricted stock vest provided the grantee has not voluntarily terminated service or been terminated for cause prior to the vesting date. There were no shares of restricted stock outstanding at March 31, 2019 and September 30, 2018.



Restricted Stock Units



In connection with the closing of the APP Acquisition, the Company issued 50,000 and 140,000 restricted stock units to an employee and an outside director, respectively, that vested on October 31, 2018. The restricted stock units were settled in common stock issued under the 2017 Plan. As of March 31, 2019, there are no outstanding restricted stock units.



Stock Appreciation Rights



In connection with the closing of the APP Acquisition, the Company issued stock appreciation rights based on 50,000 and 140,000 shares of the Company’s common stock to an employee and an outside director, respectively, that vested on October 31, 2018. The stock appreciation rights have a ten-year term and an exercise price per share of $0.95, which was the closing price per share of the Company’s common stock as quoted on NASDAQ on the trading day immediately preceding the date of the completion of the APP Acquisition. The stock appreciation rights will be settled in common stock issued under the 2017 Plan.  As of March 31, 2019, these vested stock appreciation rights remain outstanding.

 



24


 

Note 10 – Contingent Liabilities



The testing, manufacturing and marketing of consumer products by the Company entail an inherent risk that product liability claims will be asserted against the Company.  The Company maintains product liability insurance coverage for claims arising from the use of its products.  The coverage amount is currently $10.0 million.



Litigation



In response to the APP Acquisition, two purported derivative and class action lawsuits were filed against the Company and certain of its officers and directors in the Circuit Court of Cook County, Illinois, captioned Glotzer v. The Female Health Company, et al., Case No. 2016-CH-13815, and Schartz v. Parrish, et al., Case No. 2016-CH-14488.  These lawsuits were originally filed on or about October 21, 2016 and November 7, 2016, respectively. On January 9, 2017, these two lawsuits were consolidated. On March 31, 2017, the plaintiffs filed a consolidated complaint.  The consolidated complaint named as defendants Veru, the members of our board of directors prior to the closing of the APP Acquisition and the members of our board of directors after the closing of the APP Acquisition. The consolidated complaint alleged, among other things, that the directors breached their fiduciary duties, or aided and abetted such breaches, by consummating the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements and by causing us to issue the shares of our common stock and Series 4 Preferred Stock to the former stockholders of APP pursuant to the APP Acquisition in order to evade the voting requirements of the Wisconsin Business Corporation Law. The consolidated complaint also alleged that Dr. Steiner, a director and the Chairman, President and Chief Executive Officer of Veru and a co-founder of APP, and Dr. Fisch, a director and Vice Chairman of Veru and a co-founder of APP, were unjustly enriched in receiving shares of our common stock and Series 4 Preferred Stock in the APP Acquisition.



On May 5, 2017, the defendants filed a motion to dismiss the consolidated complaint. On August 15, 2017, the court entered an order dismissing without prejudice the claims that the post-acquisition directors aided and abetted the alleged breaches of fiduciary duties by the pre-acquisition directors and that Dr. Steiner and Dr. Fisch were unjustly enriched.  The court did not dismiss the claims that our directors prior to the closing of the APP Acquisition breached their fiduciary duties and the claims that Veru consummated the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements.  On November 30, 2018, plaintiffs filed an Amended Consolidated Complaint.  The Amended Consolidated Complaint makes allegations similar to those in the original consolidated complaint as to the claims that were not dismissed and names as defendants Veru and the members of our board of directors prior to the closing of the APP Acquisition. The Amended Consolidated Complaint also makes claims against Dr. Steiner for allegedly aiding and abetting the pre-acquisition directors’ breach of fiduciary duty and for unjust enrichment.  Like the original consolidated complaint, which was previously dismissed in part, the Amended Consolidated Complaint seeks equitable relief, including rescission of the APP Acquisition, money damages, disgorgement of the shares of our common stock and Series 4 Preferred Stock issued to Dr. Steiner, and costs and expenses of the litigation, including attorneys' fees.  On December 14, 2018, the defendants filed their answer to the Amended Consolidated Complaint wherein they denied any and all liability and asserted additional defenses.  On January 14, 2019, the plaintiffs filed a motion for class certification. On May 6, 2019, the Court granted plaintiffs’ motion and certified a class consisting of “All holders of common stock of the Female Health Company as of October 31, 2016 and their successors in interest, excluding the named defendants to the Action and any person, firm, trust, corporation or other entity related to or affiliated with any of the Defendants.”  The parties filed cross-motions for summary judgment on April 15, 2019 which are set for hearing on July 11, 2019.  Veru believes that this action is without merit and is vigorously defending itself. No amount has been accrued for possible losses relating to this litigation as any such losses are not both probable and reasonably estimable.



License and Purchase Agreements



From time to time, we license or purchase rights to technology or intellectual property from third parties. These licenses and purchase agreements require us to pay upfront payments as well as development or other payments upon successful completion of preclinical, clinical, regulatory or revenue milestones. In addition, these agreements may require us to pay royalties on sales of products arising from the licensed or acquired technology or intellectual property. Because the achievement of future milestones is not reasonably estimable, we have not recorded a liability in the accompanying unaudited condensed consolidated financial statements for any of these contingencies.



25


 

Note 11 – Income Taxes



The Company accounts for income taxes using the liability method, which requires the recognition of deferred tax assets or liabilities for the tax-effected temporary differences between the financial reporting and tax bases of its assets and liabilities, and for net operating loss and tax credit carryforwards.



On December 22, 2017, significant changes were enacted to the U.S. tax law pursuant to the federal tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Tax Act”).  The Tax Act includes a permanent reduction in the U.S. federal corporate income tax rate from 35% to 21%, a one-time repatriation tax on deferred foreign income, and changes to deductions, credits and business-related exclusions.



The Tax Act also repealed the alternative minimum tax (“AMT”) for corporations.  The new law provides that AMT carryovers can be utilized to reduce or eliminate the tax liability in subsequent years or to obtain a tax refund.  For tax years beginning in 2018, 2019 and 2020, to the extent the AMT credit carryovers exceed regular tax liability, 50% of the excess AMT credit carryovers will be refundable.  Any remaining credits will be fully refundable in 2021.  At September 30, 2018, the Company reclassified $0.5 million of its AMT credit carryovers from its deferred tax assets to other assets due to the expectation that the AMT credits will be refundable over the next several years.



Within the calculation of the Company’s annual effective tax rate the Company has used assumptions and estimates that may change as a result of future guidance, interpretations, and rule-making from the Internal Revenue Service, the SEC, the FASB and/or various other taxing jurisdictions.  For example, the Company anticipates that state jurisdictions will continue to determine and announce their conformity to the Tax Act which would have an impact on the annual effective tax rate. The Company’s calculations are based on the information available, prepared or analyzed (including computations) in reasonable detail.



The Company completes a detailed analysis of its deferred income tax valuation allowances on an annual basis or more frequently if information comes to its attention that would indicate that a revision to its estimates is necessary.  In evaluating the Company’s ability to realize its deferred tax assets, management considers all available positive and negative evidence on a country-by-country basis, including past operating results, forecasts of future taxable income, and the potential Section 382 limitation on the net operating loss carryforwards due to a change in control.  In determining future taxable income, management makes assumptions to forecast U.S. federal and state, U.K. and Malaysia operating income, the reversal of temporary differences, and the implementation of any feasible and prudent tax planning strategies.  These assumptions require significant judgment regarding the forecasts of the future taxable income in each tax jurisdiction and are consistent with the forecasts used to manage the Company’s business.  It should be noted that the Company realized significant losses through 2005 on a consolidated basis.  From fiscal year 2006 through fiscal year 2015, the Company generated taxable income on a consolidated basis.  However, the Company had a cumulative pretax loss in the U.S. for fiscal 2018 and the two preceding fiscal years.  Forming a conclusion that a valuation allowance is not needed is difficult when there is significant negative evidence such as cumulative losses in recent years. Management has projected future taxable losses in the U.S. driven by the investment in research and development, and based on their analysis concluded that a valuation allowance should continue to be recorded against the U.S. deferred tax assets related to federal and state net operating loss carryforwards as of March 31, 2019. An additional valuation allowance has been recorded against the U.S. deferred tax assets and net operating loss carryforwards as of March 31, 2019 of $1.6 million.  In addition, the Company’s holding company for the non-U.S. operating companies, The Female Health Company Limited, continues to have a full valuation allowance.  The operating U.K. subsidiary, The Female Health Company (UK) plc does not have a valuation allowance due to projections of future taxable income for the next 10 years.



As of September 30, 2018, the Company had U.S. federal and state net operating loss carryforwards of approximately $33.2 million and $36.2 million, respectively, for income tax purposes with $14.4 million and $19.6 million, respectively, expiring in years 2022 to 2037 and $18.8 million and $16.6 million, respectively, which can be carried forward indefinitely.  The Company’s U.K. subsidiary has U.K. net operating loss carryforwards of approximately $62.3 million as of September 30, 2018, which can be carried forward indefinitely to be used to offset future U.K. taxable income.



26


 

ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 developed a two-step process to evaluate a tax position and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has not recorded a reserve for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. 



A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to income before income taxes is as follows:





 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Income tax benefit at statutory rates

$

(841,862)

 

$

(1,077,736)

 

$

(1,273,685)

 

$

(3,628,736)

State income tax benefit, net of federal benefits

 

(199,521)

 

 

(385,395)

 

 

(301,863)

 

 

(948,395)

Effect of change in U.S. tax rate

 

 —

 

 

 —

 

 

 —

 

 

(187,000)

Non-deductible expenses – other

 

2,364 

 

 

8,702 

 

 

4,783 

 

 

12,702 

Effect of lower foreign income tax rates

 

4,830 

 

 

50,981 

 

 

(3,527)

 

 

80,386 

Effect of deemed dividend

 

32,318 

 

 

 —

 

 

63,627 

 

 

 —

Other

 

(1,025)

 

 

101,032 

 

 

(22,863)

 

 

122,574 

Change in valuation allowance

 

1,028,063 

 

 

 —

 

 

1,651,193 

 

 

 —

Income tax expense (benefit)

$

25,167 

 

$

(1,302,416)

 

$

117,665 

 

$

(4,548,469)



Significant components of the Company’s deferred tax assets and liabilities are as follows:







 

 

 

 

 



 

 

 

 

 



March 31,

 

September 30,

Deferred tax assets:

2019

 

2018



 

 

 

 

 

Federal net operating loss carryforwards

$

8,057,926 

 

$

6,973,047 

State net operating loss carryforwards

 

2,468,061 

 

 

2,195,865 

Foreign net operating loss carryforwards – U.K.

 

10,621,438 

 

 

10,595,518 

Foreign capital allowance – U.K.

 

102,098 

 

 

102,098 

U.K. bad debts

 

1,700 

 

 

1,700 

Restricted stock – U.K.

 

17,586 

 

 

17,586 

U.S. deferred rent

 

54,706 

 

 

22,902 

Share-based compensation

 

759,875 

 

 

622,442 

Other, net – U.S.

 

125,508 

 

 

91,419 

Other, net – Malaysia

 

34,314 

 

 

33,843 

Gross deferred tax assets

 

22,243,212 

 

 

20,656,420 

Valuation allowance for deferred tax assets

 

(9,282,271)

 

 

(7,631,078)

Net deferred tax assets

 

12,960,941 

 

 

13,025,342 

Deferred tax liabilities:

 

 

 

 

 

In process research and development

 

(4,675,860)

 

 

(4,675,860)

Developed technology

 

(518,431)

 

 

(549,318)

Covenant not-to-compete

 

(85,044)

 

 

(94,321)

Other

 

(7,316)

 

 

(6,843)

Net deferred tax liabilities

 

(5,286,651)

 

 

(5,326,342)

Net deferred tax asset

$

7,674,290 

 

$

7,699,000 



27


 

The deferred tax amounts have been classified in the accompanying unaudited condensed consolidated balance sheets as follows:







 

 

 

 

 



 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Long-term deferred tax asset – U.K.

 

8,535,836 

 

 

8,509,915 

Long-term deferred tax asset – Malaysia

 

34,314 

 

 

33,843 

Total long-term deferred tax asset

$

8,570,150 

 

$

8,543,758 



 

 

 

 

 

Long-term deferred tax liability – U.S.

 

(895,860)

 

 

(844,758)

Total long-term deferred tax liability

$

(895,860)

 

$

(844,758)

 

Note 12 – Net Loss Per Share



Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and warrants, and the vesting of unvested restricted stock and restricted stock units.  Due to our net loss for the periods presented, all potentially dilutive instruments were excluded because their inclusion would have been anti-dilutive. See Notes 8 and 9 for a discussion of our dilutive potential common shares.



Note 13 – Industry Segments and Financial Information about Foreign and Domestic Operations



The Company currently operates in two reporting segments: Commercial and Research and Development.  The Commercial segment consists of FC2, PREBOOST and drug commercialization costs.  The Research and Development segment consists of multiple drug products under clinical development for oncology and urology. There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of non-operating expenses and income taxes. Our chief operating decision-maker (“CODM”) is Mitchell S. Steiner, M.D., our Chairman, President and Chief Executive Officer. 



Information about the Company's operations by segment and geographic area is as follows:









 

 

 

 

 

 

 

 

 

 

 

   

For the three months ended
March 31,

 

For the six months ended
March 31,



2019

 

2018

 

2019

 

2018

Operating (loss) income:

(In thousands)

 

(In thousands)

Commercial

$

3,204 

 

$

(163)

 

$

6,872 

 

$

(19)

Research and Development

 

(2,889)

 

 

(1,960)

 

 

(5,250)

 

 

(3,992)

Corporate

 

(2,440)

 

 

(2,574)

 

 

(4,758)

 

 

(8,122)



$

(2,125)

 

$

(4,697)

 

$

(3,136)

 

$

(12,133)



 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

United States

$

2,596 

 

$

981 

 

$

5,646 

 

$

1,975 

Brazil

 

1,098 

 

 

 —

 

 

1,098 

 

 

 —

United Arab Emirates

 

677 

 

 

278 

 

 

677 

 

 

278 

South Africa

 

24 

 

 

715 

 

 

233 

 

 

1,033 

Zimbabwe

 

590 

 

 

378 

 

 

1,948 

 

 

678 

Other

 

1,991 

 

 

221 

 

 

3,746 

 

 

1,195 



$

6,976 

 

$

2,573 

 

$

13,348 

 

$

5,159 



28


 

All of our net revenues, which are primarily derived from the sale of FC2, are attributed to our Commercial reporting segment. The loss on settlement of accounts receivable and depreciation and amortization related to long-lived assets that are not utilized in the production of FC2 are not reported as part of the reporting segments or reviewed by the CODM. These amounts are included in Corporate in the reconciliations above. Total assets are not presented by reporting segment as they are not reviewed by the CODM when evaluating the reporting segments’ performance. 



Note 14 – Subsequent Events



On May 13, 2019, the Company entered into an amendment (the “Second Amendment”) to the Credit Agreement discussed in Note 7.  The Second Amendment provides for reduced percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2019, a return to the current percentages used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2020 and increased percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2021 and thereafter until the loan has been repaid. The Second Amendment also provides for an increase in the repayment amount from 175% to 176.5% of the aggregate amount advanced. In addition, the Second Amendment provides for payments under the Residual Royalty Agreement to commence at the same time as they would have commenced prior to the Second Amendment. The Second Amendment also eliminates the Company’s option to draw up to an additional $2.0 million under the Credit Agreement depending on the Company entering into agreements to distribute FC2 in Brazil and South Africa as the Company has determined that it would not make such draws. As a result of the Second Amendment, the Company’s quarterly revenue-based payment due May 15, 2019 will decrease from approximately $1.7 million to approximately $0.9 million. At this time, the Company is unable to determine all of the financial effects of the Second Amendment, which will likely result in the Company recording an extinguishment loss due to the modification of the terms of the Credit Agreement in the quarter ending June 30, 2019. An estimate of the loss amount cannot be made at this time as the Company is currently analyzing the accounting for the transaction, which includes fair value determinations.

29


 





Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations



Overview    



Veru Inc. is an oncology and urology biopharmaceutical company developing novel medicines for prostate cancer treatment and prostate cancer supportive care as well as urology specialty pharmaceuticals.



The Company’s prostate cancer pipeline includes zuclomiphene citrate (which is also known as VERU-944, cis-clomiphene) and VERU-111 (bisindole).  Zuclomiphene citrate is an estrogen receptor agonist being evaluated in a Phase 2 clinical trial to treat hot flashes, a common side effect caused by hormone treatment in men with advanced prostate cancer. VERU-111 is an oral, next-generation, first-in-class selective small molecule that targets and disrupts alpha and beta tubulin subunits of microtubules in cells to treat metastatic prostate cancer patients whose disease is resistant to both castration and novel androgen-blocking agents (abiraterone or enzalutamide).  VERU-111 is being evaluated in men with metastatic castration and androgen-blocking agent resistant prostate cancer in an open label Phase 1b/2 clinical trial.  The Company also plans to evaluate VERU-111 for a variety of other malignancies.  In June 2018, as part of the American Society of Clinical Oncology (ASCO) Annual Meeting, the Company reported preclinical results showing the activity of VERU-111 against novel androgen blocking agent-resistant human prostate cancer, and it also reported preclinical data showing VERU-111’s anti-tumor activity against paclitaxel sensitive and resistant triple negative breast, ovarian and pancreatic cancers.



The Company is also advancing new drug formulations in its specialty pharmaceutical pipeline addressing unmet medical needs in urology. The clinical trial of the Company's proprietary Tadalafil and Finasteride Combination tablet (TADFIN™ tablet) met the requirements for bioavailability and bioequivalence for the co-administration of tadalafil 5mg and finasteride 5mg dosed daily for benign prostatic hyperplasia (BPH). Tadalafil (CIALIS®) is currently approved for treatment of BPH and erectile dysfunction and finasteride is currently approved for treatment of BPH (finasteride 5mg PROSCAR®) and male pattern hair loss (finasteride 1mg PROPECIA®). The co-administration of tadalafil and finasteride has been shown to be more effective for the treatment of BPH than by finasteride alone. The Company anticipates submitting an NDA for its TADFIN™ tablet under the 505(b)(2) regulatory pathway between the fourth quarter of calendar year 2019 and first quarter of calendar year 2020.  The Company is also developing Tamsulosin DRS (Delayed Release Sachet) granules and Tamsulosin XR (Extended Release) capsules which are formulations of tamsulosin, the active ingredient in FLOMAX®, which the Company has designed to avoid the "food effect" inherent in currently marketed versions of the drug, allowing for potentially safer administration and improved patient compliance.



The Company's commercial products include the FC2 Female Condom/FC2 Internal Condom® ("FC2"), an FDA-approved product for the dual protection of unwanted pregnancy and sexually transmitted infections ("STIs"), and the PREBOOST® (also marketed as Roman Swipes) 4% benzocaine medicated individual wipe for the prevention of premature ejaculation.  The Company’s Female Health Company Division markets and sells FC2 commercially and in the public health sector both in the U.S. and globally.  FC2 is available by prescription and over-the-counter in the U.S. In the global public health sector, the Company markets FC2 to entities, including ministries of health, government health agencies, U.N. agencies, nonprofit organizations and commercial partners, that work to support and improve the lives, health and well-being of women around the world. For PREBOOST, the Company has a co-promotion and distribution agreement with Timm Medical Technologies, Inc., a specialty urology sales organization, and the Company has also entered into a U.S. distributor agreement with Roman Health Ventures Inc., a premier and fast-growing men's health and telemedicine company that discreetly sells men's health products via the internet website getroman.com.



Prior to the completion of the APP Acquisition, the Company had been a single product company, focused on manufacturing, marketing and selling FC2 in the public sector.  The Centers for Disease Control and Prevention has referenced the use of condoms, including female condoms, as a means to reduce the risk of transmitting STIs, including HIV/AIDS, and the transmission of the Zika virus by sex.  Most of the Company’s net revenues are currently derived from sales of FC2.



FC2’s primary use is for disease prevention and family planning, and the global public health sector has been the Company’s main market for FC2. Within the global public health sector, various organizations supply critical products such as FC2, at no cost or low cost, to those who need but cannot afford to buy such products for themselves.



30


 

FC2 has been distributed in the U.S. and 150 other countries.  A significant number of countries with the highest demand potential are in the developing world.  The incidence of HIV/AIDS, other STIs and unwanted pregnancy in these countries represents a remarkable potential for significant sales of a product that benefits some of the world’s most underprivileged people.  However, conditions in these countries can be volatile and result in unpredictable delays in program development, tender applications and processing orders.



FC2 has a relatively small customer base, with a limited number of customers who generally purchase in large quantities. Over the past few years, significant customers have included large global agencies, such as the United Nations Population Fund (UNFPA) and the United States Agency for International Development (USAID).  Other customers include ministries of health or other governmental agencies, which either purchase directly or via in-country distributors, and non-governmental organizations (“NGOs”). 

 

Purchasing patterns for FC2 vary significantly from one customer to another and may reflect factors other than simple demand.  For example, some governmental agencies purchase FC2 through a formal procurement process in which a tender (request for bid) is issued for either a specific or a maximum unit quantity.  Tenders also define the other elements required for a qualified bid submission (such as product specifications, regulatory approvals, clearance by WHO, unit pricing and delivery timetable).  Bidders have a limited period of time in which to submit bids.  Bids are subjected to an evaluation process which is intended to conclude with a tender award to the successful bidder.  The entire tender process, from publication to award, may take many months to complete, including administrative actions or appeals.  A tender award indicates acceptance of the bidder’s price rather than an order or guarantee of the purchase of any minimum number of units.  Many governmental tenders are stated to be “up to” the maximum number of units, which gives the applicable government agency discretion to purchase less than the full maximum tender amount.  Orders are placed after the tender is awarded; there are often no set dates for orders in the tender and there are no guarantees as to the timing or amount of actual orders or shipments.  Orders received may vary from the amount of the tender award based on a number of factors including vendor supply capacity, quality inspections and changes in demand.  Administrative issues, politics, bureaucracy, process errors, changes in leadership, funding priorities and/or other pressures may delay or derail the process and affect the purchasing patterns of public sector customers.  As a result, the Company may experience significant quarter-to-quarter sales variances in the global public sector due to the timing and shipment of large orders of FC2.



In April 2017, the Company launched a small-scale marketing and sales program to support the promotion of FC2 in the U.S. market. The commercial team developed a plan to confirm the “proof of concept” that FC2 represented a significant business opportunity. This required changes in the distribution process for FC2 in the U.S. As part of this reorganization the Company announced new distribution agreements with three of the country's largest distributors that support the pharmaceutical industry. This newly developed network now allows up to 98% of major retail pharmacies the ability to make FC2 available to their customers. In addition to the distribution system, the Company expanded sales and market access efforts that resulted in FC2 now being available through the following access points: community-based organizations, by prescription, partnering with leading telemedicine providers including the “HeyDoctor” App, through 340B covered entities, colleges and universities and our patient assistance program. We continue to increase healthcare provider awareness, education and acceptance which has resulted in more women utilizing FC2 in the U.S. We believe that the results from these efforts support the U.S. market opportunity and that we will continue to see increased utilization of FC2. We are experiencing an increase in revenue from sales in the prescription channel in the U.S. primarily through telemedicine distribution partners.



On August 27, 2018, the Company announced that through six of its distributors in the Republic of South Africa, the Company had received a tender award to supply 75% of a tender covering up to 120 million female condoms over three years, which includes an award to the Company of up to 29.8 million units of the 40 million total units for the first year. As of March 31, 2019, the Company has not shipped any units under this tender award and expects to begin shipping units under the tender award in the third quarter of fiscal 2019. 



31


 

Details of the quarterly unit sales of FC2 for the last five fiscal years are as follows:







 

 

 

 

 

 

 

 

 

 

Period

 

2019

 

2018

 

2017

 

2016

 

2015



 

 

 

 

 

 

 

 

 

 

October 1 — December 31

 

7,382,524 

 

4,399,932 

 

6,389,320 

 

15,380,240 

 

12,154,570 

January 1 — March 31

 

9,792,584 

 

4,125,032 

 

4,549,020 

 

9,163,855 

 

20,760,519 

April 1 — June 30

 

 —

 

10,021,188 

 

8,466,004 

 

10,749,860 

 

14,413,032 

July 1 — September 30

 

 —

 

6,755,124 

 

6,854,868 

 

6,690,080 

 

13,687,462 

Total

 

17,175,108 

 

25,301,276 

 

26,259,212 

 

41,984,035 

 

61,015,583 



Revenues.  The Company's revenues are primarily derived from sales of FC2 in the global public sector and into the prescription channel in the U.S. Generally, these sales are recognized upon shipment of the product to the customers. Other revenues are from sales of PREBOOST; however, these revenues were not material to our results for the three and six months ended March 31, 2019 or 2018.



The Company is working to further develop a global market and distribution network for FC2 by maintaining relationships with global public health sector groups and completing strategic arrangements with companies with the necessary marketing and financial resources and local market expertise.



The Company’s most significant customers have been global public health sector agencies who purchase and/or distribute FC2 for use in HIV/AIDS prevention and/or family planning and, in the U.S., telemedicine providers who sell into the prescription channel.



In 2017, the Company began expanding access to FC2 in the U.S. by making it available by prescription.  With a prescription, FC2 is covered by most insurance companies with no copay.  The Company retained an independent sales organization to help educate doctors, pharmacists, clinics and student health centers on the benefits of FC2.  In the U.S., FC2 is sold to major distributors and telemedicine providers for sale into the prescription channel and sold directly to city and state public health departments and non-profit organizations.



Because the Company manufactures FC2 in a leased facility located in Malaysia, a portion of the Company's operating costs are denominated in foreign currencies. While a material portion of the Company's future sales are likely to be in foreign markets, all sales are denominated in the U.S. dollar. Effective October 1, 2009, the Company’s U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currency, further reducing the Company’s foreign currency risk. 



Operating Expenses.  The Company manufactures FC2 at its facility located in Selangor D.E., Malaysia.  The Company's cost of sales consists primarily of direct material costs, direct labor costs and indirect production and distribution costs.  Direct material costs include raw materials used to make FC2, principally a nitrile polymer.  Indirect production costs include logistics, quality control and maintenance expenses, as well as costs for electricity and other utilities.  All of the key components for the manufacture of FC2 are essentially available from either multiple sources or multiple locations within a source.    



Conducting research and development is central to our business model.  Since the completion of the APP Acquisition we have invested and expect to continue to invest significant time and capital in our research and development operations.  Our research and development expenses were $2.9 million and $2.1 million for the three months ended March 31, 2019 and 2018, respectively. Our research and development expenses were $5.3 million and $4.0 million for the six months ended March 31, 2019 and 2018, respectively. For the remainder of fiscal 2019, we expect to continue this trend of increased expenses relating to research and development due to advancement of multiple drug candidates.





32


 

Results of Operations



THREE MONTHS ENDED MARCH 31, 2019 COMPARED TO THREE MONTHS ENDED MARCH 31, 2018



The Company generated net revenues of $7.0 million and net loss of $4.0 million, or $(0.06) per basic and diluted common share, for the three months ended March 31, 2019, compared to net revenues of $2.6 million and net loss of $3.8 million, or $(0.07) per basic and diluted common share, for the three months ended March 31, 2018.   



Net revenues increased 171%, of which 166% relate to FC2. The Company experienced an increase in FC2 net revenues in both the public sector and the U.S. prescription channels. There was a 137% increase in FC2 unit sales and an increase in FC2 average sales price per unit of 12%. The principal factors for the increase in the FC2 average sales price per unit compared to the same period last year were changes in customer mix and unit price increases for customers in the U.S.



Cost of sales increased to $2.4 million in the three months ended March 31, 2019 from $1.4 million for the same period last year. The increase is primarily due to the increase in unit sales.

   

Gross profit increased to $4.6 million for the three months ended March 31, 2019 from $1.2 million for the three months ended March 31, 2018.  Gross profit margin for the three months ended March 31, 2019 was 66% of net revenues, compared to 47% of net revenues for the same period in 2018. In the three months ended March 31, 2019, the Company experienced an increase in FC2 sales into the prescription channel in the U.S. with higher profit margins.



Significant quarter-to-quarter variances in the Company’s results have historically resulted from the timing and shipment of large orders rather than from any fundamental changes in the business or the underlying demand for FC2.  The Company is also currently seeing pressure on spending for FC2 by large global agencies and donor governments in the developed world.  As a result, the Company may continue to experience challenges for unit sales of FC2 in the global public sector. The Company is experiencing an increase in revenue from sales in the prescription channel in the U.S., which should help smooth quarter to quarter and year to year revenue fluctuations.



Research and development expenses increased to $2.9 million for the three months ended March 31, 2019 from $2.1 million in the prior year period.  The increase is primarily due to increased costs associated with the in-process research and development projects acquired pursuant to the APP Acquisition and increased personnel costs.



Selling, general and administrative expenses were $3.8 million for the three months ended March 31, 2019, which was comparable to the $3.8 million in the prior year period. 



Interest expense, which consists of items related to the SWK Credit Agreement and the SWK Residual Royalty Agreement, was approximately $1.3 million for the three months ended March 31, 2019 compared to $0.4 million for the three months ended March 31, 2018. These agreements, which were entered into in March 2018, were outstanding for the entire fiscal 2019 period, but outstanding for only one month in the fiscal 2018 period.



Expense associated with the change in fair value of the embedded derivatives was $0.6 million for the three months ended March 31, 2019 compared to expense of $21,000 for the three months ended March 31, 2018.  The liabilities associated with embedded derivatives represent the fair value of the change of control provisions in the SWK Credit Agreement and Residual Royalty Agreement. See Note 3 and Note 7 to the financial statements included in this report for additional information.



The Company realized a foreign currency transaction loss of approximately $24,000 in the most recent quarter, compared to approximately $63,000 for the same period last year.  This foreign currency transaction loss was primarily due to the adverse movement of the U.S. dollar against the Malaysian Ringgit during the periods.



The income tax expense for the three months ended March 31, 2019 was $25,000, compared to an income tax benefit of $1.3 million for the same period in fiscal 2018. The increase in income tax expense of $1.3 million is primarily due to a valuation allowance recorded against the U.S. net deferred tax assets of $1.0 million and a decrease in the income tax benefit of $0.4 million due to the decrease in the loss before income taxes in addition to a decrease of $0.1 million in income tax expense for the effect of change in the U.S. and foreign tax rates.



33


 

SIX MONTHS ENDED MARCH 31, 2019 COMPARED TO SIX MONTHS ENDED MARCH 31, 2018



The Company generated net revenues of $13.3 million and net loss of $6.2 million, or $(0.10) per basic and diluted common share, for the six months ended March 31, 2019, compared to net revenues of $5.2 million and net loss of $8.1 million, or $(0.15) per basic and diluted common share, for the six months ended March 31, 2018.   



Net revenues increased 159%, of which 155% relate to FC2. The Company experienced an increase in FC2 net revenues in both the public sector and the U.S. prescription channels. There was a 101% increase in FC2 unit sales and an increase in FC2 average sales price per unit of 27%. The principal factors for the increase in the FC2 average sales price per unit compared to the same period last year were changes in customer mix and unit price increases for customers in the U.S.



Cost of sales increased to $4.1 million in the six months ended March 31, 2019 from $2.6 million for the same period last year.  The increase is primarily due to the increase in unit sales.

   

Gross profit increased to $9.3 million for the six months ended March 31, 2019 from $2.5 million for the six months ended March 31, 2018.  Gross profit margin for the six months ended March 31, 2019 was 69% of net revenues, compared to 49% of net revenues for the same period in 2018. In the six months ended March 31, 2019, the Company experienced an increase in FC2 sales into the prescription channel in the U.S. with higher profit margins.



Significant quarter-to-quarter variances in the Company’s results have historically resulted from the timing and shipment of large orders rather than from any fundamental changes in the business or the underlying demand for FC2.  The Company is also currently seeing pressure on spending for FC2 by large global agencies and donor governments in the developed world.  As a result, the Company may continue to experience challenges for unit sales of FC2 in the global public sector. The Company is experiencing an increase in revenue from sales in the prescription channel in the U.S., which should help smooth quarter to quarter and year to year revenue fluctuations.



Research and development expenses increased to $5.3 million for the six months ended March 31, 2019 from $4.0 million in the prior year period.  The increase is primarily due to increased costs associated with the in-process research and development projects acquired pursuant to the APP Acquisition and increased personnel costs.



Selling, general and administrative expenses increased by $0.3 million to $7.1 million for the six months ended March 31, 2019 from $6.8 million in the prior year period. 



The Company incurred a loss on net accounts receivable of approximately $3.8 million in the first quarter of fiscal 2018 in connection with a settlement agreement we entered with Semina, our distributor in Brazil, in December 2017. This amount is presented as a separate line item in the accompanying unaudited condensed consolidated statement of operations for the six months ended March 31, 2018.  



Interest expense, which consists of items related to the SWK Credit Agreement and the SWK Residual Royalty Agreement, was approximately $2.5 million for the six months ended March 31, 2019 compared to $0.4 million for the six months ended March 31, 2018. These agreements, which were entered into in March 2018, were outstanding for the entire fiscal 2019 period, but outstanding for only one month in the fiscal 2018 period.



Expense associated with the change in fair value of the embedded derivatives related to the SWK Credit Agreement and the SWK Residual Royalty Agreement was $0.4 million for the six months ended March 31, 2019 compared to expense of $21,000 for the six months ended March 31, 2018.



The Company realized a foreign currency transaction loss of approximately $41,000 in the six months ended March 31, 2019, compared to approximately $0.1 million for the same period last year.  This foreign currency transaction loss was primarily due to the adverse movement of the U.S. dollar against the Malaysian Ringgit during the periods.



The income tax expense for the six months ended March 31, 2019 was $0.1 million, compared to an income tax benefit of $4.5 million for the same period in fiscal 2018. The increase in income tax expense of $4.6 million is primarily due to a valuation allowance recorded against the U.S. net deferred tax assets of $1.6 million and the decrease in the income taxes benefit of $3.0 million due to the decrease in the loss before income taxes.



34


 

Liquidity and Sources of Capital



Liquidity



Our cash on hand at March 31, 2019 was $5.9 million, compared to $3.8 million (including restricted cash) at September 30, 2018.  At March 31, 2019, the Company had working capital of $2.9 million and stockholders’ equity of $33.5 million compared to negative working capital of $2.4 million and stockholders’ equity of $29.5 million as of September 30, 2018.  The increase in working capital is primarily due to the net proceeds from the common stock offering discussed below.



We have incurred quarterly operating losses since the fourth quarter of fiscal 2016 and anticipate that we will continue to consume cash and incur substantial net losses as we develop our drug candidates. Because of the numerous risks and uncertainties associated with the development of pharmaceutical products, we are unable to estimate the exact amounts of capital outlays and operating expenditures necessary to fund development of our drug candidates and obtain regulatory approvals. Our future capital requirements will depend on many factors. See Part I, Item 1A, "Risk Factors - Risks Related to Our Financial Position and Need for Capital" in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, for a description of certain risks that will affect our future capital requirements.



The Company believes its current cash position and its ability to secure equity financing or other financing alternatives are adequate to fund planned operations of the Company for the next 12 months. Such financing alternatives may include debt financing, common stock offerings or financing involving convertible debt or other equity-linked securities and may include financings under the Company's effective shelf registration statement on Form S-3 (File No. 333-221120) (the “Shelf Registration Statement”).  The Company intends to be opportunistic when pursuing equity financing which could include selling common stock under the Purchase Agreement with Aspire Capital and/or a marketed deal with an investment bank. See Part I, Item 1A, "Risk Factors - Risks Related to Our Financial Position and Need for Capital" in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, for a description of certain risks related to our ability to raise capital on acceptable terms. 

 

Operating activities



Our operating activities used cash of $4.0 million in the six months ended March 31, 2019. Cash used in operating activities included a net loss of $6.2 million, adjustments for non-cash items totaling $4.3 million and changes in operating assets and liabilities of $2.1 million. Adjustments for non-cash items primarily consisted of $2.5 million of interest expense and $0.4 million of expense due to the increase in fair value of the embedded derivatives related to the SWK Credit Agreement and the SWK Residual Royalty Agreement, and $0.9 million of share-based compensation. The decrease in cash from changes in operating assets and liabilities included decreases in accounts payable and accrued expenses of $1.0 million and an increase in inventories of $0.7 million.



Our operating activities used cash of $4.2 million in the six months ended March 31, 2018. Cash used in operating activities included a net loss of $8.1 million, adjustments for non-cash items totaling $0.3 million and cash from changes in operating assets and liabilities of $3.6 million. Adjustments for non-cash items primarily consisted of a $3.8 million loss on the settlement of net accounts receivable, $0.6 million of share-based compensation, and $0.4 million of interest expense related to the SWK Credit Agreement and the SWK Residual Royalty Agreement. These amounts were mostly offset by a $4.7 million change in deferred income taxes. The increase in cash from changes in operating assets and liabilities included a decrease in net accounts receivable and long-term other receivables of $3.3 million and increases in accounts payable and accrued expenses of $1.2 million.



35


 

On December 27, 2017, we entered into a settlement agreement with Semina, our distributor in Brazil, pursuant to which Semina made a payment of $2.2 million and was obligated to make a second payment of $1.5 million by February 28, 2018, to settle net amounts due to us totaling $7.5 million relating to the Brazil tender in 2014.  The settlement was not related to our belief in the ultimate collectability of the receivables or in the creditworthiness of Semina.  We elected to settle these amounts due to the uncertainty regarding the timing of payment by the Brazilian Government and, ultimately to us, on the remaining amounts due. The result of the settlement was a net loss of $3.8 million in the three and six months ended March 31, 2018, which is presented as a separate line item in the accompanying unaudited condensed consolidated statements of operations. Semina did not make its second payment of $1.5 million by February 28, 2018. In July 2018, the Company agreed to accept $1.3 million as settlement of the second payment of $1.5 million that was owed, which resulted in an additional loss of $0.2 million in the third quarter of fiscal 2018.



Financing activities



Net cash provided by financing activities in the six months ended March 31, 2019 was $6.1 million and primarily consisted of the net proceeds from the underwritten public offering of the Company’s common stock of $9.1 million (see discussion below), proceeds from stock option exercises of $0.2 million, less payments on the SWK Credit Agreement (see discussion below) totaling $3.2 million.



Sources of Capital



Common Stock Offering



On October 1, 2018, we completed an underwritten public offering of 7,142,857 shares of our common stock, at a public offering price of $1.40 per share. Net proceeds to the Company from this offering were $9.1 million after deducting underwriting discounts and commissions and costs paid by the Company. All of the shares sold in the offering were by the Company.  The offering was made pursuant to the Shelf Registration Statement.



SWK Credit Agreement



On March 5, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with the financial institutions party thereto from time to time (the “Lenders”) and SWK Funding LLC, as agent for the Lenders (the “Agent”), for a synthetic royalty financing transaction. On and subject to the terms of the Credit Agreement, the Lenders agreed to provide the Company with a multi-draw term loan of up to $12.0 million, with $10.0 million advanced to the Company on the date of the Credit Agreement. The Company may draw up to an additional $1.0 million if the Company enters into an agreement to distribute at least 47.5 million units of FC2 in Brazil upon the terms described in the Credit Agreement and up to an additional $1.0 million if the Company enters into an agreement to distribute at least 30 million units of FC2 in South Africa upon the terms described in the Credit Agreement. Under the Credit Agreement, the Company is required to make quarterly payments on the term loan based on the Company’s product revenue from net sales of FC2 until the earlier of receipt by the Lenders of a return premium specified in the Credit Agreement or a required payment upon termination of the Credit Agreement on March 5, 2025 or an earlier change of control of the Company or sale of the FC2 business.  The recourse of the Lenders and the Agent for obligations under the Credit Agreement is limited to assets relating to FC2.

In connection with the Credit Agreement, Veru and the Agent also entered into a Residual Royalty Agreement, dated as of March 5, 2018 (the “Residual Royalty Agreement”), which provides for an ongoing royalty payment of 5% of product revenue from net sales of FC2 commencing upon the payment in full by the Company of the required amount pursuant to the Credit Agreement.  The Residual Royalty Agreement will terminate upon (i) a change of control or sale of the FC2 business and the payment by the Company of the amount due in connection therewith pursuant to the Credit Agreement, or (ii) mutual agreement of the parties.



36


 

After payment by the Company of certain fees and expenses of the Agent and the Lenders as required in the Credit Agreement, the Company received net proceeds of approximately $9.9 million from the initial $10.0 million advance under the Credit Agreement. The first quarterly revenue-based payment due May 15, 2018 was approximately $0.6 million and was paid on that date. On August 10, 2018, the Company entered into an amendment (the “Credit Agreement Amendment”) to the Credit Agreement.  The Credit Agreement Amendment deferred until November 15, 2018 the due date for the quarterly revenue-based payment that would have otherwise been due on August 15, 2018. The Company made a payment of approximately $2.6 million on November 15, 2018, consisting of approximately $1.4 million for the quarterly revenue-based payment originally due on August 15, 2018 and approximately $1.2 million for the quarterly revenue-based payment due on November 15, 2018. On February 15, 2019, the Company paid approximately $0.6 million for the quarterly revenue-based payment due on that date.



On May 13, 2019, the Company entered into an amendment (the “Second Amendment”) to the Credit Agreement.  The Second Amendment provides for reduced percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2019, a return to the current percentages to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2020 and increased percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2021 and thereafter until the loan has been repaid. The Second Amendment also provides for an increase in the repayment amount from 175% to 176.5% of the aggregate amount advanced. In addition, the Second Amendment provides for payments under the Residual Royalty Agreement to commence at the same time as they would have commenced prior to the Second Amendment. The Second Amendment also eliminates the Company’s option to draw up to an additional $2.0 million under the Credit Agreement depending on the Company entering into agreements to distribute FC2 in Brazil and South Africa as the Company has determined that it would not make such draws. As a result of the Second Amendment, the Company currently estimates the aggregate amount of quarterly revenue-based payments payable during the 12-month period subsequent to March 31, 2019 will be approximately $2.9 million.



Aspire Capital Purchase Agreement



On December 29, 2017, the Company entered into the Purchase Agreement with Aspire Capital which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right, from time to time and in its sole discretion during the 36-month term of the Purchase Agreement, to direct Aspire Capital purchase up to $15.0 million of the Company's common stock in the aggregate.  Other than the 304,457 shares of common stock issued to Aspire Capital in consideration for entering into the Purchase Agreement, the Company has no obligation to sell any shares of common stock pursuant to the Purchase Agreement and the timing and amount of any such sales are in the Company's sole discretion subject to the conditions and terms set forth in the Purchase Agreement. During fiscal 2018, we sold an aggregate of 1,717,010 shares of common stock to Aspire Capital under the Purchase Agreement resulting in proceeds to the Company of $3.0 million. As of March 31, 2019, the amount remaining under the Purchase Agreement was $12.0 million. During fiscal 2019 to date, we have not sold any shares of common stock to Aspire Capital under the Purchase Agreement.



Fair Value Measurements



As of March 31, 2019 and September 30, 2018, the Company’s financial liabilities measured at fair value on a recurring basis, which consisted of embedded derivatives, represent the fair value of the change of control provisions in the SWK Credit Agreement and Residual Royalty Agreement. See Note 7 to the financial statements included in this report for additional information.



The fair values of these liabilities were estimated based on unobservable inputs (Level 3 measurement), which requires highly subjective judgment and assumptions. The Company determined the fair value of the embedded derivatives at inception and on subsequent valuation dates using a Monte Carlo simulation model. This valuation model incorporates transaction details such as the contractual terms, expected cash outflows, expected repayment dates, probability of a change of control, expected volatility, and risk-free interest rates. The assumptions used in calculating the fair value of financial instruments represent the Company’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, the use of different estimates or assumptions would result in a higher or lower fair value and different amounts being recorded in the Company’s financial statements. Material changes in any of these inputs could result in a significantly higher or lower fair value measurement at future reporting dates, which could have a material effect on our results of operations. See Note 3 to the financial statements included in this report for additional information.  

37


 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk



The Company's exposure to market risk is limited to fluctuations in raw material commodity prices, particularly the nitrile polymer used to manufacture FC2, and foreign currency exchange rate risk associated with the Company's foreign operations.  The Company does not utilize financial instruments for trading purposes or to hedge risk and holds no derivative financial instruments which would expose it to significant market risk.  Effective October 1, 2009, the Company's U.K. subsidiary and Malaysia subsidiary each adopted the U.S. dollar as its functional currency.  The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results.  The Company’s distributors are subject to exchange rate risk as their orders are denominated in U.S. dollars and they generally sell to their customers in the local country currency.  If currency fluctuations have a material impact on a distributor it may ask the Company for pricing concessions or other financial accommodations.  The Company currently has no significant exposure to interest rate risk. 



Item 4Controls and Procedures



Evaluation of Disclosure Controls and Procedures



As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective. It should be noted that in designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. The Company has designed its disclosure controls and procedures to reach a level of reasonable assurance of achieving desired control objectives and, based on the evaluation described above, the Company's Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective at reaching that level of reasonable assurance. 



Changes in Internal Control over Financial Reporting



There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

38


 

PART II.       OTHER INFORMATION



Item 1.  Legal Proceedings 



In response to the APP Acquisition, two purported derivative and class action lawsuits were filed against the Company and certain of its officers and directors in the Circuit Court of Cook County, Illinois, captioned Glotzer v. The Female Health Company, et al., Case No. 2016-CH-13815, and Schartz v. Parrish, et al., Case No. 2016-CH-14488. These lawsuits were originally filed on or about October 21, 2016 and November 7, 2016, respectively. On January 9, 2017, these two lawsuits were consolidated. On March 31, 2017, the plaintiffs filed a consolidated complaint.  The consolidated complaint named as defendants Veru, the members of our board of directors prior to the closing of the APP Acquisition and the members of our board of directors after the closing of the APP Acquisition. The consolidated complaint alleged, among other things, that the directors breached their fiduciary duties, or aided and abetted such breaches, by consummating the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements and by causing us to issue the shares of our common stock and Series 4 Preferred Stock to the former stockholders of APP pursuant to the APP Acquisition in order to evade the voting requirements of the Wisconsin Business Corporation Law. The consolidated complaint also alleged that Dr. Steiner, a director and the Chairman, President and Chief Executive Officer of Veru and a co-founder of APP, and Dr. Fisch, a director and Vice Chairman of Veru and a co-founder of APP, were unjustly enriched in receiving shares of our common stock and Series 4 Preferred Stock in the APP Acquisition.



On May 5, 2017, the defendants filed a motion to dismiss the consolidated complaint. On August 15, 2017, the court entered an order dismissing without prejudice the claims that the post-acquisition directors aided and abetted the alleged breaches of fiduciary duties by the pre-acquisition directors and that Dr. Steiner and Dr. Fisch were unjustly enriched.  The court did not dismiss the claims that our directors prior to the closing of the APP Acquisition breached their fiduciary duties and the claims that Veru consummated the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements.  On November 30, 2018, plaintiffs filed an Amended Consolidated Complaint.  The Amended Consolidated Complaint makes allegations similar to those in the original consolidated complaint as to the claims that were not dismissed and names as defendants Veru and the members of our board of directors prior to the closing of the APP Acquisition. The Amended Consolidated Complaint also makes claims against Dr. Steiner for allegedly aiding and abetting the pre-acquisition directors’ breach of fiduciary duty and for unjust enrichment.  Like the original consolidated complaint, which was previously dismissed in part, the Amended Consolidated Complaint seeks equitable relief, including rescission of the APP Acquisition, money damages, disgorgement of the shares of our common stock and Series 4 Preferred Stock issued to Dr. Steiner, and costs and expenses of the litigation, including attorneys' fees.  On December 14, 2018, the defendants filed their answer to the Amended Consolidated Complaint wherein they denied any and all liability and asserted additional defenses.  On January 14, 2019, the plaintiffs filed a motion for class certification. On May 6, 2019, the Court granted plaintiffs’ motion and certified a class consisting of “All holders of common stock of the Female Health Company as of October 31, 2016 and their successors in interest, excluding the named defendants to the Action and any person, firm, trust, corporation or other entity related to or affiliated with any of the Defendants.”  The parties filed cross-motions for summary judgment on April 15, 2019 which are set for hearing on July 11, 2019. Veru believes that this action is without merit and is vigorously defending itself.



39


 

Item 1A.  Risk Factors



In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risks and uncertainties relating to the Company's business disclosed in Part I, Item 1A, "Risk Factors," of the Company's Form 10-K for the year ended September 30, 2018.  There have been no material changes from the risk factors previously disclosed in Part I, Item 1A, "Risk Factors," of the Company's Form 10-K for the year ended September 30, 2018, except for the following additional risk factor.



Disruptions from an exit of the United Kingdom from the European Union could adversely affect our business and results of operations.



On June 23, 2016, the United Kingdom held a referendum in which voters approved an exit from the European Union, commonly referred to as “Brexit.”  At this time, the exact timing of Brexit and the terms of the United Kingdom’s relationship with the European Union after Brexit takes effect are uncertain.  We have operations and government oversight in the United Kingdom relating to our FC2 business and a modest amount of sales of FC2 in the European Union.  It is possible that changes made as a result of Brexit could subject us to heightened risks in that region, including disruptions to trade, increased foreign exchange volatility with respect to the British pound and additional legal and economic uncertainty.  Such changes may adversely affect our business and results of operations.



Item 5.  Other Information



Disclosure Pursuant to Item 1.01 of Form 8-K - Entry into a Material Definitive Agreement



On May 13, 2019, the Company entered into the Second Amendment to the Credit Agreement. The Second Amendment provides for reduced percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2019, a return to the current percentages to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2020 and increased percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2021 and thereafter until the loan has been repaid. The Second Amendment also provides for an increase in the repayment amount from 175% to 176.5% of the aggregate amount advanced. In addition, the Second Amendment provides for payments under the Residual Royalty Agreement to commence at the same time as they would have commenced prior to the Second Amendment. The Second Amendment also eliminates the Company’s option to draw up to an additional $2.0 million under the Credit Agreement depending on the Company entering into agreements to distribute FC2 in Brazil and South Africa as the Company has determined that it would not make such draws.



The foregoing is a summary description of certain terms of the Second Amendment and, by its nature, is incomplete.  A copy of the Second Amendment is filed herewith as Exhibit 10.3 to this Quarterly Report on Form 10-Q and is incorporated herein by reference.  All readers are encouraged to read the entire text of the Second Amendment.

40


 

Item 6.  Exhibits 



























 

Exhibit

Number

Description

 

 

3.1

Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form SB-2 Registration Statement (File No. 333-89273) filed with the SEC on October 19, 1999).

 

 

3.2

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 27,000,000 shares (incorporated by reference to Exhibit 3.2 to the Company's Form SB-2 Registration Statement (File No. 333-46314) filed with the SEC on September 21, 2000).

 

 

3.3

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 35,500,000 shares (incorporated by reference to Exhibit 3.3 to the Company's Form SB-2 Registration Statement (File No. 333-99285) filed with the SEC on September 6, 2002).

 

 

3.4

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 38,500,000 shares (incorporated by reference to Exhibit 3.4 to the Company's Form 10-QSB (File No. 1-13602) filed with the SEC on May 15, 2003).

 

 

3.5

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company designating the terms and preferences for the Class A Preferred Stock – Series 3 (incorporated by reference to Exhibit 3.5 to the Company's Form 10-QSB (File No. 1-13602) filed with the SEC on May 17, 2004).

 

 

3.6

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company designating the terms and preferences for the Class A Preferred Stock – Series 4 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on November 2, 2016).

 

 

3.7

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company changing the corporate name to Veru Inc. and increasing the number of authorized shares of common stock to 77,000,000 shares (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on August 1, 2017).

 

 

3.8

Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 154,000,000 shares (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on March 29, 2019). 



 

3.9

Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on May 4, 2018). 

 

 

4.1

Amended and Restated Articles of Incorporation, as amended (same as Exhibits 3.1,  3.2,  3.3,  3.4,  3.5,  3.6, 3.7 and 3.8).

 

 

4.2

Articles II, VII and XI of the Amended and Restated By-Laws (included in Exhibit 3.9).

 

 

10.1

Separation Agreement and General Release, dated as of March 27, 2019, between the Company and Charles T. Todd, Jr.  (1) (2)

41


 

 

 

10.2

Veru Inc. 2018 Equity Incentive Plan (as amended and restated effective March 26, 2019) (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 1-13602) filed with the SEC on March 29, 2019. (1)



 

10.3

Second Amendment to Credit Agreement & Amendment to Residual Royalty Agreement, dated as of May 13, 2019, among the Company, SWK Funding LLC and the financial institutions party thereto from time to time. (2)



 

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (2)

 

 

31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (2)

 

 

32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002). (2) (3)

 

 

101

The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, formatted in XBRL (Extensible Business Reporting Language):  (1) the Unaudited Condensed Consolidated Balance Sheets, (2) the Unaudited Condensed Consolidated Statements of Operations, (3) the Unaudited Condensed Consolidated Statements of Stockholders’ Equity, (4) the Unaudited Condensed Consolidated Statements of Cash Flows and (5) the Notes to the Unaudited Condensed Consolidated Financial Statements.







 

(1)

Management contract or compensatory plan or arrangement

(2)

Filed herewith

(3)

This certification is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

42


 

SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.





VERU INC.





DATE: May 15, 2019



/s/ Mitchell S. Steiner

Mitchell S. Steiner

Chairman, Chief Executive Officer and President





DATE: May 15, 2019



/s/ Michele Greco

Michele Greco

Chief Financial Officer and Chief Administrative Officer



43


EX-10.1 2 veru-20190331xex10_1.htm EX-10.1 Exhibit 10.1

Exhibit 10.1

 

SEPARATION AGREEMENT
AND GENERAL RELEASE



THIS SEPARATION AGREEMENT AND GENERAL RELEASE ("Agreement") is between Veru Inc. ("Company") and Charles T. Todd, Jr. ("Employee").



RECITALS



The Company and Employee desire to effect a final resolution and settlement of all matters and issues relating directly or indirectly to Employee's employment with the Company and Employee's March 27, 2019 resignation from that employment (the "Resignation Date”), and have arrived at a compromise of all such matters in this Agreement.



AGREEMENTS



1. Acknowledgment of Full Compensation.  Employee acknowledges and agrees that, with the payment on March 29, 2019 by the Company to Employee of $11,995.83, gross, less ordinary tax withholding and all required deductions, and the payment on April 15, 2019 by the Company to Employee of $2,796.66, gross, less ordinary tax withholding and all required deductions, Employee has received from the Company all salary, fringe benefits (including without limitation by enumeration vacation pay, bonuses, and retirement plan contributions) and all other compensation and benefits owed by the Company to Employee through and including the Resignation Date, except for the reimbursement for outstanding business-related expenses Employee incurred on behalf of the Company, which shall be handled and reimbursed in accordance with the Company’s expense reimbursement practices.



2. Consideration.  Conditioned upon (i) Employee's signing of this Agreement and Employee's return of this Agreement to the Company, (ii) expiration of the seven day revocation period without revocation, (iii) Employee's properly executing and returning the attached acknowledgment form to the Company (Exhibit A) indicating Employee's decision not to revoke this Agreement and (iv) Employee’s compliance with Employee’s obligations under this Agreement, the Company shall:



(a) pay Employee a total gross separation payment of $143,950.00, less ordinary tax withholding and all required deductions, an amount representing the approximate equivalent of six (6) months’ base salary, which shall be paid in twenty-four substantially equal installments.  The first installment payment shall be made payable on the Company’s next regularly scheduled payroll date following Employee's satisfaction of the above conditions and subsequent installments shall continue to be made on each of the next 23 regularly scheduled payroll dates;



(b) not contest any claim for unemployment insurance benefits filed by Employee after the Resignation Date; provided, however, that nothing in this Agreement shall prohibit the Company from responding truthfully to any inquiries from the unemployment insurance division of the pertinent state unemployment insurance agency.  Employee acknowledges and agrees that it is the parties' intent that Employee shall not be eligible for unemployment insurance benefits during the twelve (12) month period following Employee's satisfaction of the conditions specified in this paragraph 2 because Employee will be receiving separation pay allocated to that


 

period of time.  The Company reserves the right to challenge any application seeking benefits for any portion of the aforementioned twelve (12) month period; and



(c) permit (i) the part of the non-qualified stock option to purchase 280,000 shares of common stock issued to Employee on March 20, 2018 (the "March 2018 Stock Option") under the Company's 2017 Equity Incentive Plan that vested on March 20, 2019 (93,333 shares) to be exercised in accordance with the terms of the Company's 2017 Equity Incentive Plan and the applicable stock option grant agreement through March 20, 2020, (ii) the part of the March 2018 Stock Option that is scheduled to vest on March 20, 2020 (93,333 shares) to vest on such vesting date conditioned on Employee being available to provide transition consulting assistance pursuant to paragraph 17 of this Agreement through such vesting date and permit such part of such stock option, if it so vests, to be exercised in accordance with the terms of the Company's 2017 Equity Incentive Plan and the applicable stock option grant agreement through March 20, 2021, and (iii) the part of the non-qualified stock option to purchase 42,226 shares of common stock issued to Employee on January 2, 2019 (the "January 2019 Stock Option") under the Company's 2018 Equity Incentive Plan that is scheduled to vest on January 2, 2020 (42,226 shares) to vest on such vesting date conditioned on Employee being available to provide transition consulting assistance pursuant to paragraph 17 of this Agreement through such vesting date and permit such part of such stock option, if it so vests, to be exercised in accordance with the terms of the Company's 2018 Equity Incentive Plan and the applicable stock option grant agreement through January 2, 2021.  Employee acknowledges and agrees that all other stock options issued to Employee under the Company's 2017 Equity Incentive Plan or the Company’s 2018 Equity Incentive Plan, including the remainder of the March 2018 Stock Option that is scheduled to vest and March 20, 2021 (93,334 shares total) are unvested, shall terminate as of the Resignation Date and may not be exercised. 



The consideration specified in paragraph 2(a) shall be subject to ordinary tax withholding and all required deductions.  The consideration specified in this paragraph 2  shall not be deemed "compensation" for purposes of any of the Company's qualified retirement plans or other benefit programs, and payment of this separation pay does not entitle Employee to any retirement plan contributions by the Company for Employee's benefit or account.  This consideration is not an amount to which Employee is otherwise entitled, and constitutes additional consideration for Employee's release and waiver of potential claims identified in paragraph 5 below, including without limitation a potential claim for age discrimination under the Age Discrimination in Employment Act, and for the promises contained in paragraphs 13 and 17.



3. Confidentiality and Non-Disclosure.  Employee agrees that this Agreement, and its terms and provisions, are strictly confidential and shall not be divulged or disclosed in any way to any person other than Employee's spouse, legal counsel, or tax advisor.  Should Employee choose to divulge the terms and conditions of this Agreement to Employee's spouse, legal counsel, or tax advisor, Employee shall ensure that they will be similarly bound to keep the same confidential.  A breach of this paragraph by Employee's spouse, legal counsel, or tax advisor shall be considered a breach of this paragraph by Employee.



4. Non-Admission of Liability.  Neither this Agreement nor any action taken by the Company or Employee pursuant to it shall in any way be construed as an admission by the Company or Employee of any liability, wrongdoing, or violation of law, regulation, contract or

2

 


 

policy regarding any of the Company's or Employee’s decisions and actions regarding the employment or separation from employment of Employee.



5. Release.  For valuable consideration from the Company as stated above, Employee, for Employee and Employee's heirs, personal representatives, successors and assigns, hereby releases all claims of whatever nature that Employee may have against the Company, its affiliates, subsidiaries, predecessors, successors and assigns and its and their present, former or later insurers, agents, representatives, officers, administrators, directors, shareholders and employees (collectively "Releasees"), which arise out of or are in any manner based upon or related to the employment relationship between Employee and the Company, and the end of that relationship, and from all other claims or liabilities of any nature whatsoever which have arisen from any occurrence, transaction, omission or communication which transpired or occurred at any time before or on the date of this Agreement; provided, however, that this Agreement will not affect any existing obligations that the Company may have to indemnify Employee and will not prevent any party from asserting a claim against the other party for breach of this Agreement.



Without limitation to the foregoing, Employee specifically releases, waives and forever discharges the Releasees from and against all liabilities, claims, actions, demands, damages and costs of every nature, whether known or unknown, asserted or unasserted, which arise under the New Hampshire Protective Legislation Law; New Hampshire Unemployment Compensation Law; New Hampshire Uniform Trade Secrets Act; New Hampshire Whistleblowers' Protection Act; New Hampshire Minimum Wage Act; New Hampshire Public Employee Labor Relations Act; New Hampshire Safety and Health of Employees Law; New Hampshire Law Against Discrimination; Florida Civil Rights Act; Florida Whistleblower Protection Act; Florida Workers' Compensation Retaliation provision, Florida Minimum Wage Act; Article X, Section 24 of the Florida Constitution; Title VII of the Civil Rights Act of 1964, as amended; the Genetic Information Nondiscrimination Act; the Age Discrimination in Employment Act (29 U.S.C. § 621 et seq.); the Americans With Disabilities Act, as amended; Section 1981 of U.S.C. Title 42; National Labor Relations Act; Employee Retirement Income Security Act of 1974; the Equal Pay Act; state or federal parental, family and medical leave acts; the Uniformed Services Employment and Reemployment Rights Act (USERRA), or any other local, state, or federal military and/or veterans rights act, or any other claim based on veteran status; or arising under any other local, state or federal statute, ordinance, regulation or order, or which involve a claim or action for wrongful discharge, breach of contract (express or implied) and/or any other tort or common law cause of action. 



6. No Limitation of Rights.  The waiver and release in paragraph 5 does not affect those rights or claims that arise after the execution of this Agreement.  Nor does the waiver and release affect those rights or claims that cannot be waived by law.  While nothing contained in this Agreement shall be interpreted to prevent the United States Equal Employment Opportunity Commission ("EEOC") or equivalent state or local agency, the United States Securities and Exchange Commission ("SEC"), the National Labor Relations Board ("NLRB"), the Occupational Safety and Health Administration ("OSHA"), or any other federal, state or local agency or commission from investigating and pursuing any matter which it deems appropriate, Employee understands and agrees that, by signing this Agreement, Employee is waiving any and all rights Employee may have to reinstatement, damages, remedies, costs, attorney's fees or other relief as to any claims Employee has released and any rights Employee has waived as a result of Employee's execution of this Agreement.  Nothing contained in this Agreement is intended to limit Employee's

3

 


 

right or ability to file a charge with the EEOC or equivalent state or local agency, SEC, NLRB, OSHA, or any other federal, state or local agency or commission, or to receive an award for providing information to these agencies.  The EEOC or equivalent state or local agency, SEC, NLRB, OSHA, and any other federal, state or local agency or commission have  the authority to carry out their statutory duties by investigating the charge, issuing a determination, filing a lawsuit in court in their own name, or taking any other action authorized under law.  Employee retains the right to testify, assist or participate in any such action.  Employee retains the right to communicate with the EEOC or equivalent state or local agency, SEC, NLRB, OSHA, or any other federal, state or local agency or commission and such communication can be initiated by Employee or in response to the government and is not limited by the confidentiality or non-disparagement obligations contained in paragraphs 3, 11, 12, 22 and 27 of this Agreement.



7. No Reinstatement, Reemployment or Rehire.  Employee expressly declines reinstatement, reemployment or rehire by the Company and waives all rights to claim such relief.  If Employee should apply for employment with the Company or with any of its related entities in the future, Employee agrees that Employee has no entitlement to such employment and may be denied employment on the basis of this Agreement.



8. No Representations as Employee.  After the Resignation Date, Employee agrees that Employee will not represent Employee as being a current employee, officer, attorney, agent or representative of Company for any purpose.  Within five business days of the Resignation Date, Employee specifically agrees to update any and all social media accounts the Employee accesses, uses or maintains to remove any reference to Employee being a current employee of the Company.  For purposes of this paragraph 8, social media accounts include, without limitation, Facebook, LinkedIn and Twitter.



9. No Pending Matters.  Employee warrants and represents that Employee has not filed any pending complaint, charge, claim or grievance concerning Employee's compensation, separation from employment or terms and conditions of employment against the Company with any local, state or federal agency, court or commission, and that if any agency, commission or court assumes jurisdiction of any such complaint or charge on behalf of Employee, Employee will immediately request that agency, commission, or court to dismiss such proceeding with prejudice.



10. No Injuries.  Employee acknowledges and agrees that Employee has reported to Company management any and all workplace injuries (if any) sustained by Employee during Employee's employment with the Company and that Employee is not aware of any facts that would give rise to a worker's compensation claim that has not already been properly reported. 



11. Non-Disparagement.  Employee agrees to maintain a positive and constructive attitude and demeanor towards the Company, its directors, officers, shareholders, employees and agents, and agrees to refrain from making derogatory comments or statements of a negative nature about the Company, its directors, officers, shareholders, employees and agents, to anyone, including, but not limited to, current and former Company customers, employees, suppliers, vendors, and referral sources.  Nothing contained in this paragraph shall be construed to prohibit Employee from providing truthful testimony in any administrative, state or federal proceeding or cooperating in an investigation conducted by the EEOC or equivalent state or local agency, SEC, NLRB, OSHA, or any other federal, state or local agency or commission.  The Company agrees to

4

 


 

cause its officers to maintain a positive and constructive attitude and demeanor towards Employee and to refrain from making derogatory comments or statements of a negative nature about Employee.



12. Restrictive Covenant Obligations.  Employee reaffirms that Employee will abide by the confidentiality obligations in Section 7 of the Executive Employment Agreement between the parties dated as of January 2, 2019 (the "Employment Agreement"); the non-competition, non-solicitation and non-interference obligations in Section 8 of the Employment Agreement; the intellectual property obligations in Section 13 of the Employment Agreement; and the security and exit obligations in Section 14 of the Employment Agreement (collectively, the "Restrictive Covenant Obligations").  Employee agrees that the Restrictive Covenant Obligations are reasonable as to their terms and are fully enforceable against him.  Employee represents and agrees that Employee has not to-date breached any of the Restrictive Covenant Obligations.



13. Trade Secrets.



(a) Protection of Trade Secrets.  Notwithstanding the provisions of Section 7 of the Employment Agreement, the parties agree that nothing in this Agreement nor in Section 7 of the Employment Agreement shall be construed to limit or negate any statutory or common law of torts or trade secrets, where such law provides Company with broader protection than that provided in this Agreement or in Section 7 of the Employment Agreement.  After termination of employment, Employee shall not use or disclose the trade secrets of Company as long as they remain trade secrets.



(b) Notification of Trade Secret Rights.  Employee will be immune from criminal and civil liability under any federal or state trade secret law for any disclosure of the Company's trade secret(s) that is made (i) in confidence to an attorney or to a federal, state or local government official solely for the purpose of reporting or investigating a suspected violation of law and/or (ii) in a complaint or other document filed in a lawsuit or other proceeding, provided such filing is made under seal.  If Employee files a lawsuit alleging retaliation by the Company for reporting a suspected violation of law, Employee may disclose the relevant trade secret to Employee's attorney, and may use the trade secret information in the court proceeding provided (i) any filing containing the trade secret is made under seal; and (ii) Employee does not disclose the trade secret, except pursuant to a court order.



14. Specific Performance.  Employee acknowledges and agrees that irreparable injury to Company may result in the event that Employee breaches any covenant in this Agreement, and that the remedy at law for the breach of any such covenant will be inadequate.  If Employee engages in any act in violation of any provision of paragraph 13, Employee agrees that Company shall be entitled, in addition to such other remedies and damages that may be available to it by law or under this Agreement, to injunctive relief to enforce such provisions without the necessity of posting a bond.



15. Return of Company Property.  Employee represents and agrees that Employee has returned any and all Company records and files and any copies thereof (whether in electronic or paper form), keys, keyless entry cards, documents, confidential or proprietary information, computer equipment, CDs, computer software programs, vehicles, credit cards and any other

5

 


 

property owned by or belonging to the Company in Employee's possession or under Employee's control on or after the Resignation Date without any originals or copies being kept by Employee or conveyed to any other person or entity.  Employee acknowledges and agrees that Employee will use reasonable care to properly ship any Company property back to the Company via a shipment method that does not cause damage or destruction to Company property.  Employee also agrees to cooperate with any request by the Company to review the Employee's personal electronic device(s) for purposes of removing any Company data.  Employee acknowledges that, to the extent permitted by law, Employee will be liable to Company for the Company's costs incurred in enforcing its rights under this paragraph 15, including Company's reasonable attorneys' fees.



16. Waiver of Reimbursement of COBRA Premiums. Employee waives any right to receive reimbursement by the Company for any and all COBRA premiums paid by Employee, as stated under section 5.2(a)(iv) of the Employment Agreement, should Employee elect to continue Employee’s healthcare coverage.



17. Transition Consulting Assistance.  As a precondition for receiving certain benefit(s) specified in paragraph 2(c) above, following execution of this Agreement, Employee agrees that Employee will make himself available at reasonable times and use his best efforts to answer any of the Company's questions or to otherwise assist the Company in making an orderly transition.  Without limitation to the foregoing, Employee acknowledges and agrees that he will use his best efforts to answer any of the Company's inquiries concerning matters for which he was responsible during his active employment with the Company.  Employee further acknowledges and agrees that he shall receive no additional consideration for time spent answering the Company's questions or otherwise providing such assistance as described in this paragraph 17, as the consideration referenced in paragraph 2(c) above represents adequate consideration for his answering such questions and otherwise providing such assistance.



18. Binding Agreement.  This Agreement shall be binding upon Employee and upon Employee's heirs, administrators, representatives, executors, successors and assigns and shall inure to the benefit of the Releasees and to their heirs, administrators, representatives, executors, successors and assigns.



19. Jurisdiction and Venue.  This Agreement shall be governed by and construed in accordance with the laws of the State of Florida.  Any controversy between Company and Employee arising under or relating to this Agreement shall be determined by the Circuit Court of Miami-Dade County, Florida, and the parties agree not to present any such controversy to any other court or forum.  The parties expressly consent to the exclusive jurisdiction of the Circuit Court of Miami-Dade County, Florida.



20. Severability.  It is understood and agreed that the provisions of this Agreement shall be deemed severable, and the invalidity or unenforceability of any one or more of the provisions herein shall not affect the validity and enforceability of the other provisions herein.



21. Complete and Exclusive Agreement.  The parties understand and agree that this Agreement is final and binding and constitutes the complete and exclusive statement of the terms and conditions of settlement, that no representations or commitments were made by the parties to induce this Agreement other than as expressly set forth herein and that this Agreement is fully

6

 


 

understood by the parties.  This Agreement may not be modified or supplemented except by a subsequent written agreement signed by the party against whom enforcement is sought.



22. Effect of Termination.  Employee acknowledges and agrees that the Employment Agreement has terminated and that all obligations imposed on either party under the Employment Agreement have ceased effective the date of Employee's termination from employment, except as otherwise expressly provided in the Employment Agreement.  Notwithstanding the foregoing, Employee agrees that Sections 5.8(a), 5.8(b), 6, 7, 7.1(a), 7.1(b), 7.1(c), 7.1(d), 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 9, 10, 11, 13.1, 13.2, 13.3, 13.4, 14.1, 14.2, 15, 16, 17, 18, 19, 20, 21, 22.1, 22.2, 22.3, 22.4, 22.5, 23, 24, 26, 27, 28, and 29 of the Employment Agreement shall continue in full force and effect notwithstanding the termination of Employee's employment with the Company and the termination of the Employment Agreement.



23. Acknowledgement of Resignation.  By signing this Agreement, Employee acknowledges that Employee has resigned from the position of Chief Executive Officer of The Female Health Company Division of the Company, and all other positions Employee holds with respect to the Company or any subsidiary thereof, effective as of the Resignation Date.



24. Complete and Exclusive Agreement.  The parties understand and agree that this Agreement (with Exhibit A attached hereto) is final and binding and, excepting solely the Restrictive Covenant Obligations referenced in paragraph 12 and the provisions of the Employment Agreement referenced in paragraph 22, constitutes the complete and exclusive statement of the terms and conditions of settlement, that no representations or commitments were made by the parties to induce this Agreement other than as expressly set forth herein and that this Agreement is fully understood by the parties.  This Agreement may not be modified or supplemented except by a subsequent written agreement signed by the party against whom enforcement is sought.



25. Consideration Period.  Employee represents and agrees that Employee has had the opportunity and time to consult with legal counsel concerning the provisions of this Agreement, and that the Company has given Employee up to twenty-one (21) days to consider this Agreement.  Any changes made to this Agreement before Employee signs it, whether material or immaterial, will not restart the 21-day consideration period.  Employee understands and agrees that if Employee does not return the signed Agreement by the close of business on the 22nd day after Employee receives this Agreement, this Agreement will be automatically revoked by the Company and amounts payable hereunder shall be forfeited.  Employee further understands and agrees that if Employee does not return the signed Exhibit A by the close of business on the 10th day after the date on which Employee signs the Agreement, this Agreement will be automatically revoked by the Company and amounts payable hereunder shall be forfeited. 



26. Employee Right to Revoke.  Employee may revoke the Agreement within seven (7) calendar days of Employee's signing of the Agreement.  For this revocation to be effective, written notice must be received by Philip R. Greenberg, Executive Vice President – Legal, Veru Inc., 4400 Biscayne Boulevard, Suite 888, Miami, Florida 33137, no later than the seventh calendar day after Employee signs the Agreement.



27. Company Right to Revoke.  The parties understand and agree that this Agreement will not be effective until the Company's signing of this Agreement, and that the Company has the

7

 


 

right to revoke its offer at any time prior to the Company’s signing of this Agreement, which revocation may be made for any reason including, without limitation, Employee's making of derogatory comments or statements of a negative nature about the Company, its directors, officers, shareholders, employees and agents to anyone, including, but not limited to, current and former Company customers, employees, suppliers, vendors, and referral sources.



28. Counterparts.  This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement.  Signatures to this Agreement transmitted by facsimile, by electronic mail in portable document format (.pdf) form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document will have the same effect as physical delivery of the paper document bearing the original signature.



29. Code Section 409A.  This Agreement is intended to satisfy the requirements for the deferral of compensation under section 409A of the Internal Revenue Code of 1986, as amended (the "Code") or an exemption thereunder.  All terms used in this Agreement shall be interpreted to the maximum extent possible to satisfy Code section 409A.  Notwithstanding anything herein to the contrary, payments provided under this Agreement may be made upon a permissible payment event in a manner that complies with Code section 409A or an applicable exemption.  Any right to a series of installment payments pursuant to this Agreement is to be treated as a right to a series of separate payments.  Any separate payment or benefit under this Agreement or otherwise that may be excluded from Code section 409A as separation pay, a short-term deferral or any other applicable exemption or provision of Code section 409A shall be excluded from Code section 409A to the maximum extent possible.  Notwithstanding anything herein to the contrary, the Company may amend this Agreement without the consent of Employee to add, alter or remove any provision that the Company deems necessary, appropriate or advisable to comply with Code section 409A.  If there is more than one way to add, alter or remove a provision to comply with Code section 409A, the Company shall have the discretion to choose the alternative it believes to be in the best interest of Employee and the Company. 



30. Acknowledgment.  The undersigned parties acknowledge and agree that they have carefully read the foregoing document, that a copy of the document was available to them prior to execution, that they understand its contents including its release of claims, that they have been given the opportunity to ask any questions concerning the Agreement and its contents, and have signed this Agreement as their free and voluntary act.













8

 


 

IN WITNESS WHEREOF, the parties herein executed this Separation Agreement and General Release as of the date appearing next to their signatures.







 

 

 



Veru Inc.

 

 



Date: April 18, 2019

 

By:  /s/ Mitchell S. Steiner                                        

 

Its:  Chief Executive Officer and President



 





CAUTION: THIS IS A RELEASE.  THE COMPANY HEREBY
ADVISES EMPLOYEE TO CONSULT WITH AN ATTORNEY AND READ IT BEFORE SIGNING.  THIS AGREEMENT MAY BE REVOKED
IN WRITING BY EMPLOYEE WITHIN SEVEN (7) CALENDAR DAYS OF EMPLOYEE'S EXECUTION OF THE DOCUMENT.



 

 

 

 



 

Date:  April 18, 2019

 

 

/s/ Charles T. Todd, Jr.       

Charles T. Todd, Jr.



9

 


EX-10.3 3 veru-20190331xex10_3.htm EX-10.3 Exhibit 10.3

Exhibit 10.3



SECOND AMENDMENT TO

CREDIT AGREEMENT & AMENDMENT TO RESIDUAL ROYALTY AGREEMENT



THIS SECOND AMENDMENT TO CREDIT AGREEMENT AND AMENDMENT TO RESIDUAL ROYALTY AGREEMENT (this “Amendment”), dated as of May 13, 2019, is entered into by and among VERU INC., a Wisconsin corporation (Borrower”), each of the undersigned financial institutions (individually each a “Lender” and collectively “Lenders”) and SWK FUNDING LLC, a Delaware limited liability company, in its capacity as administrative agent for the other Lenders (in such capacity, “Agent).

RECITALS

WHEREAS, Borrower, Agent and Lenders entered into that certain Credit Agreement dated as March 5, 2018 (as the same may be amended, modified or restated from time to time, being hereinafter referred to as the “Credit Agreement”);

WHEREAS, Borrower and Agent entered into that certain Residual Royalty Agreement dated as of March 5, 2018, (as the same may be amended, modified or restated from time to time, being hereinafter referred to as the “Royalty Agreement”); and

WHEREAS, Borrower, Agent and Lenders, desire to amend the Credit Agreement and the Royalty Agreement as set forth herein.

AGREEMENT

NOW, THEREFORE, in consideration of the premises herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:

Article I

Definitions

1.1 Capitalized terms used in this Amendment are defined in the Credit Agreement or the Royalty Agreement, as applicable, as each is amended hereby, unless otherwise stated.

Article II

Amendments

2.1 Amendments to Credit Agreement

2.1.1 Amendments to Section 1.1.  Effective as of the date hereof, Section 1.1 of the Credit Agreement is hereby amended as follows:

(a) The definition of “Revenue-Based Cap” is amended and restated to read as follows:


 

Revenue-Based Cap means, as of any date of determination, an amount equal to (i) 1.765 multiplied by (ii) the aggregate amount of the Term Loan actually advanced by Lenders pursuant to Section 2.2 hereof on or prior to such date.”

(b) The definitions of “Subsequent Term Loan A” and “Subsequent Term Loan B” are deleted in their entirety, and any reference to such terms in the Credit Agreement or any other Loan Document shall be deemed to be a reference to the Term Loan as made on the Closing Date.

(c) The definition of “Term Loan” is amended and restated to read as follows:

Term Loan has the meaning set forth in Section 2.1.”

(d) The definition of “Term Loan Commitment” is amended and restated to read as follows:

Term Loan Commitment means $10,000,000.”

2.1.2 Amendment to Section 2.1.  Effective as of the date hereof, Section 2.1 of the Credit Agreement is amended and restated in its entirety to read as follows:

“2.1Term Loan Commitments

On and subject to the terms and conditions of this Agreement, each Lender, severally and for itself alone, agrees to make a multi-draw term loan to Borrower (each such loan, individually and collectively, a “Term Loan”) in an amount equal to such Lender’s applicable Pro Rata Term Loan Share of the Term Loan Commitment.  The Commitments of Lenders to make any portion of the Term Loan shall terminate concurrently with the making of such portion of the Term Loan, such portion terminated to equal the amount of such Term Loan.  The Loan is not a revolving credit facility, and therefore any amount thereof that is repaid or prepaid by Borrower, in whole or in part, may not be re-borrowed.”

2.1.3 Amendment to Section 2.2.  Effective as of the date hereof, Section 2.2 of the Credit Agreement is amended and restated in its entirety to read as follows:

“2.2Loan Procedures

On the Closing Date, Lenders advanced to Borrower an amount equal to Ten Million and No/100 Dollars ($10,000,000).  Pursuant to that certain Second Amendment to Credit Agreement  and Amendment to Residual Royalty Agreement, dated as of May 13, 2019, Agent, Lenders and Borrower agreed to terminate the availability of the “Subsequent Term Loan A” and “Subsequent Term Loan B” (as such terms were defined in this Agreement prior to giving effect to such Amendment).”

2


 

2.1.4 Amendment to Section 2.3.  Effective as of the date hereof, Section 2.3 of the Credit Agreement is amended and restated in its entirety to read as follows:

“2.3Commitments Several.

The failure of any Lender to make the initial Term Loan on the Closing Date shall not relieve any other Lender of its obligation (if any) to make a Loan on the applicable date, but no Lender shall be responsible for the failure of any other Lender to make any Term Loan to be made by such other Lender.”

2.1.5 Amendment to Section 2.9.1(a). Effective as of the date hereof, Section 2.9.1(a)(i) of the Credit Agreement is amended and restated in its entirety to read as follows:

“(i) the aggregate Revenue-Based Payments payable during the period commencing as of January 1 of the calendar year of which such Fiscal Quarter is part, through the end of such Fiscal Quarter (such elapsed portion of the Fiscal Year, the “Elapsed Period”), calculated as,

(A)if the Product Revenue for the twelve (12) month period ended as of the last day of such Fiscal Quarter is less than $10,000,000, then thirty-two and one-half of one percent (32.50%) of Product Revenue during the Elapsed Period; or

(B)if the Product Revenue for the twelve (12) month period ended as of the last day of such Fiscal Quarter is equal to or greater than $10,000,000, then:

(1) as it relates to each Fiscal Quarter in the 2019 calendar year, the sum of:

(aa)Twelve and one-half of one percent (12.50%) of Product Revenue during the Elapsed Period up to and including $12,500,000; plus

(bb)Five percent (5.00%) of Product Revenue during the Elapsed Period greater than $12,500,000; minus;

(2) as it relates to each Fiscal Quarter in the 2020 calendar year, the sum of:

(aa)Twenty-five percent (25.00%) of Product Revenue during the Elapsed Period up to and including $12,500,000; plus

(bb)Ten percent (10.00%) of Product Revenue during the Elapsed Period greater than $12,500,000; minus; or

3


 

(3) as it relates to the Fiscal Quarter ending March 31, 2021 and for each Fiscal Quarter thereafter, the sum of:

(aa)Thirty percent (30.00%) of Product Revenue during the Elapsed Period up to and including $12,500,000; plus

(bb)Twenty percent (20.00%) of Product Revenue during the Elapsed Period greater than $12,500,000; minus

2.1.6 Amendment to Section 5.  Effective as of the date hereof, the introductory sentence in Section 5 of the Credit Agreement is amended and restated to read as follows:

To induce Agent and Lenders to enter into this Agreement and to induce Lenders to make the Loan hereunder, Borrower represents and warrants to Agent and Lenders, as of the Closing Date that:”

2.1.7 Amendment to Annex I.  Effective as of the date hereof, Annex I to the Credit Agreement is amended and restated to read as follows:

ANNEX I

Commitments and Pro Rata Term Loan Shares







 

 

Lender

Commitment

Pro Rata Term Loan Share

SWK Funding LLC

$10,000,000

100%



2.2 Amendments to Royalty Agreement.

2.2.1 Amendment to Section 1.1.  Effective as of the date hereof, the definition of “Residual Royalty Commencement Date” in Section 1.1 of the Royalty Agreement is hereby amended and restated to read as follows:

“‘Residual Royalty Commencement Date” means, the date on which Product Revenue received by the Company would have otherwise resulted in the payment in full of the Deemed Residual Royalty Return Premium (as defined herein) pursuant to the payment mechanics set forth in Section 2.9.1 of the Credit Agreement without taking into account the amendments to such Section 2.9.1 as set forth in that certain Second Amendment to Credit Agreement and Amendment to Residual Royalty Agreement dated as of May 13, 2019.  For the avoidance of doubt, because the Deemed Residual Royalty Return Premium will be calculated without giving effect to the amendments to Section 2.9.1 as set forth in that certain Second Amendment to Credit Agreement and Amendment to Residual Royalty

4


 

Agreement dated as of May 13, 2019, SWK may not have actually received an amount equal to the Deemed Residual Royalty Return Premium on such date pursuant to Section 2.9.1 as of the Residual Royalty Commencement Date.”

2.2.2 Addition to Section 1.1.  Effective as of the date hereof, the following definitions are hereby added to Section 1.1 of the Royalty Agreement:

“‘Deemed Residual Royalty Return Premium’ means, as of any date of determination, an amount equal to the sum (if positive) of: (a) Residual Royalty Revenue-Based Cap, minus (b) all Revenue-Based Payments that would have been paid to Agent, for the benefit of Lenders, on or prior to such date pursuant to the payment mechanics set forth in Section 2.9.1 of the Credit Agreement without taking into account the amendments to such Section 2.9.1 as set forth in that certain Second Amendment to Credit Agreement and Amendment to Residual Royalty Agreement dated as of May 13, 2019, minus (c) the outstanding principal amount of the Loans as of such date.”

“‘Residual Royalty Revenue-Based Cap’ means, as of any date of determination, an amount equal to (i) 1.75 multiplied by (ii) the aggregate amount of the Term Loan actually advanced by Lenders pursuant to Section 2.2 of the Credit Agreement on or prior to such date.”

2.2.3 Amendment to Section 2.1(a). Effective as of the date hereof, Section 2.1(a) of the Royalty Agreement is amended and restated in its entirety to read as follows:

“(a)Commencing as of the Residual Royalty Commencement Date, the Company promises to pay to SWK an amount based on a percentage of the aggregate of (without duplication) the Net Sales, Royalties and any other income or revenue realized by the Company solely related to or arising from the FC2 Product, calculated in accordance with GAAP (collectively, the “Product Revenue”) in each Fiscal Quarter (or, in the case of the initial Fiscal Quarter in which the Residual Royalty Commencement Date occurs, partial Fiscal Quarter) (the “Revenue-Based Payment”).  The Revenue-Based Payment with respect to each Fiscal Quarter shall be payable on the Payment Date next following the end of such Fiscal Quarter.  The Revenue-Based Payment with respect to each Fiscal Quarter shall be calculated as, five percent (5.00%) of Product Revenue during the applicable Fiscal Quarter (or portion thereof during the first Fiscal Quarter).  For purposes of clarity, (i) Product Revenue pertaining to any Fiscal Quarter (or portion thereof with respect to the Fiscal Quarter containing the Residual Royalty Commencement Date) arising prior to the Residual Royalty Commencement Date, and all payments relating thereto, shall be payable in accordance with the terms of the Credit Agreement, (ii) all Product Revenue pertaining to the portion of the Fiscal Quarter containing the Residual Royalty Commencement Date occurring after the Residual Royalty Commencement Date and all Product Revenue pertaining to any Fiscal Quarters thereafter until the date on which the Obligations under the Credit Agreement are Paid in Full (the “Payoff Date”), and all payments

5


 

relating thereto, shall be payable in accordance with the terms of both the Credit Agreement and this Agreement, on a separate basis, and (iii) all Product Revenue pertaining to the portion of the Fiscal Quarter containing the Payoff Date occurring after the Payoff Date and all Product Revenue pertaining to any Fiscal Quarters thereafter, and all payments relating thereto, shall be payable in accordance with the terms of this Agreement.  For further clarity, (i) each dollar of Product Revenue pertaining to the period between the Residual Royalty Commencement Date and the Payoff Date, will be subject to both the obligation to pay a percentage thereof to the Agent under the Credit Agreement and the obligation to pay a percentage thereof to SWK as a Revenue-Based Payment hereunder, and (ii) in no event will any amounts paid under the Credit Agreement satisfy any portion of the Company’s obligations under this Agreement nor shall any amounts paid under this Agreement satisfy any portion of the Company’s obligations under the Credit Agreement.”

Article III

Conditions Precedent

3.1 Conditions Precedent.  The effectiveness of this Amendment is subject to the satisfaction of the following conditions precedent in a manner satisfactory to Agent, unless specifically waived in writing by Agent in its sole discretion:

(A) Agent shall have received this Amendment duly executed by Borrower.

(B) The representations and warranties contained herein and in the Credit Agreement and the other Loan Documents, as each is amended hereby, shall be true and correct as of the date hereof, as if made on the date hereof, except for such representations and warranties as are by their express terms limited to a specific date.

(C) No Default or Event of Default under the Credit Agreement, as amended hereby, shall have occurred and be continuing, unless such Default or Event of Default has been otherwise specifically waived in writing by Agent.

(D) All corporate proceedings taken in connection with the transactions contemplated by this Amendment and all documents, instruments and other legal matters incident thereto shall be satisfactory to Agent; and Borrower shall provide to Agent an officer’s certificate with resolutions in form and substance acceptable to Agent.

Article IV

No Waiver, Ratifications, Representations and Warranties

4.1 No Waiver.  Nothing contained in this Amendment or any other communication between Agent, any Lender, Borrower or any other Loan Party shall be a waiver of any past, present or future violation, Default or Event of Default of Borrower under the Credit Agreement or any Loan Document.  Agent and each Lender hereby expressly reserves any rights, privileges and remedies under the Credit Agreement and each Loan Document that Lender may have with respect to any violation, Default or Event of Default, and any failure by Agent or any Lender to

6


 

exercise any right, privilege or remedy as a result of the violations set forth above shall not directly or indirectly in any way whatsoever either (i) impair, prejudice or otherwise adversely affect the rights of Agent or any Lender, except as set forth herein, at any time to exercise any right, privilege or remedy in connection with the Credit Agreement or any Loan Document, (ii) amend or alter any provision of the Credit Agreement or any Loan Document or any other contract or instrument or (iii) constitute any course of dealing or other basis for altering any obligation of Borrower or any other Loan Party or any rights, privilege or remedy of Agent or any Lender under the Credit Agreement or any Loan Document or any other contract or instrument.  Nothing in this Amendment shall be construed to be a consent by Agent or any Lender to any prior, existing or future violations of the Credit Agreement or any Loan Document.

4.2 Ratifications.  The terms and provisions set forth in this Amendment shall modify and supersede all inconsistent terms and provisions set forth in the Credit Agreement and the other Loan Documents, and, except as expressly modified and superseded by this Amendment, the terms and provisions of the Credit Agreement and the other Loan Documents are ratified and confirmed and shall continue in full force and effect.  Borrower, the other Loan Parties, Lenders and Agent agree that the Credit Agreement and the other Loan Documents, as amended hereby, shall continue to be legal, valid, binding and enforceable in accordance with their respective terms.  Borrower and the other Loan Parties agrees that this Amendment is not intended to and shall not cause a novation with respect to any or all of the Obligations.

4.3 Representations and Warranties.  Borrower hereby represents and warrants to Agent and Lenders that (a) the execution, delivery and performance of this Amendment, any and all other Loan Documents executed and/or delivered in connection herewith have been authorized by all requisite action (as applicable) on the part of Borrower and will not violate the organizational documents of Borrower or such Loan Parties; (b) Borrower’s directors have authorized the execution, delivery and performance of this Amendment any and all other Loan Documents executed and/or delivered in connection herewith; (c) the representations and warranties contained in the Credit Agreement, as amended hereby, and any other Loan Document are true and correct on and as of the date hereof and on and as of the date of execution hereof as though made on and as of each such date (except to the extent such representations and warranties expressly relate to an earlier date); (d) no Default or Event of Default under the Credit Agreement, as amended hereby, has occurred and is continuing; (e) Loan Parties are in full compliance in all material respects with all covenants and agreements contained in the Credit Agreement and the other Loan Documents, as amended hereby; and (f) except as disclosed to Agent, Borrower has not amended its organizational documents since the date of the Credit Agreement.

Article V

Miscellaneous Provisions

5.1 Survival of Representations and Warranties.   All representations and warranties made in the Credit Agreement or any other Loan Document, including, without limitation, any document furnished in connection with this Amendment, shall survive the execution and delivery of this Amendment and the other Loan Documents, and no investigation by Agent or any Lender or any closing shall affect the representations and warranties or the right of Agent and each Lender to rely upon them.

7


 

5.2 Reference to Credit Agreement.  Each of the Credit Agreement and the other Loan Documents, and any and all other Loan Documents, documents or instruments now or hereafter executed and delivered pursuant to the terms hereof or pursuant to the terms of the Credit Agreement, as amended hereby, are hereby amended so that any reference in the Credit Agreement and such other Loan Documents to the Credit Agreement shall mean a reference to the Credit Agreement, as amended hereby.

5.3 Expenses of Agent.  As provided in the Credit Agreement, Borrower agrees to pay on demand all costs and expenses incurred by Agent, or its Affiliates, in connection with the preparation, negotiation, and execution of this Amendment and the other Loan Documents executed pursuant hereto and any and all amendments, modifications, and supplements thereto, including, without limitation, the reasonable costs and fees of legal counsel, and all costs and expenses incurred by Agent and each Lender in connection with the enforcement or preservation of any rights under the Credit Agreement, as amended hereby, or any other Loan Documents, including, without, limitation, the reasonable costs and fees of legal counsel.    

5.4 Severability.  Any provision of this Amendment held by a court of competent jurisdiction to be invalid or unenforceable shall not impair or invalidate the remainder of this Amendment and the effect thereof shall be confined to the provision so held to be invalid or unenforceable.

5.5 Successors and Assigns.  This Amendment is binding upon and shall inure to the benefit of Agent and each Lender and Borrower and their respective successors and assigns, except that no Loan Party may assign or transfer any of its rights or obligations hereunder without the prior written consent of Agent.

5.6 Counterparts.  This Amendment may be executed in one or more counterparts, each of which when so executed shall be deemed to be an original, but all of which when taken together shall constitute one and the same instrument.  This Amendment may be executed by facsimile or electronic (.pdf) transmission, which facsimile or electronic (.pdf) signatures shall be considered original executed counterparts for purposes of this Section 5.6, and each party to this Amendment agrees that it will be bound by its own facsimile or electronic (.pdf) signature and that it accepts the facsimile or electronic (.pdf) signature of each other party to this Amendment.

5.7 Effect of Waiver.  No consent or waiver, express or implied, by Agent to or for any breach of or deviation from any covenant or condition by Borrower shall be deemed a consent to or waiver of any other breach of the same or any other covenant, condition or duty.

5.8 Headings.  The headings, captions, and arrangements used in this Amendment are for convenience only and shall not affect the interpretation of this Amendment.

5.9 Applicable Law.  THE TERMS AND PROVISIONS OF SECTIONS 10.17 (GOVERNING LAW) AND 10.18 (FORUM SELECTION; CONSENT TO JURISDICTION) OF THE CREDIT AGREEMENT ARE HEREBY INCORPORATED HEREIN BY REFERENCE, AND SHALL APPLY TO THIS AMENDMENT MUTATIS MUTANDIS AS IF FULLY SET FORTH HEREIN. 

8


 

5.10 Final Agreement.  THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS, EACH AS AMENDED HEREBY, REPRESENT THE ENTIRE EXPRESSION OF THE PARTIES WITH RESPECT TO THE SUBJECT MATTER HEREOF ON THE DATE THIS AMENDMENT IS EXECUTED.  THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS AMENDED HEREBY, MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES.  THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.  NO MODIFICATION, RESCISSION, WAIVER, RELEASE OR AMENDMENT OF ANY PROVISION OF THIS AMENDMENT SHALL BE MADE, EXCEPT BY A WRITTEN AGREEMENT SIGNED BY Borrower AND AGENT.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  Part 1.

 

9


 

Exhibit 10.3

 

IN WITNESS WHEREOF, this Amendment has been executed and is effective as of the date first written above.

BORROWER:





 

___________________________________________

 

VERU INC.,

a Wisconsin corporation

 

 

By:

Name:

Title:___________________________________________
















EX-31.1 4 veru-20190331xex31_1.htm EX-31.1 Exhibit 31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002





I, Mitchell S. Steiner, certify that:



1.I have reviewed this quarterly report on Form 10-Q of Veru Inc.;



2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:



(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;



(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):



(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date:  May 15, 2019





/s/Mitchell S. Steiner

Mitchell S. Steiner

Chairman, Chief Executive Officer and President




EX-31.2 5 veru-20190331xex31_2.htm EX-31.2 Exhibit 31.2

Exhibit 31.2



CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Michele Greco, certify that:



1.I have reviewed this quarterly report on Form 10-Q of Veru Inc.;



2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:



(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;



(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):



(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date:  May 15, 2019



/s/Michele Greco

Michele Greco

Chief Financial Officer and Chief Administrative Officer








EX-32.1 6 veru-20190331xex32_1.htm EX-32.1 Exhibit 32.1

Exhibit 32.1



Certification of Periodic Financial Report

Pursuant to 18 U.S.C. Section 1350





Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Veru Inc. (the "Company") certifies that the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.







 

Date:  May  15, 2019

/s/Mitchell S. Steiner



Mitchell S. Steiner



Chairman, Chief Executive Officer and President



 



 

Date:  May 15, 2019

/s/Michele Greco



Michele Greco



Chief Financial Officer and



Chief Administrative Officer





This certification is made solely for purpose of 18 U.S.C. Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.






EX-101.INS 7 veru-20190331.xml EX-101.INS 0000863894 veru:ConsultingServicesWarrantsMember 2018-05-01 2018-05-31 0000863894 country:BR 2018-10-01 2019-03-31 0000863894 srt:MaximumMember veru:SwkCreditAgreementMember veru:Scenario2Member 2018-03-05 2018-03-05 0000863894 veru:SwkCreditAgreementMember veru:Scenario3Member 2018-03-05 2018-03-05 0000863894 veru:SwkCreditAgreementMember veru:Scenario2Member 2018-03-05 2018-03-05 0000863894 veru:SwkCreditAgreementMember veru:OnOrAfterToSeptember52018Member 2018-03-05 2018-03-05 0000863894 country:ZA veru:SwkCreditAgreementMember 2018-03-05 2018-03-05 0000863894 country:BR veru:SwkCreditAgreementMember 2018-03-05 2018-03-05 0000863894 veru:SwkCreditAgreementMember 2018-03-05 2018-03-05 0000863894 srt:MinimumMember veru:MeasurementInputProbabilityOfChangeOfControlMember 2018-10-01 2019-03-31 0000863894 srt:MaximumMember veru:MeasurementInputProbabilityOfChangeOfControlMember 2018-10-01 2019-03-31 0000863894 country:ZA 2018-10-01 2019-03-31 0000863894 veru:ResidualRoyaltyAgreementMember 2018-03-05 2018-03-05 0000863894 veru:ConsultingServicesWarrantsMember 2019-03-31 0000863894 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000863894 us-gaap:PreferredStockMember 2019-01-01 2019-03-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2018-10-01 2018-12-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2017-10-01 2017-12-31 0000863894 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000863894 us-gaap:CommonStockMember 2018-10-01 2018-12-31 0000863894 us-gaap:CommonStockMember 2018-10-01 2018-10-01 0000863894 us-gaap:CommonStockMember 2017-10-01 2017-12-31 0000863894 veru:AspireCapitalMember 2018-10-01 2019-03-31 0000863894 us-gaap:TreasuryStockMember 2019-03-31 0000863894 us-gaap:RetainedEarningsMember 2019-03-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000863894 us-gaap:TreasuryStockMember 2018-12-31 0000863894 us-gaap:RetainedEarningsMember 2018-12-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000863894 2018-12-31 0000863894 us-gaap:TreasuryStockMember 2018-09-30 0000863894 us-gaap:RetainedEarningsMember 2018-09-30 0000863894 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000863894 us-gaap:TreasuryStockMember 2018-03-31 0000863894 us-gaap:RetainedEarningsMember 2018-03-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000863894 us-gaap:TreasuryStockMember 2017-12-31 0000863894 us-gaap:RetainedEarningsMember 2017-12-31 0000863894 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000863894 2017-12-31 0000863894 us-gaap:TreasuryStockMember 2017-09-30 0000863894 us-gaap:RetainedEarningsMember 2017-09-30 0000863894 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0000863894 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0000863894 us-gaap:CommonStockMember 2019-03-31 0000863894 us-gaap:CommonStockMember 2018-12-31 0000863894 us-gaap:CommonStockMember 2018-09-30 0000863894 us-gaap:CommonStockMember 2018-03-31 0000863894 us-gaap:CommonStockMember 2017-12-31 0000863894 us-gaap:CommonStockMember 2017-09-30 0000863894 us-gaap:CommonStockMember 2018-10-01 0000863894 us-gaap:StockAppreciationRightsSARSMember 2019-03-31 0000863894 us-gaap:StockAppreciationRightsSARSMember veru:AppMergerMember veru:EmployeeMember 2018-10-01 2019-03-31 0000863894 us-gaap:StockAppreciationRightsSARSMember veru:AppMergerMember us-gaap:DirectorMember 2018-10-01 2019-03-31 0000863894 us-gaap:RestrictedStockUnitsRSUMember veru:AppMergerMember veru:EmployeeMember 2018-10-01 2019-03-31 0000863894 us-gaap:RestrictedStockUnitsRSUMember veru:AppMergerMember us-gaap:DirectorMember 2018-10-01 2019-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2018-09-30 0000863894 veru:TwoThousandAndSeventeenEquityIncentivePlanMember 2019-03-31 0000863894 veru:TwentyEighteenEquityIncentivePlanMember 2019-03-31 0000863894 veru:TwentyEighteenEquityIncentivePlanMember 2018-03-31 0000863894 veru:TwoThousandAndSeventeenEquityIncentivePlanMember 2017-07-31 0000863894 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2017-10-01 2018-03-31 0000863894 veru:CommonStockPurchaseWarrantsMember 2018-10-01 2019-03-31 0000863894 us-gaap:StockAppreciationRightsSARSMember 2018-10-01 2019-03-31 0000863894 us-gaap:StockAppreciationRightsSARSMember veru:AppMergerMember 2018-10-01 2019-03-31 0000863894 us-gaap:RestrictedStockUnitsRSUMember veru:AppMergerMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:OtherCountriesMember 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZW 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZA 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:US 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:BR 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:AE 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:OtherCountriesMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZW 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZA 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:US 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:BR 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember country:AE 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:OtherCountriesMember 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZW 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZA 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:US 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:AE 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:OtherCountriesMember 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZW 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:ZA 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:US 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember country:AE 2017-10-01 2018-03-31 0000863894 veru:PerformanceBondMember 2019-03-31 0000863894 veru:SwkCreditAgreementMember 2019-02-15 2019-02-15 0000863894 veru:SwkCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2018-11-15 2018-11-15 0000863894 veru:SwkCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2018-11-15 2018-11-15 0000863894 veru:SwkCreditAgreementMember 2018-11-15 2018-11-15 0000863894 veru:SwkCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2018-05-15 2018-05-15 0000863894 veru:SwkCreditAgreementMember 2017-10-01 2018-09-30 0000863894 srt:MinimumMember us-gaap:OfficeEquipmentMember 2018-10-01 2019-03-31 0000863894 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2018-10-01 2019-03-31 0000863894 srt:MinimumMember us-gaap:EquipmentMember 2018-10-01 2019-03-31 0000863894 srt:MaximumMember us-gaap:OfficeEquipmentMember 2018-10-01 2019-03-31 0000863894 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2018-10-01 2019-03-31 0000863894 srt:MaximumMember us-gaap:EquipmentMember 2018-10-01 2019-03-31 0000863894 veru:EquipmentFurnitureAndFixturesMember 2019-03-31 0000863894 us-gaap:LeaseholdImprovementsMember 2019-03-31 0000863894 veru:EquipmentFurnitureAndFixturesMember 2018-09-30 0000863894 us-gaap:LeaseholdImprovementsMember 2018-09-30 0000863894 veru:SeminaMember 2018-07-01 2018-07-31 0000863894 veru:SeminaMember 2017-12-27 2017-12-27 0000863894 veru:PreferredClassSeries4Member 2019-03-31 0000863894 veru:PreferredClassSeries4Member 2018-09-30 0000863894 veru:PreferredClassASeries3Member 2019-03-31 0000863894 veru:PreferredClassASeries2Member 2019-03-31 0000863894 veru:PreferredClassASeries1Member 2019-03-31 0000863894 2019-03-27 0000863894 veru:PreferredClassASeries3Member 2018-09-30 0000863894 veru:PreferredClassASeries2Member 2018-09-30 0000863894 veru:PreferredClassASeries1Member 2018-09-30 0000863894 us-gaap:PreferredClassBMember 2019-03-31 0000863894 us-gaap:PreferredClassAMember 2019-03-31 0000863894 us-gaap:PreferredClassBMember 2018-09-30 0000863894 us-gaap:PreferredClassAMember 2018-09-30 0000863894 2017-10-01 2018-09-30 0000863894 veru:AspireCapitalMember 2018-09-30 0000863894 us-gaap:StateAndLocalJurisdictionMember veru:TwentyTwentyTwoToTwentyThirtySevenMember 2018-09-30 0000863894 us-gaap:StateAndLocalJurisdictionMember veru:IndefiniteMember 2018-09-30 0000863894 us-gaap:DomesticCountryMember veru:TwentyTwentyTwoToTwentyThirtySevenMember 2018-09-30 0000863894 us-gaap:DomesticCountryMember veru:IndefiniteMember 2018-09-30 0000863894 veru:AlternativeMinimumTaxMember 2018-09-30 0000863894 us-gaap:StateAndLocalJurisdictionMember 2018-09-30 0000863894 us-gaap:ForeignCountryMember 2018-09-30 0000863894 us-gaap:DomesticCountryMember 2018-09-30 0000863894 us-gaap:OperatingSegmentsMember veru:CommercialMember 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:CommercialMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember 2018-10-01 2019-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:CommercialMember 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember 2018-01-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember veru:CommercialMember 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2017-10-01 2018-03-31 0000863894 us-gaap:OperatingSegmentsMember 2017-10-01 2018-03-31 0000863894 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000863894 us-gaap:RetainedEarningsMember 2018-10-01 2018-12-31 0000863894 2018-10-01 2018-12-31 0000863894 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000863894 us-gaap:RetainedEarningsMember 2017-10-01 2017-12-31 0000863894 2017-10-01 2017-12-31 0000863894 country:ZA veru:SwkCreditAgreementMember 2018-03-05 0000863894 country:BR veru:SwkCreditAgreementMember 2018-03-05 0000863894 veru:SwkCreditAgreementMember 2018-03-05 0000863894 veru:PreboostMember 2019-03-31 0000863894 veru:Fc2Member 2019-03-31 0000863894 veru:PreboostMember 2018-09-30 0000863894 veru:Fc2Member 2018-09-30 0000863894 us-gaap:OtherIntangibleAssetsMember 2019-03-31 0000863894 us-gaap:OtherIntangibleAssetsMember 2018-09-30 0000863894 veru:SeminaMember 2018-04-01 2018-06-30 0000863894 veru:SeminaMember 2017-10-01 2018-03-31 0000863894 veru:CovenantsNotToCompeteMember 2018-10-01 2019-03-31 0000863894 us-gaap:LicensingAgreementsMember 2018-10-01 2019-03-31 0000863894 veru:CovenantsNotToCompeteMember 2019-03-31 0000863894 us-gaap:LicensingAgreementsMember 2019-03-31 0000863894 veru:CovenantsNotToCompeteMember 2018-09-30 0000863894 us-gaap:LicensingAgreementsMember 2018-09-30 0000863894 srt:MinimumMember 2018-10-01 2019-03-31 0000863894 srt:MaximumMember 2018-10-01 2019-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2019-03-31 0000863894 us-gaap:EmployeeStockOptionMember 2018-10-01 2019-03-31 0000863894 2016-10-01 2017-09-30 0000863894 srt:MinimumMember us-gaap:MeasurementInputDiscountRateMember 2019-03-31 0000863894 srt:MaximumMember us-gaap:MeasurementInputDiscountRateMember 2019-03-31 0000863894 country:US 2019-03-31 0000863894 country:US 2018-09-30 0000863894 country:GB 2019-03-31 0000863894 country:GB 2018-09-30 0000863894 country:MY 2019-03-31 0000863894 country:MY 2018-09-30 0000863894 veru:SwkCreditAgreementMember us-gaap:SubsequentEventMember 2019-05-13 2019-05-13 0000863894 veru:SwkCreditAgreementMember 2018-10-01 2019-03-31 0000863894 veru:ResidualRoyaltyAgreementMember 2019-03-31 0000863894 veru:ResidualRoyaltyAgreementMember 2018-09-30 0000863894 veru:SwkCreditAgreementMember 2019-03-31 0000863894 veru:SwkCreditAgreementMember 2018-09-30 0000863894 us-gaap:SalesRevenueNetMember 2019-01-01 2019-03-31 0000863894 veru:TotalAccountsReceivableMember 2018-10-01 2019-03-31 0000863894 veru:AssetsCurrentMember 2018-10-01 2019-03-31 0000863894 us-gaap:SalesRevenueNetMember 2018-10-01 2019-03-31 0000863894 us-gaap:SalesRevenueNetMember 2018-01-01 2018-03-31 0000863894 veru:TotalAccountsReceivableMember 2017-10-01 2018-09-30 0000863894 veru:AssetsCurrentMember 2017-10-01 2018-09-30 0000863894 us-gaap:SalesRevenueNetMember 2017-10-01 2018-03-31 0000863894 veru:AspireCapitalMember 2017-12-29 0000863894 veru:AspireCapitalMember 2019-03-31 0000863894 veru:CommonStockPurchaseWarrantsMember 2019-03-31 0000863894 veru:ConsultingServicesWarrantsMember 2018-05-31 0000863894 veru:OutsideUnitedStatesMember 2019-03-31 0000863894 veru:OutsideUnitedStatesMember 2018-09-30 0000863894 2018-03-31 0000863894 2017-09-30 0000863894 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000863894 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-03-31 0000863894 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000863894 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-10-01 2019-03-31 0000863894 us-gaap:ResearchAndDevelopmentExpenseMember 2018-10-01 2019-03-31 0000863894 us-gaap:CostOfSalesMember 2018-10-01 2019-03-31 0000863894 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-03-31 0000863894 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0000863894 us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0000863894 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-10-01 2018-03-31 0000863894 us-gaap:ResearchAndDevelopmentExpenseMember 2017-10-01 2018-03-31 0000863894 us-gaap:CostOfSalesMember 2017-10-01 2018-03-31 0000863894 veru:AspireCapitalMember 2017-10-01 2018-09-30 0000863894 2019-01-01 2019-03-31 0000863894 veru:ResidualRoyaltyAgreementMember 2018-10-01 2019-03-31 0000863894 2018-01-01 2018-03-31 0000863894 veru:ResidualRoyaltyAgreementMember 2017-10-01 2018-09-30 0000863894 2017-10-01 2018-03-31 0000863894 veru:SeminaMember 2018-02-28 0000863894 veru:SeminaMember 2017-12-27 0000863894 2019-03-31 0000863894 2018-09-30 0000863894 2019-05-10 0000863894 2018-10-01 2019-03-31 veru:customer veru:lawsuit veru:item xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --09-30 Q2 2019 2019-03-31 10-Q 0000863894 62790208 false Non-accelerated Filer VERU INC. true veru 3226036 2525162 4046733 4076745 7500000 3972632 4027235 1500000 3972632 4027235 27278 201225 27278 216297 417522 123946 3901418 3985217 -581519 -581519 95496506 105666943 85000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Advertising</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company's policy is to expense advertising costs as incurred. Advertising costs were immaterial to the Company&#x2019;s results of operations for the three and six months ended March 31, 2019 and 2018.</font> </p> <p><font size="1"> </font></p> </div> </div> 619302 5061 76897 537344 411848 1797 48045 362006 913465 15730 163300 734435 496209 7778 81005 407426 38103 36161 36201 36201 5570 5570 54570 26704 317747 317747 2265828 1107622 137631 69000 154617 77000 48452639 5200000 51012054 5000000 11182516 14142880 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 1 &#x2013; Basis of Presentation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (&#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company&#x201D;) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (&#x201C;U.S. GAAP&#x201D;) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;">. The accompanying condensed consolidated balance sheet as of </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;"> has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and six months ended March 31, 2019 and cash flows for the </font><font style="display: inline;">six months ended March 31, 2019</font><font style="display: inline;"> are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending </font><font style="display: inline;">September 30, 201</font><font style="display: inline;">9</font><font style="display: inline;">. &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Principles of consolidation and nature of operations</font><font style="display: inline;">: Veru Inc. is </font><font style="display: inline;color:#000000;">referred to in these notes collectively with its subsidiaries as &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company.&#x201D; </font><font style="display: inline;">The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (&#x201C;APP&#x201D;) and The Female Health Company Limited, and The Female Health Company Limited&#x2019;s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the &#x201C;U.K. subsidiary&#x201D;), and The Female Health Company (UK) plc&#x2019;s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the &#x201C;Malaysia subsidiary&#x201D;). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the &#x201C;APP Acquisition&#x201D;) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer health care product, the FC2 </font><font style="display: inline;">Female Condom/FC2 Internal Condom&#xAE; (&#x201C;FC2&#x201D;)</font><font style="display: inline;">.&nbsp;&nbsp;The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company </font><font style="display: inline;">focused on oncology and urology</font><font style="display: inline;"> with multiple drug products under clinical development.&nbsp;&nbsp;Most of the Company&#x2019;s net revenues during the three and six months ended March 31, 2019 and 2018 were derived from sales of FC2.&nbsp; </font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Reclassifications</font><font style="display: inline;">: &nbsp;</font><font style="display: inline;">Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. </font><font style="display: inline;">These reclassifications had no effect on </font><font style="display: inline;color:#000000;">the results of operations or financial position for any period presented.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Cash concentration</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company&#x2019;s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia.</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Restricted cash</font><font style="display: inline;">: Restricted cash relates to security provided to one of the Company&#x2019;s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of </font><font style="display: inline;">$250,000</font><font style="display: inline;"> for such performance bonds.&nbsp;&nbsp;Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life.&nbsp;&nbsp;The Company had </font><font style="display: inline;">no</font><font style="display: inline;"> restricted cash at March 31, 2019. Restricted cash was approximately </font><font style="display: inline;">$135,000</font><font style="display: inline;"> at September 30, 2018 and is included in cash on the accompanying unaudited condensed consolidated balance sheets</font><font style="display: inline;color:#FF0000;">. &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#FF0000;text-decoration:underline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Patents and trademarks</font><font style="display: inline;">: The costs for patents and trademarks are expensed when incurred.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Deferred financing costs</font><font style="display: inline;">:</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font><font style="display: inline;">Costs incurred in connection with the </font><font style="display: inline;">common stock purchase agreement discussed in Note 8 </font><font style="display: inline;">have been included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. When shares of the Company&#x2019;s common stock are sold under the common stock purchase agreement, a pro-rata portion of the deferred costs is recorded to additional paid-in-capital. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As discussed in Note 8, in connection with the </font><font style="display: inline;">common stock offering that closed on October 1, 2018, we incurred c</font><font style="display: inline;">osts </font><font style="display: inline;">of approximately </font><font style="display: inline;">$190,000</font><font style="display: inline;"> through September 30, 2018. This amount was included in </font><font style="display: inline;">other assets on the accompanying unaudited condensed consolidated balance sheet at September 30, 2018. These costs were charged to additional paid-in capital in the six months ended March 31, 2019 after the common stock offering was closed.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Costs incurred in connection with the </font><font style="display: inline;">issuance of debt discussed in Note 7 are presented as a reduction of the debt on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. These issuance costs are being amortized using the effective interest method over the expected repayment period of the debt, which is currently estimated to occur in the third quarter of fiscal 2021. The amortization is included in interest expense on the accompanying unaudited condensed consolidated statements of operations.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Fair value measurements</font><font style="display: inline;">: Financial Accounting Standards Board (&#x201C;FASB&#x201D;) Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 820 &#x2013;</font><font style="display: inline;font-style:italic;"> Fair Value Measurements and Disclosures,</font><font style="display: inline;"> defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to us as of the reporting dates. Accordingly, the estimates presented in the accompanying unaudited condensed consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. See Note 3 </font><font style="display: inline;">for a discussion of fair value measurements</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash, accounts receivable, accounts payable and other accrued liabilities approximate their fair value based on the short-term nature of these instruments. The carrying value of long-term debt, taking into consideration debt discounts and related derivative instruments, is estimated to approximate fair value.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Unearned revenue</font><font style="display: inline;">: The Company records an unearned revenue liability if a customer pays consideration before the Company transfers the product to the customer under the terms of a contract. Unearned revenue is recognized as revenue after control of the product is transferred to the customer and all revenue recognition criteria have been met.&nbsp;&nbsp;The Company had no unearned revenue at March 31, 2019. Unearned revenue at September&nbsp;30, 2018 was approximately </font><font style="display: inline;">$187,000</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;">and was comprised of sales made to a large distributor who has the right to return product under certain conditions. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Derivative instruments</font><font style="display: inline;">: The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company reviews the terms of debt instruments it enters into to determine whether there are embedded derivative instruments, which are required to be bifurcated and accounted for separately as derivative financial instruments. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. Liabilities incurred in connection with an embedded derivative are discussed in Note 7.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Revenue recognition</font><font style="display: inline;">: Revenue is recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company generates nearly all of its revenue from direct product sales. Revenue from direct product sales is generally recognized when the customer obtains control of the product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have significant unusual payment terms beyond </font><font style="display: inline;">120</font><font style="display: inline;"> days in its contracts with customers. See Note 4 for additional information regarding credit terms.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The amount of consideration the Company ultimately receives varies depending upon sales discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an </font><font style="display: inline;color:#000000;">assessment of current contract sales terms and historical payment experience.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Research and development costs</font><font style="display: inline;">: Research and development costs are expensed as they are incurred and include salaries and benefits, clinical trial costs and contract services. Nonrefundable advance payments made for goods or services to be used in research and development activities are deferred and capitalized until the goods have been delivered or the related services have been performed. If the goods are no longer expected to be delivered or the services are no longer expected to be performed, the Company would be required to expense the related capitalized advance payments. The Company did not have any capitalized nonrefundable advance payments as of March 31, 2019 and September 30, 2018.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Company records estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials and contract manufacturing activities. These costs are a significant component of the Company&#x2019;s research and development expenses. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed, number of patients enrolled and the rate of patient enrollments may vary from the Company&#x2019;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#x2019;s accruals could materially affect the Company&#x2019;s results of operations. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Share-based compensation</font><font style="display: inline;">: The Company recognizes share-based compensation expense in connection with its share-based awards based on the estimated fair value of the awards on the date of grant, on a straight-line basis over the vesting period. Calculating share-based compensation expense requires the input of highly subjective judgment and assumptions, including estimates of the expected life of the share-based award, stock price volatility and risk-free interest rates.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Advertising</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company's policy is to expense advertising costs as incurred. Advertising costs were immaterial to the Company&#x2019;s results of operations for the three and six months ended March 31, 2019 and 2018.</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Income taxes</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company files separate income tax returns for its foreign subsidiaries. FASB ASC Topic&nbsp;740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Foreign currency translation and operations</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: Effective October&nbsp;1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries&#x2019; functional currency.&nbsp;&nbsp;The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries.&nbsp;&nbsp;Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company&#x2019;s first-generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October&nbsp;1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent&#x2019;s operations, it, too, adopted the U.S. dollar as its functional currency as of October&nbsp;1, 2009. The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$0.6</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million as of March 31, 2019 and September 30, 2018. Assets located outside of the U.S. totaled approximately </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$5.0</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million and </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$5.2</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million at March 31, 2019 and September 30, 2018, respectively.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp; &nbsp;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Other comprehensive loss</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss.&nbsp;&nbsp;Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company&#x2019;s policy and intent is to settle the intercompany trade account on a current basis.&nbsp;&nbsp;Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October&nbsp;1, 2009, no foreign currency gains or losses from intercompany trade are recognized.&nbsp;&nbsp;For the three and six months ended March 31, 2019 and 2018, comprehensive loss is equivalent to the reported net loss. </font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Recently Issued Accounting Pronouncements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In May 2014, the FASB issued Accounting Standards Update (&#x201C;ASU&#x201D;) 2014-09, </font><font style="display: inline;font-style:italic;color:#000000;">Revenue from Contracts with Customers (Topic 606)</font><font style="display: inline;color:#000000;">.&nbsp;&nbsp;This new accounting guidance on revenue recognition provides for a single five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation. The new guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts.&nbsp;&nbsp;The Company adopted the new guidance on October 1, 2018 using the modified retrospective method and elected to apply the guidance only to contracts that were not completed as of the date of adoption. The adoption of this guidance did not have a material effect on our consolidated financial statements and related disclosures. See discussion above for disclosures relating to the Company's revenue recognition.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In February 2016, the FASB issued ASU 2016-02, </font><font style="display: inline;font-style:italic;">Leases (Topic 842)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;color:#000000;">which requires that lessees recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of</font><font style="display: inline;"> key information about leasing arrangements.&nbsp;&nbsp;ASU 2016-02 </font><font style="display: inline;color:#000000;">is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required upon adoption.</font><font style="display: inline;"> &nbsp;Early adoption is permitted. I</font><font style="display: inline;color:#000000;">n July 2018, the FASB issued ASU No. 2018-10, </font><font style="display: inline;font-style:italic;color:#000000;">Codification Improvements to Topic 842, Leases</font><font style="display: inline;color:#000000;"> to clarify the implementation guidance and ASU No. 2018-11, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842) Targeted Improvements</font><font style="display: inline;color:#000000;">. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n December 2018, the FASB issued ASU 2018-20, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Narrow-Scope Improvements for Lessors</font><font style="display: inline;color:#000000;"> to address certain implementation issues facing lessors when adopting ASU 2016-02. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n March 2019, the FASB issued ASU 2019-01, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Codification Improvements</font><font style="display: inline;color:#000000;"> to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016-02. The Company will adopt the new accounting standard </font><font style="display: inline;">on October&nbsp;1, 2019 and intends to elect certain </font><font style="display: inline;color:#000000;">practical expedients,&nbsp;including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;color:#000000;">We have begun to identify our significant lease contracts and are in the process of </font><font style="display: inline;">evaluating the effect of the new guidance on our consolidated financial statements and related disclosures. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In November 2016, the FASB issued ASU 2016-18,&nbsp;</font><font style="display: inline;font-style:italic;">Statement of Cash Flows</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-style:italic;">(Topic 230):</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-style:italic;">Restricted Cash</font><font style="display: inline;">.&nbsp;The purpose of ASU 2016-18 is to clarify guidance and presentation related to restricted cash in the statements of cash flows as well as increased disclosure requirements. It requires beginning-of-period and end-of-period total amounts shown on the statements of cash flows to include cash and cash equivalents as well as restricted cash and restricted cash equivalents. We adopted ASU 2016-18 effective October 1, 2018. The adoption of ASU 2016-18 did not have a material effect on the presentation of our consolidated statements of cash flows or related disclosures.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In January 2017, the FASB issued ASU 2017-04,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Intangibles - Goodwill and Other Topics&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 350)</font><font style="display: inline;font-style:italic;color:#000000;">: Simplifying the Test for Goodwill Impairment</font><font style="display: inline;color:#000000;">. The purpose of ASU 2017-04 is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the impaired fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January&nbsp;1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position or results of operations.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In May 2017, the FASB issued ASU 2017-09,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Compensation - Stock Compensation&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 718)</font><font style="display: inline;font-style:italic;color:#000000;">: Scope of Modification Accounting</font><font style="display: inline;color:#000000;">. The purpose of ASU 2017-09 is to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. </font><font style="display: inline;color:#000000;">The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. We adopted </font><font style="display: inline;color:#000000;">ASU 2017-09 effective October&nbsp;1, 2018. The adoption of ASU 2017-09 did not have a material effect on our financial position or results of operations.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In June 2018, the FASB issued ASU 2018-07,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Compensation - Stock Compensation&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 718)</font><font style="display: inline;font-style:italic;color:#000000;">: Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display: inline;color:#000000;">. The purpose of ASU 2018-07 is to expand the scope of </font><font style="display: inline;font-style:italic;color:#000000;">Topic 718, Compensation&#x2014;Stock Compensation</font><font style="display: inline;color:#000000;"> (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 will be effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than the Company&#x2019;s adoption date of </font><font style="display: inline;font-style:italic;color:#000000;">Topic 606, Revenue from Contracts with Customers</font><font style="display: inline;color:#000000;">. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. The adoption of ASU 2018-07 is not expected to have a material effect on our financial position or results of operations but should simplify the process by which the Company measures compensation expense for share-based payments to nonemployees.</font><font style="display: inline;font-weight:bold;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In August 2018, the FASB issued ASU 2018-13, </font><font style="display: inline;font-style:italic;color:#000000;">Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Change to the Disclosure Requirements for Fair Value Measurement</font><font style="display: inline;color:#000000;">. ASU 2018-13 </font><font style="display: inline;color:#000000;">modifies the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy.&nbsp;ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 and early adoption is permitted</font><font style="display: inline;color:#000000;">. The adoption of ASU 2018-13 is not expected to have a material effect on our financial position or results of operations </font><font style="display: inline;color:#000000;">as it modifies disclosure requirements only.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (&#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company&#x201D;) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (&#x201C;U.S. GAAP&#x201D;) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;">. The accompanying condensed consolidated balance sheet as of </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;"> has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and six months ended March 31, 2019 and cash flows for the </font><font style="display: inline;">six months ended March 31, 2019</font><font style="display: inline;"> are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending </font><font style="display: inline;">September 30, 201</font><font style="display: inline;">9</font><font style="display: inline;">. &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.</font> </p> <p><font size="1"> </font></p> </div> </div> 3759509 5896536 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Restricted cash</font><font style="display: inline;">: Restricted cash relates to security provided to one of the Company&#x2019;s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of </font><font style="display: inline;">$250,000</font><font style="display: inline;"> for such performance bonds.&nbsp;&nbsp;Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life.&nbsp;&nbsp;The Company had </font><font style="display: inline;">no</font><font style="display: inline;"> restricted cash at March 31, 2019. Restricted cash was approximately </font><font style="display: inline;">$135,000</font><font style="display: inline;"> at September 30, 2018 and is included in cash on the accompanying unaudited condensed consolidated balance sheets</font><font style="display: inline;color:#FF0000;">. &nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 3277602 8972498 3759509 5896536 5694896 2137027 2.31 750000 2585379 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 11pt"> <font style="display: inline;font-family:Arial Narrow;font-size:11pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 11pt"> </p> <p><font size="1"> </font></p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-family:Arial Narrow;font-size:11pt;"></font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 10 &#x2013; Contingent Liabilities </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The testing, manufacturing and marketing of consumer products by the Company entail an inherent risk that product liability claims will be asserted against the Company.&nbsp;&nbsp;The Company maintains product liability insurance coverage for claims arising from the use of its products.&nbsp;&nbsp;The coverage amount is currently </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$10.0</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;million.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Litigation</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In response to the APP Acquisition, </font><font style="display: inline;">two</font><font style="display: inline;"> purported derivative and class action lawsuits were filed against the Company and certain of its officers and directors in the Circuit Court of Cook County, Illinois, captioned Glotzer v. The Female Health Company, et al., Case No. 2016-CH-13815, and Schartz v. Parrish, et al., Case No. 2016-CH-14488.&nbsp;&nbsp;These lawsuits were originally filed on or about October 21, 2016 and November 7, 2016, respectively. On January&nbsp;9, 2017, these two lawsuits were consolidated. On March&nbsp;31, 2017, the plaintiffs filed a consolidated complaint.&nbsp;&nbsp;The consolidated complaint named as defendants Veru, the members of our board of directors prior to the closing of the APP Acquisition and the members of our board of directors after the closing of the APP Acquisition. The consolidated complaint alleged, among other things, that the directors breached their fiduciary duties, or aided and abetted such breaches, by consummating the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements and by causing us to </font><font style="display: inline;">issue the shares of our common stock and Series 4 Preferred Stock to the former stockholders of APP pursuant to the APP Acquisition in order to evade the voting requirements of the Wisconsin Business Corporation Law. The consolidated complaint also alleged that Dr. Steiner, a director and the Chairman, President and Chief Executive Officer of Veru and a co-founder of APP, and Dr. Fisch, a director and Vice Chairman of Veru and a co-founder of APP, were</font><font style="display: inline;"> unjustly enriched in receiving shares of our common stock and Series 4 Preferred Stock in the APP Acquisition. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">On May 5, 2017, the defendants filed a motion to dismiss the consolidated complaint. On August&nbsp;15, 2017, the court entered an order dismissing without prejudice the claims that the post-acquisition directors aided and abetted the alleged breaches of fiduciary duties by the pre-acquisition directors and that Dr. Steiner and Dr. Fisch were unjustly enriched.&nbsp;&nbsp;The court did not dismiss the claims that our directors prior to the closing of the APP Acquisition breached their fiduciary duties and the claims that Veru consummated the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements.&nbsp;&nbsp;On November 30, 2018, plaintiffs filed an Amended Consolidated Complaint.&nbsp;&nbsp;The Amended Consolidated Complaint makes allegations similar to those in the original consolidated complaint as to the claims that were not dismissed and names as defendants Veru and the members of our board of directors prior to the closing of the APP Acquisition. The Amended Consolidated Complaint also makes claims against Dr. Steiner for allegedly aiding and abetting the pre-acquisition directors&#x2019; breach of fiduciary duty and for unjust enrichment.&nbsp;&nbsp;Like the original consolidated complaint, which was previously dismissed in part, the Amended Consolidated Complaint seeks equitable relief, including rescission of the APP Acquisition, money damages, disgorgement of the shares of our common stock and Series 4 Preferred Stock issued to Dr. Steiner, and costs and expenses of the litigation, including attorneys' fees</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">.&nbsp;&nbsp;On December 14, 2018, the defendants filed their answer to the Amended Consolidated Complaint wherein they denied any and all liability and asserted additional defenses.&nbsp;&nbsp;On January 14, 2019, the plaintiffs filed a motion for class certification. </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">On May 6, 2019, the Court granted plaintiffs&#x2019; motion and certified a class consisting of &#x201C;All holders of common stock of the Female Health Company as of October 31, 2016 and their successors in interest, excluding the named defendants to the Action and any person, firm, trust, corporation or other entity related to or affiliated with any of the Defendants.&#x201D;&nbsp; The parties filed cross-motions for summary judgment on April 15, 2019 which are set for hearing on July 11, 2019.</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> &nbsp;Veru believes that this action is without merit and is vigorously defending itself. </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">No</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> amount has been accrued for possible losses relating to this litigation as any such losses are not both probable and reasonably estimable. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">License and Purchase Agreements </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">From time to time, we license or purchase rights to technology or intellectual property from third parties. These licenses and purchase agreements require us to pay upfront payments as well as development or other payments upon successful completion of preclinical, clinical, regulatory or revenue milestones. In addition, these agreements may require us to pay royalties on sales of products arising from the licensed or acquired technology or intellectual property. Because the achievement of future milestones is not reasonably estimable, we have not recorded a liability in the accompanying unaudited condensed consolidated financial statements for any of these contingencies. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.01 0.01 77000000 154000000 200000 57468660 64968184 55284956 62784480 15000000 574687 649682 12000000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Other comprehensive loss</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss.&nbsp;&nbsp;Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company&#x2019;s policy and intent is to settle the intercompany trade account on a current basis.&nbsp;&nbsp;Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October&nbsp;1, 2009, no foreign currency gains or losses from intercompany trade are recognized.&nbsp;&nbsp;For the three and six months ended March 31, 2019 and 2018, comprehensive loss is equivalent to the reported net loss. </font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;"> &nbsp; &nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Cash concentration</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company&#x2019;s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia.</font> </p> <p><font size="1"> </font></p> </div> </div> 0.50 0.15 0.74 0.44 0.66 0.11 0.65 0.82 2647928 1374936 4094993 2367264 17500000 17500000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 7 &#x2013; Debt</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">SWK Credit Agreement</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">On March&nbsp;5, 2018, the Company entered into a Credit Agreement (the &#x201C;Credit Agreement&#x201D;) with the financial institutions party thereto from time to time (the &#x201C;Lenders&#x201D;) and SWK Funding LLC, as agent for the Lenders (the &#x201C;Agent&#x201D;), for a synthetic royalty financing transaction. On and subject to the terms of the Credit Agreement, the Lenders agreed to provide the Company with a multi-draw term loan of up to </font><font style="display: inline;">$12.0</font><font style="display: inline;">&nbsp;million, with </font><font style="display: inline;">$10.0</font><font style="display: inline;">&nbsp;million advanced to the Company on the date of the Credit Agreement. The Company may draw up to an additional </font><font style="display: inline;">$1.0</font><font style="display: inline;">&nbsp;million if the Company enters into an agreement to distribute at least </font><font style="display: inline;">47.5</font><font style="display: inline;">&nbsp;million units of FC2 in Brazil upon the terms described in the Credit Agreement and up to an additional </font><font style="display: inline;">$1.0</font><font style="display: inline;">&nbsp;million if the Company enters into an agreement to distribute at least </font><font style="display: inline;">30</font><font style="display: inline;">&nbsp;million units of FC2 in South Africa upon the terms described in the Credit Agreement. </font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Lenders will be entitled to receive quarterly payments on the term loan based on the Company&#x2019;s product revenue from net sales of FC2 as provided in the Credit Agreement until the Company has paid </font><font style="display: inline;">175%</font><font style="display: inline;"> of the aggregate amount advanced to the Company under the Credit Agreement. I</font><font style="display: inline;">f product revenue from net sales of FC2 for the </font><font style="display: inline;">12</font><font style="display: inline;">-month period ended as of the last day of the respective quarterly payment period is less than </font><font style="display: inline;">$10.0</font><font style="display: inline;"> million, the quarterly payments will be </font><font style="display: inline;">32.5%</font><font style="display: inline;"> of product revenue from net sales of FC2 during the quarterly period. If product revenue from net sales of FC2 for the </font><font style="display: inline;">12</font><font style="display: inline;">-month period ended as of the last day of the respective quarterly payment period is equal to or greater than </font><font style="display: inline;">$10.0</font><font style="display: inline;"> million, the</font><font style="display: inline;"> quarterly payments are calculated as the sum of </font><font style="display: inline;">25%</font><font style="display: inline;"> of product revenue from net sales of FC2 up to and including </font><font style="display: inline;">$12.5</font><font style="display: inline;"> million in the Elapsed Period (as defined in the Credit Agreement), plus </font><font style="display: inline;">10%</font><font style="display: inline;"> of product revenue from net sales of FC2 greater than </font><font style="display: inline;">$12.5</font><font style="display: inline;"> million in the Elapsed Period.&nbsp;&nbsp;U</font><font style="display: inline;">pon the Credit Agreement&#x2019;s termination date of March&nbsp;5, 2025, the Company must pay 175% of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue. </font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The first quarterly revenue-based payment due May 15, 2018 was approximately </font><font style="display: inline;">$0.6</font><font style="display: inline;"> million and</font><font style="display: inline;"> was paid on that date. </font><font style="display: inline;">On August&nbsp;10, 2018, the Company entered into an amendment (the &#x201C;Credit Agreement Amendment&#x201D;) to the Credit Agreement.&nbsp;&nbsp;The Credit Agreement Amendment deferred until November 15, 2018 the due date for the quarterly revenue-based payment that would have otherwise been due on August&nbsp;15, 2018. The Company made a payment of approximately </font><font style="display: inline;">$2.6</font><font style="display: inline;"> million on November&nbsp;15, 2018, consisting of approximately </font><font style="display: inline;">$1.4</font><font style="display: inline;"> million for the</font><font style="display: inline;"> quarterly revenue-based payment originally due on August 15, 2018 and approximately </font><font style="display: inline;">$1.2</font><font style="display: inline;"> million for the</font><font style="display: inline;"> quarterly revenue-based payment due on November 15, 2018. On February 15, 2019, the Company paid approximately </font><font style="display: inline;">$0.6</font><font style="display: inline;"> million for the</font><font style="display: inline;"> quarterly revenue-based payment due on that date.</font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Upon a change of control of the Company or sale of the FC2 business, the Company must pay off the loan by making a payment to the Lenders equal to (i)&nbsp;</font><font style="display: inline;">175%</font><font style="display: inline;"> of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue, plus (ii)&nbsp;the greater of (A)&nbsp;</font><font style="display: inline;">$2.0</font><font style="display: inline;">&nbsp;million or (B)&nbsp;the product of (x)&nbsp;</font><font style="display: inline;">5%</font><font style="display: inline;"> of the product revenue from net sales of FC2 for the most recently completed </font><font style="display: inline;">12</font><font style="display: inline;">-month period multiplied by (y)&nbsp;five. A &#x201C;change of control&#x201D; under the Credit Agreement includes (i)&nbsp;an acquisition by any person of direct or indirect ownership of more than </font><font style="display: inline;">50%</font><font style="display: inline;"> of the Company&#x2019;s issued and outstanding voting equity, (ii)&nbsp;a change of control or similar event in the Company&#x2019;s articles of incorporation or bylaws, (iii)&nbsp;certain Key Persons as defined in the Credit Agreement cease to serve in their current executive capacities unless replaced within </font><font style="display: inline;">90</font><font style="display: inline;"> days by a person reasonably acceptable to the Agent, which acceptance not to be unreasonably withheld, or (iv)&nbsp;the sale of all or substantially all of the Company&#x2019;s assets. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> </p> <p><font size="1"> </font></p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;"></font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Credit Agreement contains customary representations and warranties in favor of the Agent and the Lenders and certain</font><font style="display: inline;"> covenants, including </font><font style="display: inline;">financial covenants addressing minimum quarterly marketing and distribution expenses for FC2 and a requirement to maintain minimum unencumbered liquid assets of </font><font style="display: inline;">$1.0</font><font style="display: inline;">&nbsp;million. The Credit Agreement also restricts the payment of dividends and share repurchases. The recourse of the Lenders and the Agent for obligations under the Credit Agreement is limited to assets relating to FC2.</font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In connection with the Credit Agreement, the Company and the Agent also entered into a Residual Royalty Agreement, dated as of March&nbsp;5, 2018 (the &#x201C;Residual Royalty Agreement&#x201D;), which provides for an ongoing royalty payment of </font><font style="display: inline;">5%</font><font style="display: inline;"> of product revenue from net sales of FC2 commencing upon the payment in full by the Company of the required amount pursuant to the Credit Agreement. The Residual Royalty Agreement will terminate upon (i)&nbsp;a change of control or sale of the FC2 business and the payment by the Company of the amount due in connection therewith pursuant to the Credit Agreement, or (ii)&nbsp;mutual agreement of the parties. </font><font style="display: inline;">If a change of control occurs prior to payment in full of the Credit Agreement, there will be no payment due with respect to the Residual Royalty Agreement.&nbsp;&nbsp;If a change of control occurs after the payment in full of the Credit Agreement, the Agent will receive a payment that is&nbsp;the greater of (A)&nbsp;</font><font style="display: inline;">$2.0</font><font style="display: inline;">&nbsp;million or (B)&nbsp;the product of (x)&nbsp;</font><font style="display: inline;">5%</font><font style="display: inline;"> of the product revenue from net sales of FC2 for the most recently completed </font><font style="display: inline;">12</font><font style="display: inline;">-month period multiplied by (y)&nbsp;five.</font> </p> <p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Pursuant to a Guarantee and Collateral Agreement dated as of March&nbsp;5, 2018 (the &#x201C;Collateral Agreement&#x201D;) and an Intellectual Property Security Agreement dated as of March&nbsp;5, 2018 (the &#x201C;IP Security Agreement&#x201D;), the Company&#x2019;s obligations under the Credit Agreement are secured by a lien against substantially all of the assets of the Company that relate to or arise from FC2. In addition, pursuant to a Pledge Agreement dated as of March&nbsp;5, 2018 (the &#x201C;Pledge Agreement&#x201D;), the Company&#x2019;s obligations under the Credit Agreement are secured by a pledge of up to </font><font style="display: inline;">65%</font><font style="display: inline;"> of the outstanding shares of The Female Health Company Limited, a wholly owned U.K. subsidiary. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">After payment by the Company of certain fees and expenses of the Agent and the Lenders as required in the Credit Agreement, the Company received net proceeds of approximately </font><font style="display: inline;">$9.9</font><font style="display: inline;">&nbsp;million from the initial $10.0&nbsp;million advance under the Credit Agreement.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For accounting purposes, the initial $10.0 million advance under the Credit Agreement was allocated</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">between the Credit Agreement and the Residual Royalty Agreement on a relative fair value basis.&nbsp;&nbsp;A portion of the amount allocated to the Credit Agreement and a portion of the amount allocated to the Residual Royalty Agreement, in both cases equal to the fair value of the respective change of control provisions, was allocated to the embedded derivative liabilities. The derivative liabilities will be adjusted to fair market value at each subsequent reporting period</font><font style="display: inline;">.&nbsp;&nbsp;For financial statement presentation, the embedded derivative liabilities have been included with their respective host instruments as noted in the following tables. The debt discounts </font><font style="display: inline;">are </font><font style="display: inline;">being amortized to interest expense over the expected term of the loan using the effective interest method. Additionally, the Company recorded deferred loan issuance costs of approximately </font><font style="display: inline;">$267,000</font><font style="display: inline;"> for legal fees incurred in connection with the Credit Agreement. The deferred loan issuance costs are</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">presented as a reduction in the Credit Agreement obligation and are </font><font style="display: inline;">being amortized to interest expense over the expected term of the loan using the effective interest method.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">At March 31, 2019 and September 30, 2018, the Credit Agreement consisted of the following:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Aggregate repayment obligation</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,500,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,500,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Cumulative payments</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,834,202) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(642,485) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized discounts </font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,212,466) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(8,475,874) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized deferred issuance costs </font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(149,783) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(204,353) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, net</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,303,549&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,177,288&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Embedded derivative liability at fair value (see Note 3)</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,251,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,217,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,554,549&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">9,394,288&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, short-term portion</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,836,615) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,692,718) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, long-term portion </font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,717,934&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,701,570&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The short-term portion of the Credit Agreement represents the aggregate of the estimated quarterly revenue-based payments payable during the 12-month periods subsequent to March 31, 2019 and September 30, 2018, respectively.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">At March 31, 2019 and September 30, 2018, the Residual Royalty Agreement liability consisted of the following:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability, fair value at inception</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">346,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">346,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized discounts</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,420) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Accretion of liability using effective interest rate</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">417,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">201,225&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability, net</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">763,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">544,805&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Embedded derivative liability at fair value (see Note 3)</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,578,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,209,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,341,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,753,805&nbsp; </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Interest expense related to the Credit Agreement and the Residual Royalty Agreement consisted of amortization of the discounts, accretion of the liability for the Residual Royalty Agreement and amortization of the deferred issuance costs.&nbsp;&nbsp;For the three and six months ended March 31, 2019, interest expense related to the Credit Agreement and Residual Royalty Agreement was as follows:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font><br /><font style="display: inline;font-weight:bold;"> March 31, </font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font><br /><font style="display: inline;font-weight:bold;"> March 31, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Amortization of Credit Agreement and Residual Royalty Agreement discounts</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,107,622&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">317,747&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,265,828&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">317,747&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Accretion of Residual Royalty Agreement liability</font></p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">123,946&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">27,278&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">216,297&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">27,278&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Amortization of deferred issuance costs</font></p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">26,704&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,570&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">54,570&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,570&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,258,272&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">350,595&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,536,695&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">350,595&nbsp; </td> </tr> </table></div> <p style="margin:0pt -14.05pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 346000 346000 1700000 900000 425000 267000 204353 149783 -4653558 24710 5326342 5286651 88161 210594 187159 20656420 33843 22243212 34314 7699000 7674290 8543758 8509915 33843 8570150 8535836 34314 13025342 12960941 8543758 8570150 6973047 8057926 10595518 10621438 2195865 2468061 91419 125508 17586 17586 622442 759875 1700 1700 22902 54706 7631078 9282271 94321 85044 844758 895860 844758 844758 895860 895860 6843 7316 17.30 15.30 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Derivative instruments</font><font style="display: inline;">: The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company reviews the terms of debt instruments it enters into to determine whether there are embedded derivative instruments, which are required to be bifurcated and accounted for separately as derivative financial instruments. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. Liabilities incurred in connection with an embedded derivative are discussed in Note 7.</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 9 &#x2013; Share-based Compensation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">We allocate share-based compensation expense to cost of sales, selling, general and administrative expense and research and development expense based on the award holder&#x2019;s employment function. For the </font><font style="display: inline;">three and six months ended March 31, 2019 and 2018</font><font style="display: inline;">, we recorded share-based compensation expenses as follows: </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Cost of sales</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,778&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,797&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">15,730&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,061&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Selling, general and administrative</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">407,426&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">362,006&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">734,435&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">537,344&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Research and development</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">81,005&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">48,045&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">163,300&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">76,897&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">496,209&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">411,848&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">913,465&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">619,302&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Equity Plans</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In March 2018, the Company&#x2019;s stockholders approved the Company's 2018 Equity Incentive Plan (the &#x201C;2018 Plan&#x201D;). </font><font style="display: inline;">On March 26, 2019, the Company&#x2019;s stockholders approved an increase in the number of shares that may be issued under the 2018 Plan to</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">6.0</font><font style="display: inline;"> million.&nbsp;&nbsp;As of March 31, 2019, </font><font style="display: inline;">4,117,272</font><font style="display: inline;"> shares remain available for issuance under the 2018 Plan.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In July 2017, the Company&#x2019;s stockholders approved the Company's 2017 Equity Incentive Plan (the &#x201C;2017 Plan&#x201D;).&nbsp;&nbsp;A total of </font><font style="display: inline;">4.7</font><font style="display: inline;">&nbsp;million shares are authorized for issuance under the 2017 Plan. As of March 31, 2019, </font><font style="display: inline;">190,868</font><font style="display: inline;"> shares remain available for issuance under the 2017 Plan.</font><font style="display: inline;"> The 2017 Plan replaced the Company's 2008 Stock Incentive Plan (the &#x201C;2008 Plan&#x201D;), and </font><font style="display: inline;">no</font><font style="display: inline;"> further awards will be made under the 2008 Plan.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Stock Options </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="font-weight:bold;display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Each option grants the holder the right to purchase from us one share of our common stock at a specified price, which is generally the closing price per share of our common stock on the date the option is issued. Options generally vest on a pro-rata basis on each anniversary of the issuance date within three years of the date the option is issued. Options may be exercised after they have vested and prior to the specified expiry date provided applicable exercise conditions are met, if any. The expiry date can be for periods of up to ten years from the date the option is issued. The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model based on the assumptions established at that time. The Company accounts for forfeitures as they occur and does not estimate forfeitures as of the option grant date.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="font-weight:bold;display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table outlines the weighted average assumptions for option</font><font style="display: inline;">s granted during the </font><font style="display: inline;">three and six months ended </font><font style="display: inline;">March 31, 2019 and 2018</font><font style="display: inline;">:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;border-bottom:1pt solid #000000 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Weighted Average Assumptions:</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected volatility</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">65.45%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">62.34%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66.88%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">61.38%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected dividend yield</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.27%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.76%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.59%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.47%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected term (in years)</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.9&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6.0&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.7&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.8&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Fair value of options granted</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.90&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.28&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.85&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.93&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">During the </font><font style="display: inline;">three and six months ended </font><font style="display: inline;">March 31, 2019 and 2018, the Company used historical volatility of our common stock over a period equal to the expected life of the options to estimate their fair value.&nbsp;&nbsp;The dividend yield assumption is based on the Company&#x2019;s recent history and expectation of future dividend payouts on the common stock.&nbsp;&nbsp;The risk-free interest rate is based on the implied yield available on U.S. treasury zero-coupon issues with an equivalent remaining term. </font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table summarizes the stock options</font><font style="display: inline;"> outstanding and exercisable at </font><font style="display: inline;">March 31, 2019:&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="4" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted Average</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Remaining</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number of</font></p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Exercise Price </font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Contractual&nbsp;Term</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Shares</font></p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Per Share</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(years)</font></p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Outstanding at September 30, 2018</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,645,312&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.59&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">880,882&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.42&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Exercised</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(166,667) </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.20&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Forfeited</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(301,834) </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.52&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Outstanding at March 31, 2019</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,057,693&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.57&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7.83&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">785,435&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Exercisable at March 31, 2019</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,042,285&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.46&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6.51&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">436,840&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The aggregate intrinsic values in the table above are before income taxes and </font><font style="display: inline;color:#000000;">represent the number of in-the-money options outstanding or exercisable multiplied by the closing price per share of the Company&#x2019;s common stock </font><font style="display: inline;">on the last trading day of the quarter ended March 31, 2019</font><font style="display: inline;color:#000000;"> of </font><font style="display: inline;color:#000000;">$1.46</font><font style="display: inline;color:#000000;">, less the respective weighted average exercise price per share at period end</font><font style="display: inline;">.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The total intrinsic value of options exercised during the six months ended March 31, 2019 was approximately </font><font style="display: inline;">$48,000</font><font style="display: inline;">. Cash received from options exercised during the six months ended March 31, 2019 was approximately </font><font style="display: inline;">$200,000</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">No</font><font style="display: inline;"> stock options were exercised during the six months ended March 31, 2018.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As </font><font style="display: inline;">of March 31, 2019, the Company had unrecognized compensation expense of approximately </font><font style="display: inline;">$2.7</font><font style="display: inline;">&nbsp;million related to unvested stock options. This expense is expected to be recognized over approximately </font><font style="display: inline;">three</font><font style="display: inline;"> years.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Restricted Stock </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company has issued restricted stock to employees, directors and consultants. Such issuances had vesting periods that ranged from one to three years. All such shares of restricted stock vest provided the grantee has not voluntarily terminated service or been terminated for cause prior to the vesting date. There were </font><font style="display: inline;">no</font><font style="display: inline;"> shares of restricted stock outstanding at March 31, 2019 and September 30, 2018.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Restricted Stock Units</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In connection with the closing of the APP Acquisition, the Company issued </font><font style="display: inline;">50,000</font><font style="display: inline;"> and </font><font style="display: inline;">140,000</font><font style="display: inline;"> restricted stock units to an employee and an outside director, respectively, that vested on </font><font style="display: inline;">October&nbsp;31, 2018</font><font style="display: inline;">. The restricted stock units were settled in common stock issued under the 2017 Plan. As of March 31, 2019, there are </font><font style="display: inline;">no</font><font style="display: inline;"> outstanding restricted stock units.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Stock Appreciation Rights</font><font style="display: inline;"></font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">In connection with the closing of the APP Acquisition, the Company issued stock appreciation rights based on </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">50,000</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> and </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">140,000</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> shares of the Company&#x2019;s common stock to an employee and an outside director, respectively, that vested on </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">October&nbsp;31, 2018</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">. The stock appreciation rights have a </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">ten</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">-year term and an exercise price per share of </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$0.95</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">, which was the closing price per share of the Company&#x2019;s common stock as quoted on NASDAQ on the trading day immediately preceding the date of the completion of the APP Acquisition. The stock appreciation rights will be settled in common stock issued under the 2017 Plan.&nbsp;&nbsp;As of March 31, 2019, these vested stock appreciation rights remain outstanding.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> -0.15 -0.07 -0.10 -0.06 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 12 &#x2013; Net Loss Per Share </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and warrants, and the vesting of unvested restricted stock and restricted stock units.&nbsp;&nbsp;Due to our net loss for the periods presented, all potentially dilutive instruments were excluded because their inclusion would have been anti-dilutive. See Notes 8 and 9 for a discussion of our dilutive potential common shares.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> 0.35 0.21 1209000 1217000 1578000 1251000 P3Y 2700000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">&#xFEFF;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Valuation Methodology</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Significant Unobservable Input</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Weighted Average</font><br /><font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">(range, if applicable)</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font><font style="display: inline;font-size:9pt;">Monte Carlo Simulation</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Estimated change of control dates</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">December 2019</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">December 2021</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Discount rate </font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">15.3%</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">17.3%</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Probability of change of control</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">0%</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">90%</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 3 &#x2013; Fair Value Measurements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">FASB ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The three levels of the fair value hierarchy are as follows:</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Level&nbsp;1 &#x2013; Quoted prices for identical instruments in active markets. </font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Level&nbsp;2 &#x2013; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&nbsp; </font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Level&nbsp;3 &#x2013; Instruments with primarily unobservable value drivers. </font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels of certain securities within the fair value hierarchy. There were no transfers between Level </font><font style="display: inline;">1</font><font style="display: inline;">, Level </font><font style="display: inline;">2</font><font style="display: inline;"> and Level </font><font style="display: inline;">3</font><font style="display: inline;"> during the six months ended March 31, 2019 and 2018.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As of March 31, 2019 and September 30, 2018, the Company&#x2019;s financial liabilities measured at fair value on a recurring basis, which consisted of embedded derivatives, were classified within Level 3 of the fair value hierarchy.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company determines the fair value of hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument. </font><font style="display: inline;">The Company estimates the fair value of hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair value. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating the fair value of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Increases in fair value during a given financial quarter result in the recognition of non-cash derivative expense. Conversely, decreases in fair value during a given financial quarter would result in the recognition of non-cash derivative income.&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table provides a reconciliation of the beginning and ending liability balance associated with embedded derivatives measured at fair value using significant unobservable inputs (Level 3)</font><font style="display: inline;"> as of March 31, 2019 and 2018:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">Six Months Ended March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Beginning balance</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,426,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Additions</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,319,000&nbsp; </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Change in fair value of derivative liabilities</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">403,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,000&nbsp; </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Ending balance</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,829,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,340,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The expense associated with the change in fair value of the embedded derivatives is included on a separate line item on our unaudited condensed consolidated statements of operations.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The liabilities associated with embedded derivatives represent the fair value of the change of control provisions in the SWK Credit Agreement and Residual Royalty Agreement. See Note 7 for additional information. There is no current observable market for these types of derivatives. </font><font style="display: inline;">The Company </font><font style="display: inline;">determined the fair value of the embedded derivatives using</font><font style="display: inline;"> a Monte Carlo simulation model to value the financial liabilities at inception and on subsequent valuation dates. This valuation model incorporates transaction details such as the contractual terms, expected cash outflows, expected repayment dates, probability of a change of control, expected volatility, and risk-free interest rates. A significant acceleration of the estimated repayment date or a significant decrease in the probability of a change of control event prior to repayment of the SWK Credit Agreement, in isolation, would result in a significantly lower fair value measurement of the liabilities associated with the embedded derivatives.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The following table presents quantitative information about the inputs and valuation methodologies used to determine the fair value of the embedded derivatives classified in Level 3 of the fair value hierarchy as of March 31, 2019: </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">&#xFEFF;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Valuation Methodology</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Significant Unobservable Input</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">Weighted Average</font><br /><font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">(range, if applicable)</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-weight:bold;color:#000000;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font><font style="display: inline;font-size:9pt;">Monte Carlo Simulation</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Estimated change of control dates</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">December 2019</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">December 2021</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Discount rate </font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">15.3%</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">17.3%</font></p> </td> </tr> <tr> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">Probability of change of control</font></p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt"> <font style="display: inline;font-size:9pt;">0%</font><font style="display: inline;font-size:9pt;"> to </font><font style="display: inline;font-size:9pt;">90%</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 0 0 0 0 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">Six Months Ended March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Beginning balance</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,426,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Additions</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,319,000&nbsp; </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Change in fair value of derivative liabilities</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">403,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,000&nbsp; </td> </tr> <tr> <td valign="middle" style="width:56.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Ending balance</font></p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,829,000&nbsp; </td> <td valign="bottom" style="width:03.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:02.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:17.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,340,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Fair value measurements</font><font style="display: inline;">: Financial Accounting Standards Board (&#x201C;FASB&#x201D;) Accounting Standards Codification (&#x201C;ASC&#x201D;) Topic 820 &#x2013;</font><font style="display: inline;font-style:italic;"> Fair Value Measurements and Disclosures,</font><font style="display: inline;"> defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to us as of the reporting dates. Accordingly, the estimates presented in the accompanying unaudited condensed consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. See Note 3 </font><font style="display: inline;">for a discussion of fair value measurements</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash, accounts receivable, accounts payable and other accrued liabilities approximate their fair value based on the short-term nature of these instruments. The carrying value of long-term debt, taking into consideration debt discounts and related derivative instruments, is estimated to approximate fair value.</font> </p> <p><font size="1"> </font></p> </div> </div> 2021-12-31 2019-12-01 0 0 3319000 21000 403000 3340000 2426000 2829000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 4 &#x2013; Accounts Receivable and Concentration of Credit Risk</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company's standard credit terms vary from </font><font style="display: inline;">30</font><font style="display: inline;"> to </font><font style="display: inline;">120</font><font style="display: inline;"> days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period.&nbsp;&nbsp;As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales.&nbsp;&nbsp;The Company has agreed to credit terms of up to </font><font style="display: inline;">150</font><font style="display: inline;"> days with our distributor in the Republic of South Africa.&nbsp;&nbsp;For the order of </font><font style="display: inline;">15</font><font style="display: inline;"> million units under the Brazil tender in 2014, the Company agreed to up to 360 days credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government.&nbsp;&nbsp;&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The components of accounts receivable consist of th</font><font style="display: inline;">e following at March 31, 2019 and </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;">: &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 6pt"> <font style="display: inline;font-size:6pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Accounts receivable</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,076,745&nbsp; </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,046,733&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: allowance for doubtful accounts</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(36,201) </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(36,201) </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: allowance for sales and payment term discounts</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(13,309) </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(37,900) </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Accounts receivable, net</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,027,235&nbsp; </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,972,632&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">On December&nbsp;27, 2017, we entered into a settlement agreement with Semina, our distributor in Brazil, pursuant to which Semina made a payment of </font><font style="display: inline;">$2.2</font><font style="display: inline;">&nbsp;million and was obligated to make a second payment of </font><font style="display: inline;">$1.5</font><font style="display: inline;">&nbsp;million by February&nbsp;28, 2018, to settle net amounts due to us totaling </font><font style="display: inline;">$7.5</font><font style="display: inline;">&nbsp;million </font><font style="display: inline;">relating to the Brazil tender in 2014</font><font style="display: inline;">. The settlement was not related to our belief in the ultimate collectability of the receivables or in the creditworthiness of Semina. </font><font style="display: inline;">We elected to settle these amounts due to the uncertainty regarding the timing of payment by the Brazilian Government and, ultimately to us, on the remaining amounts due. The result of the settlement was a net loss of </font><font style="display: inline;">$3.8</font><font style="display: inline;">&nbsp;million in the six months ended March 31, 2018, which is presented as a separate line item in the accompanying unaudited condensed consolidated statements of operations. </font><font style="display: inline;">Semina did not make its second payment of $1.5&nbsp;million by February&nbsp;28, 2018.&nbsp;&nbsp;In July 2018, the Company agreed to accept </font><font style="display: inline;">$1.3</font><font style="display: inline;"> million as settlement of the $1.5 million that was owed</font><font style="display: inline;">, which resulted in an additional loss of </font><font style="display: inline;">$0.2</font><font style="display: inline;"> million in the third quarter of fiscal 2018</font><font style="display: inline;">.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">At March 31, 2019, </font><font style="display: inline;">one </font><font style="display: inline;">customer had an accounts receivable balance that represented </font><font style="display: inline;">11%</font><font style="display: inline;"> of current assets.&nbsp;&nbsp;At September 30, 2018, </font><font style="display: inline;">one</font><font style="display: inline;"> customer had an accounts receivable balance that represented </font><font style="display: inline;">15%</font><font style="display: inline;"> of current assets.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">At March 31, 2019, </font><font style="display: inline;">two</font><font style="display: inline;"> customers had an accounts receivable balance greater than 10% of net accounts receivable, representing </font><font style="display: inline;">65%</font><font style="display: inline;"> of net accounts receivable in the aggregate.&nbsp;At September 30, 2018, </font><font style="display: inline;">three</font><font style="display: inline;"> customers had an accounts receivable balance greater than 10% of net accounts receivable, representing </font><font style="display: inline;">74%</font><font style="display: inline;"> of net accounts receivable in the aggregate.&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For the three months ended March 31, 2019, there were </font><font style="display: inline;">four</font><font style="display: inline;"> customers whose individual net revenue to the Company exceeded 10% of the Company&#x2019;s net revenues, representing </font><font style="display: inline;">82%</font><font style="display: inline;"> of the Company&#x2019;s net revenues in the aggregate. For the three months ended March 31, 2018, there were </font><font style="display: inline;">two</font><font style="display: inline;"> customers whose individual net revenue to the Company exceeded 10% of the Company&#x2019;s net revenues, representing </font><font style="display: inline;">44%</font><font style="display: inline;"> of the Company&#x2019;s net revenues in the aggregate.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">For the six months ended March 31, 2019, there were&nbsp;</font><font style="display: inline;">three</font><font style="display: inline;"> customers whose individual net revenue to the Company exceeded 10% of the Company&#x2019;s net revenues, representing </font><font style="display: inline;">66%</font><font style="display: inline;"> of the Company&#x2019;s net revenues in the aggregate. For the six months ended March 31, 2018, there were&nbsp;</font><font style="display: inline;">three</font><font style="display: inline;"> customers whose individual net revenue to the Company exceeded 10% of the Company&#x2019;s net revenues, representing </font><font style="display: inline;">50%</font><font style="display: inline;"> of the Company&#x2019;s net revenues in the aggregate.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable.&nbsp;&nbsp;Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts.&nbsp;&nbsp;Management also periodically evaluates individual customer receivables and considers a customer&#x2019;s financial condition, credit history, and the current economic conditions.&nbsp;&nbsp;Accounts receivable are charged-off when deemed uncollectible.&nbsp;&nbsp;The table below summarizes the change in the all</font><font style="display: inline;">owance for doubtful accounts for the six months ended March 31, 2019 and 2018</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">Six Months Ended March 31,</font></p> </td> </tr> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Beginning balance </font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,201&nbsp; </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">38,103&nbsp; </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Charges to expense</font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,058&nbsp; </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Charge-offs</font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,000) </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Ending balance </font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,201&nbsp; </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,161&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Recoveries of accounts receivable previously charged-off are recorded when received.&nbsp;&nbsp;The Company&#x2019;s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;">which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. In the U.S., the Company&#x2019;s customers include telemedicine providers who sell into the prescription channel. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 422271 285366 136905 576888 404269 172619 2900000 2400000 500000 2900000 2400000 500000 2477729 2114634 363095 2323112 1995731 327381 P10Y P7Y -116532 -63077 -41187 -23643 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Foreign currency translation and operations</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: Effective October&nbsp;1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries&#x2019; functional currency.&nbsp;&nbsp;The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries.&nbsp;&nbsp;Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company&#x2019;s first-generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October&nbsp;1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent&#x2019;s operations, it, too, adopted the U.S. dollar as its functional currency as of October&nbsp;1, 2009. The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$0.6</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million as of March 31, 2019 and September 30, 2018. Assets located outside of the U.S. totaled approximately </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$5.0</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million and </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$5.2</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> million at March 31, 2019 and September 30, 2018, respectively.</font> </p> <p><font size="1"> </font></p> </div> </div> -21000 -21000 -403000 -628000 -3800000 -200000 6878932 6878932 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">Note 6 &#x2013; Intangible Assets and Goodwill</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;text-decoration:underline;">Intangible Assets</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Intangible assets acquired in the APP Acquisition included in-process research and development (&#x201C;IPR&amp;D&#x201D;), developed technology consisting of PREBOOST&#xAE; medicated wipes for prevention of premature ejaculation, and covenants not-to-compete. IPR&amp;D represents incomplete research and development projects at APP as of the date of the APP Acquisition. These intangible assets are carried at cost less accumulated amortization. Intangible assets with finite lives are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. IPR&amp;D is tested for impairment at least annually in the fourth quarter of each fiscal year until the underlying projects are completed or abandoned.&nbsp;&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The gross carrying amounts and net book value of intangible assets are as follows at March 31, 2019:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Accumulated</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Net Book</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amortization</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Intangible assets with finite lives:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology - PREBOOST</font><font style="display: inline;font-family:Calibri;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,400,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">404,269&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,995,731&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenants not-to-compete</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">500,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">172,619&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">327,381&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets with finite lives</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">576,888&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,323,112&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Acquired in-process research and development assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">576,888&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,323,112&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The gross carrying amounts and net book value of intangible assets are as follows at </font><font style="display: inline;color:#000000;">September 30, 2018</font><font style="display: inline;color:#000000;">:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Accumulated</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Net Book</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amortization</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Intangible assets with finite lives:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology - PREBOOST</font><font style="display: inline;font-family:Calibri;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,400,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">285,366&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,114,634&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenants not-to-compete</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">500,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">136,905&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">363,095&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets with finite lives</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">422,271&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,477,729&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Acquired in-process research and development assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">422,271&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,477,729&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Amortization is recorded over the projected related revenue stream for the PREBOOST&#xAE; developed technology over </font><font style="display: inline;color:#000000;">10</font><font style="display: inline;color:#000000;"> years and on a straight-line basis over </font><font style="display: inline;color:#000000;">seven</font><font style="display: inline;color:#000000;"> years for the covenants not-to-compete. The amortization expense is recorded in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. The IPR&amp;D assets will not be amortized until the underlying development projects are completed. If and when development is complete, which generally occurs when regulatory approval to market the product is obtained, the associated IPR&amp;D assets would be accounted for as finite-lived intangible assets and amortized over the estimated period of economic benefit. If a development project is abandoned, the associated IPR&amp;D assets would be charged to expense.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">For the </font><font style="display: inline;color:#000000;">three months ended </font><font style="display: inline;color:#000000;">March 31, 2019 and 2018, amortization expense was approximately </font><font style="display: inline;color:#000000;">$77,000</font><font style="display: inline;color:#000000;"> and </font><font style="display: inline;color:#000000;">$69,000</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;color:#000000;">respectively. For the six months ended March 31, 2019 and 2018, amortization expense was approximately $155,000 and $138,000, respectively.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Intangible assets are highly vulnerable to impairment charges, particularly newly acquired assets for recently launched products. These assets are initially measured at fair value and therefore any reduction in expectations used in the valuations could potentially lead to impairment. Some of the more common potential risks leading to impairment include competition, earlier than expected loss of exclusivity, pricing pressures, adverse regulatory changes or clinical trial results, delay or failure to obtain regulatory approval, additional development costs, inability to achieve expected synergies, higher operating costs, changes in tax laws and other macroeconomic changes. The complexity in estimating the fair value of intangible assets in connection with an impairment test is similar to the initial valuation. Considering the high-risk nature of research and development and the industry&#x2019;s success rate of bringing developmental compounds to market, IPR&amp;D impairment charges are likely to occur in future periods.&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;text-decoration:underline;">Goodwill</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The carrying amount of goodwill at March 31, 2019 and September 30, 2018 was $6.9 million. There was no change in the balance during the six months ended March 31, 2019 and 2018. Goodwill represents the difference between the purchase price and the estimated fair value of the net assets acquired in the APP Acquisition.&nbsp;&nbsp;Goodwill from the APP Acquisition principally relates to intangible assets that do not qualify for separate recognition, our expectation to develop and market new products, and the deferred tax liability generated as a result of the transaction.&nbsp;&nbsp;Goodwill is not tax deductible for income tax purposes and was assigned to Company&#x2019;s sole reporting unit in the Company&#x2019;s Research and Development reporting segment, which consists of multiple drug products under clinical development for oncology and urology.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Goodwill is tested for impairment at least annually in the fourth quarter of each fiscal year or when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that its fair value exceeds the carrying value. Examples of qualitative factors include our share price, our financial performance compared to budgets, long-term financial plans, and macroeconomic, industry and market conditions as well as the substantial excess of fair value over the carrying value of net assets from the annual impairment test previously performed. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The estimated fair value of a reporting unit is highly sensitive to changes in projections and assumptions; therefore, in some instances changes in these assumptions could potentially lead to impairment. We perform sensitivity analyses around our assumptions in order to assess the reasonableness of the assumptions and the results of our testing. Ultimately, future potential changes in these assumptions may impact the estimated fair value of a reporting unit and cause the fair value of the reporting unit to be below its carrying value. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value; however, if actual results are not consistent with our estimates and assumptions, we may be exposed to an impairment charge that could be material.</font> </p> <p><font size="1"> </font></p> </div> </div> 2511557 1197936 9252931 4608851 -12636839 -5133634 -6065168 -4008868 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 11 &#x2013; Income Taxes</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company accounts for income taxes using the liability method, which requires the recognition of deferred tax assets or liabilities for the tax-effected temporary differences between the financial reporting and tax bases of its assets and liabilities, and for net operating loss and tax credit carryforwards. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">On December&nbsp;22, 2017, significant changes were enacted to the U.S. tax law pursuant to the federal tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (the &#x201C;Tax Act&#x201D;).&nbsp;&nbsp;The Tax Act includes a permanent reduction in the U.S. federal corporate income tax rate from </font><font style="display: inline;">35%</font><font style="display: inline;"> to </font><font style="display: inline;">21%</font><font style="display: inline;">, a one-time repatriation tax on deferred foreign income, and changes to deductions, credits and business-related exclusions.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Tax Act also repealed the alternative minimum tax (&#x201C;AMT&#x201D;) for corporations.&nbsp;&nbsp;The new law provides that AMT carryovers can be utilized to reduce or eliminate the tax liability in subsequent years or to obtain a tax refund.&nbsp;&nbsp;For tax years beginning in 2018, 2019 and 2020, to the extent the AMT credit carryovers exceed regular tax liability, 50% of the excess AMT credit carryovers will be refundable.&nbsp;&nbsp;Any remaining credits will be fully refundable in 2021.&nbsp;&nbsp;At September 30, 2018, the Company reclassified </font><font style="display: inline;">$0.5</font><font style="display: inline;"> million of its AMT credit carryovers from its deferred tax assets to other assets due to the expectation that the AMT credits will be refundable over the next several years.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Within the calculation of the Company&#x2019;s annual effective tax rate the Company has used assumptions and estimates that may change as a result of future guidance, interpretations, and rule-making from the Internal Revenue Service, the SEC, the FASB and/or various other taxing jurisdictions.&nbsp;&nbsp;For example, the Company anticipates that state jurisdictions will continue to determine and announce their conformity to the Tax Act which would have an impact on the annual effective tax rate. The Company&#x2019;s calculations are based on the information available, prepared or analyzed (including computations) in reasonable detail.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company completes a detailed analysis of its deferred income tax valuation allowances on an annual basis or more frequently if information comes to its attention that would indicate that a revision to its estimates is necessary.&nbsp;&nbsp;In evaluating the Company&#x2019;s ability to realize its deferred tax assets, management considers all available positive and negative evidence on a country-by-country basis, including past operating results, forecasts of future taxable income, and the potential Section 382 limitation on the net operating loss carryforwards due to a change in control.&nbsp;&nbsp;In determining future taxable income, management makes assumptions to forecast U.S. federal and state, U.K. and Malaysia operating income, the reversal of temporary differences, and the implementation of any feasible and prudent tax planning strategies.&nbsp;&nbsp;These assumptions require significant judgment regarding the forecasts of the future taxable income in each tax jurisdiction and are consistent with the forecasts used to manage the Company&#x2019;s business.&nbsp;&nbsp;It should be noted that the Company realized significant losses through 2005 on a consolidated basis.&nbsp;&nbsp;From fiscal year 2006 through fiscal year 2015, the Company generated taxable income on a consolidated basis.&nbsp;&nbsp;However, the Company had a cumulative pretax loss in the U.S. for fiscal 2018 and the two preceding fiscal years.&nbsp;&nbsp;Forming a conclusion that a valuation allowance is not needed is difficult when there is significant negative evidence such as cumulative losses in recent years. Management has projected future taxable losses in the U.S. driven by the investment in research and development, and based on their analysis concluded that a valuation allowance should continue to be recorded against the U.S. deferred tax assets related to federal and state net operating loss carryforwards as of March 31, 2019. An additional valuation allowance has been recorded against the U.S. deferred tax assets and net operating loss carryforwards as of March 31, 2019 of </font><font style="display: inline;">$1.6</font><font style="display: inline;"> million.&nbsp;&nbsp;In addition, the Company&#x2019;s holding company for the non-U.S. operating companies, The Female Health Company Limited, continues to have a full valuation allowance.&nbsp;&nbsp;The operating U.K. subsidiary, The Female Health Company (UK) plc does not have a valuation allowance due to projections of future taxable income for the next 10 years. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As of September 30, 2018, the Company had U.S. federal and state net operating loss carryforwards of approximately </font><font style="display: inline;">$33.2</font><font style="display: inline;"> million and </font><font style="display: inline;">$36.2</font><font style="display: inline;"> million, respectively, for income tax purposes with </font><font style="display: inline;">$14.4</font><font style="display: inline;"> million and </font><font style="display: inline;">$19.6</font><font style="display: inline;"> million, respectively, expiring in years 2022 to 2037 and </font><font style="display: inline;">$18.8</font><font style="display: inline;"> million and </font><font style="display: inline;">$16.6</font><font style="display: inline;"> million, respectively, which can be carried forward indefinitely.&nbsp;&nbsp;The Company&#x2019;s U.K. subsidiary has U.K. net operating loss carryforwards of approximately </font><font style="display: inline;">$62.3</font><font style="display: inline;"> million as of September 30, 2018, which can be carried forward indefinitely to be used to offset future U.K. taxable income. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">ASC Topic&nbsp;740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic&nbsp;740 developed a two-step process to evaluate a tax position and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.&nbsp;The Company has not recorded a reserve for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to income before income taxes is as follows:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="middle" style="width:27.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:27.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="middle" style="width:27.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:27.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Income tax benefit at statutory rates</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(841,862) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,077,736) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,273,685) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,628,736) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">State income tax benefit, net of federal benefits</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(199,521) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(385,395) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(301,863) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(948,395) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of change in U.S. tax rate</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(187,000) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Non-deductible expenses &#x2013; other</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,364&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,702&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,783&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">12,702&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of lower foreign income tax rates</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,830&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">50,981&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,527) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">80,386&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of deemed dividend </font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">32,318&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">63,627&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,025) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">101,032&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(22,863) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">122,574&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Change in valuation allowance</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,028,063&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,651,193&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Income tax expense (benefit)</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">25,167&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,302,416) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">117,665&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,548,469) </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Significant components of the Company&#x2019;s deferred tax assets and liabilities are as follows: </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30,</font></p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Deferred tax assets:</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Federal net operating loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,057,926&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,973,047&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">State net operating loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,468,061&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,195,865&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Foreign net operating loss carryforwards &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">10,621,438&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">10,595,518&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Foreign capital allowance &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">102,098&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">102,098&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">U.K. bad debts</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,700&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,700&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Restricted stock &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,586&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,586&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">U.S. deferred rent</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">54,706&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,902&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Share-based compensation</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">759,875&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">622,442&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other, net &#x2013; U.S.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">125,508&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">91,419&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other, net &#x2013; Malaysia</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">34,314&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">33,843&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Gross deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,243,212&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,656,420&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Valuation allowance for deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(9,282,271) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,631,078) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">12,960,941&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,025,342&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Deferred tax liabilities:</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">In process research and development </font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,675,860) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,675,860) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(518,431) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(549,318) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenant not-to-compete</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(85,044) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(94,321) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,316) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,843) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Net deferred tax liabilities</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,286,651) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,326,342) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Net deferred tax asset</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,674,290&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,699,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The deferred tax amounts have been classified in the accompanying unaudited condensed consolidated balance sheets as follows:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font><br /><font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30,</font><br /><font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax asset &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,535,836&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,509,915&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax asset &#x2013; Malaysia</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">34,314&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">33,843&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total long-term deferred tax asset</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,570,150&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,543,758&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax liability &#x2013; U.S.</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(895,860) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(844,758) </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total long-term deferred tax liability </font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(895,860) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(844,758) </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> -4548469 -1302416 117665 25167 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Income taxes</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">: The Company files separate income tax returns for its foreign subsidiaries. FASB ASC Topic&nbsp;740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.</font> </p> <p><font size="1"> </font></p> </div> </div> 1651193 1028063 -187000 80386 50981 -3527 4830 -3628736 -1077736 -1273685 -841862 12702 8702 4783 2364 122574 101032 -22863 -1025 -948395 -385395 -301863 -199521 853949 -656527 -3250664 54603 375957 -391011 -142147 -187159 -21000 -403000 821133 748095 -62485 73589 20477729 18000000 20323112 18000000 20900000 20900000 20477729 20323112 350595 350595 2536695 1258272 2232864 17138 2786083 677 2676753 3448565 2302030 2284892 2998201 2997524 366220 599772 391861 451041 77669 62710 18971221 17468037 48452639 51012054 13552927 11272127 10000000 9394288 8554549 12000000 1000000 1000000 2000000 6692718 6692718 5836615 5836615 2701570 2701570 2717934 2717934 10000000 9880000 6140250 -1913 -644 -4183191 -4002579 -4257152 -4257152 -8088370 -3831218 -3831218 -2148798 -2148798 -6182833 -4034035 -4034035 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Recently Issued Accounting Pronouncements</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In May 2014, the FASB issued Accounting Standards Update (&#x201C;ASU&#x201D;) 2014-09, </font><font style="display: inline;font-style:italic;color:#000000;">Revenue from Contracts with Customers (Topic 606)</font><font style="display: inline;color:#000000;">.&nbsp;&nbsp;This new accounting guidance on revenue recognition provides for a single five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation. The new guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts.&nbsp;&nbsp;The Company adopted the new guidance on October 1, 2018 using the modified retrospective method and elected to apply the guidance only to contracts that were not completed as of the date of adoption. The adoption of this guidance did not have a material effect on our consolidated financial statements and related disclosures. See discussion above for disclosures relating to the Company's revenue recognition.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In February 2016, the FASB issued ASU 2016-02, </font><font style="display: inline;font-style:italic;">Leases (Topic 842)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;color:#000000;">which requires that lessees recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of</font><font style="display: inline;"> key information about leasing arrangements.&nbsp;&nbsp;ASU 2016-02 </font><font style="display: inline;color:#000000;">is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required upon adoption.</font><font style="display: inline;"> &nbsp;Early adoption is permitted. I</font><font style="display: inline;color:#000000;">n July 2018, the FASB issued ASU No. 2018-10, </font><font style="display: inline;font-style:italic;color:#000000;">Codification Improvements to Topic 842, Leases</font><font style="display: inline;color:#000000;"> to clarify the implementation guidance and ASU No. 2018-11, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842) Targeted Improvements</font><font style="display: inline;color:#000000;">. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n December 2018, the FASB issued ASU 2018-20, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Narrow-Scope Improvements for Lessors</font><font style="display: inline;color:#000000;"> to address certain implementation issues facing lessors when adopting ASU 2016-02. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n March 2019, the FASB issued ASU 2019-01, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Codification Improvements</font><font style="display: inline;color:#000000;"> to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016-02. The Company will adopt the new accounting standard </font><font style="display: inline;">on October&nbsp;1, 2019 and intends to elect certain </font><font style="display: inline;color:#000000;">practical expedients,&nbsp;including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;color:#000000;">We have begun to identify our significant lease contracts and are in the process of </font><font style="display: inline;">evaluating the effect of the new guidance on our consolidated financial statements and related disclosures. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In November 2016, the FASB issued ASU 2016-18,&nbsp;</font><font style="display: inline;font-style:italic;">Statement of Cash Flows</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-style:italic;">(Topic 230):</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-style:italic;">Restricted Cash</font><font style="display: inline;">.&nbsp;The purpose of ASU 2016-18 is to clarify guidance and presentation related to restricted cash in the statements of cash flows as well as increased disclosure requirements. It requires beginning-of-period and end-of-period total amounts shown on the statements of cash flows to include cash and cash equivalents as well as restricted cash and restricted cash equivalents. We adopted ASU 2016-18 effective October 1, 2018. The adoption of ASU 2016-18 did not have a material effect on the presentation of our consolidated statements of cash flows or related disclosures.&nbsp; </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In January 2017, the FASB issued ASU 2017-04,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Intangibles - Goodwill and Other Topics&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 350)</font><font style="display: inline;font-style:italic;color:#000000;">: Simplifying the Test for Goodwill Impairment</font><font style="display: inline;color:#000000;">. The purpose of ASU 2017-04 is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the impaired fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January&nbsp;1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position or results of operations.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In May 2017, the FASB issued ASU 2017-09,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Compensation - Stock Compensation&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 718)</font><font style="display: inline;font-style:italic;color:#000000;">: Scope of Modification Accounting</font><font style="display: inline;color:#000000;">. The purpose of ASU 2017-09 is to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. </font><font style="display: inline;color:#000000;">The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. We adopted </font><font style="display: inline;color:#000000;">ASU 2017-09 effective October&nbsp;1, 2018. The adoption of ASU 2017-09 did not have a material effect on our financial position or results of operations.&nbsp; </font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In June 2018, the FASB issued ASU 2018-07,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Compensation - Stock Compensation&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 718)</font><font style="display: inline;font-style:italic;color:#000000;">: Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display: inline;color:#000000;">. The purpose of ASU 2018-07 is to expand the scope of </font><font style="display: inline;font-style:italic;color:#000000;">Topic 718, Compensation&#x2014;Stock Compensation</font><font style="display: inline;color:#000000;"> (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 will be effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than the Company&#x2019;s adoption date of </font><font style="display: inline;font-style:italic;color:#000000;">Topic 606, Revenue from Contracts with Customers</font><font style="display: inline;color:#000000;">. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. The adoption of ASU 2018-07 is not expected to have a material effect on our financial position or results of operations but should simplify the process by which the Company measures compensation expense for share-based payments to nonemployees.</font><font style="display: inline;font-weight:bold;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In August 2018, the FASB issued ASU 2018-13, </font><font style="display: inline;font-style:italic;color:#000000;">Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Change to the Disclosure Requirements for Fair Value Measurement</font><font style="display: inline;color:#000000;">. ASU 2018-13 </font><font style="display: inline;color:#000000;">modifies the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy.&nbsp;ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 and early adoption is permitted</font><font style="display: inline;color:#000000;">. The adoption of ASU 2018-13 is not expected to have a material effect on our financial position or results of operations </font><font style="display: inline;color:#000000;">as it modifies disclosure requirements only.</font> </p> <p><font size="1"> </font></p> </div> </div> -503707 -437084 -2928851 -1884278 14644689 5894486 12389248 6733441 -12133132 -12133000 -8122000 -3992000 -19000 -4696550 -4697000 -2574000 -1960000 -163000 -3136317 -3136000 -4758000 -5250000 6872000 -2124590 -2125000 -2440000 -2889000 3204000 33200000 62300000 36200000 500000 18800000 14400000 16600000 19600000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Principles of consolidation and nature of operations</font><font style="display: inline;">: Veru Inc. is </font><font style="display: inline;color:#000000;">referred to in these notes collectively with its subsidiaries as &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company.&#x201D; </font><font style="display: inline;">The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (&#x201C;APP&#x201D;) and The Female Health Company Limited, and The Female Health Company Limited&#x2019;s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the &#x201C;U.K. subsidiary&#x201D;), and The Female Health Company (UK) plc&#x2019;s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the &#x201C;Malaysia subsidiary&#x201D;). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the &#x201C;APP Acquisition&#x201D;) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer health care product, the FC2 </font><font style="display: inline;">Female Condom/FC2 Internal Condom&#xAE; (&#x201C;FC2&#x201D;)</font><font style="display: inline;">.&nbsp;&nbsp;The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company </font><font style="display: inline;">focused on oncology and urology</font><font style="display: inline;"> with multiple drug products under clinical development.&nbsp;&nbsp;Most of the Company&#x2019;s net revenues during the three and six months ended March 31, 2019 and 2018 were derived from sales of FC2.&nbsp; </font> </p> <p><font size="1"> </font></p> </div> </div> 340000 340000 965152 776178 -600000 -600000 2465657 2472422 30000 30000 -350595 -2536695 -15580 -2412 52031 25637 -1942 174357 120000 1913 644 0.01 0.50 0.01 0.50 5000000 15000 1040000 1500000 700000 77000000 154000000 5000000 15000 1040000 1500000 700000 0 0 0 0 0 0 0 0 0 548000 0 0 0 548000 1148345 1220908 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Reclassifications</font><font style="display: inline;">: &nbsp;</font><font style="display: inline;">Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. </font><font style="display: inline;">These reclassifications had no effect on </font><font style="display: inline;color:#000000;">the results of operations or financial position for any period presented.</font> </p> <p><font size="1"> </font></p> </div> </div> 9131967 10000000 2200000 1300000 200000 200000 4305970 287686 4018284 4306019 287686 4018333 404552 320802 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Equipment, furniture and fixtures</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,018,333&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,018,284&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Leasehold improvements</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">287,686&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">287,686&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,306,019&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,305,970&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: accumulated depreciation and amortization</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,985,217) </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,901,418) </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Plant and equipment, net</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">320,802&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">404,552&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> P10Y P10Y P5Y P5Y P7Y P3Y 3764137 642485 600000 3834202 2600000 1200000 1400000 600000 3191717 4035162 2076794 5272410 2910587 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Research and development costs</font><font style="display: inline;">: Research and development costs are expensed as they are incurred and include salaries and benefits, clinical trial costs and contract services. Nonrefundable advance payments made for goods or services to be used in research and development activities are deferred and capitalized until the goods have been delivered or the related services have been performed. If the goods are no longer expected to be delivered or the services are no longer expected to be performed, the Company would be required to expense the related capitalized advance payments. The Company did not have any capitalized nonrefundable advance payments as of March 31, 2019 and September 30, 2018.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Company records estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials and contract manufacturing activities. These costs are a significant component of the Company&#x2019;s research and development expenses. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed, number of patients enrolled and the rate of patient enrollments may vary from the Company&#x2019;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#x2019;s accruals could materially affect the Company&#x2019;s results of operations. </font> </p> <p><font size="1"> </font></p> </div> </div> 135000 0 250000 -58201651 -64384484 5159485 5159000 278000 1975000 1033000 678000 1195000 2572872 2573000 278000 981000 715000 378000 221000 13347924 13348000 677000 1098000 5646000 233000 1948000 3746000 6976115 6976000 677000 1098000 2596000 24000 590000 1991000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Unearned revenue</font><font style="display: inline;">: The Company records an unearned revenue liability if a customer pays consideration before the Company transfers the product to the customer under the terms of a contract. Unearned revenue is recognized as revenue after control of the product is transferred to the customer and all revenue recognition criteria have been met.&nbsp;&nbsp;The Company had no unearned revenue at March 31, 2019. Unearned revenue at September&nbsp;30, 2018 was approximately </font><font style="display: inline;">$187,000</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;">and was comprised of sales made to a large distributor who has the right to return product under certain conditions. </font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Revenue recognition</font><font style="display: inline;">: Revenue is recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company generates nearly all of its revenue from direct product sales. Revenue from direct product sales is generally recognized when the customer obtains control of the product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have significant unusual payment terms beyond </font><font style="display: inline;">120</font><font style="display: inline;"> days in its contracts with customers. See Note 4 for additional information regarding credit terms.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The amount of consideration the Company ultimately receives varies depending upon sales discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an </font><font style="display: inline;color:#000000;">assessment of current contract sales terms and historical payment experience.</font> </p> <p style="margin:0pt;text-indent:18pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt.</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Accounts receivable</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,076,745&nbsp; </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,046,733&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: allowance for doubtful accounts</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(36,201) </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(36,201) </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: allowance for sales and payment term discounts</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(13,309) </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(37,900) </td> </tr> <tr> <td valign="bottom" style="width:58.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Accounts receivable, net</font></p> </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,027,235&nbsp; </td> <td valign="bottom" style="width:02.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:17.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,972,632&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability, fair value at inception</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">346,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">346,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized discounts</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,420) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Accretion of liability using effective interest rate</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">417,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">201,225&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability, net</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">763,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">544,805&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Embedded derivative liability at fair value (see Note 3)</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,578,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,209,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Residual Royalty Agreement liability</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,341,522&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,753,805&nbsp; </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30,</font></p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Deferred tax assets:</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Federal net operating loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,057,926&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,973,047&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">State net operating loss carryforwards</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,468,061&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,195,865&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Foreign net operating loss carryforwards &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">10,621,438&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">10,595,518&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Foreign capital allowance &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">102,098&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">102,098&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">U.K. bad debts</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,700&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,700&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Restricted stock &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,586&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,586&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">U.S. deferred rent</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">54,706&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,902&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Share-based compensation</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">759,875&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">622,442&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other, net &#x2013; U.S.</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">125,508&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">91,419&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other, net &#x2013; Malaysia</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">34,314&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">33,843&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Gross deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,243,212&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,656,420&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Valuation allowance for deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(9,282,271) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,631,078) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Net deferred tax assets</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">12,960,941&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,025,342&nbsp; </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Deferred tax liabilities:</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">In process research and development </font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,675,860) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,675,860) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(518,431) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(549,318) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenant not-to-compete</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(85,044) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(94,321) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,316) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,843) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Net deferred tax liabilities</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,286,651) </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,326,342) </td> </tr> <tr> <td valign="middle" style="width:60.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Net deferred tax asset</font></p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,674,290&nbsp; </td> <td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:16.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:11.95pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,699,000&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="middle" style="width:27.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:27.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="middle" style="width:27.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:27.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:13.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:11.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Income tax benefit at statutory rates</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(841,862) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,077,736) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,273,685) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,628,736) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">State income tax benefit, net of federal benefits</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(199,521) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(385,395) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(301,863) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(948,395) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of change in U.S. tax rate</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(187,000) </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Non-deductible expenses &#x2013; other</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,364&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,702&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,783&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">12,702&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of lower foreign income tax rates</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,830&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">50,981&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,527) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">80,386&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Effect of deemed dividend </font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">32,318&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">63,627&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,025) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">101,032&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(22,863) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">122,574&nbsp; </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Change in valuation allowance</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,028,063&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,651,193&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:42.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Income tax expense (benefit)</font></p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">25,167&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,302,416) </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">117,665&nbsp; </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,548,469) </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Cost of sales</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,778&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,797&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">15,730&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,061&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Selling, general and administrative</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">407,426&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">362,006&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">734,435&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">537,344&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Research and development</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">81,005&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">48,045&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">163,300&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">76,897&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">496,209&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">411,848&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">913,465&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:11.96%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">619,302&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Accumulated</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Net Book</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amortization</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Intangible assets with finite lives:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology - PREBOOST</font><font style="display: inline;font-family:Calibri;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,400,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">404,269&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,995,731&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenants not-to-compete</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">500,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">172,619&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">327,381&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets with finite lives</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">576,888&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,323,112&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Acquired in-process research and development assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">576,888&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,323,112&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The gross carrying amounts and net book value of intangible assets are as follows at </font><font style="display: inline;color:#000000;">September 30, 2018</font><font style="display: inline;color:#000000;">:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Gross Carrying</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Accumulated</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Net Book</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amount</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Amortization</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Intangible assets with finite lives:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Developed technology - PREBOOST</font><font style="display: inline;font-family:Calibri;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,400,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">285,366&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,114,634&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Covenants not-to-compete</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">500,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">136,905&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">363,095&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets with finite lives</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">422,271&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,477,729&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Acquired in-process research and development assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,000,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total intangible assets</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,900,000&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">422,271&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:14.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,477,729&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">FC2</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Raw material</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">599,772&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">366,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Work in process</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">62,710&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">77,669&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,786,083&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,232,864&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Inventory, gross</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,448,565&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,676,753&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: inventory reserves</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(451,041) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(391,861) </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">FC2, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,997,524&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,284,892&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">PREBOOST</font><font style="display: inline;font-family:Calibri;color:#000000;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,138&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Inventory, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,998,201&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,302,030&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30, </font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Aggregate repayment obligation</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,500,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,500,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Cumulative payments</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,834,202) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(642,485) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized discounts </font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,212,466) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(8,475,874) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Less: Unamortized deferred issuance costs </font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(149,783) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(204,353) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, net</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7,303,549&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,177,288&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Add: Embedded derivative liability at fair value (see Note 3)</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,251,000&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,217,000&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,554,549&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">9,394,288&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, short-term portion</font></p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,836,615) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(6,692,718) </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Credit agreement, long-term portion </font></p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,717,934&nbsp; </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:14.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,701,570&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:64.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.92%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:14.80%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">&nbsp; &nbsp;</font></p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">For the three months ended</font><br /><font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">For the six months ended</font><br /><font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Operating (loss) income:</font></p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(In thousands)</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(In thousands)</font></p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Commercial</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,204&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(163) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,872&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(19) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Research and Development </font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,889) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,960) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,250) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,992) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Corporate</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,440) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,574) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,758) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(8,122) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,125) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,697) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,136) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(12,133) </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Revenues:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">United States</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,596&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">981&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,646&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,975&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Brazil</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,098&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,098&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">United Arab Emirates</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">278&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">278&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">South Africa</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">715&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">233&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,033&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Zimbabwe</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">590&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">378&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,948&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">678&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,991&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">221&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,746&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,195&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,976&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,573&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,348&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,159&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="4" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Weighted Average</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Remaining</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Aggregate</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Number of</font></p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Exercise Price </font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Contractual&nbsp;Term</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Intrinsic</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Shares</font></p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Per Share</font></p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(years)</font></p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Value</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Outstanding at September 30, 2018</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,645,312&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.59&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Granted</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">880,882&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.42&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Exercised</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(166,667) </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.20&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Forfeited</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(301,834) </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.52&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Outstanding at March 31, 2019</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,057,693&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.57&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">7.83&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">785,435&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:39.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Exercisable at March 31, 2019</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,042,285&nbsp; </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.46&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:16.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6.51&nbsp; </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">436,840&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;border-bottom:1pt solid #000000 ;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Weighted Average Assumptions:</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected volatility</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">65.45%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">62.34%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66.88%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">61.38%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected dividend yield</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Risk-free interest rate</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.27%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.76%&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.59%&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2.47%&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Expected term (in years)</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.9&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6.0&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.7&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5.8&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:38.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Fair value of options granted</font></p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.90&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.28&nbsp; </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.85&nbsp; </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.93&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 13 &#x2013; Industry Segments and Financial Information about Foreign and Domestic Operations</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company currently operates in two reporting segments: </font><font style="display: inline;">Commercial</font><font style="display: inline;"> and </font><font style="display: inline;">Research and Development</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;color:#000000;">The Commercial segment consists of FC2, PREBOOST and drug commercialization costs.&nbsp;&nbsp;The Research and Development segment consists of multiple drug products under clinical development for oncology and urology. </font><font style="display: inline;">There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of non-operating expenses and income taxes. Our chief operating decision-maker (&#x201C;CODM&#x201D;) is Mitchell S. Steiner, M.D., our Chairman, President and Chief Executive Officer.</font><font style="display: inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Information about the Company's operations by segment and geographic area is as follows:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">&nbsp; &nbsp;</font></p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">For the three months ended</font><br /><font style="display: inline;font-weight:bold;">March 31,</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">For the six months ended</font><br /><font style="display: inline;font-weight:bold;">March 31,</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Operating (loss) income:</font></p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(In thousands)</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">(In thousands)</font></p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Commercial</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,204&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(163) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,872&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(19) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Research and Development </font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,889) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,960) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,250) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,992) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Corporate</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,440) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,574) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,758) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(8,122) </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,125) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,697) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,136) </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(12,133) </td> </tr> <tr> <td valign="bottom" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font><font style="display: inline;font-weight:bold;">Revenues:</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">United States</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,596&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">981&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,646&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,975&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Brazil</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,098&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,098&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">United Arab Emirates</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">278&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">278&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">South Africa</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">715&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">233&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,033&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Zimbabwe</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">590&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">378&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,948&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">678&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Other</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,991&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">221&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,746&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,195&nbsp; </td> </tr> <tr> <td valign="middle" style="width:39.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,976&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,573&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,348&nbsp; </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:12.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,159&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">All of our net revenues, which are primarily derived from the sale of FC2, are attributed to our Commercial reporting segment. The loss on settlement of accounts receivable and depreciation and amortization related to long-lived assets that are not utilized in the production of FC2 are not reported as part of the reporting segments or reviewed by the CODM. These amounts are included in Corporate in the reconciliations above. Total assets are not presented by reporting segment as they are not reviewed by the CODM when evaluating the reporting segments&#x2019; performance.&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div> 6845390 3817692 7116838 3822854 619302 913465 2018-10-31 2018-10-31 P10Y P5Y 0.0000 0.0000 0.0000 0.0000 P5Y9M18D P6Y P5Y8M12D P5Y10M24D 0.6138 0.6234 0.6688 0.6545 Monte Carlo Simulation 0.0247 0.0276 0.0259 0.0227 0 4700000 6000000 0 4117272 190868 2042285 1.46 P6Y6M4D 48000 880882 785435 5645312 6057693 1.59 1.57 P7Y9M29D 436840 140000 50000 140000 50000 1.20 1.52 1.42 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Share-based compensation</font><font style="display: inline;">: The Company recognizes share-based compensation expense in connection with its share-based awards based on the estimated fair value of the awards on the date of grant, on a straight-line basis over the vesting period. Calculating share-based compensation expense requires the input of highly subjective judgment and assumptions, including estimates of the expected life of the share-based award, stock price volatility and risk-free interest rates.</font> </p> <p><font size="1"> </font></p> </div> </div> 0.95 1.46 1.40 0.50 55392193 55696650 55696650 57468660 64801517 64968184 48453205 -581519 90550669 553922 -34263262 -7806605 44750588 -581519 91102159 556967 -38520414 -7806605 41331218 -581519 91514007 556967 -42351632 -7806605 29481418 -581519 95496506 574687 -58201651 -7806605 36881843 -581519 104972401 648015 -60350449 -7806605 33544017 -581519 105666943 649682 -64384484 -7806605 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Note 8 &#x2013; Stockholders&#x2019; Equity</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Preferred Stock</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">The Company has </font><font style="display: inline;font-size:10pt;">5,000,000</font><font style="display: inline;font-size:10pt;"> shares designated as Class A Preferred Stock with a par value of </font><font style="display: inline;font-size:10pt;">$0.01</font><font style="display: inline;font-size:10pt;"> per share. There are </font><font style="display: inline;font-size:10pt;">1,040,000</font><font style="display: inline;font-size:10pt;"> shares of Class A Preferred Stock &#x2013; Series 1 authorized; </font><font style="display: inline;font-size:10pt;">1,500,000</font><font style="display: inline;font-size:10pt;"> shares of Class A Preferred Stock &#x2013; Series 2 authorized; </font><font style="display: inline;font-size:10pt;">700,000</font><font style="display: inline;font-size:10pt;"> shares of Class A Preferred Stock &#x2013; Series 3 authorized; and </font><font style="display: inline;font-size:10pt;">548,000</font><font style="display: inline;font-size:10pt;"> shares of Class A Preferred Stock &#x2013; Series 4 (the &#x201C;Series 4 Preferred Stock&#x201D;) authorized.&nbsp;&nbsp;There were </font><font style="display: inline;font-size:10pt;">no</font><font style="display: inline;font-size:10pt;"> shares of Class A Preferred Stock of any series </font><font style="display: inline;font-size:10pt;">issued</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">outstanding</font><font style="display: inline;font-size:10pt;"> at March 31, 2019 and September 30, 2018.&nbsp;&nbsp;The Company has </font><font style="display: inline;font-size:10pt;">15,000</font><font style="display: inline;font-size:10pt;"> shares designated as Class B Preferred Stock with a par value of </font><font style="display: inline;font-size:10pt;">$0.50</font><font style="display: inline;font-size:10pt;"> per share. There were no shares of Class&nbsp;B Preferred Stock </font><font style="display: inline;font-size:10pt;">issued</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">outstanding</font><font style="display: inline;font-size:10pt;"> at March 31, 2019 and September 30, 2018. </font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt"> <font style="display: inline;text-decoration:underline;">Common Stock </font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">On March 27, 2019, following approval by stockholders at the Company&#x2019;s annual meeting of stockholders held on March 26, 2019, the Company filed an amendment to its articles of incorporation to increase the number of authorized shares of common stock from </font><font style="display: inline;font-size:10pt;">77,000,000</font><font style="display: inline;font-size:10pt;"> to </font><font style="display: inline;font-size:10pt;">154,000,000</font><font style="display: inline;font-size:10pt;"> shares. </font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;text-decoration:underline;">Common Stock Offering</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">On October 1, 2018, we completed an underwritten public offering of </font><font style="display: inline;font-size:10pt;">7,142,857</font><font style="display: inline;font-size:10pt;"> shares of our common stock, at a public offering price of </font><font style="display: inline;font-size:10pt;">$1.40</font><font style="display: inline;font-size:10pt;"> per share. Net proceeds to the Company from this offering were </font><font style="display: inline;font-size:10pt;">$9.1</font><font style="display: inline;font-size:10pt;"> million after deducting underwriting discounts and commissions and costs paid by the </font><font style="display: inline;font-size:10pt;">Company. </font><font style="display: inline;font-size:10pt;">All of the shares sold in the offering were by the Company. The offering was made pursuant to the Shelf Registration Statement.</font> </p> <p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Common Stock Purchase Warrants</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">In connection with the closing of the APP Acquisition, the Company issued a warrant to purchase up to </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">2,585,379</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> shares of the Company's common stock to Torreya Capital, the Company's financial advisor (the &#x201C;Financial Advisor Warrant&#x201D;).&nbsp;&nbsp;The Financial Advisor Warrant has a </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">five</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">-year term expiring October 31, 2021, a cashless exercise&nbsp;feature and a strike price equal to </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$1.93</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> per share. The Financial Advisor Warrant vested upon issuance and remains outstanding at March 31, 2019.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">In May 2018, the Company issued </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">two</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> warrants to purchase a total of up to </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">750,000</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> shares of the Company's common stock at </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">$2.31</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> per share in connection with a services agreement. The services agreement was terminated in March 2019 and the warrants were cancelled at the same time. Prior to termination of the services agreement, for measurement and recognition purposes, the Company utilized the lowest aggregate amount within the range of potential values, which was </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">zero</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">. Therefore, in prior periods, the Company had determined the fair value of these warrants to be zero and had not recognized any compensation expense related to these warrants.</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;text-decoration:underline;">Aspire Capital Purchase Agreement </font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-style:italic;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">On December&nbsp;29, 2017, the Company entered into a common stock purchase agreement (the &#x201C;Purchase Agreement&#x201D;) with Aspire Capital Fund, LLC (&#x201C;Aspire Capital&#x201D;) which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right, from time to time in its sole discretion during the </font><font style="display: inline;font-size:10pt;">36</font><font style="display: inline;font-size:10pt;">-month term of the Purchase Agreement, to direct Aspire Capital to purchase up to </font><font style="display: inline;font-size:10pt;">$15.0</font><font style="display: inline;font-size:10pt;">&nbsp;million of the Company&#x2019;s common stock in the aggregate.&nbsp;&nbsp;Concurrently with entering into the Purchase Agreement, the Company also entered into a registration rights agreement with Aspire Capital (the &#x201C;Registration Rights Agreement&#x201D;), in which the Company agreed to prepare and file under the Securities Act of 1933 and under the Shelf Registration Statement, a prospectus supplement for the sale or potential sale of the shares of the Company&#x2019;s common stock that have been and may be issued to Aspire Capital under the Purchase Agreement.</font> </p> <p style="margin:0pt -14.05pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt -14.05pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Under the Purchase Agreement, on any trading day selected by the Company, the Company has the right, in its sole discretion, to present Aspire Capital with a purchase notice (each, a &#x201C;Purchase Notice&#x201D;), directing Aspire Capital (as principal) to purchase up to </font><font style="display: inline;">200,000</font><font style="display: inline;"> shares of the Company&#x2019;s common stock per business day, up to </font><font style="display: inline;">$15.0</font><font style="display: inline;">&nbsp;million of the Company&#x2019;s common stock in the aggregate at a per share price (the "Purchase Price") equal to the lesser of the lowest sale price of the Company&#x2019;s common stock on the purchase date or the average of the three </font><font style="display: inline;">lowest closing sale prices for the Company&#x2019;s common stock during the ten consecutive trading days ending on </font><font style="display: inline;">the trading day immediately preceding the </font><font style="display: inline;">purchase date.</font> </p> <p style="margin:0pt -14.05pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt -14.05pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In addition, on any date on which the Company submits a Purchase Notice to Aspire Capital in an amount equal to </font><font style="display: inline;">200,000</font><font style="display: inline;"> shares and the closing sale price of our common stock is equal to or greater than </font><font style="display: inline;">$0.50</font><font style="display: inline;"> per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a &#x201C;VWAP Purchase Notice&#x201D;) directing Aspire Capital to purchase an amount of common stock equal to up to </font><font style="display: inline;">30%</font><font style="display: inline;"> of the aggregate shares of the common stock traded on its principal market on the next trading day (the VWAP Purchase Date), subject to a maximum number of shares the Company may determine.&nbsp;&nbsp;The purchase price per share pursuant to such VWAP Purchase Notice is generally </font><font style="display: inline;">97%</font><font style="display: inline;"> of the volume-weighted average price for the Company&#x2019;s common stock traded on its principal market on the VWAP Purchase Date.</font> </p> <p style="margin:0pt -14.05pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In consideration for entering into the Purchase Agreement, concurrently with the execution of the Purchase Agreement, the Company issued to Aspire Capital </font><font style="display: inline;">304,457</font><font style="display: inline;"> shares of the Company&#x2019;s common stock.&nbsp;The shares of common stock issued as consideration were valued at approximately </font><font style="display: inline;">$347,000</font><font style="display: inline;">. This amount and related expenses of approximately </font><font style="display: inline;">$78,000</font><font style="display: inline;">, which total approximately </font><font style="display: inline;">$425,000</font><font style="display: inline;">, were recorded as deferred costs. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">During fiscal 2018, we sold an aggregate of </font><font style="display: inline;color:#000000;">1,717,010</font><font style="display: inline;color:#000000;"> shares of common stock to Aspire Capital under the Purchase Agreement resulting in proceeds to the Company of </font><font style="display: inline;color:#000000;">$3.0</font><font style="display: inline;color:#000000;"> million. As a result of these sales, we recorded approximately </font><font style="display: inline;color:#000000;">$85,000</font><font style="display: inline;color:#000000;"> of the deferred costs noted above to additional paid-in capital. The unamortized amount of deferred costs of approximately </font><font style="display: inline;color:#000000;">$340,000</font><font style="display: inline;color:#000000;"> is included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. As of March 31, 2019, the amount remaining under the Purchase Agreement was </font><font style="display: inline;color:#000000;">$12.0</font><font style="display: inline;color:#000000;"> million. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> 304457 304457 1717010 7142857 7142857 301834 0 190000 166667 166667 347000 347081 344036 3045 3000000 9131967 9060539 71428 207454 207454 411848 411848 417256 417256 496209 496209 -1900 1900 200000 198333 1667 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 14 &#x2013; Subsequent Events</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">On May 13, 2019, the Company entered into an amendment (the &#x201C;Second Amendment&#x201D;) to the Credit Agreement discussed in Note 7.&nbsp; The Second Amendment provides for reduced percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2019, a return to the current percentages used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2020 and increased percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2021 and thereafter until the loan has been repaid. The Second Amendment also provides for an increase in the repayment amount from </font><font style="display: inline;">175%</font><font style="display: inline;"> to </font><font style="display: inline;">176.5%</font><font style="display: inline;"> of the aggregate amount advanced. In addition, the Second Amendment provides for payments under the Residual Royalty Agreement to commence at the same time as they would have commenced prior to the Second Amendment. The Second Amendment also eliminates the Company&#x2019;s option to draw up to an additional </font><font style="display: inline;">$2.0</font><font style="display: inline;"> million under the Credit Agreement depending on the Company entering into agreements to distribute FC2 in Brazil and South Africa as the Company has determined that it would not make such draws. As a result of the Second Amendment, the Company&#x2019;s quarterly revenue-based payment due May 15, 2019 will decrease from approximately </font><font style="display: inline;">$1.7</font><font style="display: inline;"> million to approximately </font><font style="display: inline;">$0.9</font><font style="display: inline;"> million. At this time, the Company is unable to determine all of the financial effects of the Second Amendment, which will likely result in the Company recording an extinguishment loss due to the modification of the terms of the Credit Agreement in the quarter ending June&nbsp;30, 2019. An estimate of the loss amount cannot be made at this time as the Company is currently analyzing the accounting for the transaction, which includes fair value determinations. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> </p> <p><font size="1"> </font></p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;color:#000000;"></font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 5 &#x2013; Balance Sheet Information </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Inventory</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Inventories are valued at the lower of cost or net realizable value.&nbsp;&nbsp;The cost is determined using the first-in, first-out (&#x201C;FIFO&#x201D;) method.&nbsp;&nbsp;Inventories are also written down for management&#x2019;s estimates of product which will not sell prior to its expiration date.&nbsp;&nbsp;Write-downs of inventories establish a new cost basis which is not increased for future increases in the net realizable value of inventories or changes in estimated obsolescence.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Inventory consisted of the following at March 31, 2019 </font><font style="display: inline;">and </font><font style="display: inline;">September 30, 2018</font><font style="display: inline;">: &nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31, </font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">FC2</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Raw material</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">599,772&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">366,220&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Work in process</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">62,710&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">77,669&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,786,083&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,232,864&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Inventory, gross</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,448,565&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,676,753&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: inventory reserves</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(451,041) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(391,861) </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">FC2, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,997,524&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,284,892&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">PREBOOST</font><font style="display: inline;font-family:Calibri;color:#000000;">&#xAE;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 12pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Finished goods</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">677&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,138&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Inventory, net</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,998,201&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,302,030&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Fixed Assets</font> </p> <p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">We record equipment, furniture and fixtures, and leasehold improvements at historical cost.&nbsp;&nbsp;Expenditures for maintenance and repairs are recorded to expense. Depreciation and amortization are primarily computed using the straight-line method.&nbsp;&nbsp;Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows:</font> </p> <p style="margin:0pt;border-top:1pt none #D9D9D9 ;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Manufacturing equipment</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">5</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">10</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Office equipment</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">3</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">5</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Furniture and fixtures</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">7</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">10</font><font style="display: inline;"> years</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">Leasehold improvements are depreciated on a straight-line basis over the lesser of the remaining lease term or the estimated useful lives of the improvements.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Plant and equipment consisted of the following at March 31, 2019 </font><font style="display: inline;">and September 30, 2018:</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">March 31,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">September 30,</font><br /><font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Equipment, furniture and fixtures</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,018,333&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,018,284&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Leasehold improvements</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">287,686&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">287,686&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,306,019&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,305,970&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Less: accumulated depreciation and amortization</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,985,217) </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,901,418) </td> </tr> <tr> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font><font style="display: inline;color:#000000;">Plant and equipment, net</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">320,802&nbsp; </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:auto;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">404,552&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> 2183704 2183704 7806605 7806605 1600000 0 53253901 53355944 62659352 62767258 981357 437928 5000 37900 13309 2000000 1.93 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Three Months Ended</font><br /><font style="display: inline;font-weight:bold;"> March 31, </font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Six Months Ended</font><br /><font style="display: inline;font-weight:bold;"> March 31, </font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Amortization of Credit Agreement and Residual Royalty Agreement discounts</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,107,622&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">317,747&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,265,828&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">317,747&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Accretion of Residual Royalty Agreement liability</font></p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">123,946&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">27,278&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">216,297&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">27,278&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Amortization of deferred issuance costs</font></p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">26,704&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,570&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">54,570&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 0pt 0pt 6pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,570&nbsp; </td> </tr> <tr> <td valign="bottom" style="width:49.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,258,272&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">350,595&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,536,695&nbsp; </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.28%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">$</font></p> </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">350,595&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> P150D P120D P30D 78000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Deferred financing costs</font><font style="display: inline;">:</font><font style="display: inline;font-weight:bold;font-style:italic;">&nbsp;</font><font style="display: inline;">Costs incurred in connection with the </font><font style="display: inline;">common stock purchase agreement discussed in Note 8 </font><font style="display: inline;">have been included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. When shares of the Company&#x2019;s common stock are sold under the common stock purchase agreement, a pro-rata portion of the deferred costs is recorded to additional paid-in-capital. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">As discussed in Note 8, in connection with the </font><font style="display: inline;">common stock offering that closed on October 1, 2018, we incurred c</font><font style="display: inline;">osts </font><font style="display: inline;">of approximately </font><font style="display: inline;">$190,000</font><font style="display: inline;"> through September 30, 2018. This amount was included in </font><font style="display: inline;">other assets on the accompanying unaudited condensed consolidated balance sheet at September 30, 2018. These costs were charged to additional paid-in capital in the six months ended March 31, 2019 after the common stock offering was closed.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Costs incurred in connection with the </font><font style="display: inline;">issuance of debt discussed in Note 7 are presented as a reduction of the debt on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. These issuance costs are being amortized using the effective interest method over the expected repayment period of the debt, which is currently estimated to occur in the third quarter of fiscal 2021. The amortization is included in interest expense on the accompanying unaudited condensed consolidated statements of operations.</font> </p> <p><font size="1"> </font></p> </div> </div> 102098 102098 549318 518431 4675860 4675860 88239 84394 0.90 0.00 0.93 1.28 0.85 0.90 0.97 63627 32318 77840 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 2 &#x2013; Liquidity</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The Company has incurred quarterly operating losses since the fourth quarter of fiscal 2016 and anticipates that it will continue to consume cash and incur substantial net losses as it develops its drug candidates. Because of the numerous risks and uncertainties associated with the development of pharmaceutical products, the Company is unable to estimate the exact amounts of capital outlays and operating expenditures necessary to fund development of its drug candidates and obtain regulatory approvals. The Company&#x2019;s future capital requirements will depend on many factors.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The Company believes its current cash position and its ability to secure equity financing or other financing alternatives are adequate to fund planned operations of the Company for the next 12 months. Such financing alternatives may include debt financing, common stock offerings or financing involving convertible debt or other equity-linked securities and may include financings under the Company's effective shelf registration statement on Form S-3 (File No. 333-221120) (the &#x201C;Shelf Registration Statement&#x201D;).&nbsp;&nbsp;The Company intends to be opportunistic when pursuing equity financing which could include selling common stock under its common stock purchase agreement with Aspire Capital Fund, LLC (see Note 8) and/or a marketed deal with an investment bank. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> </p> <p><font size="1"> </font></p> <p style="margin:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;"></font> </p> <p><font size="1"> </font></p> </div> </div> 0.30 10000000 47500000 30000000 8177288 7303549 9900000 2000000 10000000 12500000 12500000 2 3 1 3 2 3 1 2 4 15000000 2 <div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Patents and trademarks</font><font style="display: inline;">: The costs for patents and trademarks are expensed when incurred.&nbsp; </font> </p> <p><font size="1"> </font></p> </div> </div> 0.50 1.75 1.75 1.765 1.75 0.05 0.325 0.05 0.25 0.10 P12M P12M P12M P12M P90D 0.65 3058 1000000 544805 763522 1753805 1753805 2341522 2341522 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">Six Months Ended March 31,</font></p> </td> </tr> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2019</font></p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;color:#000000;">2018</font></p> </td> </tr> <tr> <td valign="top" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 14pt"> <font style="display: inline;font-weight:bold;font-size:14pt;">&#xFEFF;</font></p> </td> <td valign="top" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.20pt;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Beginning balance </font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,201&nbsp; </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">38,103&nbsp; </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Charges to expense</font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">3,058&nbsp; </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Charge-offs</font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt 3.25pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;"> &nbsp;&#x2014;</font></p> </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,000) </td> </tr> <tr> <td valign="middle" style="width:54.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Ending balance </font></p> </td> <td valign="middle" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,201&nbsp; </td> <td valign="middle" style="width:02.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:19.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">36,161&nbsp; </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">March 31,</font><br /><font style="display: inline;font-weight:bold;">2019</font></p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">September 30,</font><br /><font style="display: inline;font-weight:bold;">2018</font></p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">&#xFEFF;</font></p> </td> <td valign="middle" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="middle" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax asset &#x2013; U.K.</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,535,836&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,509,915&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax asset &#x2013; Malaysia</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">34,314&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">33,843&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total long-term deferred tax asset</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,570,150&nbsp; </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,543,758&nbsp; </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Long-term deferred tax liability &#x2013; U.S.</font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(895,860) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(844,758) </td> </tr> <tr> <td valign="middle" style="width:57.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Total long-term deferred tax liability </font></p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(895,860) </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> <td valign="bottom" style="width:01.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">$</font></p> </td> <td valign="bottom" style="width:18.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(844,758) </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="bottom" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 1pt"> <font style="display: inline;font-size:1pt;">&#xFEFF;</font></p> </td> <td valign="bottom" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> &nbsp;</p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Manufacturing equipment</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">5</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">10</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Office equipment</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">3</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">5</font><font style="display: inline;"> years</font></p> </td> </tr> <tr> <td valign="middle" style="width:76.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font><font style="display: inline;">Furniture and fixtures</font></p> </td> <td valign="middle" style="width:23.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> <p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">7</font><font style="display: inline;"> &#x2013; </font><font style="display: inline;">10</font><font style="display: inline;"> years</font></p> </td> </tr> </table></div> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div> 347081 190000 143943 P36M 2420 8475874 6212466 EX-101.SCH 8 veru-20190331.xsd EX-101.SCH 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Components Of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Balance Sheet Information (Components Of Inventory) (Details) link:presentationLink link:calculationLink link:definitionLink 40504 - Disclosure - Balance Sheet Information (Plant and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Income Taxes (Reconciliation Of Income Tax Expense (Benefit)) (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements Of Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Liquidity link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Accounts Receivable and Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Basis of Presentation (Policy) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Intangible Assets and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Basis of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Fair Value Measurements (Schedule of Qualitative Information) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Summary Of Components Of Allowance For Doubtful Accounts) (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Balance Sheet Information (Schedule of Estimated Useful Lives of Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets and Goodwill (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Intangible Assets and Goodwill (Gross Carrying Amounts of Finite Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Debt (Credit Agreement) (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Debt (Residual Royalty Agreement Liability) (Details) link:presentationLink link:calculationLink link:definitionLink 40704 - Disclosure - Debt (Credit Agreement Interest Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Share-Based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Share-Based Compensation (Recorded Share-Based Compensation Expenses) (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Share-Based Compensation (Weighted Average Assumptions For Options Granted) (Details) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Share-Based Compensation (Summary Of Stock Options Outstanding And Exercisable) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Contingent Liabilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41105 - Disclosure - Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Net Loss Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations (Schedule of Segment Reporting Information) (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Subsequent Events (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 veru-20190331_cal.xml EX-101.CAL EX-101.DEF 10 veru-20190331_def.xml EX-101.DEF EX-101.LAB 11 veru-20190331_lab.xml EX-101.LAB EX-101.PRE 12 veru-20190331_pre.xml EX-101.PRE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document And Entity Information - shares
6 Months Ended
Mar. 31, 2019
May 10, 2019
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Amendment Flag false  
Entity Registrant Name VERU INC.  
Entity Central Index Key 0000863894  
Current Fiscal Year End Date --09-30  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Trading Symbol veru  
Entity Common Stock, Shares Outstanding   62,790,208
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Current assets:    
Cash $ 5,896,536 $ 3,759,509
Accounts receivable, net 4,027,235 3,972,632
Inventory, net 2,998,201 2,302,030
Prepaid expenses and other current assets 1,220,908 1,148,345
Total current assets 14,142,880 11,182,516
Plant and equipment, net 320,802 404,552
Deferred income taxes 8,570,150 8,543,758
Intangible assets, net 20,323,112 20,477,729
Goodwill 6,878,932 6,878,932
Other assets 776,178 965,152
Total assets 51,012,054 48,452,639
Current liabilities:    
Accounts payable 2,525,162 3,226,036
Accrued research and development costs 437,928 981,357
Accrued expenses and other current liabilities 2,472,422 2,465,657
Credit agreement, short-term portion (Note 7) 5,836,615 6,692,718
Unearned revenue   187,159
Total current liabilities 11,272,127 13,552,927
Credit agreement, long-term portion (Note 7) 2,717,934 2,701,570
Residual royalty agreement (Note 7) 2,341,522 1,753,805
Deferred income taxes 895,860 844,758
Deferred rent 210,594 88,161
Other liabilities 30,000 30,000
Total liabilities 17,468,037 18,971,221
Commitments and contingencies (Note 11)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at March 31, 2019 and September 30,2018
Common stock, par value $0.01 per share; 154,000,000 and 77,000,000 shares authorized, 64,968,184 and 57,468,660 shares issued and 62,784,480 and 55,284,956 shares outstanding at March 31, 2019 and September 30, 2018, respectively 649,682 574,687
Additional paid-in-capital 105,666,943 95,496,506
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (64,384,484) (58,201,651)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 33,544,017 29,481,418
Total liabilities and stockholders' equity $ 51,012,054 $ 48,452,639
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2019
Sep. 30, 2018
Condensed Consolidated Balance Sheets [Abstract]    
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Common Stock, par value $ 0.01 $ 0.01
Common Stock, shares authorized 154,000,000 77,000,000
Common Stock, shares issued 64,968,184 57,468,660
Common Stock, shares outstanding 62,784,480 55,284,956
Treasury stock, shares 2,183,704 2,183,704
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Condensed Consolidated Statements Of Operations [Abstract]        
Net revenues $ 6,976,115 $ 2,572,872 $ 13,347,924 $ 5,159,485
Cost of sales 2,367,264 1,374,936 4,094,993 2,647,928
Gross profit 4,608,851 1,197,936 9,252,931 2,511,557
Operating expenses:        
Research and development 2,910,587 2,076,794 5,272,410 4,035,162
Selling, general and administrative 3,822,854 3,817,692 7,116,838 6,845,390
Loss on settlement of accounts receivable       3,764,137
Total operating expenses 6,733,441 5,894,486 12,389,248 14,644,689
Operating loss (2,124,590) (4,696,550) (3,136,317) (12,133,132)
Non-operating (expenses) income:        
Interest expense (1,258,272) (350,595) (2,536,695) (350,595)
Other income (expense), net 25,637 (2,412) 52,031 (15,580)
Change in fair value of derivative liabilities (628,000) (21,000) (403,000) (21,000)
Foreign currency transaction loss (23,643) (63,077) (41,187) (116,532)
Total non-operating expenses (1,884,278) (437,084) (2,928,851) (503,707)
Loss before income taxes (4,008,868) (5,133,634) (6,065,168) (12,636,839)
Income tax expense (benefit) 25,167 (1,302,416) 117,665 (4,548,469)
Net loss $ (4,034,035) $ (3,831,218) $ (6,182,833) $ (8,088,370)
Net loss per basic and diluted common share outstanding $ (0.06) $ (0.07) $ (0.10) $ (0.15)
Basic and diluted weighted average common shares outstanding 62,767,258 53,355,944 62,659,352 53,253,901
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements Of Stockholders’ Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Treasury Stock, at Cost [Member]
Total
Balance at Sep. 30, 2017   $ 553,922 $ 90,550,669 $ (581,519) $ (34,263,262) $ (7,806,605) $ 48,453,205
Balance (in Shares) at Sep. 30, 2017   55,392,193          
Share-based compensation     207,454       207,454
Issuance of shares   $ 3,045 344,036       347,081
Issuance of shares (in Shares)   304,457          
Net loss         (4,257,152)   (4,257,152)
Balance at Dec. 31, 2017   $ 556,967 91,102,159 (581,519) (38,520,414) (7,806,605) 44,750,588
Balance (in Shares) at Dec. 31, 2017   55,696,650          
Balance at Sep. 30, 2017   $ 553,922 90,550,669 (581,519) (34,263,262) (7,806,605) 48,453,205
Balance (in Shares) at Sep. 30, 2017   55,392,193          
Net loss             (8,088,370)
Balance at Mar. 31, 2018   $ 556,967 91,514,007 (581,519) (42,351,632) (7,806,605) 41,331,218
Balance (in Shares) at Mar. 31, 2018   55,696,650          
Balance at Sep. 30, 2017   $ 553,922 90,550,669 (581,519) (34,263,262) (7,806,605) 48,453,205
Balance (in Shares) at Sep. 30, 2017   55,392,193          
Balance at Sep. 30, 2018   $ 574,687 95,496,506 (581,519) (58,201,651) (7,806,605) 29,481,418
Balance (in Shares) at Sep. 30, 2018   57,468,660          
Balance at Dec. 31, 2017   $ 556,967 91,102,159 (581,519) (38,520,414) (7,806,605) 44,750,588
Balance (in Shares) at Dec. 31, 2017   55,696,650          
Share-based compensation     411,848       411,848
Net loss         (3,831,218)   (3,831,218)
Balance at Mar. 31, 2018   $ 556,967 91,514,007 (581,519) (42,351,632) (7,806,605) 41,331,218
Balance (in Shares) at Mar. 31, 2018   55,696,650          
Balance at Sep. 30, 2018   $ 574,687 95,496,506 (581,519) (58,201,651) (7,806,605) 29,481,418
Balance (in Shares) at Sep. 30, 2018   57,468,660          
Share-based compensation     417,256       417,256
Issuance of shares   $ 71,428 9,060,539       9,131,967
Issuance of shares (in Shares)   7,142,857          
Issuance of shares pursuant to share-based awards   $ 1,900 (1,900)        
Issuance of shares pursuant to share-based awards ( in Shares)   190,000          
Net loss         (2,148,798)   (2,148,798)
Balance at Dec. 31, 2018   $ 648,015 104,972,401 (581,519) (60,350,449) (7,806,605) 36,881,843
Balance (in Shares) at Dec. 31, 2018   64,801,517          
Balance at Sep. 30, 2018   $ 574,687 95,496,506 (581,519) (58,201,651) (7,806,605) 29,481,418
Balance (in Shares) at Sep. 30, 2018   57,468,660          
Net loss             (6,182,833)
Balance at Mar. 31, 2019   $ 649,682 105,666,943 (581,519) (64,384,484) (7,806,605) 33,544,017
Balance (in Shares) at Mar. 31, 2019   64,968,184          
Balance at Dec. 31, 2018   $ 648,015 104,972,401 (581,519) (60,350,449) (7,806,605) 36,881,843
Balance (in Shares) at Dec. 31, 2018   64,801,517          
Share-based compensation 496,209 496,209
Issuance of shares pursuant to share-based awards   $ 1,667 198,333       200,000
Issuance of shares pursuant to share-based awards ( in Shares)   166,667          
Net loss         (4,034,035)   (4,034,035)
Balance at Mar. 31, 2019   $ 649,682 $ 105,666,943 $ (581,519) $ (64,384,484) $ (7,806,605) $ 33,544,017
Balance (in Shares) at Mar. 31, 2019   64,968,184          
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements Of Cash Flows
6 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
OPERATING ACTIVITIES    
Net loss $ (6,182,833) $ (8,088,370)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 84,394 88,239
Amortization of intangible assets 154,617 137,631
Noncash interest expense 2,536,695 350,595
Share-based compensation 913,465 619,302
Deferred income taxes 24,710 (4,653,558)
Loss on settlement of accounts receivable   3,764,137
Change in fair value of derivative liabilities 403,000 21,000
Other 174,357 (1,942)
Changes in current assets and liabilities:    
(Increase) decrease in accounts receivable (54,603) 3,250,664
Increase in inventory (748,095) (821,133)
(Increase) decrease in prepaid expenses and other assets (73,589) 62,485
(Decrease) increase in accounts payable (656,527) 853,949
Decrease in unearned revenue (187,159) (142,147)
(Decrease) increase in accrued expenses and other current liabilities (391,011) 375,957
Net cash used in operating activities (4,002,579) (4,183,191)
INVESTING ACTIVITIES    
Capital expenditures (644) (1,913)
Net cash used in investing activities (644) (1,913)
FINANCING ACTIVITIES    
Proceeds from sale of shares in public offering , net of fees and costs 9,131,967  
Installment payments on SWK credit agreement (3,191,717)  
Proceeds from stock option exercises 200,000  
Proceeds from SWK credit agreement   10,000,000
Payment of debt issuance costs   (120,000)
Net cash provided by financing activities 6,140,250 9,880,000
Net increase in cash 2,137,027 5,694,896
CASH AT BEGINNING OF PERIOD 3,759,509 3,277,602
CASH AT END OF PERIOD $ 5,896,536 8,972,498
Schedule of noncash investing and financing activities:    
Shares issued in connection with common stock purchase agreement   347,081
Increase in deferred assets from accrued expenses   77,840
Debt issuance costs in accounts payable and accrued expenses   $ 143,943
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation
6 Months Ended
Mar. 31, 2019
Basis of Presentation [Abstract]  
Basis of Presentation

Note 1 – Basis of Presentation



The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (“we,” “our,” “us,” “Veru” or the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018. The accompanying condensed consolidated balance sheet as of September 30, 2018 has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and six months ended March 31, 2019 and cash flows for the six months ended March 31, 2019 are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending September 30, 2019.  



The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.



In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.



Principles of consolidation and nature of operations: Veru Inc. is referred to in these notes collectively with its subsidiaries as “we,” “our,” “us,” “Veru” or the “Company.” The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (“APP”) and The Female Health Company Limited, and The Female Health Company Limited’s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the “U.K. subsidiary”), and The Female Health Company (UK) plc’s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the “Malaysia subsidiary”). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the “APP Acquisition”) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer health care product, the FC2 Female Condom/FC2 Internal Condom® (“FC2”).  The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company focused on oncology and urology with multiple drug products under clinical development.  Most of the Company’s net revenues during the three and six months ended March 31, 2019 and 2018 were derived from sales of FC2. 



Reclassifications:  Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. These reclassifications had no effect on the results of operations or financial position for any period presented.



Cash concentration: The Company’s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia.



Restricted cash: Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds.  Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life.  The Company had no restricted cash at March 31, 2019. Restricted cash was approximately $135,000 at September 30, 2018 and is included in cash on the accompanying unaudited condensed consolidated balance sheets.  



Patents and trademarks: The costs for patents and trademarks are expensed when incurred. 



Deferred financing costs: Costs incurred in connection with the common stock purchase agreement discussed in Note 8 have been included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. When shares of the Company’s common stock are sold under the common stock purchase agreement, a pro-rata portion of the deferred costs is recorded to additional paid-in-capital.



As discussed in Note 8, in connection with the common stock offering that closed on October 1, 2018, we incurred costs of approximately $190,000 through September 30, 2018. This amount was included in other assets on the accompanying unaudited condensed consolidated balance sheet at September 30, 2018. These costs were charged to additional paid-in capital in the six months ended March 31, 2019 after the common stock offering was closed.



Costs incurred in connection with the issuance of debt discussed in Note 7 are presented as a reduction of the debt on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. These issuance costs are being amortized using the effective interest method over the expected repayment period of the debt, which is currently estimated to occur in the third quarter of fiscal 2021. The amortization is included in interest expense on the accompanying unaudited condensed consolidated statements of operations.



Fair value measurements: Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 – Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to us as of the reporting dates. Accordingly, the estimates presented in the accompanying unaudited condensed consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. See Note 3 for a discussion of fair value measurements.



The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash, accounts receivable, accounts payable and other accrued liabilities approximate their fair value based on the short-term nature of these instruments. The carrying value of long-term debt, taking into consideration debt discounts and related derivative instruments, is estimated to approximate fair value.



Unearned revenue: The Company records an unearned revenue liability if a customer pays consideration before the Company transfers the product to the customer under the terms of a contract. Unearned revenue is recognized as revenue after control of the product is transferred to the customer and all revenue recognition criteria have been met.  The Company had no unearned revenue at March 31, 2019. Unearned revenue at September 30, 2018 was approximately $187,000 and was comprised of sales made to a large distributor who has the right to return product under certain conditions.



Derivative instruments: The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company reviews the terms of debt instruments it enters into to determine whether there are embedded derivative instruments, which are required to be bifurcated and accounted for separately as derivative financial instruments. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. Liabilities incurred in connection with an embedded derivative are discussed in Note 7.



Revenue recognition: Revenue is recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products.



The Company generates nearly all of its revenue from direct product sales. Revenue from direct product sales is generally recognized when the customer obtains control of the product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have significant unusual payment terms beyond 120 days in its contracts with customers. See Note 4 for additional information regarding credit terms.



The amount of consideration the Company ultimately receives varies depending upon sales discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of current contract sales terms and historical payment experience.



Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt.



Research and development costs: Research and development costs are expensed as they are incurred and include salaries and benefits, clinical trial costs and contract services. Nonrefundable advance payments made for goods or services to be used in research and development activities are deferred and capitalized until the goods have been delivered or the related services have been performed. If the goods are no longer expected to be delivered or the services are no longer expected to be performed, the Company would be required to expense the related capitalized advance payments. The Company did not have any capitalized nonrefundable advance payments as of March 31, 2019 and September 30, 2018.



The Company records estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials and contract manufacturing activities. These costs are a significant component of the Company’s research and development expenses. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed, number of patients enrolled and the rate of patient enrollments may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accruals could materially affect the Company’s results of operations.



Share-based compensation: The Company recognizes share-based compensation expense in connection with its share-based awards based on the estimated fair value of the awards on the date of grant, on a straight-line basis over the vesting period. Calculating share-based compensation expense requires the input of highly subjective judgment and assumptions, including estimates of the expected life of the share-based award, stock price volatility and risk-free interest rates.



Advertising: The Company's policy is to expense advertising costs as incurred. Advertising costs were immaterial to the Company’s results of operations for the three and six months ended March 31, 2019 and 2018.

 

Income taxes: The Company files separate income tax returns for its foreign subsidiaries. FASB ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.

 

Foreign currency translation and operations: Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency.  The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries.  Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first-generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $0.6 million as of March 31, 2019 and September 30, 2018. Assets located outside of the U.S. totaled approximately $5.0 million and $5.2 million at March 31, 2019 and September 30, 2018, respectively.

   

Other comprehensive loss: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss.  Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss.



The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis.  Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized.  For the three and six months ended March 31, 2019 and 2018, comprehensive loss is equivalent to the reported net loss.    



Recently Issued Accounting Pronouncements



In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606).  This new accounting guidance on revenue recognition provides for a single five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation. The new guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts.  The Company adopted the new guidance on October 1, 2018 using the modified retrospective method and elected to apply the guidance only to contracts that were not completed as of the date of adoption. The adoption of this guidance did not have a material effect on our consolidated financial statements and related disclosures. See discussion above for disclosures relating to the Company's revenue recognition.



In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842),  which requires that lessees recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of key information about leasing arrangements.  ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required upon adoption.  Early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases to clarify the implementation guidance and ASU No. 2018-11, Leases (Topic 842) Targeted Improvements. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. In December 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors to address certain implementation issues facing lessors when adopting ASU 2016-02. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842): Codification Improvements to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016-02. The Company will adopt the new accounting standard on October 1, 2019 and intends to elect certain practical expedients, including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts.  We have begun to identify our significant lease contracts and are in the process of evaluating the effect of the new guidance on our consolidated financial statements and related disclosures.



In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The purpose of ASU 2016-18 is to clarify guidance and presentation related to restricted cash in the statements of cash flows as well as increased disclosure requirements. It requires beginning-of-period and end-of-period total amounts shown on the statements of cash flows to include cash and cash equivalents as well as restricted cash and restricted cash equivalents. We adopted ASU 2016-18 effective October 1, 2018. The adoption of ASU 2016-18 did not have a material effect on the presentation of our consolidated statements of cash flows or related disclosures. 



In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment. The purpose of ASU 2017-04 is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the impaired fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position or results of operations.



In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The purpose of ASU 2017-09 is to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. We adopted ASU 2017-09 effective October 1, 2018. The adoption of ASU 2017-09 did not have a material effect on our financial position or results of operations. 



In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The purpose of ASU 2018-07 is to expand the scope of Topic 718, Compensation—Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 will be effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than the Company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. The adoption of ASU 2018-07 is not expected to have a material effect on our financial position or results of operations but should simplify the process by which the Company measures compensation expense for share-based payments to nonemployees. 

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Change to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 and early adoption is permitted. The adoption of ASU 2018-13 is not expected to have a material effect on our financial position or results of operations as it modifies disclosure requirements only.

 

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Liquidity
6 Months Ended
Mar. 31, 2019
Liquidity [Abstract]  
Liquidity

Note 2 – Liquidity



The Company has incurred quarterly operating losses since the fourth quarter of fiscal 2016 and anticipates that it will continue to consume cash and incur substantial net losses as it develops its drug candidates. Because of the numerous risks and uncertainties associated with the development of pharmaceutical products, the Company is unable to estimate the exact amounts of capital outlays and operating expenditures necessary to fund development of its drug candidates and obtain regulatory approvals. The Company’s future capital requirements will depend on many factors.



The Company believes its current cash position and its ability to secure equity financing or other financing alternatives are adequate to fund planned operations of the Company for the next 12 months. Such financing alternatives may include debt financing, common stock offerings or financing involving convertible debt or other equity-linked securities and may include financings under the Company's effective shelf registration statement on Form S-3 (File No. 333-221120) (the “Shelf Registration Statement”).  The Company intends to be opportunistic when pursuing equity financing which could include selling common stock under its common stock purchase agreement with Aspire Capital Fund, LLC (see Note 8) and/or a marketed deal with an investment bank.

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
6 Months Ended
Mar. 31, 2019
Fair Value Measurements [Abstract]  
Fair Value Measurements

Note 3 – Fair Value Measurements



FASB ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).



The three levels of the fair value hierarchy are as follows:



Level 1 – Quoted prices for identical instruments in active markets.



Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. 



Level 3 – Instruments with primarily unobservable value drivers.



We review the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels of certain securities within the fair value hierarchy. There were no transfers between Level 1, Level 2 and Level 3 during the six months ended March 31, 2019 and 2018.



As of March 31, 2019 and September 30, 2018, the Company’s financial liabilities measured at fair value on a recurring basis, which consisted of embedded derivatives, were classified within Level 3 of the fair value hierarchy. 



The Company determines the fair value of hybrid instruments based on available market data using appropriate valuation models, giving consideration to all of the rights and obligations of each instrument. The Company estimates the fair value of hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair value. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating the fair value of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. Increases in fair value during a given financial quarter result in the recognition of non-cash derivative expense. Conversely, decreases in fair value during a given financial quarter would result in the recognition of non-cash derivative income. 



The following table provides a reconciliation of the beginning and ending liability balance associated with embedded derivatives measured at fair value using significant unobservable inputs (Level 3) as of March 31, 2019 and 2018:







 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018

Beginning balance

$

2,426,000 

 

$

 —

Additions

 

 —

 

 

3,319,000 

Change in fair value of derivative liabilities

 

403,000 

 

 

21,000 

Ending balance

$

2,829,000 

 

$

3,340,000 



The expense associated with the change in fair value of the embedded derivatives is included on a separate line item on our unaudited condensed consolidated statements of operations.



The liabilities associated with embedded derivatives represent the fair value of the change of control provisions in the SWK Credit Agreement and Residual Royalty Agreement. See Note 7 for additional information. There is no current observable market for these types of derivatives. The Company determined the fair value of the embedded derivatives using a Monte Carlo simulation model to value the financial liabilities at inception and on subsequent valuation dates. This valuation model incorporates transaction details such as the contractual terms, expected cash outflows, expected repayment dates, probability of a change of control, expected volatility, and risk-free interest rates. A significant acceleration of the estimated repayment date or a significant decrease in the probability of a change of control event prior to repayment of the SWK Credit Agreement, in isolation, would result in a significantly lower fair value measurement of the liabilities associated with the embedded derivatives.



The following table presents quantitative information about the inputs and valuation methodologies used to determine the fair value of the embedded derivatives classified in Level 3 of the fair value hierarchy as of March 31, 2019:





 

 

 

 



 

 

 

 

Valuation Methodology

 

Significant Unobservable Input

 

Weighted Average
(range, if applicable)



 

 

 

 

Monte Carlo Simulation

 

Estimated change of control dates

 

December 2019 to December 2021



 

Discount rate

 

15.3% to 17.3%



 

Probability of change of control

 

0% to 90%

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Receivable and Concentration of Credit Risk
6 Months Ended
Mar. 31, 2019
Accounts Receivable and Concentration of Credit Risk [Abstract]  
Accounts Receivable and Concentration of Credit Risk

Note 4 – Accounts Receivable and Concentration of Credit Risk



The Company's standard credit terms vary from 30 to 120 days, depending on the class of trade and customary terms within a territory, so accounts receivable is affected by the mix of purchasers within the period.  As is typical in the Company's business, extended credit terms may occasionally be offered as a sales promotion or for certain sales.  The Company has agreed to credit terms of up to 150 days with our distributor in the Republic of South Africa.  For the order of 15 million units under the Brazil tender in 2014, the Company agreed to up to 360 days credit terms with our distributor in Brazil subject to earlier payment upon receipt of payment by the distributor from the Brazilian Government.   



The components of accounts receivable consist of the following at March 31, 2019 and September 30, 2018:  









 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Accounts receivable

 

$

4,076,745 

 

$

4,046,733 

Less: allowance for doubtful accounts

 

 

(36,201)

 

 

(36,201)

Less: allowance for sales and payment term discounts

 

 

(13,309)

 

 

(37,900)

Accounts receivable, net

 

$

4,027,235 

 

$

3,972,632 



On December 27, 2017, we entered into a settlement agreement with Semina, our distributor in Brazil, pursuant to which Semina made a payment of $2.2 million and was obligated to make a second payment of $1.5 million by February 28, 2018, to settle net amounts due to us totaling $7.5 million relating to the Brazil tender in 2014. The settlement was not related to our belief in the ultimate collectability of the receivables or in the creditworthiness of Semina. We elected to settle these amounts due to the uncertainty regarding the timing of payment by the Brazilian Government and, ultimately to us, on the remaining amounts due. The result of the settlement was a net loss of $3.8 million in the six months ended March 31, 2018, which is presented as a separate line item in the accompanying unaudited condensed consolidated statements of operations. Semina did not make its second payment of $1.5 million by February 28, 2018.  In July 2018, the Company agreed to accept $1.3 million as settlement of the $1.5 million that was owed, which resulted in an additional loss of $0.2 million in the third quarter of fiscal 2018



At March 31, 2019, one customer had an accounts receivable balance that represented 11% of current assets.  At September 30, 2018, one customer had an accounts receivable balance that represented 15% of current assets.



At March 31, 2019, two customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 65% of net accounts receivable in the aggregate. At September 30, 2018, three customers had an accounts receivable balance greater than 10% of net accounts receivable, representing 74% of net accounts receivable in the aggregate. 



For the three months ended March 31, 2019, there were four customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 82% of the Company’s net revenues in the aggregate. For the three months ended March 31, 2018, there were two customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 44% of the Company’s net revenues in the aggregate.



For the six months ended March 31, 2019, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 66% of the Company’s net revenues in the aggregate. For the six months ended March 31, 2018, there were three customers whose individual net revenue to the Company exceeded 10% of the Company’s net revenues, representing 50% of the Company’s net revenues in the aggregate.



The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments on accounts receivable.  Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts.  Management also periodically evaluates individual customer receivables and considers a customer’s financial condition, credit history, and the current economic conditions.  Accounts receivable are charged-off when deemed uncollectible.  The table below summarizes the change in the allowance for doubtful accounts for the six months ended March 31, 2019 and 2018.







 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018



 

 

 

 

 

Beginning balance

$

36,201 

 

$

38,103 

Charges to expense

 

 —

 

 

3,058 

Charge-offs

 

 —

 

 

(5,000)

Ending balance

$

36,201 

 

$

36,161 



Recoveries of accounts receivable previously charged-off are recorded when received.  The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other governmental agencies,  which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. In the U.S., the Company’s customers include telemedicine providers who sell into the prescription channel.

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Information
6 Months Ended
Mar. 31, 2019
Balance Sheet Information [Abstract]  
Balance Sheet Information

Note 5 – Balance Sheet Information



Inventory



Inventories are valued at the lower of cost or net realizable value.  The cost is determined using the first-in, first-out (“FIFO”) method.  Inventories are also written down for management’s estimates of product which will not sell prior to its expiration date.  Write-downs of inventories establish a new cost basis which is not increased for future increases in the net realizable value of inventories or changes in estimated obsolescence.



Inventory consisted of the following at March 31, 2019 and September 30, 2018:  







 

 

 

 

 



March 31,

 

September 30,



2019

 

2018

FC2

 

 

 

 

 

Raw material

$

599,772 

 

$

366,220 

Work in process

 

62,710 

 

 

77,669 

Finished goods

 

2,786,083 

 

 

2,232,864 

Inventory, gross

 

3,448,565 

 

 

2,676,753 

Less: inventory reserves

 

(451,041)

 

 

(391,861)

FC2, net

 

2,997,524 

 

 

2,284,892 

PREBOOST®

 

 

 

 

 

Finished goods

 

677 

 

 

17,138 

Inventory, net

$

2,998,201 

 

$

2,302,030 



Fixed Assets



We record equipment, furniture and fixtures, and leasehold improvements at historical cost.  Expenditures for maintenance and repairs are recorded to expense. Depreciation and amortization are primarily computed using the straight-line method.  Depreciation and amortization are computed over the estimated useful lives of the respective assets which range as follows:







 



 

Manufacturing equipment

510 years

Office equipment

35 years

Furniture and fixtures

710 years



Leasehold improvements are depreciated on a straight-line basis over the lesser of the remaining lease term or the estimated useful lives of the improvements.



Plant and equipment consisted of the following at March 31, 2019 and September 30, 2018:







 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Equipment, furniture and fixtures

 

$

4,018,333 

 

$

4,018,284 

Leasehold improvements

 

 

287,686 

 

 

287,686 



 

 

4,306,019 

 

 

4,305,970 

Less: accumulated depreciation and amortization

 

 

(3,985,217)

 

 

(3,901,418)

Plant and equipment, net

 

$

320,802 

 

$

404,552 



XML 24 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets and Goodwill
6 Months Ended
Mar. 31, 2019
Intangible Assets and Goodwill [Abstract]  
Intangible Assets and Goodwill

Note 6 – Intangible Assets and Goodwill



Intangible Assets



Intangible assets acquired in the APP Acquisition included in-process research and development (“IPR&D”), developed technology consisting of PREBOOST® medicated wipes for prevention of premature ejaculation, and covenants not-to-compete. IPR&D represents incomplete research and development projects at APP as of the date of the APP Acquisition. These intangible assets are carried at cost less accumulated amortization. Intangible assets with finite lives are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. IPR&D is tested for impairment at least annually in the fourth quarter of each fiscal year until the underlying projects are completed or abandoned.  



The gross carrying amounts and net book value of intangible assets are as follows at March 31, 2019:

 



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

404,269 

 

$

1,995,731 

Covenants not-to-compete

 

500,000 

 

 

172,619 

 

 

327,381 

Total intangible assets with finite lives

 

2,900,000 

 

 

576,888 

 

 

2,323,112 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

576,888 

 

$

20,323,112 



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2018:





 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

285,366 

 

$

2,114,634 

Covenants not-to-compete

 

500,000 

 

 

136,905 

 

 

363,095 

Total intangible assets with finite lives

 

2,900,000 

 

 

422,271 

 

 

2,477,729 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

422,271 

 

$

20,477,729 



Amortization is recorded over the projected related revenue stream for the PREBOOST® developed technology over 10 years and on a straight-line basis over seven years for the covenants not-to-compete. The amortization expense is recorded in selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. The IPR&D assets will not be amortized until the underlying development projects are completed. If and when development is complete, which generally occurs when regulatory approval to market the product is obtained, the associated IPR&D assets would be accounted for as finite-lived intangible assets and amortized over the estimated period of economic benefit. If a development project is abandoned, the associated IPR&D assets would be charged to expense.



For the three months ended March 31, 2019 and 2018, amortization expense was approximately $77,000 and $69,000,  respectively. For the six months ended March 31, 2019 and 2018, amortization expense was approximately $155,000 and $138,000, respectively. 



Intangible assets are highly vulnerable to impairment charges, particularly newly acquired assets for recently launched products. These assets are initially measured at fair value and therefore any reduction in expectations used in the valuations could potentially lead to impairment. Some of the more common potential risks leading to impairment include competition, earlier than expected loss of exclusivity, pricing pressures, adverse regulatory changes or clinical trial results, delay or failure to obtain regulatory approval, additional development costs, inability to achieve expected synergies, higher operating costs, changes in tax laws and other macroeconomic changes. The complexity in estimating the fair value of intangible assets in connection with an impairment test is similar to the initial valuation. Considering the high-risk nature of research and development and the industry’s success rate of bringing developmental compounds to market, IPR&D impairment charges are likely to occur in future periods. 



Goodwill



The carrying amount of goodwill at March 31, 2019 and September 30, 2018 was $6.9 million. There was no change in the balance during the six months ended March 31, 2019 and 2018. Goodwill represents the difference between the purchase price and the estimated fair value of the net assets acquired in the APP Acquisition.  Goodwill from the APP Acquisition principally relates to intangible assets that do not qualify for separate recognition, our expectation to develop and market new products, and the deferred tax liability generated as a result of the transaction.  Goodwill is not tax deductible for income tax purposes and was assigned to Company’s sole reporting unit in the Company’s Research and Development reporting segment, which consists of multiple drug products under clinical development for oncology and urology.



Goodwill is tested for impairment at least annually in the fourth quarter of each fiscal year or when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that its fair value exceeds the carrying value. Examples of qualitative factors include our share price, our financial performance compared to budgets, long-term financial plans, and macroeconomic, industry and market conditions as well as the substantial excess of fair value over the carrying value of net assets from the annual impairment test previously performed.



The estimated fair value of a reporting unit is highly sensitive to changes in projections and assumptions; therefore, in some instances changes in these assumptions could potentially lead to impairment. We perform sensitivity analyses around our assumptions in order to assess the reasonableness of the assumptions and the results of our testing. Ultimately, future potential changes in these assumptions may impact the estimated fair value of a reporting unit and cause the fair value of the reporting unit to be below its carrying value. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value; however, if actual results are not consistent with our estimates and assumptions, we may be exposed to an impairment charge that could be material.

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Debt
6 Months Ended
Mar. 31, 2019
Debt [Abstract]  
Debt

Note 7 – Debt



SWK Credit Agreement



On March 5, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with the financial institutions party thereto from time to time (the “Lenders”) and SWK Funding LLC, as agent for the Lenders (the “Agent”), for a synthetic royalty financing transaction. On and subject to the terms of the Credit Agreement, the Lenders agreed to provide the Company with a multi-draw term loan of up to $12.0 million, with $10.0 million advanced to the Company on the date of the Credit Agreement. The Company may draw up to an additional $1.0 million if the Company enters into an agreement to distribute at least 47.5 million units of FC2 in Brazil upon the terms described in the Credit Agreement and up to an additional $1.0 million if the Company enters into an agreement to distribute at least 30 million units of FC2 in South Africa upon the terms described in the Credit Agreement.

The Lenders will be entitled to receive quarterly payments on the term loan based on the Company’s product revenue from net sales of FC2 as provided in the Credit Agreement until the Company has paid 175% of the aggregate amount advanced to the Company under the Credit Agreement. If product revenue from net sales of FC2 for the 12-month period ended as of the last day of the respective quarterly payment period is less than $10.0 million, the quarterly payments will be 32.5% of product revenue from net sales of FC2 during the quarterly period. If product revenue from net sales of FC2 for the 12-month period ended as of the last day of the respective quarterly payment period is equal to or greater than $10.0 million, the quarterly payments are calculated as the sum of 25% of product revenue from net sales of FC2 up to and including $12.5 million in the Elapsed Period (as defined in the Credit Agreement), plus 10% of product revenue from net sales of FC2 greater than $12.5 million in the Elapsed Period.  Upon the Credit Agreement’s termination date of March 5, 2025, the Company must pay 175% of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue.

The first quarterly revenue-based payment due May 15, 2018 was approximately $0.6 million and was paid on that date. On August 10, 2018, the Company entered into an amendment (the “Credit Agreement Amendment”) to the Credit Agreement.  The Credit Agreement Amendment deferred until November 15, 2018 the due date for the quarterly revenue-based payment that would have otherwise been due on August 15, 2018. The Company made a payment of approximately $2.6 million on November 15, 2018, consisting of approximately $1.4 million for the quarterly revenue-based payment originally due on August 15, 2018 and approximately $1.2 million for the quarterly revenue-based payment due on November 15, 2018. On February 15, 2019, the Company paid approximately $0.6 million for the quarterly revenue-based payment due on that date.

Upon a change of control of the Company or sale of the FC2 business, the Company must pay off the loan by making a payment to the Lenders equal to (i) 175% of the aggregate amount advanced to the Company under the Credit Agreement less the amounts previously paid by the Company from product revenue, plus (ii) the greater of (A) $2.0 million or (B) the product of (x) 5% of the product revenue from net sales of FC2 for the most recently completed 12-month period multiplied by (y) five. A “change of control” under the Credit Agreement includes (i) an acquisition by any person of direct or indirect ownership of more than 50% of the Company’s issued and outstanding voting equity, (ii) a change of control or similar event in the Company’s articles of incorporation or bylaws, (iii) certain Key Persons as defined in the Credit Agreement cease to serve in their current executive capacities unless replaced within 90 days by a person reasonably acceptable to the Agent, which acceptance not to be unreasonably withheld, or (iv) the sale of all or substantially all of the Company’s assets.

The Credit Agreement contains customary representations and warranties in favor of the Agent and the Lenders and certain covenants, including financial covenants addressing minimum quarterly marketing and distribution expenses for FC2 and a requirement to maintain minimum unencumbered liquid assets of $1.0 million. The Credit Agreement also restricts the payment of dividends and share repurchases. The recourse of the Lenders and the Agent for obligations under the Credit Agreement is limited to assets relating to FC2.

In connection with the Credit Agreement, the Company and the Agent also entered into a Residual Royalty Agreement, dated as of March 5, 2018 (the “Residual Royalty Agreement”), which provides for an ongoing royalty payment of 5% of product revenue from net sales of FC2 commencing upon the payment in full by the Company of the required amount pursuant to the Credit Agreement. The Residual Royalty Agreement will terminate upon (i) a change of control or sale of the FC2 business and the payment by the Company of the amount due in connection therewith pursuant to the Credit Agreement, or (ii) mutual agreement of the parties. If a change of control occurs prior to payment in full of the Credit Agreement, there will be no payment due with respect to the Residual Royalty Agreement.  If a change of control occurs after the payment in full of the Credit Agreement, the Agent will receive a payment that is the greater of (A) $2.0 million or (B) the product of (x) 5% of the product revenue from net sales of FC2 for the most recently completed 12-month period multiplied by (y) five.

Pursuant to a Guarantee and Collateral Agreement dated as of March 5, 2018 (the “Collateral Agreement”) and an Intellectual Property Security Agreement dated as of March 5, 2018 (the “IP Security Agreement”), the Company’s obligations under the Credit Agreement are secured by a lien against substantially all of the assets of the Company that relate to or arise from FC2. In addition, pursuant to a Pledge Agreement dated as of March 5, 2018 (the “Pledge Agreement”), the Company’s obligations under the Credit Agreement are secured by a pledge of up to 65% of the outstanding shares of The Female Health Company Limited, a wholly owned U.K. subsidiary.



After payment by the Company of certain fees and expenses of the Agent and the Lenders as required in the Credit Agreement, the Company received net proceeds of approximately $9.9 million from the initial $10.0 million advance under the Credit Agreement.



For accounting purposes, the initial $10.0 million advance under the Credit Agreement was allocated between the Credit Agreement and the Residual Royalty Agreement on a relative fair value basis.  A portion of the amount allocated to the Credit Agreement and a portion of the amount allocated to the Residual Royalty Agreement, in both cases equal to the fair value of the respective change of control provisions, was allocated to the embedded derivative liabilities. The derivative liabilities will be adjusted to fair market value at each subsequent reporting period.  For financial statement presentation, the embedded derivative liabilities have been included with their respective host instruments as noted in the following tables. The debt discounts are being amortized to interest expense over the expected term of the loan using the effective interest method. Additionally, the Company recorded deferred loan issuance costs of approximately $267,000 for legal fees incurred in connection with the Credit Agreement. The deferred loan issuance costs are presented as a reduction in the Credit Agreement obligation and are being amortized to interest expense over the expected term of the loan using the effective interest method.



At March 31, 2019 and September 30, 2018, the Credit Agreement consisted of the following:







 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Aggregate repayment obligation

$

17,500,000 

 

$

17,500,000 

Less: Cumulative payments

 

(3,834,202)

 

 

(642,485)

Less: Unamortized discounts

 

(6,212,466)

 

 

(8,475,874)

Less: Unamortized deferred issuance costs

 

(149,783)

 

 

(204,353)

Credit agreement, net

 

7,303,549 

 

 

8,177,288 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,251,000 

 

 

1,217,000 



 

8,554,549 

 

 

9,394,288 

Credit agreement, short-term portion

 

(5,836,615)

 

 

(6,692,718)

Credit agreement, long-term portion

$

2,717,934 

 

$

2,701,570 



 

 

 

 

 



The short-term portion of the Credit Agreement represents the aggregate of the estimated quarterly revenue-based payments payable during the 12-month periods subsequent to March 31, 2019 and September 30, 2018, respectively.

At March 31, 2019 and September 30, 2018, the Residual Royalty Agreement liability consisted of the following:







 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Residual Royalty Agreement liability, fair value at inception

$

346,000 

 

$

346,000 

Less: Unamortized discounts

 

 —

 

 

(2,420)

Add: Accretion of liability using effective interest rate

 

417,522 

 

 

201,225 

Residual Royalty Agreement liability, net

 

763,522 

 

 

544,805 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,578,000 

 

 

1,209,000 

Residual Royalty Agreement liability

$

2,341,522 

 

$

1,753,805 



 

 

 

 

 

Interest expense related to the Credit Agreement and the Residual Royalty Agreement consisted of amortization of the discounts, accretion of the liability for the Residual Royalty Agreement and amortization of the deferred issuance costs.  For the three and six months ended March 31, 2019, interest expense related to the Credit Agreement and Residual Royalty Agreement was as follows:







 

 

 

 

 

 

 

 

 

 

 



Three Months Ended
March 31,

 

Six Months Ended
March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Amortization of Credit Agreement and Residual Royalty Agreement discounts

$

1,107,622 

 

$

317,747 

 

$

2,265,828 

 

$

317,747 

Accretion of Residual Royalty Agreement liability

 

123,946 

 

 

27,278 

 

 

216,297 

 

 

27,278 

Amortization of deferred issuance costs

 

26,704 

 

 

5,570 

 

 

54,570 

 

 

5,570 



$

1,258,272 

 

$

350,595 

 

$

2,536,695 

 

$

350,595 

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity
6 Months Ended
Mar. 31, 2019
Stockholders' Equity [Abstract]  
Stockholders' Equity

Note 8 – Stockholders’ Equity



Preferred Stock



The Company has 5,000,000 shares designated as Class A Preferred Stock with a par value of $0.01 per share. There are 1,040,000 shares of Class A Preferred Stock – Series 1 authorized; 1,500,000 shares of Class A Preferred Stock – Series 2 authorized; 700,000 shares of Class A Preferred Stock – Series 3 authorized; and 548,000 shares of Class A Preferred Stock – Series 4 (the “Series 4 Preferred Stock”) authorized.  There were no shares of Class A Preferred Stock of any series issued and outstanding at March 31, 2019 and September 30, 2018.  The Company has 15,000 shares designated as Class B Preferred Stock with a par value of $0.50 per share. There were no shares of Class B Preferred Stock issued and outstanding at March 31, 2019 and September 30, 2018.



Common Stock



On March 27, 2019, following approval by stockholders at the Company’s annual meeting of stockholders held on March 26, 2019, the Company filed an amendment to its articles of incorporation to increase the number of authorized shares of common stock from 77,000,000 to 154,000,000 shares.



Common Stock Offering



On October 1, 2018, we completed an underwritten public offering of 7,142,857 shares of our common stock, at a public offering price of $1.40 per share. Net proceeds to the Company from this offering were $9.1 million after deducting underwriting discounts and commissions and costs paid by the Company. All of the shares sold in the offering were by the Company. The offering was made pursuant to the Shelf Registration Statement.



Common Stock Purchase Warrants



In connection with the closing of the APP Acquisition, the Company issued a warrant to purchase up to 2,585,379 shares of the Company's common stock to Torreya Capital, the Company's financial advisor (the “Financial Advisor Warrant”).  The Financial Advisor Warrant has a five-year term expiring October 31, 2021, a cashless exercise feature and a strike price equal to $1.93 per share. The Financial Advisor Warrant vested upon issuance and remains outstanding at March 31, 2019.



In May 2018, the Company issued two warrants to purchase a total of up to 750,000 shares of the Company's common stock at $2.31 per share in connection with a services agreement. The services agreement was terminated in March 2019 and the warrants were cancelled at the same time. Prior to termination of the services agreement, for measurement and recognition purposes, the Company utilized the lowest aggregate amount within the range of potential values, which was zero. Therefore, in prior periods, the Company had determined the fair value of these warrants to be zero and had not recognized any compensation expense related to these warrants.



Aspire Capital Purchase Agreement    



On December 29, 2017, the Company entered into a common stock purchase agreement (the “Purchase Agreement”) with Aspire Capital Fund, LLC (“Aspire Capital”) which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right, from time to time in its sole discretion during the 36-month term of the Purchase Agreement, to direct Aspire Capital to purchase up to $15.0 million of the Company’s common stock in the aggregate.  Concurrently with entering into the Purchase Agreement, the Company also entered into a registration rights agreement with Aspire Capital (the “Registration Rights Agreement”), in which the Company agreed to prepare and file under the Securities Act of 1933 and under the Shelf Registration Statement, a prospectus supplement for the sale or potential sale of the shares of the Company’s common stock that have been and may be issued to Aspire Capital under the Purchase Agreement.



Under the Purchase Agreement, on any trading day selected by the Company, the Company has the right, in its sole discretion, to present Aspire Capital with a purchase notice (each, a “Purchase Notice”), directing Aspire Capital (as principal) to purchase up to 200,000 shares of the Company’s common stock per business day, up to $15.0 million of the Company’s common stock in the aggregate at a per share price (the "Purchase Price") equal to the lesser of the lowest sale price of the Company’s common stock on the purchase date or the average of the three lowest closing sale prices for the Company’s common stock during the ten consecutive trading days ending on the trading day immediately preceding the purchase date.



In addition, on any date on which the Company submits a Purchase Notice to Aspire Capital in an amount equal to 200,000 shares and the closing sale price of our common stock is equal to or greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of common stock equal to up to 30% of the aggregate shares of the common stock traded on its principal market on the next trading day (the VWAP Purchase Date), subject to a maximum number of shares the Company may determine.  The purchase price per share pursuant to such VWAP Purchase Notice is generally 97% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.



In consideration for entering into the Purchase Agreement, concurrently with the execution of the Purchase Agreement, the Company issued to Aspire Capital 304,457 shares of the Company’s common stock. The shares of common stock issued as consideration were valued at approximately $347,000. This amount and related expenses of approximately $78,000, which total approximately $425,000, were recorded as deferred costs.



During fiscal 2018, we sold an aggregate of 1,717,010 shares of common stock to Aspire Capital under the Purchase Agreement resulting in proceeds to the Company of $3.0 million. As a result of these sales, we recorded approximately $85,000 of the deferred costs noted above to additional paid-in capital. The unamortized amount of deferred costs of approximately $340,000 is included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. As of March 31, 2019, the amount remaining under the Purchase Agreement was $12.0 million.



XML 27 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation
6 Months Ended
Mar. 31, 2019
Share-Based Compensation [Abstract]  
Share-Based Compensation

Note 9 – Share-based Compensation



We allocate share-based compensation expense to cost of sales, selling, general and administrative expense and research and development expense based on the award holder’s employment function. For the three and six months ended March 31, 2019 and 2018, we recorded share-based compensation expenses as follows:





 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,



 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

$

7,778 

 

$

1,797 

 

$

15,730 

 

$

5,061 

Selling, general and administrative

 

 

407,426 

 

 

362,006 

 

 

734,435 

 

 

537,344 

Research and development

 

 

81,005 

 

 

48,045 

 

 

163,300 

 

 

76,897 



 

$

496,209 

 

$

411,848 

 

$

913,465 

 

$

619,302 



Equity Plans



In March 2018, the Company’s stockholders approved the Company's 2018 Equity Incentive Plan (the “2018 Plan”). On March 26, 2019, the Company’s stockholders approved an increase in the number of shares that may be issued under the 2018 Plan to 6.0 million.  As of March 31, 2019, 4,117,272 shares remain available for issuance under the 2018 Plan. 



In July 2017, the Company’s stockholders approved the Company's 2017 Equity Incentive Plan (the “2017 Plan”).  A total of 4.7 million shares are authorized for issuance under the 2017 Plan. As of March 31, 2019, 190,868 shares remain available for issuance under the 2017 Plan. The 2017 Plan replaced the Company's 2008 Stock Incentive Plan (the “2008 Plan”), and no further awards will be made under the 2008 Plan.



Stock Options



Each option grants the holder the right to purchase from us one share of our common stock at a specified price, which is generally the closing price per share of our common stock on the date the option is issued. Options generally vest on a pro-rata basis on each anniversary of the issuance date within three years of the date the option is issued. Options may be exercised after they have vested and prior to the specified expiry date provided applicable exercise conditions are met, if any. The expiry date can be for periods of up to ten years from the date the option is issued. The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model based on the assumptions established at that time. The Company accounts for forfeitures as they occur and does not estimate forfeitures as of the option grant date.



The following table outlines the weighted average assumptions for options granted during the three and six months ended March 31, 2019 and 2018:





 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,

Weighted Average Assumptions:

 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

65.45% 

 

 

62.34% 

 

 

66.88% 

 

 

61.38% 

Expected dividend yield

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

Risk-free interest rate

 

 

2.27% 

 

 

2.76% 

 

 

2.59% 

 

 

2.47% 

Expected term (in years)

 

 

5.9 

 

 

6.0 

 

 

5.7 

 

 

5.8 

Fair value of options granted

 

$

0.90 

 

$

1.28 

 

$

0.85 

 

$

0.93 



During the three and six months ended March 31, 2019 and 2018, the Company used historical volatility of our common stock over a period equal to the expected life of the options to estimate their fair value.  The dividend yield assumption is based on the Company’s recent history and expectation of future dividend payouts on the common stock.  The risk-free interest rate is based on the implied yield available on U.S. treasury zero-coupon issues with an equivalent remaining term.



The following table summarizes the stock options outstanding and exercisable at March 31, 2019: 





 

 

 

 

 

 

 

 

 



 

 

Weighted Average

 

 

 



 

 

 

 

 

Remaining

 

Aggregate



Number of

 

Exercise Price

 

Contractual Term

 

Intrinsic



Shares

 

Per Share

 

(years)

 

Value



 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2018

5,645,312 

 

$

1.59 

 

 

 

 

 

Granted

880,882 

 

 

1.42 

 

 

 

 

 

Exercised

(166,667)

 

 

1.20 

 

 

 

 

 

Forfeited

(301,834)

 

 

1.52 

 

 

 

 

 

Outstanding at March 31, 2019

6,057,693 

 

$

1.57 

 

7.83 

 

$

785,435 

Exercisable at March 31, 2019

2,042,285 

 

$

1.46 

 

6.51 

 

$

436,840 



The aggregate intrinsic values in the table above are before income taxes and represent the number of in-the-money options outstanding or exercisable multiplied by the closing price per share of the Company’s common stock on the last trading day of the quarter ended March 31, 2019 of $1.46, less the respective weighted average exercise price per share at period end



The total intrinsic value of options exercised during the six months ended March 31, 2019 was approximately $48,000. Cash received from options exercised during the six months ended March 31, 2019 was approximately $200,000.  No stock options were exercised during the six months ended March 31, 2018.



As of March 31, 2019, the Company had unrecognized compensation expense of approximately $2.7 million related to unvested stock options. This expense is expected to be recognized over approximately three years.



Restricted Stock



The Company has issued restricted stock to employees, directors and consultants. Such issuances had vesting periods that ranged from one to three years. All such shares of restricted stock vest provided the grantee has not voluntarily terminated service or been terminated for cause prior to the vesting date. There were no shares of restricted stock outstanding at March 31, 2019 and September 30, 2018.



Restricted Stock Units



In connection with the closing of the APP Acquisition, the Company issued 50,000 and 140,000 restricted stock units to an employee and an outside director, respectively, that vested on October 31, 2018. The restricted stock units were settled in common stock issued under the 2017 Plan. As of March 31, 2019, there are no outstanding restricted stock units.



Stock Appreciation Rights



In connection with the closing of the APP Acquisition, the Company issued stock appreciation rights based on 50,000 and 140,000 shares of the Company’s common stock to an employee and an outside director, respectively, that vested on October 31, 2018. The stock appreciation rights have a ten-year term and an exercise price per share of $0.95, which was the closing price per share of the Company’s common stock as quoted on NASDAQ on the trading day immediately preceding the date of the completion of the APP Acquisition. The stock appreciation rights will be settled in common stock issued under the 2017 Plan.  As of March 31, 2019, these vested stock appreciation rights remain outstanding.

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Contingent Liabilities
6 Months Ended
Mar. 31, 2019
Contingent Liabilities [Abstract]  
Contingent Liabilities



Note 10 – Contingent Liabilities



The testing, manufacturing and marketing of consumer products by the Company entail an inherent risk that product liability claims will be asserted against the Company.  The Company maintains product liability insurance coverage for claims arising from the use of its products.  The coverage amount is currently $10.0 million.



Litigation



In response to the APP Acquisition, two purported derivative and class action lawsuits were filed against the Company and certain of its officers and directors in the Circuit Court of Cook County, Illinois, captioned Glotzer v. The Female Health Company, et al., Case No. 2016-CH-13815, and Schartz v. Parrish, et al., Case No. 2016-CH-14488.  These lawsuits were originally filed on or about October 21, 2016 and November 7, 2016, respectively. On January 9, 2017, these two lawsuits were consolidated. On March 31, 2017, the plaintiffs filed a consolidated complaint.  The consolidated complaint named as defendants Veru, the members of our board of directors prior to the closing of the APP Acquisition and the members of our board of directors after the closing of the APP Acquisition. The consolidated complaint alleged, among other things, that the directors breached their fiduciary duties, or aided and abetted such breaches, by consummating the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements and by causing us to issue the shares of our common stock and Series 4 Preferred Stock to the former stockholders of APP pursuant to the APP Acquisition in order to evade the voting requirements of the Wisconsin Business Corporation Law. The consolidated complaint also alleged that Dr. Steiner, a director and the Chairman, President and Chief Executive Officer of Veru and a co-founder of APP, and Dr. Fisch, a director and Vice Chairman of Veru and a co-founder of APP, were unjustly enriched in receiving shares of our common stock and Series 4 Preferred Stock in the APP Acquisition.



On May 5, 2017, the defendants filed a motion to dismiss the consolidated complaint. On August 15, 2017, the court entered an order dismissing without prejudice the claims that the post-acquisition directors aided and abetted the alleged breaches of fiduciary duties by the pre-acquisition directors and that Dr. Steiner and Dr. Fisch were unjustly enriched.  The court did not dismiss the claims that our directors prior to the closing of the APP Acquisition breached their fiduciary duties and the claims that Veru consummated the APP Acquisition in violation of the Wisconsin Business Corporation Law and NASDAQ voting requirements.  On November 30, 2018, plaintiffs filed an Amended Consolidated Complaint.  The Amended Consolidated Complaint makes allegations similar to those in the original consolidated complaint as to the claims that were not dismissed and names as defendants Veru and the members of our board of directors prior to the closing of the APP Acquisition. The Amended Consolidated Complaint also makes claims against Dr. Steiner for allegedly aiding and abetting the pre-acquisition directors’ breach of fiduciary duty and for unjust enrichment.  Like the original consolidated complaint, which was previously dismissed in part, the Amended Consolidated Complaint seeks equitable relief, including rescission of the APP Acquisition, money damages, disgorgement of the shares of our common stock and Series 4 Preferred Stock issued to Dr. Steiner, and costs and expenses of the litigation, including attorneys' fees.  On December 14, 2018, the defendants filed their answer to the Amended Consolidated Complaint wherein they denied any and all liability and asserted additional defenses.  On January 14, 2019, the plaintiffs filed a motion for class certification. On May 6, 2019, the Court granted plaintiffs’ motion and certified a class consisting of “All holders of common stock of the Female Health Company as of October 31, 2016 and their successors in interest, excluding the named defendants to the Action and any person, firm, trust, corporation or other entity related to or affiliated with any of the Defendants.”  The parties filed cross-motions for summary judgment on April 15, 2019 which are set for hearing on July 11, 2019.  Veru believes that this action is without merit and is vigorously defending itself. No amount has been accrued for possible losses relating to this litigation as any such losses are not both probable and reasonably estimable.



License and Purchase Agreements



From time to time, we license or purchase rights to technology or intellectual property from third parties. These licenses and purchase agreements require us to pay upfront payments as well as development or other payments upon successful completion of preclinical, clinical, regulatory or revenue milestones. In addition, these agreements may require us to pay royalties on sales of products arising from the licensed or acquired technology or intellectual property. Because the achievement of future milestones is not reasonably estimable, we have not recorded a liability in the accompanying unaudited condensed consolidated financial statements for any of these contingencies.



XML 29 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
6 Months Ended
Mar. 31, 2019
Income Taxes [Abstract]  
Income Taxes

Note 11 – Income Taxes



The Company accounts for income taxes using the liability method, which requires the recognition of deferred tax assets or liabilities for the tax-effected temporary differences between the financial reporting and tax bases of its assets and liabilities, and for net operating loss and tax credit carryforwards.



On December 22, 2017, significant changes were enacted to the U.S. tax law pursuant to the federal tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Tax Act”).  The Tax Act includes a permanent reduction in the U.S. federal corporate income tax rate from 35% to 21%, a one-time repatriation tax on deferred foreign income, and changes to deductions, credits and business-related exclusions.



The Tax Act also repealed the alternative minimum tax (“AMT”) for corporations.  The new law provides that AMT carryovers can be utilized to reduce or eliminate the tax liability in subsequent years or to obtain a tax refund.  For tax years beginning in 2018, 2019 and 2020, to the extent the AMT credit carryovers exceed regular tax liability, 50% of the excess AMT credit carryovers will be refundable.  Any remaining credits will be fully refundable in 2021.  At September 30, 2018, the Company reclassified $0.5 million of its AMT credit carryovers from its deferred tax assets to other assets due to the expectation that the AMT credits will be refundable over the next several years.



Within the calculation of the Company’s annual effective tax rate the Company has used assumptions and estimates that may change as a result of future guidance, interpretations, and rule-making from the Internal Revenue Service, the SEC, the FASB and/or various other taxing jurisdictions.  For example, the Company anticipates that state jurisdictions will continue to determine and announce their conformity to the Tax Act which would have an impact on the annual effective tax rate. The Company’s calculations are based on the information available, prepared or analyzed (including computations) in reasonable detail.



The Company completes a detailed analysis of its deferred income tax valuation allowances on an annual basis or more frequently if information comes to its attention that would indicate that a revision to its estimates is necessary.  In evaluating the Company’s ability to realize its deferred tax assets, management considers all available positive and negative evidence on a country-by-country basis, including past operating results, forecasts of future taxable income, and the potential Section 382 limitation on the net operating loss carryforwards due to a change in control.  In determining future taxable income, management makes assumptions to forecast U.S. federal and state, U.K. and Malaysia operating income, the reversal of temporary differences, and the implementation of any feasible and prudent tax planning strategies.  These assumptions require significant judgment regarding the forecasts of the future taxable income in each tax jurisdiction and are consistent with the forecasts used to manage the Company’s business.  It should be noted that the Company realized significant losses through 2005 on a consolidated basis.  From fiscal year 2006 through fiscal year 2015, the Company generated taxable income on a consolidated basis.  However, the Company had a cumulative pretax loss in the U.S. for fiscal 2018 and the two preceding fiscal years.  Forming a conclusion that a valuation allowance is not needed is difficult when there is significant negative evidence such as cumulative losses in recent years. Management has projected future taxable losses in the U.S. driven by the investment in research and development, and based on their analysis concluded that a valuation allowance should continue to be recorded against the U.S. deferred tax assets related to federal and state net operating loss carryforwards as of March 31, 2019. An additional valuation allowance has been recorded against the U.S. deferred tax assets and net operating loss carryforwards as of March 31, 2019 of $1.6 million.  In addition, the Company’s holding company for the non-U.S. operating companies, The Female Health Company Limited, continues to have a full valuation allowance.  The operating U.K. subsidiary, The Female Health Company (UK) plc does not have a valuation allowance due to projections of future taxable income for the next 10 years.



As of September 30, 2018, the Company had U.S. federal and state net operating loss carryforwards of approximately $33.2 million and $36.2 million, respectively, for income tax purposes with $14.4 million and $19.6 million, respectively, expiring in years 2022 to 2037 and $18.8 million and $16.6 million, respectively, which can be carried forward indefinitely.  The Company’s U.K. subsidiary has U.K. net operating loss carryforwards of approximately $62.3 million as of September 30, 2018, which can be carried forward indefinitely to be used to offset future U.K. taxable income.



ASC Topic 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 developed a two-step process to evaluate a tax position and also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has not recorded a reserve for any tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. 



A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate to income before income taxes is as follows:





 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Income tax benefit at statutory rates

$

(841,862)

 

$

(1,077,736)

 

$

(1,273,685)

 

$

(3,628,736)

State income tax benefit, net of federal benefits

 

(199,521)

 

 

(385,395)

 

 

(301,863)

 

 

(948,395)

Effect of change in U.S. tax rate

 

 —

 

 

 —

 

 

 —

 

 

(187,000)

Non-deductible expenses – other

 

2,364 

 

 

8,702 

 

 

4,783 

 

 

12,702 

Effect of lower foreign income tax rates

 

4,830 

 

 

50,981 

 

 

(3,527)

 

 

80,386 

Effect of deemed dividend

 

32,318 

 

 

 —

 

 

63,627 

 

 

 —

Other

 

(1,025)

 

 

101,032 

 

 

(22,863)

 

 

122,574 

Change in valuation allowance

 

1,028,063 

 

 

 —

 

 

1,651,193 

 

 

 —

Income tax expense (benefit)

$

25,167 

 

$

(1,302,416)

 

$

117,665 

 

$

(4,548,469)



Significant components of the Company’s deferred tax assets and liabilities are as follows:







 

 

 

 

 



 

 

 

 

 



March 31,

 

September 30,

Deferred tax assets:

2019

 

2018



 

 

 

 

 

Federal net operating loss carryforwards

$

8,057,926 

 

$

6,973,047 

State net operating loss carryforwards

 

2,468,061 

 

 

2,195,865 

Foreign net operating loss carryforwards – U.K.

 

10,621,438 

 

 

10,595,518 

Foreign capital allowance – U.K.

 

102,098 

 

 

102,098 

U.K. bad debts

 

1,700 

 

 

1,700 

Restricted stock – U.K.

 

17,586 

 

 

17,586 

U.S. deferred rent

 

54,706 

 

 

22,902 

Share-based compensation

 

759,875 

 

 

622,442 

Other, net – U.S.

 

125,508 

 

 

91,419 

Other, net – Malaysia

 

34,314 

 

 

33,843 

Gross deferred tax assets

 

22,243,212 

 

 

20,656,420 

Valuation allowance for deferred tax assets

 

(9,282,271)

 

 

(7,631,078)

Net deferred tax assets

 

12,960,941 

 

 

13,025,342 

Deferred tax liabilities:

 

 

 

 

 

In process research and development

 

(4,675,860)

 

 

(4,675,860)

Developed technology

 

(518,431)

 

 

(549,318)

Covenant not-to-compete

 

(85,044)

 

 

(94,321)

Other

 

(7,316)

 

 

(6,843)

Net deferred tax liabilities

 

(5,286,651)

 

 

(5,326,342)

Net deferred tax asset

$

7,674,290 

 

$

7,699,000 



The deferred tax amounts have been classified in the accompanying unaudited condensed consolidated balance sheets as follows:







 

 

 

 

 



 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Long-term deferred tax asset – U.K.

 

8,535,836 

 

 

8,509,915 

Long-term deferred tax asset – Malaysia

 

34,314 

 

 

33,843 

Total long-term deferred tax asset

$

8,570,150 

 

$

8,543,758 



 

 

 

 

 

Long-term deferred tax liability – U.S.

 

(895,860)

 

 

(844,758)

Total long-term deferred tax liability

$

(895,860)

 

$

(844,758)

 

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Net Loss Per Share
6 Months Ended
Mar. 31, 2019
Net Loss Per Share [Abstract]  
Net Loss Per Share

Note 12 – Net Loss Per Share



Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and warrants, and the vesting of unvested restricted stock and restricted stock units.  Due to our net loss for the periods presented, all potentially dilutive instruments were excluded because their inclusion would have been anti-dilutive. See Notes 8 and 9 for a discussion of our dilutive potential common shares.



XML 31 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Industry Segments and Financial Information About Foreign and Domestic Operations
6 Months Ended
Mar. 31, 2019
Industry Segments and Financial Information About Foreign and Domestic Operations [Abstract]  
Industry Segments and Financial Information About Foreign and Domestic Operations

Note 13 – Industry Segments and Financial Information about Foreign and Domestic Operations



The Company currently operates in two reporting segments: Commercial and Research and Development.  The Commercial segment consists of FC2, PREBOOST and drug commercialization costs.  The Research and Development segment consists of multiple drug products under clinical development for oncology and urology. There are no significant inter-segment sales. We evaluate the performance of each segment based on operating profit or loss. There is no inter-segment allocation of non-operating expenses and income taxes. Our chief operating decision-maker (“CODM”) is Mitchell S. Steiner, M.D., our Chairman, President and Chief Executive Officer. 



Information about the Company's operations by segment and geographic area is as follows:









 

 

 

 

 

 

 

 

 

 

 

   

For the three months ended
March 31,

 

For the six months ended
March 31,



2019

 

2018

 

2019

 

2018

Operating (loss) income:

(In thousands)

 

(In thousands)

Commercial

$

3,204 

 

$

(163)

 

$

6,872 

 

$

(19)

Research and Development

 

(2,889)

 

 

(1,960)

 

 

(5,250)

 

 

(3,992)

Corporate

 

(2,440)

 

 

(2,574)

 

 

(4,758)

 

 

(8,122)



$

(2,125)

 

$

(4,697)

 

$

(3,136)

 

$

(12,133)



 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

United States

$

2,596 

 

$

981 

 

$

5,646 

 

$

1,975 

Brazil

 

1,098 

 

 

 —

 

 

1,098 

 

 

 —

United Arab Emirates

 

677 

 

 

278 

 

 

677 

 

 

278 

South Africa

 

24 

 

 

715 

 

 

233 

 

 

1,033 

Zimbabwe

 

590 

 

 

378 

 

 

1,948 

 

 

678 

Other

 

1,991 

 

 

221 

 

 

3,746 

 

 

1,195 



$

6,976 

 

$

2,573 

 

$

13,348 

 

$

5,159 



All of our net revenues, which are primarily derived from the sale of FC2, are attributed to our Commercial reporting segment. The loss on settlement of accounts receivable and depreciation and amortization related to long-lived assets that are not utilized in the production of FC2 are not reported as part of the reporting segments or reviewed by the CODM. These amounts are included in Corporate in the reconciliations above. Total assets are not presented by reporting segment as they are not reviewed by the CODM when evaluating the reporting segments’ performance. 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
6 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 14 – Subsequent Events



On May 13, 2019, the Company entered into an amendment (the “Second Amendment”) to the Credit Agreement discussed in Note 7.  The Second Amendment provides for reduced percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2019, a return to the current percentages used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2020 and increased percentages to be used to calculate the quarterly revenue-based payments due on product revenue from net sales of FC2 during calendar 2021 and thereafter until the loan has been repaid. The Second Amendment also provides for an increase in the repayment amount from 175% to 176.5% of the aggregate amount advanced. In addition, the Second Amendment provides for payments under the Residual Royalty Agreement to commence at the same time as they would have commenced prior to the Second Amendment. The Second Amendment also eliminates the Company’s option to draw up to an additional $2.0 million under the Credit Agreement depending on the Company entering into agreements to distribute FC2 in Brazil and South Africa as the Company has determined that it would not make such draws. As a result of the Second Amendment, the Company’s quarterly revenue-based payment due May 15, 2019 will decrease from approximately $1.7 million to approximately $0.9 million. At this time, the Company is unable to determine all of the financial effects of the Second Amendment, which will likely result in the Company recording an extinguishment loss due to the modification of the terms of the Credit Agreement in the quarter ending June 30, 2019. An estimate of the loss amount cannot be made at this time as the Company is currently analyzing the accounting for the transaction, which includes fair value determinations.

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation (Policy)
6 Months Ended
Mar. 31, 2019
Basis of Presentation [Abstract]  
Basis of presentation

The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (“we,” “our,” “us,” “Veru” or the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018. The accompanying condensed consolidated balance sheet as of September 30, 2018 has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and six months ended March 31, 2019 and cash flows for the six months ended March 31, 2019 are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending September 30, 2019.  



The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.



In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.

Principles of consolidation and nature of operations

Principles of consolidation and nature of operations: Veru Inc. is referred to in these notes collectively with its subsidiaries as “we,” “our,” “us,” “Veru” or the “Company.” The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (“APP”) and The Female Health Company Limited, and The Female Health Company Limited’s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the “U.K. subsidiary”), and The Female Health Company (UK) plc’s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the “Malaysia subsidiary”). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the “APP Acquisition”) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer health care product, the FC2 Female Condom/FC2 Internal Condom® (“FC2”).  The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company focused on oncology and urology with multiple drug products under clinical development.  Most of the Company’s net revenues during the three and six months ended March 31, 2019 and 2018 were derived from sales of FC2. 

Reclassifications

Reclassifications:  Certain prior period amounts in the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. These reclassifications had no effect on the results of operations or financial position for any period presented.

Cash concentration

Cash concentration: The Company’s cash is maintained primarily in three financial institutions, located in Chicago, Illinois, London, England and Kuala Lumpur, Malaysia.

Restricted cash

Restricted cash: Restricted cash relates to security provided to one of the Company’s U.K. banks for performance bonds issued in favor of customers. The Company has a facility of $250,000 for such performance bonds.  Such security has been extended infrequently and only on occasions where it has been a contract term expressly stipulated as an absolute requirement by the customer or its provider of funds. The expiration of the bond is defined by the completion of the event such as, but not limited to, a period of time after the product has been distributed or expiration of the product shelf life.  The Company had no restricted cash at March 31, 2019. Restricted cash was approximately $135,000 at September 30, 2018 and is included in cash on the accompanying unaudited condensed consolidated balance sheets.  

Patents and trademarks

Patents and trademarks: The costs for patents and trademarks are expensed when incurred. 

Deferred financing costs

Deferred financing costs: Costs incurred in connection with the common stock purchase agreement discussed in Note 8 have been included in other assets on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. When shares of the Company’s common stock are sold under the common stock purchase agreement, a pro-rata portion of the deferred costs is recorded to additional paid-in-capital.



As discussed in Note 8, in connection with the common stock offering that closed on October 1, 2018, we incurred costs of approximately $190,000 through September 30, 2018. This amount was included in other assets on the accompanying unaudited condensed consolidated balance sheet at September 30, 2018. These costs were charged to additional paid-in capital in the six months ended March 31, 2019 after the common stock offering was closed.



Costs incurred in connection with the issuance of debt discussed in Note 7 are presented as a reduction of the debt on the accompanying unaudited condensed consolidated balance sheets at March 31, 2019 and September 30, 2018. These issuance costs are being amortized using the effective interest method over the expected repayment period of the debt, which is currently estimated to occur in the third quarter of fiscal 2021. The amortization is included in interest expense on the accompanying unaudited condensed consolidated statements of operations.

Fair value measurements

Fair value measurements: Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 – Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to us as of the reporting dates. Accordingly, the estimates presented in the accompanying unaudited condensed consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. See Note 3 for a discussion of fair value measurements.



The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash, accounts receivable, accounts payable and other accrued liabilities approximate their fair value based on the short-term nature of these instruments. The carrying value of long-term debt, taking into consideration debt discounts and related derivative instruments, is estimated to approximate fair value.

Unearned revenue

Unearned revenue: The Company records an unearned revenue liability if a customer pays consideration before the Company transfers the product to the customer under the terms of a contract. Unearned revenue is recognized as revenue after control of the product is transferred to the customer and all revenue recognition criteria have been met.  The Company had no unearned revenue at March 31, 2019. Unearned revenue at September 30, 2018 was approximately $187,000 and was comprised of sales made to a large distributor who has the right to return product under certain conditions.

Derivative instruments

Derivative instruments: The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company reviews the terms of debt instruments it enters into to determine whether there are embedded derivative instruments, which are required to be bifurcated and accounted for separately as derivative financial instruments. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. Liabilities incurred in connection with an embedded derivative are discussed in Note 7.

Revenue recognition

Revenue recognition: Revenue is recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products.



The Company generates nearly all of its revenue from direct product sales. Revenue from direct product sales is generally recognized when the customer obtains control of the product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have significant unusual payment terms beyond 120 days in its contracts with customers. See Note 4 for additional information regarding credit terms.



The amount of consideration the Company ultimately receives varies depending upon sales discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of current contract sales terms and historical payment experience.



Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt.

Research and development costs

Research and development costs: Research and development costs are expensed as they are incurred and include salaries and benefits, clinical trial costs and contract services. Nonrefundable advance payments made for goods or services to be used in research and development activities are deferred and capitalized until the goods have been delivered or the related services have been performed. If the goods are no longer expected to be delivered or the services are no longer expected to be performed, the Company would be required to expense the related capitalized advance payments. The Company did not have any capitalized nonrefundable advance payments as of March 31, 2019 and September 30, 2018.



The Company records estimated costs of research and development activities conducted by third-party service providers, which include the conduct of preclinical studies and clinical trials and contract manufacturing activities. These costs are a significant component of the Company’s research and development expenses. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed, number of patients enrolled and the rate of patient enrollments may vary from the Company’s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company’s accruals could materially affect the Company’s results of operations.

Share-based compensation

Share-based compensation: The Company recognizes share-based compensation expense in connection with its share-based awards based on the estimated fair value of the awards on the date of grant, on a straight-line basis over the vesting period. Calculating share-based compensation expense requires the input of highly subjective judgment and assumptions, including estimates of the expected life of the share-based award, stock price volatility and risk-free interest rates.

Advertising

Advertising: The Company's policy is to expense advertising costs as incurred. Advertising costs were immaterial to the Company’s results of operations for the three and six months ended March 31, 2019 and 2018.

Income taxes

Income taxes: The Company files separate income tax returns for its foreign subsidiaries. FASB ASC Topic 740 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are also provided for carryforwards for income tax purposes. In addition, the amount of any future tax benefits is reduced by a valuation allowance to the extent such benefits are not expected to be realized.

Foreign currency translation and operations

Foreign currency translation and operations: Effective October 1, 2009, the Company determined that there were significant changes in facts and circumstances, triggering an evaluation of its subsidiaries’ functional currency.  The evaluation indicated that the U.S. dollar is the currency with the most significant influence upon the subsidiaries.  Because all of the U.K. subsidiary's future sales and cash flows would be denominated in U.S. dollars following the October 2009 cessation of production of the Company’s first-generation product, FC1, the U.K. subsidiary adopted the U.S. dollar as its functional currency effective October 1, 2009. As the Malaysia subsidiary is a direct and integral component of the U.K. parent’s operations, it, too, adopted the U.S. dollar as its functional currency as of October 1, 2009. The consistent use of the U.S. dollar as the functional currency across the Company reduces its foreign currency risk and stabilizes its operating results. The cumulative foreign currency translation loss included in accumulated other comprehensive loss was $0.6 million as of March 31, 2019 and September 30, 2018. Assets located outside of the U.S. totaled approximately $5.0 million and $5.2 million at March 31, 2019 and September 30, 2018, respectively.

Other comprehensive loss

Other comprehensive loss: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss.  Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss.



The U.S. parent company and its U.K. subsidiary routinely purchase inventory produced by its Malaysia subsidiary for sale to their respective customers. These intercompany trade accounts are eliminated in consolidation. The Company’s policy and intent is to settle the intercompany trade account on a current basis.  Since the U.K. and Malaysia subsidiaries adopted the U.S. dollar as their functional currencies effective October 1, 2009, no foreign currency gains or losses from intercompany trade are recognized.  For the three and six months ended March 31, 2019 and 2018, comprehensive loss is equivalent to the reported net loss.    

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements



In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606).  This new accounting guidance on revenue recognition provides for a single five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation. The new guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts.  The Company adopted the new guidance on October 1, 2018 using the modified retrospective method and elected to apply the guidance only to contracts that were not completed as of the date of adoption. The adoption of this guidance did not have a material effect on our consolidated financial statements and related disclosures. See discussion above for disclosures relating to the Company's revenue recognition.



In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842),  which requires that lessees recognize a right-of-use asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of key information about leasing arrangements.  ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required upon adoption.  Early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases to clarify the implementation guidance and ASU No. 2018-11, Leases (Topic 842) Targeted Improvements. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. In December 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors to address certain implementation issues facing lessors when adopting ASU 2016-02. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842): Codification Improvements to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016-02. The Company will adopt the new accounting standard on October 1, 2019 and intends to elect certain practical expedients, including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts.  We have begun to identify our significant lease contracts and are in the process of evaluating the effect of the new guidance on our consolidated financial statements and related disclosures.



In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The purpose of ASU 2016-18 is to clarify guidance and presentation related to restricted cash in the statements of cash flows as well as increased disclosure requirements. It requires beginning-of-period and end-of-period total amounts shown on the statements of cash flows to include cash and cash equivalents as well as restricted cash and restricted cash equivalents. We adopted ASU 2016-18 effective October 1, 2018. The adoption of ASU 2016-18 did not have a material effect on the presentation of our consolidated statements of cash flows or related disclosures. 



In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment. The purpose of ASU 2017-04 is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the impaired fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We do not expect the adoption of ASU 2017-04 to have a material effect on our financial position or results of operations.



In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The purpose of ASU 2017-09 is to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. We adopted ASU 2017-09 effective October 1, 2018. The adoption of ASU 2017-09 did not have a material effect on our financial position or results of operations. 



In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The purpose of ASU 2018-07 is to expand the scope of Topic 718, Compensation—Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. ASU 2018-07 will be effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than the Company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. The adoption of ASU 2018-07 is not expected to have a material effect on our financial position or results of operations but should simplify the process by which the Company measures compensation expense for share-based payments to nonemployees. 

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Change to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 modifies the disclosure requirements by adding, removing, and modifying certain required disclosures for fair value measurements for assets and liabilities disclosed within the fair value hierarchy. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 and early adoption is permitted. The adoption of ASU 2018-13 is not expected to have a material effect on our financial position or results of operations as it modifies disclosure requirements only.

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2019
Fair Value Measurements [Abstract]  
Reconciliation of the Beginning and Ending Liability Balance



 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018

Beginning balance

$

2,426,000 

 

$

 —

Additions

 

 —

 

 

3,319,000 

Change in fair value of derivative liabilities

 

403,000 

 

 

21,000 

Ending balance

$

2,829,000 

 

$

3,340,000 



Schedule of Qualitative Information



 

 

 

 



 

 

 

 

Valuation Methodology

 

Significant Unobservable Input

 

Weighted Average
(range, if applicable)



 

 

 

 

Monte Carlo Simulation

 

Estimated change of control dates

 

December 2019 to December 2021



 

Discount rate

 

15.3% to 17.3%



 

Probability of change of control

 

0% to 90%



XML 35 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Receivable and Concentration of Credit Risk (Tables)
6 Months Ended
Mar. 31, 2019
Accounts Receivable and Concentration of Credit Risk [Abstract]  
Components Of Accounts Receivable



 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Accounts receivable

 

$

4,076,745 

 

$

4,046,733 

Less: allowance for doubtful accounts

 

 

(36,201)

 

 

(36,201)

Less: allowance for sales and payment term discounts

 

 

(13,309)

 

 

(37,900)

Accounts receivable, net

 

$

4,027,235 

 

$

3,972,632 



Summary Of Components Of Allowance For Doubtful Accounts



 

 

 

 

 



Six Months Ended March 31,



 

2019

 

 

2018



 

 

 

 

 

Beginning balance

$

36,201 

 

$

38,103 

Charges to expense

 

 —

 

 

3,058 

Charge-offs

 

 —

 

 

(5,000)

Ending balance

$

36,201 

 

$

36,161 



XML 36 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Information (Tables)
6 Months Ended
Mar. 31, 2019
Balance Sheet Information [Abstract]  
Components Of Inventory



 

 

 

 

 



March 31,

 

September 30,



2019

 

2018

FC2

 

 

 

 

 

Raw material

$

599,772 

 

$

366,220 

Work in process

 

62,710 

 

 

77,669 

Finished goods

 

2,786,083 

 

 

2,232,864 

Inventory, gross

 

3,448,565 

 

 

2,676,753 

Less: inventory reserves

 

(451,041)

 

 

(391,861)

FC2, net

 

2,997,524 

 

 

2,284,892 

PREBOOST®

 

 

 

 

 

Finished goods

 

677 

 

 

17,138 

Inventory, net

$

2,998,201 

 

$

2,302,030 



Schedule of Estimated Useful Lives of Assets



 



 

Manufacturing equipment

510 years

Office equipment

35 years

Furniture and fixtures

710 years



Plant and Equipment



 

 

 

 

 

 



 

March 31,
2019

 

September 30,
2018



 

 

 

 

 

 

Equipment, furniture and fixtures

 

$

4,018,333 

 

$

4,018,284 

Leasehold improvements

 

 

287,686 

 

 

287,686 



 

 

4,306,019 

 

 

4,305,970 

Less: accumulated depreciation and amortization

 

 

(3,985,217)

 

 

(3,901,418)

Plant and equipment, net

 

$

320,802 

 

$

404,552 



XML 37 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets and Goodwill (Tables)
6 Months Ended
Mar. 31, 2019
Intangible Assets and Goodwill [Abstract]  
Gross Carrying Amounts of Finite Intangible Assets



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

404,269 

 

$

1,995,731 

Covenants not-to-compete

 

500,000 

 

 

172,619 

 

 

327,381 

Total intangible assets with finite lives

 

2,900,000 

 

 

576,888 

 

 

2,323,112 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

576,888 

 

$

20,323,112 



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2018:





 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

285,366 

 

$

2,114,634 

Covenants not-to-compete

 

500,000 

 

 

136,905 

 

 

363,095 

Total intangible assets with finite lives

 

2,900,000 

 

 

422,271 

 

 

2,477,729 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

422,271 

 

$

20,477,729 



XML 38 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Tables)
6 Months Ended
Mar. 31, 2019
Debt [Abstract]  
Credit Agreement



 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Aggregate repayment obligation

$

17,500,000 

 

$

17,500,000 

Less: Cumulative payments

 

(3,834,202)

 

 

(642,485)

Less: Unamortized discounts

 

(6,212,466)

 

 

(8,475,874)

Less: Unamortized deferred issuance costs

 

(149,783)

 

 

(204,353)

Credit agreement, net

 

7,303,549 

 

 

8,177,288 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,251,000 

 

 

1,217,000 



 

8,554,549 

 

 

9,394,288 

Credit agreement, short-term portion

 

(5,836,615)

 

 

(6,692,718)

Credit agreement, long-term portion

$

2,717,934 

 

$

2,701,570 



 

 

 

 

 



Residual Royalty Agreement Liability



 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Residual Royalty Agreement liability, fair value at inception

$

346,000 

 

$

346,000 

Less: Unamortized discounts

 

 —

 

 

(2,420)

Add: Accretion of liability using effective interest rate

 

417,522 

 

 

201,225 

Residual Royalty Agreement liability, net

 

763,522 

 

 

544,805 

Add: Embedded derivative liability at fair value (see Note 3)

 

1,578,000 

 

 

1,209,000 

Residual Royalty Agreement liability

$

2,341,522 

 

$

1,753,805 



 

 

 

 

 



Credit Agreement Interest Expense



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended
March 31,

 

Six Months Ended
March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Amortization of Credit Agreement and Residual Royalty Agreement discounts

$

1,107,622 

 

$

317,747 

 

$

2,265,828 

 

$

317,747 

Accretion of Residual Royalty Agreement liability

 

123,946 

 

 

27,278 

 

 

216,297 

 

 

27,278 

Amortization of deferred issuance costs

 

26,704 

 

 

5,570 

 

 

54,570 

 

 

5,570 



$

1,258,272 

 

$

350,595 

 

$

2,536,695 

 

$

350,595 



XML 39 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Tables)
6 Months Ended
Mar. 31, 2019
Share-Based Compensation [Abstract]  
Recorded Share-Based Compensation Expenses



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,



 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

$

7,778 

 

$

1,797 

 

$

15,730 

 

$

5,061 

Selling, general and administrative

 

 

407,426 

 

 

362,006 

 

 

734,435 

 

 

537,344 

Research and development

 

 

81,005 

 

 

48,045 

 

 

163,300 

 

 

76,897 



 

$

496,209 

 

$

411,848 

 

$

913,465 

 

$

619,302 



Weighted Average Assumptions For Options Granted



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

March 31,

 

March 31,

Weighted Average Assumptions:

 

 

2019

 

 

2018

 

 

2019

 

 

2018



 

 

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

65.45% 

 

 

62.34% 

 

 

66.88% 

 

 

61.38% 

Expected dividend yield

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

 

 

0.00% 

Risk-free interest rate

 

 

2.27% 

 

 

2.76% 

 

 

2.59% 

 

 

2.47% 

Expected term (in years)

 

 

5.9 

 

 

6.0 

 

 

5.7 

 

 

5.8 

Fair value of options granted

 

$

0.90 

 

$

1.28 

 

$

0.85 

 

$

0.93 



Summary Of Stock Options Outstanding And Exercisable



 

 

 

 

 

 

 

 

 



 

 

Weighted Average

 

 

 



 

 

 

 

 

Remaining

 

Aggregate



Number of

 

Exercise Price

 

Contractual Term

 

Intrinsic



Shares

 

Per Share

 

(years)

 

Value



 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2018

5,645,312 

 

$

1.59 

 

 

 

 

 

Granted

880,882 

 

 

1.42 

 

 

 

 

 

Exercised

(166,667)

 

 

1.20 

 

 

 

 

 

Forfeited

(301,834)

 

 

1.52 

 

 

 

 

 

Outstanding at March 31, 2019

6,057,693 

 

$

1.57 

 

7.83 

 

$

785,435 

Exercisable at March 31, 2019

2,042,285 

 

$

1.46 

 

6.51 

 

$

436,840 



XML 40 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Tables)
6 Months Ended
Mar. 31, 2019
Income Taxes [Abstract]  
Reconciliation Of Income Tax Expense (Benefit)



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Six Months Ended



March 31,

 

March 31,



2019

 

2018

 

2019

 

2018



 

 

 

 

 

 

 

 

 

 

 

Income tax benefit at statutory rates

$

(841,862)

 

$

(1,077,736)

 

$

(1,273,685)

 

$

(3,628,736)

State income tax benefit, net of federal benefits

 

(199,521)

 

 

(385,395)

 

 

(301,863)

 

 

(948,395)

Effect of change in U.S. tax rate

 

 —

 

 

 —

 

 

 —

 

 

(187,000)

Non-deductible expenses – other

 

2,364 

 

 

8,702 

 

 

4,783 

 

 

12,702 

Effect of lower foreign income tax rates

 

4,830 

 

 

50,981 

 

 

(3,527)

 

 

80,386 

Effect of deemed dividend

 

32,318 

 

 

 —

 

 

63,627 

 

 

 —

Other

 

(1,025)

 

 

101,032 

 

 

(22,863)

 

 

122,574 

Change in valuation allowance

 

1,028,063 

 

 

 —

 

 

1,651,193 

 

 

 —

Income tax expense (benefit)

$

25,167 

 

$

(1,302,416)

 

$

117,665 

 

$

(4,548,469)



Significant Components Of Deferred Tax Assets And Liabilities



 

 

 

 

 



 

 

 

 

 



March 31,

 

September 30,

Deferred tax assets:

2019

 

2018



 

 

 

 

 

Federal net operating loss carryforwards

$

8,057,926 

 

$

6,973,047 

State net operating loss carryforwards

 

2,468,061 

 

 

2,195,865 

Foreign net operating loss carryforwards – U.K.

 

10,621,438 

 

 

10,595,518 

Foreign capital allowance – U.K.

 

102,098 

 

 

102,098 

U.K. bad debts

 

1,700 

 

 

1,700 

Restricted stock – U.K.

 

17,586 

 

 

17,586 

U.S. deferred rent

 

54,706 

 

 

22,902 

Share-based compensation

 

759,875 

 

 

622,442 

Other, net – U.S.

 

125,508 

 

 

91,419 

Other, net – Malaysia

 

34,314 

 

 

33,843 

Gross deferred tax assets

 

22,243,212 

 

 

20,656,420 

Valuation allowance for deferred tax assets

 

(9,282,271)

 

 

(7,631,078)

Net deferred tax assets

 

12,960,941 

 

 

13,025,342 

Deferred tax liabilities:

 

 

 

 

 

In process research and development

 

(4,675,860)

 

 

(4,675,860)

Developed technology

 

(518,431)

 

 

(549,318)

Covenant not-to-compete

 

(85,044)

 

 

(94,321)

Other

 

(7,316)

 

 

(6,843)

Net deferred tax liabilities

 

(5,286,651)

 

 

(5,326,342)

Net deferred tax asset

$

7,674,290 

 

$

7,699,000 



Schedule Of Deferred Tax Amounts Classified In Balance Sheets



 

 

 

 

 



 

 

 

 

 



March 31,
2019

 

September 30,
2018



 

 

 

 

 

Long-term deferred tax asset – U.K.

 

8,535,836 

 

 

8,509,915 

Long-term deferred tax asset – Malaysia

 

34,314 

 

 

33,843 

Total long-term deferred tax asset

$

8,570,150 

 

$

8,543,758 



 

 

 

 

 

Long-term deferred tax liability – U.S.

 

(895,860)

 

 

(844,758)

Total long-term deferred tax liability

$

(895,860)

 

$

(844,758)



XML 41 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Industry Segments and Financial Information About Foreign and Domestic Operations (Tables)
6 Months Ended
Mar. 31, 2019
Industry Segments and Financial Information About Foreign and Domestic Operations [Abstract]  
Schedule of Segment Reporting Information



 

 

 

 

 

 

 

 

 

 

 

   

For the three months ended
March 31,

 

For the six months ended
March 31,



2019

 

2018

 

2019

 

2018

Operating (loss) income:

(In thousands)

 

(In thousands)

Commercial

$

3,204 

 

$

(163)

 

$

6,872 

 

$

(19)

Research and Development

 

(2,889)

 

 

(1,960)

 

 

(5,250)

 

 

(3,992)

Corporate

 

(2,440)

 

 

(2,574)

 

 

(4,758)

 

 

(8,122)



$

(2,125)

 

$

(4,697)

 

$

(3,136)

 

$

(12,133)



 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

United States

$

2,596 

 

$

981 

 

$

5,646 

 

$

1,975 

Brazil

 

1,098 

 

 

 —

 

 

1,098 

 

 

 —

United Arab Emirates

 

677 

 

 

278 

 

 

677 

 

 

278 

South Africa

 

24 

 

 

715 

 

 

233 

 

 

1,033 

Zimbabwe

 

590 

 

 

378 

 

 

1,948 

 

 

678 

Other

 

1,991 

 

 

221 

 

 

3,746 

 

 

1,195 



$

6,976 

 

$

2,573 

 

$

13,348 

 

$

5,159 



XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Basis of Presentation (Narrative) (Details) - USD ($)
6 Months Ended 12 Months Ended
Mar. 31, 2019
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]    
Restricted cash $ 0 $ 135,000
Stock issuance costs incurred   190,000
Unearned revenue   187,159
Total assets 51,012,054 48,452,639
Cumulative foreign currency translation gain (loss) (600,000) (600,000)
Performance Bond [Member]    
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]    
Restricted cash 250,000  
Outside United States [Member]    
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]    
Total assets $ 5,000,000 $ 5,200,000
Minimum [Member]    
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]    
Credit terms 30 days  
Maximum [Member]    
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Line Items]    
Credit terms 120 days  
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Narrative) (Details) - USD ($)
6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Fair Value Measurements [Abstract]    
Transfers to level 1 $ 0 $ 0
Transfers to level 2 0 0
Transfers to Level 3 $ 0 $ 0
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) - USD ($)
6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Fair Value Measurements [Abstract]    
Beginning balance $ 2,426,000
Additions   3,319,000
Change in fair value of derivative liabilities 403,000 21,000
Ending balance $ 2,829,000 $ 3,340,000
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Schedule of Qualitative Information) (Details)
6 Months Ended
Mar. 31, 2019
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Valuation Methodology Monte Carlo Simulation
Maximum [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Estimated change of control dates Dec. 31, 2021
Maximum [Member] | Measurement Input, Discount Rate [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Discount rate 17.30
Maximum [Member] | Measurement Input, Probability Of Change Of Control [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Probability of change of control 90.00%
Minimum [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Estimated change of control dates Dec. 01, 2019
Minimum [Member] | Measurement Input, Discount Rate [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Discount rate 15.30
Minimum [Member] | Measurement Input, Probability Of Change Of Control [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Probability of change of control 0.00%
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Receivable and Concentration of Credit Risk (Narrative) (Details)
item in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 27, 2017
USD ($)
Jul. 31, 2018
USD ($)
Mar. 31, 2019
USD ($)
customer
Jun. 30, 2018
USD ($)
Mar. 31, 2018
customer
Mar. 31, 2019
USD ($)
customer
item
Mar. 31, 2018
USD ($)
customer
Sep. 30, 2018
USD ($)
customer
Feb. 28, 2018
USD ($)
Current accounts receivable, net     $ 4,027,235     $ 4,027,235   $ 3,972,632  
Minimum [Member]                  
Credit terms           30 days      
Maximum [Member]                  
Credit terms           120 days      
Assets, Current [Member]                  
Concentration risk, percentage           11.00%   15.00%  
Number of Customers | customer           1   1  
Accounts Receivable [Member]                  
Concentration risk, percentage           65.00%   74.00%  
Number of Customers | customer           2   3  
Total Revenue [Member]                  
Concentration risk, percentage     82.00%   44.00% 66.00% 50.00%    
Number of Customers | customer     4   2 3 3    
Semina [Member]                  
Current accounts receivable, net                 $ 1,500,000
Payments to settle agreement $ 2,200,000 $ 1,300,000              
Long term trade receivable $ 7,500,000                
Settlement loss on receivables       $ 200,000     $ 3,800,000    
South Africa [Member]                  
Credit terms           150 days      
Brazil [Member]                  
Number of units ordered | item           15      
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Receivable and Concentration of Credit Risk (Components Of Accounts Receivable) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2017
Accounts Receivable and Concentration of Credit Risk [Abstract]        
Accounts receivable $ 4,076,745 $ 4,046,733    
Less: allowance for doubtful accounts (36,201) (36,201) $ (36,161) $ (38,103)
Less: allowance for sales and payment term discounts (13,309) (37,900)    
Accounts receivable, net $ 4,027,235 $ 3,972,632    
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Receivable and Concentration of Credit Risk (Summary Of Components Of Allowance For Doubtful Accounts) (Details)
6 Months Ended
Mar. 31, 2018
USD ($)
Accounts Receivable and Concentration of Credit Risk [Abstract]  
Beginning balance $ 38,103
Charges to expense 3,058
Charge-offs (5,000)
Ending balance $ 36,161
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Information (Components Of Inventory) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Inventory [Line Items]    
Inventory, net $ 2,998,201 $ 2,302,030
FC2 [Member]    
Inventory [Line Items]    
Raw material 599,772 366,220
Work in process 62,710 77,669
Finished goods 2,786,083 2,232,864
Inventory, gross 3,448,565 2,676,753
Less: inventory reserves (451,041) (391,861)
Inventory, net 2,997,524 2,284,892
PREBOOST [Member]    
Inventory [Line Items]    
Finished goods $ 677 $ 17,138
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Information (Schedule of Estimated Useful Lives of Assets) (Details)
6 Months Ended
Mar. 31, 2019
Manufacturing Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 10 years
Manufacturing Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 5 years
Office Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 5 years
Office Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 3 years
Furniture And Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 10 years
Furniture And Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Useful lives 7 years
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Information (Plant and Equipment) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 4,306,019 $ 4,305,970
Less: accumulated depreciation and amortization (3,985,217) (3,901,418)
Plant and equipment, net 320,802 404,552
Equipment, Furniture And Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 4,018,333 4,018,284
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 287,686 $ 287,686
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets and Goodwill (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Sep. 30, 2018
Amortization expense $ 77,000 $ 69,000 $ 154,617 $ 137,631  
Goodwill $ 6,878,932   $ 6,878,932   $ 6,878,932
Developed Technology - PREBOOST [Member]          
Amortization period     10 years    
Covenants Not To Compete [Member]          
Amortization period     7 years    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets and Goodwill (Gross Carrying Amounts of Finite Intangible Assets) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Finite-Lived Intangible Assets [Line Items]    
Intangible assets with finite lives, Gross Carrying Amount $ 2,900,000 $ 2,900,000
Accumulated Amortization 576,888 422,271
Intangible assets with finite lives, Net Book Value 2,323,112 2,477,729
Intangible assets with Indefinite lives,Net Book Value 20,323,112 20,477,729
Total intangible assets, Gross Carrying Amount 20,900,000 20,900,000
Total intangible assets, Net Book Value 20,323,112 20,477,729
Acquired In Process Research And Development Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets with Indefinite lives,Net Book Value 18,000,000 18,000,000
Developed Technology - PREBOOST [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets with finite lives, Gross Carrying Amount 2,400,000 2,400,000
Accumulated Amortization 404,269 285,366
Intangible assets with finite lives, Net Book Value 1,995,731 2,114,634
Covenants Not To Compete [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets with finite lives, Gross Carrying Amount 500,000 500,000
Accumulated Amortization 172,619 136,905
Intangible assets with finite lives, Net Book Value $ 327,381 $ 363,095
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Narrative) (Details)
item in Millions
6 Months Ended 12 Months Ended
May 13, 2019
Feb. 15, 2019
USD ($)
Nov. 15, 2018
USD ($)
May 15, 2018
USD ($)
Mar. 05, 2018
USD ($)
item
Mar. 31, 2019
USD ($)
Sep. 30, 2018
USD ($)
SWK Credit Agreement [Member]              
Line of Credit Facility [Line Items]              
Line of credit facility, maximum borrowing capacity         $ 12,000,000    
Line of credit facility, amount outstanding         $ 10,000,000 $ 8,554,549 $ 9,394,288
Additional credit draw based on agreement           $ 2,000,000  
Percentage of paid advanced amount         175.00% 175.00%  
Period in which net revenue will be calculated         12 months    
Minimum amount of net revenue required         $ 10,000,000    
Percentage of product revenue         32.50%    
Repayments   $ 600,000 $ 2,600,000     $ 3,834,202 $ 642,485
Percentage of outstanding shares acquired which constitutes a change of control         50.00%    
Period to replace key persons         90 days    
Required minimum liquid assets           1,000,000  
Pledge percentage         65.00%    
Net proceeds after fees and expenses           9,900,000  
Deferred loan issuance costs           $ 267,000  
SWK Credit Agreement [Member] | May 15, 2018 [Member]              
Line of Credit Facility [Line Items]              
Repayments       $ 600,000      
SWK Credit Agreement [Member] | November 15, 2018 [Member]              
Line of Credit Facility [Line Items]              
Repayments     1,200,000        
SWK Credit Agreement [Member] | August 15, 2018 [Member]              
Line of Credit Facility [Line Items]              
Repayments     $ 1,400,000        
SWK Credit Agreement [Member] | Subsequent Event [Member]              
Line of Credit Facility [Line Items]              
Percentage of paid advanced amount 176.50%            
SWK Credit Agreement [Member] | Brazil [Member]              
Line of Credit Facility [Line Items]              
Additional credit draw based on agreement         $ 1,000,000    
Minimum units to be distributed under agreement | item         47.5    
SWK Credit Agreement [Member] | South Africa [Member]              
Line of Credit Facility [Line Items]              
Additional credit draw based on agreement         $ 1,000,000    
Minimum units to be distributed under agreement | item         30.0    
SWK Credit Agreement [Member] | On or after to September 5, 2018 [Member]              
Line of Credit Facility [Line Items]              
Period in which net revenue will be calculated         12 months    
Percentage of product revenue         5.00%    
Net Revenue required         $ 2,000,000    
Percentage of paid advanced amount that must be paid         175.00%    
SWK Credit Agreement [Member] | Scenario 2 [Member]              
Line of Credit Facility [Line Items]              
Period in which net revenue will be calculated         12 months    
Percentage of product revenue         25.00%    
Net Revenue required         $ 10,000,000    
SWK Credit Agreement [Member] | Scenario 3 [Member]              
Line of Credit Facility [Line Items]              
Percentage of product revenue         10.00%    
Net Revenue required         $ 12,500,000    
Residual Royalty Agreement [Member]              
Line of Credit Facility [Line Items]              
Period in which net revenue will be calculated         12 months    
Percentage of product revenue         5.00%    
Change of control minimum payment         $ 2,000,000    
Maximum [Member] | SWK Credit Agreement [Member] | Scenario 2 [Member]              
Line of Credit Facility [Line Items]              
Net Revenue required         $ 12,500,000    
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Credit Agreement) (Details) - USD ($)
6 Months Ended 12 Months Ended
Feb. 15, 2019
Nov. 15, 2018
Mar. 31, 2019
Sep. 30, 2018
Mar. 05, 2018
Credit agreement, short-term portion     $ (5,836,615) $ (6,692,718)  
Credit agreement, long-term portion     2,717,934 2,701,570  
SWK Credit Agreement [Member]          
Aggregate repayment obligation     17,500,000 17,500,000  
Less: Cumulative payments $ (600,000) $ (2,600,000) (3,834,202) (642,485)  
Less: Unamortized discounts     (6,212,466) (8,475,874)  
Less: Unamortized deferred issuance costs     (149,783) (204,353)  
Credit agreement, net     7,303,549 8,177,288  
Add: Embedded derivative liability at fair value (see Note 3)     1,251,000 1,217,000  
Credit agreement     8,554,549 9,394,288 $ 10,000,000
Credit agreement, short-term portion     (5,836,615) (6,692,718)  
Credit agreement, long-term portion     $ 2,717,934 $ 2,701,570  
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Residual Royalty Agreement Liability) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Sep. 30, 2018
Add: Accretion of liability using effective interest rate $ 123,946 $ 27,278 $ 216,297 $ 27,278  
Residual Royalty Agreement liability 2,341,522   2,341,522   $ 1,753,805
Residual Royalty Agreement [Member]          
Residual Royalty Agreement liability, fair value at inception 346,000   346,000   346,000
Less: Unamortized discounts         (2,420)
Add: Accretion of liability using effective interest rate     417,522   201,225
Residual Royalty Agreement liability, net 763,522   763,522   544,805
Add: Embedded derivative liability at fair value (see Note 3) 1,578,000   1,578,000   1,209,000
Residual Royalty Agreement liability $ 2,341,522   $ 2,341,522   $ 1,753,805
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Credit Agreement Interest Expense) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Debt [Abstract]        
Amortization of Credit Agreement and Residual Royalty Agreement discounts $ 1,107,622 $ 317,747 $ 2,265,828 $ 317,747
Accretion of Residual Royalty Agreement liability 123,946 27,278 216,297 27,278
Amortization of deferred issuance costs 26,704 5,570 54,570 5,570
Interest expense $ 1,258,272 $ 350,595 $ 2,536,695 $ 350,595
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Narrative) (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 01, 2018
May 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Mar. 31, 2019
Sep. 30, 2018
Mar. 27, 2019
Dec. 29, 2017
Preferred stock, shares authorized         154,000,000   77,000,000  
Preferred stock, issued         0 0    
Preferred stock, outstanding         0 0    
Aggregate purchase price of shares         $ 649,682 $ 574,687    
Maximum purchase of shares per business day         154,000,000 77,000,000    
Net proceeds from sale of shares     $ 9,131,967 $ 347,081        
Proceeds from sale of shares in public offering , net of fees and costs         $ 9,131,967      
Aspire Capital [Member]                
Aggregate purchase price of shares         $ 12,000,000     $ 15,000,000
Term of purchase agreement         36 months      
Price per share of common stock agreed to sell under purchase agreement         $ 0.50      
Maximum purchase of shares per business day         200,000      
Maximum VWAP percentage         30.00%      
General percentage of VWAP pursuant to notice         97.00%      
Issuance of common stock         304,457      
Common stock         $ 347,000      
Issuance of shares (in Shares)           1,717,010    
Net proceeds from sale of shares           $ 3,000,000    
Additional paid-in capital           85,000    
Related expenses         78,000      
Deferred assets         425,000      
Unamortized deferred assets         $ 340,000 $ 340,000    
Financial Advisor Warrant [Member]                
Warrant to purchase common stock shares         2,585,379      
Award expiration period         5 years      
Strike price per share         $ 1.93      
Consulting Services Warrants [Member]                
Number or Warrants Issued   2            
Warrant to purchase common stock shares   750,000            
Closing price per share   $ 2.31            
Fair value of warrant         $ 0      
Preferred Class A [Member]                
Preferred stock, shares authorized         5,000,000 5,000,000    
Preferred stock, par or stated value per share (in Dollars per share)         $ 0.01 $ 0.01    
Preferred stock, issued         0 0    
Preferred stock, outstanding         0 0    
Preferred Class A Series 1 [Member]                
Preferred stock, shares authorized         1,040,000 1,040,000    
Preferred Class A Series 2 [Member]                
Preferred stock, shares authorized         1,500,000 1,500,000    
Preferred Class A Series 3 [Member]                
Preferred stock, shares authorized         700,000 700,000    
Preferred Class A Series 4 [Member]                
Preferred stock, outstanding         548,000 548,000    
Preferred Class B [Member]                
Preferred stock, shares authorized         15,000 15,000    
Preferred stock, par or stated value per share (in Dollars per share)         $ 0.50 $ 0.50    
Preferred stock, issued         0 0    
Preferred stock, outstanding         0 0    
Common Stock [Member]                
Price per share of common stock agreed to sell under purchase agreement $ 1.40              
Issuance of shares (in Shares) 7,142,857   7,142,857 304,457        
Net proceeds from sale of shares     $ 71,428 $ 3,045        
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Jul. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Proceeds from stock option exercises     $ 200,000    
Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares exercised 166,667 190,000      
Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares exercised     166,667 0  
Proceeds from stock option exercises     $ 200,000    
Options, exercises in period, intrinsic value     $ 48,000    
Share price $ 1.46   $ 1.46    
Unrecognized compensation expense, stock options $ 2,700,000   $ 2,700,000    
Unrecognized compensation expense, period for recognition     3 years    
Restricted Stock Units (RSUs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Restricted stock outstanding 0   0    
Restricted Stock Units (RSUs) [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vest date     Oct. 31, 2018    
Restricted Stock Units (RSUs) [Member] | Employee [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued     50,000    
Restricted Stock Units (RSUs) [Member] | Outside Directors [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued     140,000    
Stock Appreciation Rights (SARs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award expiration period     10 years    
Exercise price per share $ 0.95   $ 0.95    
Stock Appreciation Rights (SARs) [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vest date     Oct. 31, 2018    
Stock Appreciation Rights (SARs) [Member] | Employee [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued     50,000    
Stock Appreciation Rights (SARs) [Member] | Outside Directors [Member] | The APP Merger [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued     140,000    
2017 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized         4,700,000
Number of shares available 190,868   190,868    
2018 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized 0   0 6,000,000  
Number of shares available 4,117,272   4,117,272    
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Recorded Share-Based Compensation Expenses) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation $ 496,209 $ 411,848 $ 913,465 $ 619,302
Cost of Sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation 7,778 1,797 15,730 5,061
Selling, General and Administrative [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation 407,426 362,006 734,435 537,344
Research and Development [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Share-based compensation $ 81,005 $ 48,045 $ 163,300 $ 76,897
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Weighted Average Assumptions For Options Granted) (Details) - Stock Option [Member] - $ / shares
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected volatility 65.45% 62.34% 66.88% 61.38%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Risk-free interest rate 2.27% 2.76% 2.59% 2.47%
Expected term (in years) 5 years 10 months 24 days 6 years 5 years 8 months 12 days 5 years 9 months 18 days
Fair Value of Options Granted $ 0.90 $ 1.28 $ 0.85 $ 0.93
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Summary Of Stock Options Outstanding And Exercisable) (Details) - Stock Option [Member]
6 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Mar. 31, 2018
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Shares Outstanding at Beginning of Period | shares 5,645,312  
Number of Shares Granted | shares 880,882  
Number of Shares Exercised | shares (166,667) 0
Number of Shares Forfeited | shares (301,834)  
Number of Shares Outstanding at End of Period | shares 6,057,693  
Number of Shares Exercisable at End of Period | shares 2,042,285  
Weighted Average Exercise Price Per Share, Outstanding at Beginning of Period | $ / shares $ 1.59  
Weighted Average Exercise Price Per Share, Granted | $ / shares 1.42  
Weighted Average Exercise Price Per Share, Exercised | $ / shares 1.20  
Weighted Average Exercise Price Per Share, Forfeited | $ / shares 1.52  
Weighted Average Exercise Price Per Share, Outstanding at End of Period | $ / shares 1.57  
Weighted Average Exercise Price Per Share, Exercisable at End of Period | $ / shares $ 1.46  
Weighted Average Remaining Contractual Term, Outstanding at End of Period 7 years 9 months 29 days  
Weighted Average Remaining Contractual Term, Exercisable at End of Period 6 years 6 months 4 days  
Aggregate Intrinsic Value, Outstanding at End of Period | $ $ 785,435  
Aggregate Intrinsic Value, Exercisable at End of Period | $ $ 436,840  
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.19.1
Contingent Liabilities (Narrative) (Details)
$ in Millions
6 Months Ended
Mar. 31, 2019
USD ($)
lawsuit
Contingent Liabilities [Abstract]  
Loss contingency, range of possible loss, maximum | $ $ 10.0
Number of class action lawsuits filed | lawsuit 2
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Mar. 31, 2019
Sep. 30, 2017
Sep. 30, 2018
Income Tax Expense (Benefit) [Line Items]      
Corporate income tax rate 21.00% 35.00%  
Valuation allowance $ 1.6    
Alternative Minimum Tax [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     $ 0.5
Foreign Tax Authority [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     62.3
Federal [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     33.2
Federal [Member] | 2022 to 2037 [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     14.4
Federal [Member] | Indefinite [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     18.8
State [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     36.2
State [Member] | 2022 to 2037 [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     19.6
State [Member] | Indefinite [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards     $ 16.6
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Reconciliation Of Income Tax Expense (Benefit)) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Income Taxes [Abstract]        
Income tax benefit at statutory rates $ (841,862) $ (1,077,736) $ (1,273,685) $ (3,628,736)
State income tax benefit, net of federal benefits (199,521) (385,395) (301,863) (948,395)
Effect of change in U.S. tax rate       (187,000)
Non-deductible expenses- other 2,364 8,702 4,783 12,702
Effect of lower foreign income tax rates 4,830 50,981 (3,527) 80,386
Effect of deemed dividend 32,318   63,627  
Other (1,025) 101,032 (22,863) 122,574
Change in valuation allowance 1,028,063   1,651,193  
Income tax expense (benefit) $ 25,167 $ (1,302,416) $ 117,665 $ (4,548,469)
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Federal net operating loss carryforwards $ 8,057,926 $ 6,973,047
State net operating loss carryforwards 2,468,061 2,195,865
Foreign net operating loss carryforwards - U.K. 10,621,438 10,595,518
Foreign capital allowance - U.K. 102,098 102,098
U.K. bad debts 1,700 1,700
Restricted stock - U.K. 17,586 17,586
U.S. deferred rent 54,706 22,902
Share-based compensation 759,875 622,442
Gross deferred tax assets 22,243,212 20,656,420
Valuation allowance for deferred tax assets (9,282,271) (7,631,078)
Net deferred tax assets 12,960,941 13,025,342
Deferred Tax Liabilities:    
In process research and development (4,675,860) (4,675,860)
Developed Technology (518,431) (549,318)
Covenant not-to-compete (85,044) (94,321)
Other (7,316) (6,843)
Net deferred tax liabilities (5,286,651) (5,326,342)
Net deferred tax assets 7,674,290 7,699,000
Malaysia [Member]    
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Gross deferred tax assets 34,314 33,843
U.S. [Member]    
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Other, net $ 125,508 $ 91,419
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Long-term deferred tax asset $ 8,570,150 $ 8,543,758
Long-term deferred tax liability (895,860) (844,758)
U.K. [Member]    
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Long-term deferred tax asset 8,535,836 8,509,915
Malaysia [Member]    
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Long-term deferred tax asset 34,314 33,843
U.S. [Member]    
Components Of Deferred Tax Assets And Liabilities [Line Items]    
Long-term deferred tax liability $ (895,860) $ (844,758)
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.19.1
Industry Segments and Financial Information About Foreign and Domestic Operations (Schedule of Segment Reporting Information) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Revenues $ 6,976,115 $ 2,572,872 $ 13,347,924 $ 5,159,485
Operating (loss) income (2,124,590) (4,696,550) (3,136,317) (12,133,132)
Operating Segments [Member]        
Revenues 6,976,000 2,573,000 13,348,000 5,159,000
Operating (loss) income (2,125,000) (4,697,000) (3,136,000) (12,133,000)
Commercial [Member] | Operating Segments [Member]        
Operating (loss) income 3,204,000 (163,000) 6,872,000 (19,000)
Research and Development [Member] | Operating Segments [Member]        
Operating (loss) income (2,889,000) (1,960,000) (5,250,000) (3,992,000)
Corporate [Member] | Operating Segments [Member]        
Operating (loss) income (2,440,000) (2,574,000) (4,758,000) (8,122,000)
South Africa [Member] | Operating Segments [Member]        
Revenues 24,000 715,000 233,000 1,033,000
U.S. [Member] | Operating Segments [Member]        
Revenues 2,596,000 981,000 5,646,000 1,975,000
Zimbabwe [Member] | Operating Segments [Member]        
Revenues 590,000 378,000 1,948,000 678,000
Brazil [Member] | Operating Segments [Member]        
Revenues 1,098,000   1,098,000  
UNITED ARAB EMIRATES | Operating Segments [Member]        
Revenues 677,000 278,000 677,000 278,000
Other Countries [Member] | Operating Segments [Member]        
Revenues $ 1,991,000 $ 221,000 $ 3,746,000 $ 1,195,000
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events (Narrative) (Details) - SWK Credit Agreement [Member] - USD ($)
$ in Millions
6 Months Ended
May 13, 2019
Mar. 05, 2018
Mar. 31, 2019
Subsequent Event [Line Items]      
Percentage of paid advanced amount   175.00% 175.00%
Debt Instrument, Periodic Payment     $ 1.7
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Percentage of paid advanced amount 176.50%    
Debt Instrument, Periodic Payment $ 0.9    
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +%JKTX?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ L6JO3B?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " "Q:J].MCR=[^\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+!:L,P#(9?9?B>R$YH82;U9:6G#08K;.QF;+4UBQUC:R1]^R59 MFS*V!]C1TN]/GT"-B=)T"9]3%S&1PWPW^#9D:>*&G8BB!,CFA%[G%W$_:==0?WCXVO@JJ!7W>AO@!02P,$% @ L6JO3IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " "Q:J].8C2V/7$" #:" & 'AL+W=OPH^,_JHLMMO(ZC"[O2.]C!NX]<1H%((K M]XR*N]*B'JP85VKZUK^KQKV[?F>1#C280 8"&0F$_)>0#H1T)&"G@'K/7*@? MJ*:[7(HNDGVV6FH_"OR0"0*/"&1L MCP($$CB0@$[^%3B&B!062,$(4D=/)_0%3%^ ](6C+R;TS#N $+&$!3)0( OH M*T\@1*QA@24HL SH&T\@1. $5EB!"JN0CST) $)@B34HL0[YJ2 M=_VO5-ZJ1D5GH4V_! MQM^9W1]02P,$% @ L6JO3APGV'2T! ]A4 !@ !X;"]W;W)K[ MJNJ>UFE7=Y^;0]KG7YZ;=E?W^;9]J;I#F^K5&+3;5JB4JW;U9C^=S\9G#^U\ MUKSVV\T^/;23[G6WJ]O_%FG;'.^G,'U_\&7SLNZ'!]5\=JA?TI^I_^OPT.:[ MZE+*:K-+^V[3["=M>KZ?_@1W2^V&@%'Q]R8=NZOKR="4QZ;Y.MS\MKJ?JL%1 MVJ:G?BBBSE]O:9FVVZ&D[./?^F_C(W/C7FLN[1LMO]L5OWZ M?AJFDU5ZKE^W_9?F^&LZ-\A.)^?6_Y[>TC;+!R>YCJ=FVXW_)T^O7=_LSJ5D M*[OZV^E[LQ^_C^?RW\/D #P'X"4 S(>ZK^>SMCE.VM-H M'>IA4L"=SIWY-#P<^V[\+;>VRT_?YAAGU=M0SEFR.$GP6G*K6'*%5A=)E>N_ MF$#1!([Q^CH>Y'@MQNLQWES'$XN+D\2-DOTHL2$ZJQUI"M=I;Z-54?9C1#^& M^]'$STEBK^HQ"CUJ2_QPG8X>W57[;OQ8T8_E?@SQ8UD]&&- !<2/H-,*56F\ MG>C'<3^DW0O'Z@%$%54@?@0=F*"-E?UXT8_G?LB\6'A>CP&#(2AB2! "!+3@ M9$=!=!2X(T\&M M)QFM@-P34$_(JO+>@:=K3=!EA$)I+H$,:^"T-I369\UU3184H+*&>N)*$XS- MA"R-G8QL,&P/,KI0@@Q9X)0UE+(@X-,.;&"CSX4:T2E=H C(H 5.6D-)"QRA M>4%&9*//=3& MK[@2$8M<-8:REK@#$7CT2#K)4GHK"MZDF$+G+:&TA8X1VW0 MS@'=L 6A:CS%+D+#64I<@)F3'J,7^()TFI M\W83L3 F*+,4.4OI7K) CLC4 93 C![.EZ3@*O%7YC_KYGNS6CPQEY%"FV]H"A;S6&Q<430.7 MDC)$G[/E4B_)8$8.9DNW"DE#7Z ^UMPZD7&,@6W%):"C#$_D\+1L40@:UI8/ M-;KI7#5')G.1!9$H6^T#%;-P4I!L-"%MYX*QPJWPBNULZ;1#)JSFA'44:)J3\Y,/RCE%$Y8?4=ZZDC&K.68=Q9H6^*FM M,0HHU@0E1A/R2W=A-](R;#6'K:-8.VMN#H?DMPU!67C;J*X.X(83T3_J]F6S M[R:/3=\WN_'$[;EI^I1+59]S*]>I7EUNMNFY'RY]OFY/)Y&GF[XYG$]9J\M1 M[_Q_4$L#!!0 ( +%JKTX4W!'#/@( !X' 8 >&PO=V]R:W-H965T M&ULA95MKYL@&(;_BO$'U#<$;6R3V679DBUISK*SS[2EU1P4 M![2>_?L!>HP%U_I!WN[[>:X'#10]XV^B(D1Z[PUMQ<:OI.S602".%6FP6+&. MM&KES'B#I1KR2R Z3O#)F!H:Q&$(@P;7K;\MS-R>;PMVE;1NR9Y[XMHTF/\M M"67]QH_\CXF7^E))/1%LBPY?R$\B?W5[KD;!%.54-Z05-6L]3LX;_U.TWN5: M;P2O->G%K._I2@Z,O>G!M]/&#S40H>0H=02LFAO9$4IU((7Q9XSI3RFU<=[_ MB/[%U*YJ.6!!=HS^KD^RVOB9[YW(&5^I?&']5S+6D_K>6/QW%MPUGM\^%@=UO]$M$[49A[UI-D[LZ:J%6KVMH6P"&XZSB@I!TD\D\3WBIVK M2,))$JC\$T2\"!$;?S*'0,O^9-&?&#^8^S.KB$&2&DEK)*%5Q"/%'0-89 N M0VXQ@*<,CQ1W#.DB0^HP("M#.4C0/,,JC"R,)Z([$KA( ET2*TD)G5JC%(3F ML7!<)4*6\ X)+2(A%\GZCTOD)((@AUF4 8O(%:8(P S"_Q!EBT292Y181)E+ M%*,,@,S>(U>8IG$&\A0N$^6+1+E+9)5>YDZB.,H2%-I;]%PW\ 2SDTK?'#\P MO]2M\ Y,JD//'$UGQB11,<.5"E>IRVH:4'*6NHM4GP]']C"0K!MOHV"Z$K?_ M %!+ P04 " "Q:J].[O:S6M $ #A% & 'AL+W=OGJO[2[&)L)U_+XM \3G=M>WS(LF:S MBV7>W%?'>$C?O%1UF;?IMG[-FF,=\VT?5!:9%,)F9;X_3.>S_MFG>CZKWMIB M?XB?ZDGS5I9Y_=\B%M7I<0K3;P\^[U]W;?<@F\^.^6O\,[9_'3_5Z2Z[9-GN MRWAH]M5A4L>7Q^D3/*REZ@)ZXN]]/#57UY-.RG-5?>EN?ML^3D77HUC$3=NE MR-/'>US&HN@RI7[\.R2=7MKL J^OOV7_I1>?Q#SG35Q6Q3_[;;M[G/KI9!M? M\K>B_5R=?HV#(#.=#.I_C^^Q2'C7D]3&IBJ:_O]D\]:T53ED25TI\Z_GS_VA M_SR=O[$PA/$!<@B0EX#4]D]0Y)7E .EM M2H[&AH $3M#>\0,,* M-$2@%TC@&3'7'5?628OZLZ0<**>#PC./ MP\+3?@80QJ/5O&0XX:P+:)ZL*&>DDQK0O%M33@MEP([H"ZR^0/6A_BP":4=Y M*;W!\YOCP-F %S#E'(#URB-]E+->&Q4$KP\$[P:"*D1;SWI@;KKNK$[+,!VA2:_(N!N5'ETOZE\6IB0..#UCCCB@%!*I_V0SR@'*FMUM:'$9VLMSV! MI#H=UBE)6W<2I#9!8*$,J6VPQ@BLE"$5**O 8:4,"3+Y!*B1U0&\/P(U2#^R MOP+OD$ MTF.+'!C47>,E-K\E1RHC3#!XK!A0&F4M)M<_D?)6)V^40)T2O^H% M,)9EK,(;)8/=I?T/[R,,9J0@-L)E2R[BQ[81WB>!&F7 1@G4L>ZL]$*0*<^ M$@BWXKBTQQ-P_>.$MQIYKP1'-4JLT3$M*:L5ELAP5@E2XG*<^+F#[!D-@JOTQ%JQ#,E7UU(1;5ZK%71@E&FGPVI/,!R*6F4,NDG M+UZE;$YK@C+D?('+*;LB')^&9%?',V6L7_NSLF:RJ=X.;5= 73V]G,<]R>YX M!SU?P,,2F.%B?3]N^IS\?_OV1UZ_[0S-YKMJV*ONCGY>J:F,2(.Y3UW&PO=V]R:W-H965T&ULE9IA;]LV$(;_ MBN'OJTG>D:**),!J)_& #2@Z;/NL)DIBU+8\6TFZ?S]*5MV(]U)6@**QG8?B MB>3=0RJ^>*WVWPY/95E/OF_6V\/E]*FN=Q]GL\/=4[DI#A^J7;D-OWFH]INB M#F_WC[/#;E\6]VVCS7IFE'*S3;':3J\NVL\^[Z\NJN=ZO=J6G_>3P_-F4^S_ M^U2NJ]?+J9[^^.#+ZO&I;CZ875WLBL?RS[+^:_=Y'][-3E>Y7VW*[6%5;2?[ M\N%R^JO^N.2L:= 2?Z_*U\.;UY/F5KY6U;?FS6_WEU/51%2NR[NZN401?KR4 M\W*];JX4XOBWN^CTU&?3\.WK'U>_:6\^W,S7XE#.J_4_J_OZZ7+JIY/[\J%X M7M=?JM=EV=V0G4ZZN_^]?"G7 6\B"7W<5>M#^__D[OE05YON*B&43?']^'.U M;7^^'G_C?-<,-S!= W-J8.Q@ ^H:T,\&9K !=PWXU(#<8 /;-;"G!CSF^! ^?;G*\XO92W.=#OET1,P;1"O59^:(T7UF@1C39ZX1 M0WWF!C'<9VX18_O,$C'NQ,S"L)W&SL"Q,^T%N'>!+!J8(^-:9MLRUE)NHOM> M2"Q7UBKGHLFXEN OUFNK(^X&<,3&D7%1U[> S'SH68R7!-FS)?,&[ T:P4$C M,&@^&K0C8^-!TSGAGACVQ*"G:)@6+'HR*F,;+:?E6:P7CH7A6!F.CM/(BB$F MQ=$\+*P(AI@5N2AFA&7*:QRS@S$[$'.4UG,G^U',-L/]9+"?3/231[=SDXEN M?F%C,VVC];P< ?8B\C B#^X\ZFGN06Z[W$4E8.%%0'F8>:-MG-L2Q+D-./+6 M*-9Q&00DSFT),F=66>_QH.5PT'(P:%'UGN<@M\.@.:MP3UIA;ZD1Q;>#SE;? MCK/GRR\@\1PA,%& $8IG"9##)5@GI*]'%.$.&E^%-;:DEIJ,DWO9,;TA\,I[ MRE*K LM% [O$23'OH+-YJZ6&\C#3K.)U=@W(Q*H (!NR.JR+>%4 -+$J),F: M2!N=2%Z-?:F!,+6-!T^J\$S^8AMJH$.9O]*'.'^EZU+Y*\G$3 $PE;\ 3&MB\$;"@,V%&+S8J2 AZN?P0(V2,#QV<1( M ;/6GJ-$7Y[G^B$E#K/G-7UC@*;)]TW3Q32"[$>%A6[&"-V,%+H9+71 )H[9 MXX6.T,1!^[U"-UCH9HS0S7N%;K#0#3K?QIHP0.A($P8('6L"D(F9@B#4!$(3 M,R7)84T8+'2##MKB41(0^J F#!:Z 4*7Q4<*D'5F;+QS/\_U0\*:-$B3\<,1 M(\_;F6;CX\C!>5N%J:,\#AT=S$F_K1O]V+%U#;)N_)#$2$NUL:<>DQ"6%"%) MB:=G\M2K\_B)[8+ J;.']>/!'B/@L3CSYB3]U'24[ K[B4;XB8!UC&:?Y;&? MQI#]J!)/,X&?3+QP2?K)L5=Q*5Z0K/M:<9X9CI^E7P,4EST$.D56,4?H+4)Q MV0,D.>_#GB-QM" L* *",G'JD!34PH&B,H&BDH&BTH "9F*GQ@D)H M8J;>*RC"@J(Q@J+W"HJPH.C\X^ E@:.%R?;Q M*@0F:BU"\50!5\!+-@Z?*PO$S\N&)U^X^T>R]V%=N+LRV!OD8=B27'@DC,JO5GCQ)]>TR%'L(W*6V MWXRUSE+K8E_(P)>L*/P3V3:"[$>%?4UGZ>9F%U_OC5Z&.;^IJUWW-:W;ZKMG5_U!+ P04 M" "Q:J].^,E*W)D$ #X% & 'AL+W=O<&9X4. 82+Q8MT +!%MM>*S83&RM9KJ3$V[WNX*JB_52?W"N[K_7E%S1PU.-=<%9F/?NT"N2X>,6Z.ZK:++:?1?"?$YD%# +H) M8/@ D@T@AP!R%B#7P3B,$CU(3H-DI<&B)0JR88166$M&\(X4ZT@Q*5D^@&8# MZ"@EP#S(:=2HF54K*0]FP)916:2<-V-8,R8V0R(P8Z)N0$D-)G##R,AH2DQ* MR]JQC!T([-BH'U2D=1Y.WEA'2JB9[,9/SOK)8S\B?%9YU$\.)'5H)Y9IR$D@ M;P<$SP41&2(;&>+P!,?,50T<4OQA&D@K?'T:W@ERF M)@C/2Y QGF8@O W! PX4DU2T^*C8K(>"")G+Z B5T%HF//',! ::I$)/,0]7 M1EH1D8$36H3T0/'L! Z>X>H$,197AI3-0T^Q3J.T"5H!CT_@^&E"1S$85UII MA=&$C(56^54HL< CU!@&!HS*Z;C"JP!%0T3)Y0(,D$2Y#F*,4>!0K C0TC* M04# G"TC).-7FI0G'J08@Q1DN!9C3-*5% *5"4>*58(ER%-E(@]=Q)@H,A6" MQR0RF)0A)I'!GY9AR<.I?$:)%Q=Y2&)<58*DT(_\7WX8U0=^>.(B4U/*!""1 M!R0R@)0A(#'FGK<*N4Y-5)Y[R'!/AMQ#AGO]W#.0ZHQ'&C)(DR'2D*D)A4BN MYLB3"AE221L^\!A (,0'G1%/(&((),-WF!@" 7[0%T\68LBB0K)0S OM^8.A M<,L()B#E18S1%7I?D/MFBM8H1*Y]+FJ<_5Q/AZ9B8MG!65^I-H_K"@ M_[X/EXULME]4N>9UV%IK%[OZ[=3U^S*SN]?MNP?L]YN"^X]PMQWWH?X+,^X) M_EXTK\=3NWBNNZZNACVGE[KNG+-%5Y^G M?<;LNMFY^1=02P,$% @ L6JO3G 47UZV 0 T@, !@ !X;"]W;W)K MV$ *[Y0VRSIWW=L"*4)ZHOM&<\YF!XTWC;&*>S1MRUQO@=<1I"1+D^2.*2XT+?/H.]LR-X.70L/9$CWO M$T@S%G1'7QR/HNU\<+ R[WD+W\!_[\\6+;:PU$*!=L)H8J$IZ/WN>-J'^!CP M0\#H5F<2*KD8\Q2,SW5!DR ()%0^,'#)*JL%Y MHV86E*+X\[0+'?=QNLFR&;8-2&= N@ .,0^;$D7E'[CG96[-2.S4^YZ')]X= M4^Q-%9RQ%?$.Q3OT7LO=[2%GUT TQYRFF'0=LT0P9%]2I%LI3ND;>+H-SS85 M9A&>_:/P_3;!?I-@'PGV_RUQ(^8N>96$K7JJP+9QFARIS*#C)*^\R\#>I_%- M_H9/T_Z5VU9H1R[&X\O&_C?&>$ IR0V.4(<.3,>YZ-US[X#".1%*^,+VH70'QGS50=:^!O; M@\&;QCHM IJN9;YW(.H$THKQW>Z6:2$-+?/D.[LRMT-0TL#9$3]H+=R/$R@[ M%C2CKXY'V78A.EB9]Z*%+Q"^]F>'%EM8:JG!>&D-<= 4]#X[G@XQ/@5\DS#Z MU9G$2B[6/D?C8UW0710$"JH0&01N5W@ I2(1RO@^<](E902NSZ_L[U/M6,M% M>'BPZDG6H2OH'24U-&)0X=&.'V"NYPTE<_&?X H*PZ,2S%%9Y=-*JL$'JV<6 ME*+%R[1+D_9QNN'9#-L&\!G %\!=RL.F1$GY.Q%$F3L[$C?UOA?QB;,CQ]Y4 MT9E:D>Y0O$?OM:G!MFB9/*CN8-,DK[S*P]SR]R:_P:=H_ M"]=*X\G%!GS9U/_&V@ H97>#(]3A!UL,!4V(Q[=X=M.834:P_?R#V/*-RY]0 M2P,$% @ L6JO3M!SL'2U 0 T@, !@ !X;"]W;W)KU,8J M[M&T#7.=!5Y%D)(LV6P.3'&A:9%%W]D6F>F]%!K.EKA>*6Y?3R#-D-,M?7,\ MBJ;UP<&*K.,-_ #_LSM;M-C,4@D%V@FCB84ZIW?;XRD-\3'@EX#!+7YC_Q)KQUHNW,&]D4^B M\FU.;RFIH.:]](]F^ I3/7M*IN*_PQ4DA@+/;3[!U0#(!DAEP&_.P,5%4_IE[7F36#,2.O>]X>.+M,<'>E,$96Q'O M4+Q#[[78'M*,70/1%',:8Y)ES!S!D'U.D:RE."7_P)-U^&Y5X2["=^\4[M<) MTE6"-!*D_RUQ+>;P(0E;]%2!;>(T.5*:7L=)7GCG@;U+XIO\#1^G_8';1FA' M+L;CR\;^U\9X0"F;&QRA%C_8;$BH?3A^PK,=QVPTO.FF'\3F;US\ 5!+ P04 M " "Q:J].6Y\@0[4! #2 P &0 'AL+W=ON" M@Q59QQOX!NY[=S;>8C-+)11H*U 3 W5.[[;'4QKB8\ / 8-=G$FHY(+X'(PO M54XW01!(*%U@X'Z[PCU(&8B\C)>)D\XI W!Y?F?_'&OWM5RXA7N4/T7EVIP> M**F@YKUT3S@\P%3/!TJFXK_"%:0/#TI\CA*EC2LI>^M032Q>BN*OXRYTW(?Q M9I].L'5 ,@&2&7"(>=B8*"K_Q!TO,H,#,6/O.QZ>>'M,?&_*X(RMB'=>O/7> M:['=WV;L&HBFF-,8DRQCY@CFV><4R5J*4_(//%F'[U85[B)\]X?"PSI!NDJ0 M1H+TOR6NQ7S\*PE;]%2!:>(T65)BK^,D+[SSP-XE\4U^AX_3_LA-([0E%W3^ M96/_:T0'7LKFQH]0ZS_8;$BH73C>^K,9QVPT'';3#V+S-RY^ 5!+ P04 M" "Q:J].!PJE?;,! #2 P &0 'AL+W=O MYO5%$BF>PT.*2@=CGUT#X,FKDMIEM/&^.S#FB@:4<%>F XTWE;%*>#1MS5QG M0901I"3C27+-E&@US=/H.]D\-;V7K8:3):Y72MA?1Y!FR.B&OCD>V[KQP<'R MM!,U? ?_HSM9M-C,4K8*M&N-)A:JC-YN#L==B(\!/UL8W.),0B5G8YZ#\:7, M:!($@83"!P:!VP7N0,I A#)>)DXZIPS Y?F-_3[6CK6CY1,A7_%2X@,3PHP1R%D2ZNI.B=-VIB02E*O(Y[J^,^C#?; M_01;!_ )P&? 3H7B'WDN^ MV28XQO!ES!S!D'U.P==2'/D_<+X.WZXJW$;X]@^%_\F_6R7818+= MAR6NQ?RMDBUZJL#6<9H<*4ROXR0OO// WO+X)N_AX[1_$[9NM2-GX_%E8_\K M8SR@E.0*1ZC!#S8;$BH?CGL\VW',1L.;;OI!;/[&^6]02P,$% @ L6JO M3I-#;\.T 0 T@, !D !X;"]W;W)K&UL?5-A M;]P@#/TKB!]0[KATK4Y)I%ZG:9,VZ=1IZVM3*NH)WW_9$Q5W6@A;O!'DRX:=!JX8-I6^9Z"Z).(*T8 MW^W>,2VDH66>?&=;YCAX)0V<+7&#UL+^/('"L:![^N9XDFWGHX.5>2]:^ K^ M6W^VP6(+2RTU&"?1$ M-01_VQU,6XU/ =PFC6YU)K.2"^!*-3W5!=U$0**A\ M9!!AN\(C*!6)@HP?,R==4D;@^OS&_B'5'FJY" >/J)YE[;N"WE-20R,&Y9]P M_ AS/;>4S,5_ABNH$!Z5A!P5*I=64@W.HYY9@A0M7J==FK2/TTW&9]@V@,\ MO@#N4QXV)4K*WPLORMSB2.S4^U[$)]X?>>A-%9VI%>DNB'?!>RWW=X><72/1 M''.:8O@Z9HE@@7U)P;=2G/@_<+X-/VPJ/"3XX0^%V39!MDF0)8+LOR5NQ=S^ ME82M>JK!MFF:'*EP,&F25]YE8!_2([+?X=.T?Q&VE<:1"_KPLJG_#:*'(&5W M$T:H"Q]L,10T/A[OPME.8S89'OOY!['E&Y>_ %!+ P04 " "Q:J].E![D M6[0! #2 P &0 'AL+W=O>=.ZX"!%UK$&?H+[U9V- MM\C$4G$)RG*MD($ZQ[?KXVD;XF/ ;PZ#G9U1J.2B]7,POE4Y7@5!(*!T@8'Y M[0IW($0@\C)>$B>>4@;@_/S&_C76[FNY, MW6CSQRK4Y/F!40*_PQ6$#P]*?(Y2"QM75/;6:9E8O!3)7L>=J[@/Z6:78,L F@!T AQB M'C(FBLKOF6-%9O2 S-C[CH4G7A^I[TT9G+$5\&PO=V]R:W-H965TW%VBW-MKX![B7<\[]X)*/:)]= M!^#)BU;&%;3SOC\QYJH.M'!WV(,)-PU:+7PP;8ZWE#R5S\ M9[B!"O"828A1H7)I)=7@/.I9):2BQ S@2^$8XK#ID I M\_?"BS*W.!([];X7\8EW)QYZ4T5G:D6Z"\F[X+V5N_MW.;M%H1ESGC!\C5D0 M+*@O(?A6B#/_A\ZWZ?O-#/>)OE]'/V;; H=-@4,2./RWQ W,\>\BV:JG&FR; MILF1"@>3)GGE70;V(3TB^P.?IOV+L*TTCES1AY=-_6\0/814LKLP0EWX8(NA MH/'Q>!_.=AJSR?#8SS^(+=^X_ U02P,$% @ L6JO3A7;Q&NT 0 T@, M !D !X;"]W;W)K&UL?5-A;]P@#/TKB!]0[DC6 MG4Y)I%ZGJI-6Z=1IVV^C\38U&"^=-TS#;&Q!5!&G%^&YWR[20'2VRZ#N; M(L/!*=G!V1 [:"W,VPD4CCG=TW?'LVQ:%QRLR'K1P%=PW_JS\19;6"JIH;,2 M.V*@SNG=_GA*0WP,^"YAM*LS"95<$%^"\;G*Z2X( @6E"PS";U>X!Z4"D9?Q M<^:D2\H 7)_?V1]B[;Z6B[!PC^J'K%R;TP,E%=1B4.X9QT>8Z_E R5S\%[B" M\N%!B<]1HK)Q)>5@'>J9Q4O1XG7:91?W<;I);F?8-H#/ +X #C$/FQ)%Y9^$ M$T5F<"1FZGTOPA/OC]SWI@S.V(IXY\5;[[T6^P//V#40S3&G*8:O8Y8(YMF7 M%'PKQ8G_ ^?;\&1381+AR1\*DVV"=),@C03I?TOH]1]L,134+AP_ M^K.9QFPR'/;S#V++-RY^ 5!+ P04 " "Q:J]. 52V@;4! #2 P &0 M 'AL+W=O2X^_M2LNMYF[$72:1X#@\I*AN,?74M@"?O2FJ7 MT];[[L"8*UM0W%V9#C3>U,8J[M&T#7.=!5Y%D)(LV6QNF.)"TR*+OI,M,M-[ M*32<+'&]4MS^.H(T0TZW]-/Q+)K6!PW>R:+&9I1(*M!-&$PMU M3N^VAV,:XF/ #PYQ)J.1LS&LPOE0YW01!(*'T@8'C=H%[D#(0H8RWB9/. M*0-P>?YD?XRU8RUG[N#>R)^B\FU.]Y144/->^F)*RMYYHR86E*+X^[@+'?=AO-FE$VP=D$R 9 ;L8QXV)HK*'[CG16;- M0.S8^XZ')]X>$NQ-&9RQ%?$.Q3OT7HKM_CICET TQ1S'F&09,T;VKR1LT5,%MHG3Y$AI>ATG M>>&=!_8NB6_R.WR<]F_<-D([7S;VOS;& TK97.$(M?C!9D-"[9-/ZX&!%UHL&OH/_T9\M6FQAJ:2&SDG3$0MU3N]V MQU,:XF/ HX31K$>E I$*./7S$F7E &X M/K^P?XJU8RT7X>#>J)^R\FU.#Y144(M!^04S,5_A2LH# ]*,$=I ME(LK*0?GC9Y94(H6S],NN[B/TPU/9]@V@,\ O@ .,0^;$D7E'X4716;-2.S4 M^UZ$)]X=.?:F#,[8BGB'XAUZK\7N<,C8-1#-,:;A.DFP1I)$C?+'$CYC;Y+PE;]52#;>(T.5*:H8N3O/(N M WO'XYO\#9^F_9NPC>P-///X@MW[CX U!+ P04 " "Q:J].>>QW(+,! #2 P &0 'AL+W=O M<.3,>YZ.Q3ZX#\.192>T*VGG?'QAS M50>*NQO3@\:;QEC%/9JV9:ZWP.L(4I*EN]U;IKC0M,RC[V3+W Q>"@TG2]R@ M%+>_CB#-6-"$7AT/HNU\<+ R[WD+W\!_[T\6+;:PU$*!=L)H8J$IZ%UR..Y# M? QX%#"ZU9F$2L[&/ 7C)* MJL%YHV86E*+X\[0+'?=QNLFNL&U .@/2!7 ; 6Q*%)5_X)Z7N34CL5/O>QZ> M.#FDV)LJ.&,KXAV*=^B]E,G[)&>70#3''*>8=!VS1#!D7U*D6RF.Z0MXN@W/ M-A5F$9[]I? 5@OTFP3X2[/];XE9,]D\2MNJI MO&:7*D,H..D[SR+@-[E\8W M^1,^3?M7;ENA'3D;CR\;^]\8XP&E[&YPA#K\8(LAH?'A^ [/=AJSR?"FGW\0 M6[YQ^1M02P,$% @ L6JO3NPHCXVQ 0 T@, !D !X;"]W;W)K&UL?5-A;YLP$/TKEG] G1#:;1$@-:VJ3=JDJ-.ZSPX< M8-7V,=N$[M_/-H2R#.T+OCONO7MW/F<#FE?; CCRIJ2V.6V=Z_:,V;(%Q>T- M=J#]GQJ-XLZ[IF&V,\"K"%*2)9O-'5-<:%ID,78T18:]DT+#T1#;*\7-[P-( M''*ZI9? LVA:%P*LR#K>P'=P/[JC\1Z;62JA0%N!FABH1F_)DXZEPS I7UA?XJ]^UY. MW,(#RI^B43,U_A3-(GQZ4^!HE2AN_I.RM0S6Q M>"F*OXVGT/$<)OX+;!V03(#D"L#&0E'Y(W>\R P.Q(RS[WBXXNT^\;,I0S". M(O[SXJV/GHOMIS1CYT TY1S&G&29,VJM.T29M4W;3M,TVNC@Q59)QKX OYK=['!8C-+)348)]$0"W5.'[:G\S[&IX!O$@:W.)-8R17Q M.1H?JYQNHB!04/K((,)V@T=0*A(%&3\F3CJGC,#E^97]?:H]U'(5#AY1?9>5 M;W-ZH*2"6O3*/^'P :9ZWE R%?\);J!">%02F()4K1X&7=I MTCZ,-_PXP=8!? +P&7!(>=B8*"E_)[PH,HL#L6/O.Q&?>'OBH3=E=*96I+L@ MW@7OK=@>[S-VBT13S'F,XU@GV MJP3[1+#_;XEK,<>_DK!%3S78)DV3(R7V)DWRPCL/[ -/;_([?)SVS\(VTCAR M11]>-O6_1O00I&SNP@BUX8/-AH+:Q^-].-MQS$;#8S?](#9_X^(74$L#!!0 M ( +%JKT[L\#.JG0( *L* 9 >&PO=V]R:W-H965TAU%ZG3C)5-/HN:5^7,1LF3: M+.4U4K7D[&R-RB*B<;R(2I97X3:S>P>YS<1=%WG%#S)0][)D\L^>%Z+9A"3\ MV'C)KS?=;D3;K&97_H/KG_5!FE4TL)SSDE= >Y2C$6[OX>MZ$<>L1+_A)MQ3,# _^S(NB93)^_.Y)PT&S-1S//]@_V\.; MPQR9XL^B^)6?]6T3IF%PYA=V+_2+:+[P_D#S,.A/_XT_>&'@K2=&XR0*9;_! MZ:ZT*'L6XTK)WKLQK^S8='_F26^AO0 >#U.I$G9#U_!/3;)M)T02RN_R: MM3$F:VKNYM1NVJNP_XSSRNP^MB:B6?1HB7K,OL/0$88,B,BP#Q(42>SIQ)QB M\P1ZF%CS9*P^7V&"&22868+9?T M&P+YGANN! 2D.77K#01Y"@[!Q8" 3*>3>P.@Q%-S*"X'%&1ZXE8="/*4'8K+ M 069GKAE!X+<=Q"->H62RZOMDE1P$O?*MFBCW:$3VU';:_R#=VW<=R:O>:6" MH]"F8[%]Q44(S8TO\9-Y^S?3.0Z+@E]T.UV:N>S:IVZA1=VWAM'0GV[_ E!+ M P04 " "Q:J].^K/!',8! W! &0 'AL+W=OIA=+I [/(471V:CTFVD!+'H77)H"-9)7&3!=]9%I@;+.PEGC MNJ:UWD&*K&<-? ?[HS]K9Y&%I>H$2-,IB334.7Y(CJ?4XP/@M8/1K/;(5W)1 MZLT;7ZH<;WQ"P*&TGH&YY0J/P+DG5@K!(SBTM%L/=I M[618Q^EDG\QA\0 Z!] EX!!TR"04,G]BEA695B/2T]WWS+SV] MY&PO M=V]R:W-H965TZL'4Z$ MF*H#R+AJ9 M44JF?YU!J*G *7X+//.VLSY RGQ@+7P%^VVX:+X\/@.\<)K.9(U_)5:D7O_A4%SCQAD! 93T#<\,-GD (3^1L_%PX\2KI$[?S M-_8/H797RY49>%+B!Z]M5^ C1C4T;!3V64T?8:EGC]%2_&>X@7!P[\1I5$J8 M\$75:*R2"XNS(MGK//(^C-.\<\B6M'@"71+HFG ,.F06"L[?,\O*7*L)Z?GL M!^:O.#U1=S:5#X:C"'O.O''16TFS)"= MQM-W48>[D+[;JA^.<8(L2I %@NRO$M.[$F.8_[C<1T7V$8+=G4@,D]V)D,W% M2=!M>+(&56KL0[MLHFM7/-)P\7_@G)?. M=?&Z$-!8/WWGYGI^R_/"JF%I4[+^*\K?4$L#!!0 ( +%JKTZ!7TTQU $ M )P$ 9 >&PO=V]R:W-H965T2G[8KCCN>>Y.W-DHU2O MN@4PZ$WP7N>X-68X$*++%@33=W* WI[44@EFK*D:H@<%K/)!@A,:12D1K.MQ MD7G?2169O!C>]7!22%^$8.KW$;@<<[S![X[GKFF-YDCQ34.;[?'(ZIPWO 2P>C7NV1J^0LY:LSOE0YCEQ"P*$TCH'9Y0H/ MP+DCLFG\FCGQ(ND"U_MW]B=?NZWES#0\2/ZSJTR;XSU&%=3LPLVS'#_#7$^" MT5S\5[@"MW"7B=4H)=?^B\J+-E+,+#85P=ZFM>O].DXG<3*'A0/H'$"7@+W7 M(9.0S_R1&59D2HY(3;T?F/O%FP.UO2F=T[?"G]GDM?5>"QHG&;DZHAESG#!T MA=DL"&+9%PD:DCC2#^$T'+X-9KCUX=NU^NX_^G&0(/8$\3\EIC0P MOP5D>9"*/U!+ P04 " "Q:J].FF?3:;8! #2 P &0 'AL+W=O "E@I!/X_>L29>0@;@^OZD_QMI] M+1=AX0'5+UFY-J=WE%10BT&Y9QR?8*[G0,E<_%>X@O+PD(F/4:*R<27E8!WJ M6<6GHL7KM,LN[N-T8=/T_Y-F$9VEES0^9>-_:\1'?A4=C=^A%K_P19#0>W"\=:?S31FD^&PGW\0 M6[YQ\1=02P,$% @ L6JO3@J3*7_5 0 G 0 !D !X;"]W;W)K&UL=51M;]L@$/XKB!]0'!([661;:EI5F[1)4:=UGXE] M?E'!>(#C[M\/L.MY*?MBN..YY[G#=Z2C5*^Z 3#H3?!.9[@QIC\2HHL&!--W MLH?.GE12"6:LJ6JB>P6L]$&"$QI%"1&L[7">>M]9Y:D<#&\[."ND!R&8^GT" M+L<,;_"[X[FM&^,<)$][5L-W,#_ZL[(665C*5D"G6]DA!56&[S?'4^+P'O#2 MPJA7>^0JN4CYZHPO988CEQ!P*(QC8':YP@-P[HAL&K]F3KQ(NL#U_IW]R==N M:[DP#0^2_VQ+TV3X@%$)%1NX>9;C9YCKB3&:B_\*5^ 6[C*Q&H7DVG]1,6@C MQ+- MD=J[*9S37X4_L\EKZ[WF-(Y3@*LUD0Q+(O$C0D<:(?PFDX?!O, M<.O#MVOU_3Y,L L2[#S![I\2DYL20YC_B,1!D3A <+@1"6$^A462H$CRD2") M;D1"F-O?15;=(4#5?BXT*N30^9E<>9?1NZ>^N_["I[G]QE3==AI=I+$]ZCNI MDM* 326ZLP4W]JE8# Z5<=N]W:MI8";#R'Y^"\CR(.5_ %!+ P04 " "Q M:J].!H[F_=(! "TW3)FVRN:;M9U9')0=B =?KOR^@9^V6+\(, M;]Z;P1GR2>E7TP%8]"9%;PK<63N<"#%5!Y*9!S5 [TX:I26SSM0M,8,&5H<@ M*0C=[3(B&>]QF0??19>Y&JW@/5PT,J.43/\^@U!3@??XW?'"V\YZ!RGS@;7P M#>SWX:*=15:6FDOH#5<]TM 4^&E_.F<>'P _.$QFLT>^DJM2K][X7!=XYQ," M 97U#,PM-W@&(3R12^/7PHE721^XW;^S?PRUNUJNS,"S$C]Y;;L"'S&JH6&C ML"]J^@1+/2E&2_%?X ;"P7TF3J-2PH0OJD9CE5Q87"J2O 8] ALU#(_ .SK,RUFI">[WY@_A?O3]3=3>6=X2K"F4O>..^MI!G- MR^2M"8Q)G^%T[CX4DTPR2$)UOU8Q(G.$0)#H'@\$^) MR5V),&PO=V]R:W-H965T[^?I+L>D:FOE@B=7@.*9/*1J5?30M@T9O@TN2X MM;8_$F+*%@0S=ZH'Z4YJI06SSM0-,;T&5H4@P0E-DI0(UDE<9,%WUD6F!LL[ M"6>-S" $TW].P-68XPU^=[QT36N]@Q19SQKX#O9'?];.(@M+U0F0IE,2::AS M_+@YGE*/#X"?'8QFM4>^DHM2K][X4N4X\0D!A])Z!N:6*SP!YY[(I?%[YL2+ MI ]<[]_9/X7:72T79N!)\5]=9=L<'S"JH&8#MR]J_ QS/7N,YN*_PA6X@_M, MG$:IN E?5 [&*C&SN%0$>YO63H9UG$Y2.H?% ^@<0)> 0] ADU#(_)E95F1: MC4A/=]\S_XLW1^KNIO3.; W@R(=6C4UI[5R[9\SF-6AA;["%QO\IT6CA MO&LJ9EL#HH@DK1A?K>Z8%K*A61)C1Y,EV#DE&S@:8CNMA?ES (5]2M?T$GB6 M5>U"@&5)*RKX!>YW>S3>8Y-*(34T5F)##)0I?5CO#]N CX 7";V=V21T^C)IU2!N+/:C_H6V3. C@5\1V) H5OY5.)$E!GMBAMFW(ESQ>L_];/(0C*.(_WSQUD?/ M&=_=)>PH]@]L&PO=V]R:W-H965TKV["1.@@J8V4[2_?O9AE*" M+UWZ$K Y]]YS;GS@SBY-Q^)P5&8C6,P:>F _F7IJ'H1>!7V675&Q6A:\]@3;S_TEOE\39 (LXE?! M+G)P[QDI&\Z?S>+;;NXCPXB5;*M,"JHO9[9F96DR:1Y_NJ1^7],$#N]?LW^Q MXK68#95LSSNVIZ=2/?++5]8)BGVO4_^=G5FIX8:)KK'EI;2_ MWO8D%:^Z+)I*15_::U';ZZ7+_QH&!Y N@/0!NO9[ 6$7$+X%)%9\R\Q*_4P5 M7NY9V3B5U#6[G..8" Y)V#@&'O8\C\R40*V-8X^4!G8,MBU[,D M2\>M@4#91!W8B!ARXH25,6P=G-^NEL#>(>@&M1 H'_^WP>"S7#%QL!.,]+;\ M5-OQ:;#;3TE+8C_K;_!VQ/I!Q:&HI;?A2@\']A.^YUPQS07=Z4-RU%-=ORC9 M7IG;5-^+=K1I%XHWW=@6]+/CXA]02P,$% @ L6JO3LRGY7[] 0 : 4 M !D !X;"]W;W)K&ULA53;CILP$/T5Q >L";>T M$2 MJ5:MU$K15FV?'1@N6ANSM@G;OZ\O+"%91%^P/3[GS!EC3S(R_B(: .F\ M4=*)U&VD[ \(B:(!BL4#ZZ%3.Q7C%$NUY#42/0=<&A(ER/>\&%'<=FZ6F-B) M9PD;)&D[.'%'#)1B_C<'PL;4W;GO@>>V;J0.H"SI<0T_0?[J3URMT*Q2MA0Z MT;+.X5"E[N/N<(PUW@!^MS"*Q=S1E9P9>]&+;V7J>MH0$"BD5L!JN, 1"-%" MRL;KI.G.*35Q.7]7?S*UJUK.6,"1D3]M*9O4_>0Z)51X(/*9C5]AJB=RG:GX M[W !HN#:B.C.E?L$29PEGH\/MS^JQOA.[0Z .L]!![?)CA^1.SWZQF"U2("PP^6!N-H72!<%0B- M0'AS"G+1U]?\+MXKMJ(??57&=N#?F!> MMYUPSDRJYV,N><68!&70>U 'U*BV-R\(5%)/]VK.[>.W"\GZJ:^AN;EF_P!0 M2P,$% @ L6JO3G03@ 0A @ [ 4 !D !X;"]W;W)K&UL?53;CILP$/T5Q N^4M&+KUU)VFR 050T4BR?60:O>G!FG M6*HMOP2BXX!/IHF2 (5A%E#N%**^9\=$-9O_RU/>&\-_@!D3!M1.E43$BS*]7785D=&!1 M5BA^M\^F-<]^X+^WN1O0T(#&!J7]OX9X:(@_&A(3WCHS43]ABE+ M-JOOU"BSD^>#QL[![YA?FE9X1R;5%387[YFK- M[0"R&\FZ8;8&XX O_P)02P,$% @ L6JO3FS-!7%R @ 8 D !D !X M;"]W;W)K&ULE5;;CILP$/T5Q ?$V 0"$4%*MJI: MJ96BK;I]=H@3T *FMA.V?U_;$$J302(O^,*9,W/,#)ZDY>)=YHPIYZ,J:[EQ M;ESLWC9>BW.NS 9*DX:>V0^F?C9[H5=H8#D6%:ME MP6M'L-/&W>+UCA!C8!%O!6OE:.X8*0?.W\WBZW'C>B8B5K),&0JJARM[865I MF'04. Z MO?IO[,I*#3>1:!\9+Z5].ME%*E[U+#J4BGYT8U';L>WY;V:P >D-R&! ?*NE MXU)7&+Y,[,$YZP$Q MA/=)VX$B"ZJ[M%LM_ E'$\6! 4>K"0HP^;>8/"$73G_L U%$]W(AT$3Z8;A* M\&,)D"B+Y? U4#(C%2&0/A>+1I=0B=TKMN=85&R MDS+3E9Z+[L[O%HHW?3^#AJ8J_0M02P,$% @ L6JO3G20:"!B P I@\ M !D !X;"]W;W)K&ULC9=K;]HP%(;_2I0?T,27 MW"I 6DM+J3:IZK3M5U/#GRYKW= M,2:\SZJLVZF_$V)_&P3M:L>JO+WA>U;+7S:\J7(A'YMMT.X;EJ^[H*H,FMF$'T19U.RE\=I#5>7-OSM6\N/41_[YQ6NQW0GU(IA-]OF6 M_63BU_ZED4]!K[(N*E:W!:^]AFVF_C=T^XRI"NB(WP4[MA?WGBKEC?-W];!< M3_U09<1*MA)*(I>7#W;/RE(IR3S^:E&_;U,%7MZ?U1^[XF4Q;WG+[GGYIUB+ MW=1/?6_--OFA%*_\^,1T09'OZ>J_LP]62EQE(MM8\;+M_GNK0RMXI55D*E7^ M>;H6=7<]:OUS&!R =0#N S :#2 Z@%P;0'4 _0K(1@,B'1!=VT*L ^*O #P: MD.B I \@9#0@U0'IM35D.B"[-@"%YY$+C;*#TY!WBWPV:?C1:T[+8)^K MU89ND9JF*_6VFY7=CW(>M?+MQXP@.@D^E))F[DX,'C#1D+F'F'C(S"$F&3(/ M$),.F4>(R8;, F!P.&2>( 8-F27$X"'S##&D9P(Y /TH8'@4<*= !PK&*,Q/ M3-PQ=8&".QN));VAS)$AP3#&=.X,R)E3E.8UB!P@H44#!FQ0)B4KB5 M"&XE A0R6"&&%>(K\@28+(1;2>!6$F F1+!""BND@(*Q$A<08]2RA!A'GV=P M)AF@8*[3$Q-=S$)S!8X1@RR4%X(6%]IY$,>H()=-HBMZ%8*(92@0Y%ASR&$7 M"/(+RP&QU7'8S,5&'+Z%',L?V>N?$)>&PP"0O;JMOIU#$*'FQ@!!IC^"4&QN M#1"4..IR6 ZR/<<:I;F&+H? JLI&L%F3C1"SHC%D6(_# )'M;H0X' $Y[ U! M_F84_*RARZT)1:'Z-83QL3'_AV" B8UDY7!$!MDA# M,ZO,:BP9ZP+L\#X,>!\U+.E!0X,N 'K@">!(.I:4PTPQ8('488'8]<5D6Z"] M'0,0H:XO,X?#8<#A*'5H.!P. VY"K>\V:F]TYLX?7'S7JQ/LC[S9%G7KO7$A M#PG==_R&<\&D7G@CE7;RT-P_E&PCU&TB[YO3R?'T(/A>GXJ#_F@^^P]02P,$ M% @ L6JO3O&ULC579CILP /P5Q'O78!N31"12@:LGHR9%*#F 4$5#2H@I7F>O;RU4FKIH7%=O+0%W+DLK?:\9%LPSC\+WC MN;CDVG: 55;3"WMA^GN]EZ8%>I534;)*%:(*)#LOPX_Q8D+6-+Z=E&%E#C+.CM@K4%#>V89Q;(6/C5Z<9]D-:XK#^KO[)93=9#E2Q MC> _BY/.E^$L#$[L3*] /2'&_R6@CH >)>".@!\E)!TA&1% F]U-YI9J MNLJD: +9;H>:VET7+Q*S7$?;Z5;'_3/SJ4SO;84PR<#-"G68=8N! PR\1VRF M"!3=0[932)K>0W8>%?P7 TR./@STAH%. T$8C+S"R"O '("^,[!;#0;+88X M3.4P.$I)BI/1G/APF*0(^0UAKR'L,30?&6HQR6"@#XC *![Y>0RVQ1/;!A:3 M$6SG@\WBZ!_A$F^X9!HN&6V;=3)U'2,4C>9@XX&A=!Y%?CO$:X=,[:"1&^)9 M4YA"-%[[*0[-4T@0'/D!@V-J+^9O5%Z*2@4'H*B6=O!7D;JPCF5?W? Q%"B!-T_E\;"$\NQ MY="I5G21A%.)'I/M;FWQ#O"KA4'-]I&MY"#$FS6^'DL4VX2 0:TM S7+%9Z M,4MDTO@S[J>5 %3P)]KL]ZJ9$&Q0=X40O3+^*X0N,]60H M&HO_!E=@!FXS,1JU8,I]H_JBM. CBTF%TW>_MIU;AY'_%A8.(&, F0*(K\4+ MN0@S^X5JJ@6E\Y-@)EW>NB/Q-WE#[B?$M^I/+>=B@Y" MFQ?A[NU)" TFF?C!E-N8P309#$[:;M=F+_WS](86_3AY\#3^JG]02P,$% M @ L6JO3A&ULC9;;CILP$(9?!7'?Q0=\8)5$:E)5K=1*T59MK[V)DZ %3,%)MF]?&UA$ MS$3=FX#-/[^_&>(QBZMI7MJ3UC9Z+8NJ7<8G:^O')&EW)UVJ]L'4NG)/#J8I ME77#YIBT=:/5O@LJBX0@Q)-2Y56\6G1SVV:U,&=;Y)7>-E%[+DO5_%WKPER7 M,8[?)I[RX\GZB62UJ-51_]#V9[UMW"@97?9YJ:LV-U74Z,,R_H@?-SCU 9WB M5ZZO[>0^\JD\&_/B!U_WRQAY(EWHG?46RETN>J.+PCLYCC^#:3RNZ0.G]V_N MG[OD73+/JM4;4_S.]_:TC&4<[?5!G0O[9*Y?]) 0BZ,A^V_ZH@LG]R1NC9TI MVNXWVIU;:\K!Q:&4ZK6_YE5WO?9/!!G"X R!) QH"_.W0 Z!- @(.G)NE0_ M*:M6B\9GBZ0T%@PTH:$ [@W1J$&;12W@GJ?HLLDP2A(-< !U% M!-U+* 5YTCD/X[ ! PW8^RO"00,.$(B@)+V&35)E629$^';G,LHY(7<*(D < M >#( $?,UN%$8!30S%5"<)[!,!*$D0!,%L#(V3)$2(XD#7 ':%$\A0&RD"@ M; [$@[S7V?PMI*EDG 5 =5&S\:ZLZH[40[&6.TL MT8.K\A -U.;-6T@LU1<-2]K.$A/7:N*R;][X*+=^L2_&Y[*2Z&M(U;*48AGN_EZ MVOJAS0@XY-I2,/.XP2-P;IE,'G]Z4G^(:1W'ZSO[9R?>B#DR!8^"_RY/NMCZ M*]\[P9E=N7X2[1?H!2U]KU?_#6[ #=QF8F+D@BOWZ^57I475LYA4*O;2/_^Z&.]#>@0X.)K;5T@5RF7]BFF6I%*TGN\-OF/V/R8::L\FMT1V%>V>2 M5\9ZRZ(X2H.;)>HQ^PY#1Q@R( +#/H2@6(@]?>=.)$:#Q C!"B=(4()DOLP52K":(1/#K/$@ M:S3(^CU!$N($),0K-IPOE$P4/9DA%05-:"5HY>\(1=1.] [!JY]$'U"+US]9 MS%&+@)*)/B5XFQ"D!Y)H@@)O A)_0"W>!B29HQ8#3;0KP;N%(*V03'R7"-X+ M9#U?+<6;@88SU&*@Y&V<8#0Q*I 7-RN5EXMK[0;UR#K,XQUU$^<_O!OFWYF\ ME+7RCD*;N>6FRUD(#2:7\,$426'N#\.&PUG;96+6LANBW4:+IK\@!,,M)?L' M4$L#!!0 ( +%JKTZ^4GQW/ ( "0' 9 >&PO=V]R:W-H965TFH?+/(^.B M7XXVD!'<(B? M->O5K!_8*#LA7NS@ZV$= NN(<;;75H*:YL(VC'.K9'S\'D7#:4U+G/??U#^[ M\";,CBJV$?Q7?=#5.B1A<&!'>N;Z2?1?V!@H"8,Q_3=V8=S K1.SQEYPY9[! M_JRT:$858Z6AKT-;MZ[MASGB5\ >P6P$XC?Q<@6,09,ZC"MP\08I #FBS!>7))G-Q+% M7D.QQQ!9&!HPR6RA#S@G"8(+YQLO$, 8$K^EQ&LI\5A:.$JN%L(($+#\W->P M&,1)@OQN4J^;U.,F]PMD7H'L_CU#O +DCCU#/$DAP1@O*N+'(1+[#>5>0_FU M(7)CTT'@_YO!_46!-PX$>$=91M#\'T$D2TFZ/!?^BQLL1;/CRMX?WZD\U:T* M=D*;D\^=3T&PO=V]R:W-H965T\HHW#\&'NOOBS3:KP&O"KPAV_ MFCNJDAVE;VKQ=3]W/64($UP(I8#D<,9+3(@2DC;^&$UW2*F(U_,/]8VN7=:R M0QPO*?E=[44Y=U/7V>,#.A'Q2KLOV-03NXXI_AL^8R+ARHG,45#"]=JT6/7[\#0T.R$P!""@2!S?T8(#2&\$*)/"9$A1(]FB TA?C0# M- 0X(H#^L/3IKY! BXS1SF']_],B]9OZ,RCOMU!!?9UZ3UX E]'S(DS]#)R5 MD,'D/2:XPB3P%K*:0BXB0!H87 0V%WDPH0>W"9931)*,/-P56=\7V4PAH6>O M)+2>9ZCYT)XWJGB*@L\3U&J*\N,(^J.RUA98F,#P/Y<4 M64N+)J5%(S=Y-/6<)NES.#J!U8.XS7W_8ZCNV7$EH%X!6 6@1B$8563 P ML2=)K$D22Y+8+I!:!=('7%HPR3@)N'HZ:LR.^N'G3D%/C5!__55TZ"TO@7IZ M1O'&ULE9=A;YLP$(;_"N('%,X& M U42:>_\G#F_=1<7V3RW M1R&4]U(65;OTCTK5]T'0;H^BY.V=K$6E?]G+IN1*#YM#T-:-X#L;5!8!"4,6 ME#RO_-7"/GMH5@MY4D5>B8?&:T]ER9M_:U'(R]('__7!8WXX*O,@6"UJ?A _ MA?I5/S1Z% Q9=GDIJC:7E=>(_=+_!/<;8@.LXG5LU-4\ ]U8NY M-0_MVMG?=+6M?GI>T90M@K-)U&O6G8:,-&2JV,P5-!PD@088* A*06P\G5 D M> **)J V031)D#IE=!IF-5571A::CU/,^[H)4(0"10A0Y@!UFG@T49RPU.7> MS&41(20!'"=&<>(Y3N;4O8YG\Q!**(#[LA%=E"0)R7 @A@(Q! @<(#:?*$2) M,.%;2 F*E"!(SDSK!)D);:(;A!.D%$5*$23J(*6WKA(F?&N5,A0I0Y B/ &$ MN.6$M^]VN.):<$/[]*)QP9"&V,NZ13G%PFT,"++KZ944N)$!_<#BX-8#F/>X M9@AS5R$1NC;O"Z=0N $!XD S0X2YM41A1%CF,B$6E,:4L2M(N 4!YD&N*<+< M6R#+XH2"RX28$$#$Z+7-@9L0("Z4QE=2X*8!Z0=:"-_D@.SR>0ME\[]?: >] MJYN>$'#7(.$-#=2+)F\K(0S'O&J])ZGT(=$>Y?92*J%SAG>ZP*,^W0^#0NR5N4WT M?=,=<;N!DG5_? ^&_R%6_P%02P,$% @ L6JO3J&'1D^&ULE9EM;Z,X$,>_"N(#%.RQ>:B2 M2-MVTYYT)U5[NKO7-'$:M!!R0)N];W\\N-EB_\TF?=$ ^<^,Q_@W8\CB5-7? MF[U2K?>C+ [-TM^W[?$V")K-7I59!A&09GE!W^U&*X]UZM%]=86^4$]UU[S5I99_=^=*JK3TF?^QX5O^>N^[2\$ MJ\4Q>U5_JO:OXW/=G05G+]N\5(K79+_PN[?8K"WF!0_)VK4_/IV.M3 M>:FJ[_W);]NE'_8C4H7:M+V+K/MX5_>J*'I/W3C^U4[]<\S>\//QA_?UD'R7 MS$O6J/NJ^"??MONEG_C>5NVRMZ+]5IV>E$Y(^I[._G?UKHI.WH^DB[&IBF;X M[VW>FK8JM9=N*&7V8_S,#\/G2?O_,,,&7!OPLP&C60/2!G0VX&S60&@#<:F! MU ;RI\%\#I$VB'X:R%F#6!O$EPXIT0:)81",MV.XOP]9FZT6=77RZG&)'K.> M!':;="MHTU\<%LSP77>+F^[J^XI2N0C>>T=:/ XGCP\.Q,0!QPX(.J#! 4T< M$'8@H ,!1B",Z1HUT: YZ*D(AS\<2<)($D0R)G0M[4BA$6F\.[8PD5)(8=SI M)UN74BIXDN"11W#D$1BYL7P?(RO0[!3%,% , AD,K)'&8.!Q7C,92 ('D@ ' M)D1 PQS9IC!("APP(TCZZP4QB<1"7*1"$(N;50&)'# Q1S%DP(4P*QVSDHK M&G\ .HZ$CT!("0D>@70 9J(#.1TB)IKT1'+%P$&:B"S&I/MHC(T5<8+ED,U"QNK9O(RBE-YW+" M58N!PQ^!4)8Q(Y@LQ(^$&+)H3PN8PQC1S0R(7#!8:,RRLRQOQPP(^= ML=WTF9C+&//#$3^.DLPQ%SRY(F/,!0?MV-Q\W"$1CW HD5@]^&(Y=BC WIX8L8:1>FG6"*^<:P"PN@00B=UN,#HT!7H M$$:'+M@NKPF@,SNU&!U"Z%A3&UN%B5QA,%X$VH[3!<:+KF@[ I,C #G6KAR) M7-MR@?$2:!-K;I:1R+5'$9A! 1@D*X[-X.R#E< ,"L @D1D+B%S/3<+Q. T0 M)$?W$AA!<06" B,H$(+62D$MSC6K&#\!\+-7"A"1H[ )S)] _%EQDBN?%04F M58 >1XX>)S&I,KS\%DH,H;P$0B1R/61)#*&\!$()&B&7@ 3&+ MI+AB:ATOHM";*),.)'+1(3&%$@%F32T0N>JHQ!1*!)B5#WC^FGV'ATF4@$3A M'B\='W;RV6Z5,]%:5=3N)M\;L1DG2+K>JRMM[O5.U?;/6394; MVVTV2;MK5+[JC*HR(0B)I,J+.IZ.N[&G9CK6>U,6M7IJHG9?57GS[T&5^CB) MNH4>M)_ 6/'C%U!AWQ MNU#']JP=N51>M'YUG6^K28R<(E6JI7$N?O= M^V.7O$WF)6_53)=_BI793N(TCE9JG>]+\ZR/7]60$(^C(?OOZJ!*BSLE-L92 MEVWW'RWWK='5X,5*J?*W_EG4W?/8OQ%D,(,-R&! 3@:8?6A !P-ZJP$;#-BM M!GPPX+<:B,% > 9)/UG=[,]SDT_'C3Y&3;^!=KG;IW@D[/HNW6"WG-T[NP"M M'3U,&* 42X[O5C 7 $,N7P8P278 1((G[M1.$A(!R'AP4$L;QZ6/"5[P(&1 4%'8<3 MP#D+)PH ,YJQ\YD:JCL.3A9&Z(.SCN$BCV^I\@/$/R_S$/EAG<=PH<>W5/H! M$I^6>A"$:GUR=AMP-\8?>;,IZC9ZT<9>++K/_UIKHZQ3=&^3W-I+ZJE3JK5Q M36G;37]3ZSM&[X9;:'*Z"D__ U!+ P04 " "Q:J].5\OVO=$" "F"@ M&0 'AL+W=O_J3B5_W, MYG=4*J^,O:G%M^W"!4H1+>A& M*!>9?)SHBA:%\B1U_.VZN1E,J]90U>L^)-OQ6'A1JZSI;OL M6(@7=OY*NX0"U^FR_TY/M)!PI43&V+"BT;_.YM@(5G9>I)0R>V^?>:6?Y_8+ MP1W-3D = ?4$&?LS@M\1_ OA\PBX(^"I$8*.$$R-0#H"N1"([D=;+%W]=2:R MY9RSL\/;#51G:I_"&9']W2BC;J?^)AO02.MIB0,\]T[*48=)6@RZPH3D%K(V M(? 6D9H(%($>XTF1O5)D4YH@T\%MB)6)",.!SKM.GNX[24V(/Y*);ZVYK_GX MIN;!H.8MAFA,U184^3$>U'UEPE"(PFB0M04%"8H'>3W=-!G-"(\P5A-!(FLH:)[N_X=62$P;*/1K=-& (0 MH9%FQU8YL47.X#^3Q$:#E.!J05H/QZ\JRNSI'RO!Y[&V;!C)=1) M?F7MAZI'I*[<@3V!LQ6TV-=P]M2.3!?W[03W(^/[O&J<5R;D1:^OXQUC@DK] MX$'6_2"'QGY1T)U0KZ%\Y^WDU"X$J[NIT.M'T^5_4$L#!!0 ( +%JKTY) M0._-A ( "H( 9 >&PO=V]R:W-H965TSIR9 M,QX\F5\9?Q4%I3)XJZM&+,)"RG8612(O:$W$$VMIH]X<&:^)5%M^BD3+*3D8 MI[J*0!RCJ"9E$R[GQK;CRSD[RZILZ(X'XES7A/]9T8I=%V$2OAM>RE,AM2%: MSEMRHM^I_-'NN-I%/K- ME\,BC'5"M**YU Q$/2YT3:M*$ZDT?G><81]2.P[7[^R?C':E94\$7;/J5WF0 MQ2*F 8=.*_T@NM%%QGHF+DK!+F-\C/0K*Z8U&IU.3- M/LO&/*_V#0=@[IA\/]"%GGD/UO!-@Y0"="9+6;8FZ( M),LY9]> VW9HB>ZZ9 ;5<>7::$['O%/U%,IZ669P.H\NFJC#K"P&## 8W4(V M/B3I$9%*H,\"C&6Q IX[N VP]A$8.SD\)-G>);E),QTM5FK\TZ'*?Q%DHP29 M(H?[/:CCTMA#*?04>;# M $P1&PO=V]R M:W-H965TYOVKA--! R0)O9NU\@GFSL]YBD/YI SFL?&[^//YCOZ^9'NS:FF_VJRFU[ M$ZV[;G<=Q^WKVE1%>U7OS+;_Y:UNJJ+K+YOWN-TUIEB-0549\R1)XZK8;*/% M?+SWW"SF]4=7;K;FN9FU'U55-/_>FK+>WT0L^GWCV^9]W0TWXL5\5[R;[Z;[ M:_?<]%?QL935IC+;=E-O9XUYNXF^L.LG)8> 4?'WQNS;D^^SH2DO=?UCN'A: MW43)X,B4YK4;BBCZCT]S9\IR**GW\=,6&AWK' )/O_\N?3DVOF_,2]&:N[K\ M9[/JUC>1CF8K\U9\E-VW>O_5V :I:&9;_X?Y-&4O'YST=;S693O^G[U^M%U= MV5)Z*U7QZ_"YV8Z?^\,O&;=A.(#; 'X,8'(R0-@ \7^ F R0-D!>6H.R >K2 M@-0&I)<&9#8@NS1 VP!]:4!N W(O(#X\OW% W!==L9@W]7[6',;TKAA2AUWG M_9!['6Z.(VS\K1\3;7_WQ=/A8@3PO(/"/+@T:-FNVH M84HFXY]GF2JSS!,ZG@3T)(@GO]U+02KRK#Q.*1P/$GJ0U$/N>9!G/4PI' \* M>E#@V3#/Q$&3GE21RCS5_G"C,I7UHRG#=E)H)P5VO'J6Z:5#Y9$JIX=*!CUE MP),'A_N,M#UG@N5^TCY0G>AS03/L1T,_FOAATH/,4I_UXU24PXIRT'")"V ) MYFIRP?"RHE.SC*/G^824:NJ!L@#N&;#E=R$4I8%Z,/@8(A_A^$&4G6;PE0K4 M@V'&*,UHVC!**S[5=9A9C$)+9CXYH2@P93#,)0; I/U) XH"N<0P%"1%\2A@1##"">7GW:$4.2#.6)2Q4%Z8$0Y@0 M?ETY;=94XG+,$PYXHKU%V*,5G;9+JW!-&!$<9+_V$6%%S@2CPS4%5D< $CKU M:Z*K'LDG&H4YP0$GM,\C*W)'()A,%9WF6:@Y@:T.R/H\L) 1.$L%FM#]82_H5L1?G-EMTWFA:PKG MO0!YG_LTLR)W=97X4^$YE6L'HT'0K*=;2KJ0()TS)7%]8'0(B@ZRK;2:21]3 M$M<')HM 9 F076"R"+2T(,..DH4E:,*Z0.ANVC&() !1'J"[Q("1:&OAMTO2 MQ87=[/@G .>%KBD,(TEAI()%8-)(M \A[:+[D PVZZS.M10X8Z'D4J'$EI@S MDG*&GM/0Y862&C3JK,YUA%$C*6I4$IA.)::$1*<:Y%%1!C %&G5.YAK"N) ( M%S[-K2BT5[9VID6N&0P>2<%#6"XI3DC'3$GHFL>W\>DQ/6! M@:4HL%@HBQ3&B[K@+.16T;,0=A4X1"?O"(9WNS]633OFVT[>ZF[KJ[&=R)O M==V9OL0^B:+9VA2KXT5IWKKA:]9_;PYOU X77;VS;POCXRO+Q7]02P,$% M @ L6JO3LF+0C,A! >!4 !D !X;"]W;W)K&ULE9CK;N(X&(9O)S7 ?A1DO3]3G:>S\;S2U'^K(Y"U,[O+,VKA7NLZ]/,\ZKM461Q]52<1"[_ MLR_*+*[E;7GPJE,IXEUKE*4>]?W0R^(D=Y?S]ME;N9P7YSI-[G@^_)X5@W#[SE_!0?Q-^B_G%Z*^6==_6R2S*15TF1.Z78+]QG M,GOED\:@5?R3B$O5NW::4MZ+XF=S\\=NX?I-1B(5V[IQ$AOXCI>SLOBXI3="W2* MF_>4S$(YO]OF83N=[?_D!%3RZ<)@J'DHTI(5>%)Q.X M9D%1%BMJF--A@+6IX*&>Q$TO+Z8BBH:25U,2^!S7PN"(LM8!&S@(L ,.'?#6 M >^/)=>RW'2:L-7D7:E^\\%Q A@G,./XEED+H8/P_DHCZ" R,@A\;5)7G2;H M54I"^=$&9 UD4_N 3& Z$Y!.A!U,H8/I_0-"?(RC?WM(-DIT:TQ>@,XR'L32 M',@=KZ(2W?LN$M@!G@D%A4_T4-0(Q2?V2)A/PD"DJ=[R.E'4'^(G;DS$#=4P M'4P[,7$/B*^G WB/AH.L,KHM'":%6P,Q>T- B![+%+&(6N+@#D)"$,?F O<0 M$CT '>:> /")L0A.1F!2 S(F&2:"^P>9@D0LBP_%#83Z]P\'Q=13D_J !%JM M4&1Y\RE&G@+DB:7?4LPR?6"QI9@_BOC3&X\2]66 M7(IYH6#1->L%RRD?*1AS10%7U.8"$T$?6%(9)H*92RJ?ZN@"$0LM[R+#V#! M!-5ZYDJ)^BN&_S35X;JE&J:#Z6* +FIIK_;PBXIKW<(E(GRT![A52_JNLC: Z9]4=1"YN\_R,'4C#KPU;[9"-DR;J=PEZB YVSA24RY#+N3CJNFKY@XS4L6F8_+/BM3@O8AB_!AZKW5[;0+*<']B. M?^?ZQ^%!FEDRJ&RJAK>J$FTD^781W\+9/426X! _*WY6HW%D2WD2XME.OFP6 M,; 9\9JOM95@YG'B):]KJV3R^-V+QL.:EC@>OZI_1QM^)8=:_THSI]Y7Q")H[[ZK_S$:P.WF9@UUJ)6[C=:'Y463:]B4FG82_>L M6O<\]_JOM# A[0GI0#!K?T1 /0&]$?"'!-P3\+4KD)Y O!62KG9GYAW3;#F7 MXAS);C\&P3\-WN,)G#M Z#BRSU864 !F&.<\^4*:R "&?$-2,: X]ENM:T0FIOLP8W9'GO32@V3FF^U'5(S MEET_T4VT./2]4C(T;,N_4$L#!!0 ( +%JKTZT][1N>P( -,( 9 M>&PO=V]R:W-H965T\LBTW:4?;*2XR%]5:3AJ_M M4HAVY3B\*'&-^(*VN)%/3I352,@I.SN\91@=-:DFCN^Z2Z=&56-GJ8[M69;2 MBR!5@_?,XI>Z1NS/!A/:K6W/O@5>JG,I5,#)TA:=\7U_>RM=HG":\#/"G=\,K:4DP.EKVKRY;BV7940)K@02@')VQ7GF! E M)-/X/6C:XY**.!W?U#]I[]++ 7&<4_*K.HIR;2>V=<0G="'BA7:?\> GLJW! M_%=\Q43"529RC8(2KJ]6<>&"UH.*3*5&;_V]:O2]&_1O-)C@#P1_)/C+AX1@ M( 0CP0L?$L*!$+ZO$#TD1 ,A,@A.[UT7*I*OJU!! M_7;T,UE/+J/7+ K"U+DJH0&SZ3'^!!,O[R';.<0;$8Y,8,S"A[+8^#.Z?[] M/D?$L9'#?T5V#T7NT@S 8@6:'TR+Y4:P0 @*A%H@O*MV9%0;PACESB&,60X( MDQ@%@3!/L*$(-!3-!4+7,#3'!%Y@&/H 9OL!S.XQYL[0$C2T! QYAB$(8_8K MA#$-01CCV]M!F'^T7 P:B@$!HYTV$,9HIQS"&.VTA3!/AB$ $[FPH00TE " MYAOJ,;'&-!KC+HQ$\CG&6_BF(T@H,;[8';B:V77.9$>N,3OKXY%;!;TT0NTI MD^AX C_[:D=L/Q&T'7XAG/$_)OL+4$L#!!0 ( +%JKTZ M #&JVP( (\* 9 >&PO=V]R:W-H965T6_N4#%GV125K7:@Z:N5A%3^AQRU:N "O^%G(JQ[=1ZZ5 M5Z7>W,.7_2I.746RE#OC4@A[NS-:17S.-K+@SB7YD5=/\N^(1I'??=?Y4665NXJL8R=*K7_C'9G;535 M9[&E5.*]NQ:UOU[[_+]",$R -+&"3L3O0-G,OD2@'SPA#(!(",( :(X#6P(B M "<+.03@T#D0;!T(\ X6>D82F ML %%?(8#&P,"G(&%!Q82Y3/^@V!?0( QY)-#U(G8Z,7EG&9D[KS"SH :\@G MQV@Q066$\2SL*AG]C%>R/?J)1T<[=:Z-^[DE;%#AA\%#DH9:M]V(U#T8U?3C M7S+,H.N_4$L#!!0 ( +%JKT[R IY"S@$ #8$ 9 >&PO=V]R:W-H M965T6TI07;(_/G'/&]I"-2K^:%L"B-\&ER7%K;7\BQ)0M"&8> M5 _2[=1*"V;=4C?$]!I8%9($)S1)]D2P3N(B"[&++C(U6-Y)N&AD!B&8_GT& MKL8<;_![X+EK6NL#I,AZUL!WL#_ZBW8K,K-4G0!I.B61ACK'CYO3.?7X 'CI M8#2+.?*57)5Z]8LO58X3;P@XE-8S,#??<_\%6]. MU)U-Z8/A*,*>,V]<]%:DAVU&;IYHPIPCABXPFQE!'/LL0=K$&E&F3HED5T;HI'&N[]+SQVU#>FFTX:=%76O9YPQ[52%IR1 MY,%Y:%T3SPL.M?73@YOK^)3CPJI^ZE(R_RJ*/U!+ P04 " "Q:J].@,K: M*>P" ":# &0 'AL+W=O*^22$VK:9,VJ>JT[;.;. DJ8&8[2??O9PRE))PK\@5L<_?GQAM7ZRXZ+BBH]%7M?-H+1K7&J M2A^"(/$K6M3N:F'6GL1JP8^J+&KV)!QYK"HJ_JU9R<]+E[CO"\_%_J#:!7^U M:.B>_63J5_,D],P?4+9%Q6I9\-H1;+=T[\G=(^2M@['X7;"S'(V=ELH+YZ_M MY-MVZ09M1JQD&]5"4/TZL0=6EBV2SN-O#^H.,5O'\?@=_8LAK\F\4,D>>/FG MV*K#TLU<9\MV]%BJ9W[^RGI"L>OT[+^S$RNU>9N)CK'AI31/9W.4BE<]BDZE MHF_=NZC-^]Q]B?/>#7> W@$&!QW[,X>P=P@_'))/':+>(?IPB$RU.BJF-H]4 MT=5"\+,CNNUM:'N*R%VDJ[]I%TVQS3=='JE73ZLX31?^J07J;=:=#8QLR*7% MP]0"LF"P\74&0QJ I;&&*)0 !+*<"X(+B=R@)()+B6 :F-"-)G3#T -+(%PJ!--*:H' =4"2 M&^CB2B#I'+KIA"Z)O,@2"%<,P21CRQ67 \GGTP5<#Q#,H-L;7=#-/%L@7#6 MJ2:W0.!Z +B!+JX'".?0#:>'.;$=9L!5 XAJ&PO=V]R:W-H965TJSU*!A8=GDIJB:7E5>+_<)_P+,-)FV 0?S,Q;49O7NME6/" MY[ZW$_OL7*@G>?TL>D/,]WKW7\5%%!K>*M$YMK)HS*^W/3=*ECV+EE)FK]TS MK\SSVO._A<$!I \@0X#._5$ [0/H>T#X84#8!X3_FX'U 33'33&7+ M>2VO7MWMAU/6;CL\8WJYMNVD61WSGZYGHV7!IB7K,JL.0$2:.II#4 MA> !$6@!@PH"J5@1)]S2L'81<6QI^"?)YD.2B4P*%HN:>#IVR1.8( 0)0D,0 M3JI-K6IWF,A@*H.YXR'FD5T1 (=1',?47AL(2#2,,ZL\ )!&A(\9)QX9Z)$! M'D/+8X=A$TE)P@BV/ (XRAE-+.4IA$.Z9E9M-P N"?F8;V(P @U&@$&[E!%@ MD,<((3A1#":*@436XJYB)Q&AD57NM0O26JS]E+J@,.9V 5V0WDHCJHDK#KKB M@"OK4UYQ5PNGR'+E@AA*N+6%4A=U1QFQ$FY<%$>4W]CW">@K 7QQRU?BI*&$ M8@N5NJA(?XV XQ()UP9&M*(6#$,!X=SU-1X$7V@(DCRCX;5CUF?,X2AJ/8 MKKH+N\,4D1 [EZ^+Q#B.(OM0@AA#%O(PLB^Q8-0^E*(^F%ZN\;;R7*GV AS- M#OWB@VD7K?D5GJTQ,)^V_:5I5][IN^;T6U8?\JKQGJ7238]I3?92*J$-H'N] M/$?=#P^#0NQ5^QKK][IK"KN!DJ>^X0V&KGOY%U!+ P04 " "Q:J].:=DI MJIH# !W#P &0 'AL+W=ON.]TE2;L[VC)KW]0G6[E_#G539IUK-H]) M>VILMA^"RB)!QE129GD5KY?#L_MFO:R?NB*O['T3M4]EF36_-K:HSZL8XI<' MG_/'8]<_2-;+4_9HO]CNZ^F^<:WDDF6?E[9J\[J*&GM8Q?_ W195'S HON7V MW%[=1WU7'NKZ>]_XL%_%K">RA=UU?8K,79[MUA9%G\EQ_)B2QI>:?>#U_4OV M=T/G76<>LM9NZ^+??-\=5W$:1WM[R)Z*[G-]?F^G#LDXFGK_T3[;PLE[$E=C M5Q?M\!OMGMJN+J:N?SB,W?"?ZVWKGCZO%6/+Y+E/-&DVHP:O M-'BKV(8*_B=)X@ N%$A2X!#/;RB 3L#)!'Q((&X2>)";4:,&335H4B:U0>5U M)M0IHSD3F@82)) @@+@'-&KD52$4*F4*/"!"!T:F2M) D@22!)#P@&10")A" M$#SUB"BA-%)"2B,I$DD12-)#4D0E9,8'>E5V@Z-)'$W@>'-CH\,ZVE\OVU=$ M-R@IB9(2*-I#28DJ;E)X+*^I;F ,"6,(&&_\-R8H(X7V1V\;JA#-U3J]@0%& M&Q8+<( 9W[%84$E+DVKI^U:H4XA"S"'->"@0(Q0@ =%Y%!PA,%-"R914 F?F M$-"F"AAB0>#M&!1;&$P1M>]"E%(K#DS/K#*@K1H(KP;PL7@X;]&X414!%J'D M#"6??8FT88,(OT$PEX*V6" \%GS3A] [%T+U:]*WD?^CO,6B;18(GP7?^B%T MT(6S<\&#\::$PO YZP?:;(%P6_#-'T(G7:22">$S$3K3+ZT9)-IT(71=X/XF M D)#76@.OM-1,N5&OM('05!<24Z5D\.8H)4C<2D7:U5#^Q;#0#H24 P7#HH)]-Z"4_E9C2^@,B*MT M(U%R=0+JCZ2?LN8QK]KHH>[<86HX\ASJNK,N)7OCNGATI^!+H["'KK_5[KX9 MCX)CHZM/TS$WN9RUU[\!4$L#!!0 ( +%JKTYR2QLK1@( *L' 9 M>&PO=V]R:W-H965TV$[=_7-H2RY*1*7_!MSGCFF&/GG9 OJF1,>Z\U;]3* M+[5NEPBI?,7N9O;RB(7 M9\VKAFVEI\YU3>7O->.B6_G8OTX\5Z=2VPE4Y"T]L6],?V^WTHS0R'*H:M:H M2C2>9,>5_QXO-YC8 (?X4;%.3?J>M;(3XL4./A]6?F 5,<[VVE)0TUS8AG%N MF8R.7P.I/^YI Z?]*_M'9]Z8V5'%-H+_K ZZ7/F9[QW8D9ZY?A;=)S88BGUO MJ!Q4BIZ6O?5HUKNX'_&@8'A$- . ;@Z)\! M9 @@LP#4*W-6/U!-BUR*SI/]:;74_A1X24PR]W;2YCBR51%@&$" A(01Q"]L8%G-GI,XC"- MPV1Q&N!X9G<#X2*2QADL* (%18"@6=;6/2:>;/0N6\19,A<$X:+HKJ 8%!0# M@@A,D( $R>-GE(($Z0-GE-Y8S6(29R29I03"!8L%CF%!&2@HNQ6$4YA@ 1(L M'D\)#N#R"QY(R@":NB41P=&\" $8R:([AXSOW <82,J='PW#Q8S_HYHQ7,X8 MJN=Y^>#;0H7K!P1"!80FMZ9]QKY2>:H:Y>V$-A>PNR:/0FAF2(,GD^?2O)SC M@+.CMMW4]&7_?/0#+=KA:43C^US\ 5!+ P04 " "Q:J].B3!OT_<# !F M$@ &0 'AL+W=OJE5KI:*NVUYS$2=#RD05RLOWWM8&3#?@EFYL SC/CF6%X#9Y? MR^I;?5*J<7[D65$OW%/3G&>>5^].*D_JS^59%?J?0UGE2:,OJZ-7GRN5[%NC M//.8[X=>GJ2%NYRW8Z_5FBPMU&OEU)<\3ZK_5BHKKPN7W(^!K^GQU)@! M;SD_)T?UEVK^/K]6^LJ[>=FGN2KJM"R<2AT6[@O-MDP8@Y;X)U77^N[<,:F\ ME>4W<_'[?N'Z)B*5J5UC7"3Z\*[6*LN,)QW']]ZI>YO3&-Z??WC_TB:ODWE+ M:K4NLW_3?7-:N+'K[-4AN63-U_+ZF^H3$J[39_^'>E>9QDTD>HY=F=7MK[.[ MU$V9]UYT*'GRHSNF17N\]OX_S+ !ZPW8S8#$0P/>&_"?!L%#@Z W")Z=0?0& M8C2#U^7>%G.3-,ER7I57I^KZX9R8MJ.9T+=K9P;;N]/^I^M9Z]'W9)NHD^,6""D/TH1@$$H0R%&X : G'C(:72+MP DINM!G.$L M!&C93'$N[3(@D M:7ID7"A$BK8_QZ5"))>235<+KF,OQ.Q4^90+O,806F2L:G%0K2"P,UM#4D1V M^VT0&40"" PB8V(/JH47&P*K#9]X;R"LY(2D?*S$/3206/#\ 2PB6\TVR!VW MG],MX,A_(%&$UQH"B\W4=\P@66;7J!(0_LA^G#>!(HH4=@.'0X?!5&RLZ M XK.@PD76-$94O1QF9BMJ>1+D/\3X# HK+T,:>_$RR_#VLN>><%GMOJ%D?TN MLP8<0[?_27_;7_L;IH@UER'-#2=<8,UESVAN#PV^6Z2T56(-0,: F@".1TA- MT,PD@9IX=]_(N:J.[89%[>S*2]&8+\"[T=NFR LSW]BC\17-U@3&-S3;=EL> M/]UW.S!_)M4Q+6KGK6STEWW[_7THRT;I^/W/.OZ32O:WBTP=&G,:Z?.JV_GH M+IKRW._J>+>MI>7_4$L#!!0 ( +%JKT[J=I$[_@$ -D% 9 >&PO M=V]R:W-H965TV$): SF-I.N+Y];4-H E:N?[!WF9F=7;#3CO$W40)(Y[VFC=BXI93M M&B%Q*J$F8L%::-2;@O&:2!7R,Q(M!Y(;4DU1X'D1JDG5N%EJ<@>>I>PB:=7 M@3OB4M>$_]D"9=W&]=U;XJ4ZEU(G4):VY P_0/YL#UQ%:%3)JQH:4;'&X5!L MW$_^>I]HO &\5M")N[VC.SDR]J:#K_G&];0AH'"26H&HY0H[H%0+*1N_!TUW M+*F)]_N;^F?3N^KE2 3L&/U5Y;+3JGBY"L'E24E9J\]VO5F+4;]&\T.R$8",%(\,.GA' @A/\(^"D! M#P0\(:"^%3.;/9$D2SGK'-Y_W9;HG\A?8S7]DTZ:89MW:CQ"9:]9%,8INFJA M ;/M,<$=)EQ%CYC='(,Q?L3LYYA@1"#E8QZ,8*L1/!.(PM6D2(_Q/0-J#,A?Q/8J2VN5Y;P*]NP"D54@ M^O^!QU:!^..!;RV8(+(72:Q%DH^'N4WFP_06JTD5='=F]*7WG?!SU0CGR*0Z M?N:0%(Q)4(+>0@VW5/?L&% HI-[&:L_[VZ8/)&N'BQ2-MWGV%U!+ P04 M" "Q:J].]J?D/=*8 ;6@( % 'AL+W-H87)E9%-T&ULU+UY M<]Q(DB?Z]_)3P'K4W909F)7WH9H9,XJ2JM6MDC2BJLO>6WM_@)E($EV90 Z0 M*8K]Z9^?$1XXDDE55>_LVDX710*!.#S\]I__>U7MHZ_;35[]QQ_N]OO=B^^^ MJY9WZ3:I>L4NS>$OZZ+<)GOX9WG[7;4KTV15W:7I?KOY;MCO3[_;)EG^A^B0 M9_]]2*^*0[[_CS],QX,__.>_5]E__OO^/U\5R\,VS??19;Z*7N?[;/\0O_?X3O\WC3ZLG]#;#Q<"K[Y-MXZF_ MO_[T4_3V_56OX_4K^&:9;&![5NG7Z&_I0_VY/OR_^70T7XSK?[DZE"7-.*N6 M,,+_DR9EY_(O+OJ+BU&_8Q)OLDU:1E?PWFU1-F;POL@ODN4RA6?@B14_W3'2 MZVU:WF;Y;?1#6=SO[Z*K8KM+\L:0\O3U-MELHI>'*LO3JD&<^_+06(<[;KOH M-_#+QMM'Z5+>%III??^_AO7??"Z3%2[M^F%[4VSJ?_V2EH>N,RZV6Z#ZZWVQ M_"6.KNDF1A\.^VJ?Y#ABXV +((:\@JV&GZIBDZUHWU\FFR1?IC ,(8*[O1/ MUZ^B\V?/ZZ]?ISL@=;Z:\RZB2:H*!GG1^'-2W37NQG*)'*>*RG299E^2FTT: M1WFZKS_W-O\"(P,!M?[U8YGNDFP5I5]WN+8J@K5'Q?X."&\9S*FQ[<4>CNKX M,Q\W>/]PQ/2_#]D.S[AU$J_2=0KCK*(L7Q;;--HG7YM,\6T.YW*;P3+E:ZU# M_5 4J_MLTZ"##[2D8TMI_YL>S"9+;K)-ML_2YNFXD]@E#W@,+7^'.[."@ZK@ M7BSO:$=6Z9=T4]">1,NB:GY9WSIR,F92C7G#=F:P][=EFO*^5W=%N;_8I^4V MVL%/R/#/WQ?[-)HU2/6G'.:9TXR!=IK7/3S[)\UB4^2WITWB4UIEJP-\IRP> MD@W<5S=*YRN.CG!>[11P9+*\JF.K 8:1[7$&?!A+$-+ )])\"0_+I :#^JQ0 MP7A1[9)E^A]_V"$)E%_2/_QGU& /R(;NBLTJ+:L_TWW9/S0H#6ZKK+#"Q[^/ M\D)4B"BK*J06(A+/PZ)D'_U(-*<* ST!O&B?;F]@/X AM?(CYHT5\\8=:01L_ZO?X@VL&+]-GOH\%D'(,HQ/^CD6/ONTGT&LOPYR,-GT7<=>NYI(W:KI;7K$ OY//I8<4S(6Z7 M$?[QQQJ4?M+C[9-M??3(A.LD\Z2=OM[#?YBA?5A''W:H2@+]']%B1B>;)BT\ MY6ESZ#[W]^E>15/+2L&F*]91E6R:?P3UMP(Q71;KYMV3+P,S48G;8+^?.@1X M4]7;;&"@. +9D*(9@<\GJVV6DTV"S*?^RCN<&'+<=+_?L)2#121-':_]/A>- MR76U[8^9 1VA]9:(/)3$*[^Q4CB9E2KP+I3>=^RLNO6(QW/NN8 ML[!SD-[$GSJ?+UIT#16'\+*U(6==SYW##K U^_S1=^BY"R W)C&D7>*^#0H' M646#(V=ME3#-)^Q$CJSI5;IT,N/4-9WT#NN$W?*H8^R3WJGMZZEC'WVG90=W MAQ)_MX_VHN?+427W2;DZY0B.#Q"=1T\^HE.7>M([M>UN>(9..*+&.R=Q+72H M1&\VQ7UC$X.Q._A70"(=SWSX^/K3Y>>W[W^(+J\^O_W[V\]O7U\W6=<_#I48 ME'! (.0+L"4W*8I)%@;P6_QYB=,]5.0A,;(>Q=R7=I_$JQ3XV3)CQRZI'UNT MM__9>KLOS=^0>+*ZJZ5%7: I9:>H >T"O\*EA.XCFN,0#T_V)7^$S M>G\*I35V]OW?7U\_0N-G@"]:&ERV^*JO+J__$EU^CEZ^_N'M^_=X7A_> M1, @WWYXU?7HZ_>ONA^Z7MZEJP.?9.YXD:,7.+.VF3?XR77@=,*Y%WF>LNUP MG^WOG*I,)P2R='F'B^S<<UH>(MCG7G2.DQCVO[]/8_H) MIB._*0YE_5>'JOX;'$A_!>,"C]2_2'!,_O@\N@/#":S 5"0!GJE5J_#-$FB1 M>469WJ)M0 X,V!?\XW4*O->[VEY_7;+%2^[DJB(?N'SZ^O65^RRN%KZ'DAEV MCJ4R;9G?F\P';WO1QW!.5<>LXFB9EON$&*P/_=*5*8I]CN>[RJHE:!_(I>%V ME1@-?, KOCFL^)HD>8Z.^=9#LW0[)YO]77&XO:-! MY7CA^4T&PA5TK#M0*?$O=MW;9 6T"[8V_/>_#_!]W-9M\DM*3]JM@RV+X!PW M*84A>]$E+1I^W#S$U8%O2"[&6&@M?YIM^4E^F%+YL1NT407QPZ W+FP MW V\!S0 TQ+.]H]#;EC;CTF>W-(K8K57T2N8Q($)$@>Y!)/Z0>[W&_ =(@G ]HE[+NE/;C<,#-: M_B<>%*;R!K8L&O0O_D:[@U]8F0G%>X0.3Z..5C*^9I>-[8,0>S1?#UPF^WKGE_!W*)SS_[&FW9 M3\N+;PF.D-!P0$FY*1ME!SK/= M!(IKW &?=&''+KLI4GZ&;$L.I?.F=5OD0-Z&&:,%10JE?^6YNPH/2 8[UH+(D0VOA/N^*RK/-TO/-\U%3IS. ML')TI+=#=EF_D:[,[GWTPI3I0S9 OY8G>Z$=\[$71I+3%/8HJNYXXNJR Y*./2?E+]!&LA&VR3 \4T82_!>KGY4>OA^"X.+TWZ1;- MS+^DJ'@XA>-=MLU8'3GE,2>5VR<)ND7W$.<__>UYM-LLH_-'/_/(9'2D.""" MV)[/3[V_]6Z:._*O6^>/SZ/K5^][+O[R*SLV4?@1I#9I+TC(MX%)P MZZOL-L_6<)SYGCF(\!8;/:K4RF+:\3HFZ(U;(+F],QG];0,M'&YIJ68!CKI) M533A;SXL]P6),Q:I4Q@?!(HP!KL$("O@I^YOCL1@'/P3B'JGT&)N'PR),J1K M$_7SNG&PY@+'B8/?WB4K7B%L'.JO*%R+U6&YCW1[TOP6F#*M>PM7(]U3E!-8 M]6$-F\;"@6-/8#]F-P[MHU\OO1CNFKN2!+=9,4NN.YNZ6O, M1D2[ L;.X3(4MP^TU$/)/Q-?W )31SX5O4]3]$@SO0=-.M1**4!.NOW5T,B23^ER VH%W0X5%%=B M,>Z(N$5S4UU!;+7?4#[[JU:ZR;!@$L6,-YMNF'@U94X[XX8@DD KN+$@I/.\ MB%)6R(H\T%I#(8GJ:5."JRH;?C40R11@0'<^)1+36R^(1NMGS+XK5"@S-9I@ MF[>J7,M96YL?%)3]06SY3;%41G1U!PN\+4 \8?)!D<%?W^&UR>/H-5QF8F;P M?W\#%2V)WH%N"F(Y4DX9$ #>75+9:6XOHOIORG1#Z@G&E-BW\>"]AO!+N%Q= M%$W"XB;)?V&C S:0#&DTK6Y@LM87MTZ^%,35X-[M"^ >8B=Y;@4<&IY:HM9+ M'.[9<,*99SAT=8![T!B_%UWC[]VTG<&6?MWS!0+3'I5\.+8-7W!2 _'6+V'Q M1!3W:):" N'?)A9''K.( MA)IYI4AV&?E2:%-I%]8'FC[N (R>>8L'7\2U(1%A6EG.#H-V^8/,9,][DP"! M (R"=QIAF\DFWA9J]A3:R#BCCP9J[R>7:X-">F;X#=O%G#9]9I M_1#I*I8U"FND\_4:1'B/V[F#\;^2,0%;_6PPFG >XK[--D]XBZPO@08JCO*O M4_P!E;5)/\+?G6U5)JL4!64EEY\]ND3Y[8^A8!1K:X5TAEXZXG&6M[@T5^_D MYH%?4'9!Y=YI:@D#D,NW[EARH$WQH3!?I.=/#61LQ?]C+NC M22SMW"98)VXM?'8ETOB$?:"[4!870-*)2U=6 TW/0)ST%'PL2N& 26BTFA7.]24FYY]0!^ *6 M"[%ZRHH5>@1=?L VW=^A2/DB6^R\@NB]XS"ED3JR4J!>T&E(.Q(]#XA5O4>L M:2SA#WK ^[NL7$7_?4C*O8A,=B@.^\.!>'IMGD--%M13&;YMF[M\M(9DWO@L MQRUEA\GS+XR3_=('2JXQ.8^2=5X6\!]O_5Q>OW3F3^OS5\7**;W>77'M(TR? MBUVVC.;#OHOGT=S^3G/[T.5#U'$HFA4-F4SJ43B9\N4V=*]#T)@7@8? M696BURUG;A&1),SH#V2:H:LP<;[,!PXV18NB=%D]00Y-%G0EL;8CO%*2& M.MNLX>\VNP7:/]A2Q&]';,0I)Y8WUQUWLQ9S6"9E^2#<3Q*/Q('^37M3X\TX M,=1,X[;$IK@]&4 DL*0$!+$ +^IQ:K ^LTA'.20@?8&8=QBS'SC8PV '''GZ MPBYFW?OD%_P[^57(K[X27N@E("^#W>%:%N-ROH/+!;PZX/MV47XYYI3J%6RA M\2VZ&MEC]4PKRWS0H^9L,MCNJK8220VW?B3E8LH,V?Q1?Z".Y550W#%6R9P) MV8L:LQ?UDAD*7F 7G2&EA=XL-G6C"][2Z8AC/Y@$>00V&S>6?(%6M@3K&,XB M,6H_B/!6VZVQ@2W&6V-![29:FTTWG[G:,M+ ,%$[(ZJ5&@\.U9/W;H/JH#=* MX1[=WQ5DK1*WPSQXSK,$ZL[=-HEW3GQ<2XUO5X'%U4:7-:):%12\WV,&6P1"$AM: M5[;WG))\WBN@5B $YY5"_M%SF]3Y".Z&SU*J;V3HN;M!+E)UL&2]/&2WD)Z* MCH6,%#9RMG'4;)M@>E)TV%&9#A?.(UG1+U;I!BBB? B%MQ(Y!N#QE1T98VW" MY9I61'5,1G6HLBTHB:7\WJ5$Z0Y+](_6I3YWHE?9W@M>8)AO*=XLL;%H=^7Q M7COCW#_L,$"R>6"Q8Z-TA_Q0'E_8];_O-? :LQE>IN0&JPYMO2U&O$)\4O W5"[61F&@T22B0U4 0.A MB/DJW4F2"Q\SG8K3BF)S-!D%$;(O;>>"E$(>"LN60\:;\"=)50QG2M0K>I7: M[GY5>G&D,($H7OS/HHKA4QU#.ZO*GN$_#JM;#GK9TQ"VJ7#/67#O)E( M.A+0(U&=V.%5I8GB>K>=S&2ZY-N&\[H#Y:HH*8RI5Q$Y.9 T;%"0DL+\DW4M M9@7^>N,&V_.Y29?)@6)U_FG/Z@M9B:[8@/1>O.$LL4G'XE=%J&HE M12?N2(U5^Y1U2@\D[RF[]H#]<)XJ?\H;!2*,./S#+@56P-Q43/8T!^/P)KQ= MF]%8GR,#,BV]9Y#7T/B &_CH:^Y;88:#\4AYS54=?G;Z=O7UC:\)KXRR57F= M)"K-J_GQ$V1/S&F.V';-1PU9SPJ6ZN,_Y=31V#G0ME'$,"M7%^A(>]!==A%( MI_;;O"IY&S^&Q69*V=7^L%+"#\F]1NFUO!$WK=#33Q(MX!9H Q:Y<*RVN$_G MTC61,3Q"=INX-%CW9:=@X22+LM*X:?D _/2I3H4%C5, 6GQ(ZJ BBV9YU\C] M[$67523*IVQ=2A7QO^3%?1Y>0K&C!+=]JQOCQ2=V$AV*?ZA M;'9<%C.YI(-57-7-*SZG&AO\2*S'U9?0Y/+IS>W7,=F:HUA M:%U%Z"U..]+2JJ"4.7C#;$;=LJ:38:^M[I8O#S\J3F5M\BQ&", MOP4>!6P-?4P7&_2LW'!ME$:\M#A-;\Q5LEF2'@J_>W0Y3IVF:&*^.Q#KNX./ M88K)X>8?$F_3>U[/0(^%;Q/819UY.=&)Z1GZR\9.Q1HF)WWR2X%3)R\I^6^S MZI>+-28JN3!:6@$!0F#<_TS7*MBDRT?R.?@Z3DQ+\A5MI?WLO%G M"@EG6T?*'23_!'&66SH ML[1+1/Y\V'$-?O=U-K0VL4$89,4]#96^A)B^K M^[6F<6L\KG?6#LFS\;9M4(3PVB4+!+DK_46H-A@Z4"<(S(.N?* :6F_M4DVK MK 2C'U%NEE114V:WMZGD*@.9N_6+Q]#>0$6T64OMG(,]7#Z(/>]?E\BEF2$7 M#JU YB.U5"9C=?G@70=;=%*'&>GK#=U#-M*)'0=E"]4$\'CR:B<*WNF=CA)OA:9[GKK*SV%^*E M9:>$N$/?7 WBMOD#51<[WLIP%Q/6'%O.PZ2=U"B)U%,"$/$I<_.^M,90]M9+/,14$)^ MGTCQOF?]WC3:9IL-,8\GV,MPYL1>-4,:<:Z NP;[MT>X)51PPICCI-?WGX31 MX1=#_XMO0IKLG7WH6N4+F[W36A8M$E]U=N>K%/=E[,S:F )0(M<*=.SA';?[ MKL R6 8C-=$N\.E99UQQ->TNA"OFM.%&O>+42#OB+FN[H//$,W%=8*.TZJYH(A"F)VX(I$M+"LSLW* DMAD+A< MEJE#H1%FR.(87V[C4A1!338JF;/24%9S*)>=)V1GJ%L%4=NKIN4P&YF*NDL#;:'KW4* M@QB=A@T"YGLCD=M4T#K:EA3$BWM8>/Z-9D/@4J0&7T/OC+F]0 MK<-ID6^Y;L*PDH]ED1<8MJ"K&)3:8I, F,-8:J_0QL@:[_M$PI]V9.WZ%,*? M7 HACG*!FQK$4*_"^-N5TF=TSF;,M#_EDJT,([;W%A?B]I"QQXR"2,V0MBC) ME:1O29W:&G;P F3D#K9^E6Z84[K $CP/@Z\?5)5Q#DCVRKG[$S>>M/4CQ31LOP M]JB@56NZ0AUC\EW' W"[3H:(LS!->+0M?]%F3'+")P;/P'Q"9S?H*B7Q"/); M$L0D+8]3RV(Q5&)UME$IG8FQU2K0C>Y*+GK:Q<*'W5W$M^;9-0:\.ZDFKCB'<5!P3=9 M;2L&@I*$9?D7/X59"/J-,.S@_7>^J V1$$Y(P;39=_X\.5)NDB.3FX*5O.#4 M[5D8'?//5=O=#,-?(^; SW#X M\Q9,7"X1@$NVOT\W2!/,Z84?!-I'SZZ!DM)@HP[H\J_T$S9UB$\GE2]2@:'1 MNNFW+L9/9UQ%=\4]?59'*UW6*E-I(V777]T:[D"^"O_FKYNRG4:2-#[V2_H0 M9AI3ZC).AZYT6:)&*0$*NQF9E<^<'>V@/U!EO MFZGUI0J/@*=&J\6T(3LLS*#K8ONB8+8$$JXY<#%"#I6[B_F:4XST:F84%F"H MH5[T-LJCOQXV#S+1-K)^7_3HKQ?8IR=(TG^[1?&6.M>^HW=W!9"K8%QYS2PG M0T:R=;A=GHWG]4\-6F_19TP&0 ()OBR2^;!CON%&=;*72%,$@]D\]>T)E6X" M;)D,F0!"80._U/4*[ZNI )4H'IK&[W::>*3'+ F\GXFQ12^$"7I+1/D3=G7" M3^A%)2DC5;>:JV>8LJ=$3>-R-2J>'/#$'8EVGSH=P[#?=@POHO=P5XK[B^LE M3# \"]R^=\#5"A:F()&QL-1C>(4$0-^KJ"B6F :_1TDL/&'XK;F(/'E64%$Y M[9SYXJ+?2D OCM.OS):$/6XB)[#I!6,P8*L M]"=UA)X\2F8-76#A#9T5AR10W+L)[U"F4U ;[>Y5)BGJCB4QH75=#TE/"B]' MQZ6P-X% M5+C3(TQ'XF8/: P4Q2Q@PP'/M?@#-A>Y7M]TBQ5M&GL.B5P=V8XF_>?1B^@:^;^Q5S]C MY!69BAL 6'*2E43_742-$Q"B9M^PV+;57M)U4,9\%8P%<^5O]1L4G7+?(7IT M'J9*>(&$M<@VS;3J@2/@J:HR"6E;8>3=?>2&\BZ13%>$L<(B'_&K!J][+)RE:('H%XUNI"D>[LJ-9&<&\M MRF\;&!D5 4&0PZD\<94NLZ%6D@;:;FX'YTKI6AF DSX<,X1O^W!FK< K__:#([B/<4R6!Q5SB6*RA_UL^G^O,OV M(6XA^1N"S$;?U_LMC0B(A0G )T='NW05VAZL!3IJO;<@SQ#7.9Y-X_U[1WG. M(B8]R:6:7$B;C>"7PFUF@SEQ&U)/,0)CE3[C,CS"81;"8<2&,&*3;$8FO%KR MD90OE*8FBR^!34[1+&1*4G&A$G_WG(MF:R?M]4"M#)=K2T1GI^VA5$E)PR]Z MTY']/)A%35]W]B6?E$<4"!2W-DE'GWJZI*/73G,%?3,Q_?60IX_9-?W9TZFI M;BR\+_(4)$WQD*;?#+K]JSNGO4T$*QB3PJIFP*A8@Z M9A0,3NJ@^Q<+5\XP !5D+]E\&Y"TE&9E=E8?_=U]-UB&YT<]RM05PPC-=[B= MZIUK2UT,C"='#M/^]-3H13,W58[OI&U7\RE!,7^@"!H5-DAA_@XKC51BN"0> M3>(XX0,QU2OG#YW,0F]'/7GG-^,;M"SAEY5HIH')&&@8+EN97995>^;CJ52- M67C1Y>$6#NLQ9C48Q1U %\ZU,42CT(,R1&]*$!"4Y*U(&=*U3"25>?23=5S@ M[#L^U;,34LE122I9NQL$5>#5BB 7X5<@1_$GJA?$MQF^6GP4SG=IO?5T6SL0 M#KA2K%5)EB$D4UWS_OPX=W#MT(7T$"[IJ),W=BZ6DYRW\>.J'[.U(]K?D7O! ML_W][@4E_O@S[CI?E"Z-AN3O,GABU=*.T_WAL78-0T>T[I7V8I([DV"K.#HH M](+.@519H+'[->P$L,@VS!W$-B7(089E<3GGF80)&<6:ZPL%']3["6@65B2Y MV'>JNREE'9R>1'";2W@S$R 3S9!37Q2BCQ:'BFOH:\%&-@2;)7VV< 3]:B$N MJ)8DAVF*Z#;/E:6[.DG.I:02= ^PK?!4H/YBWH/-C-26A-(J)P29QG*B^MQ: M]H#'NQ%N0.T?,-F$ AQP;ZOV1 ^1-SJW@#SIV+AL%2_!EA),N3*FHSK)M5@@ M"U5+"ZG)C 7#)@-=@G"**>G2@3S&':)!DBO$]';9$$ L%\?6NS701NTV8.:E M0 \_;J/!D,)Z0E09,>GL'A#]3J"6W#/Q>WH819)E#2?+\7FB_0; MH#QV)!E&]])5\OJQEN 7JJ<+FHC8";AA;8V0C\1Z)LP@C$ ,TH649NF\H])% MX?IB%)V_P29D&#P:C4870^ =(! #>.)K&NJ3'!%"R>]PFG3W&(UW&U>/E> 'TW05M3N5&_@ M]3AZ]^XJ.J^T3'Q.H-[?4:X)0W.@3$WA:45KX+9#C.*9Y+\T^'<'I-:)CSW& MVT>/07<9W+$F]A6:L9FDB#@ISH7)FM2\3Y=W.8B-U%3*&,P0+D81BQVE=NN; MU+/T!NT88HV(9)#[?_>B#_YO,IZ@22@B(00OZZ/P=,O)H8)6QYR[&B27/C>\WUR:#C()!:BR9$]0V M^*#C@&TZ''-13?ZN7OA1=*9*X4!E_8W&AOA; M_=9,F#B.QX8.*"$8WHSWJ6VSPU$\O];+@ MK:>FHL>M[@AO/UA^X/-W B2B0C90.I#0H<1.+G)] *4EM& 'X8,$ENJ1U&5G M=2>.L(,.Q MJ;X4(@N9&AC*]%+%UR=KXK902H^;4*B9V*+8$];"DT7H#C0HC)0[EVB9QH6D M?U6Q?NX9C$[?E4V9Z@YG>!2NGA-FP!1!#CX39GF+-X7Z<6C9MMD\-Z?0-M%O MU_(Q1(6/37:F;JA?-O]5SHR-*+7F@.0*5^_/EH[8T#!UWG[?U+X7O0[Q9CI[ MOK?#70:%L#4CR+);RFCS=;&UNF=@3;%+:]ADO[ ?/Y;X@Z_9!181Y&3XF2CX MD:!%>.Z8:H;;D0&%3>[*N MS#:*'XU\QU2$B)YC[6[[Y,]SW=B3)\&EBS5>8LK+B"'X[+)(&R%G(X4]WZUO/N@B3D^T9W.O+#-'UGVO YE MCW\&A\7_F;M?12_=9LBZSYY%PW@\G"):XMFS,PEJ^![$@'.8UGXV=V7S(GWH6P6?'_>!Y(@=7]MWBB5EV M3(NX3=OQ6FQG+LW7JB,JS<=Z(/7C_1:0SCC_,*W@!!(L4VT7UN2#9M&,+T98 MKSTL]4"SX*&8D& M;E6MN"(DW?DRY-PF%GJ-0UR(E -;TT.(DY6[@LO";0G'"M-(-QXBAE-H/"8? MQ;)C+QNY]<1A+TG6+7CH*X;^8%@SU^,D:=*%>=O#,L3'<1FBRU!<+I>@383" MSF-AA'.*I/#&OVV;I4NXYY$I2Q^2G3;+\E^0C[<1-G5&R*J"#SYN"*-@4B#1 MT7KN"GCH=X[=VBZ*?%2.T:VN4&AB"H**P'J:O/&>X%$92J,\4>PJQ9@$K"MZ MR-8GW!VC\Y^F[[=*M),$&?F>> $_N@4\@'CS=/*3E:5O<>E@GZ+.CM$Y4$X2 MH)%SJAG@6"8GQ<+#SUL^9]G!M6,'9Z\]$%:#Z.A&G=E<[07NK/G%<& P?P6+ MD6[,V6#2&_T1GQ[,X(< Y\[2>N.C9WUZ:]'_8]U_=ZD5F9\?(*[_%N,\9A+<>R<#]\R>JN]^.?*IS);1$T#@#3JT^8*D&=LX#$E4Y-( MF4B7"S'1UJ+(/(5%:#0Q:Q/\9YEAN"..JJ(-19VJ_LDOGKIF25M0Q##,(\[B M,G! &)PKS"]A($/E=WZ5FAX8^WY2P7H)KE/Z2%&>!;K""3=$JZ,)K0&Q> L- M*1(:B'I'&+"V'K0COS8W2+-?@]4<=K2M$\%');Z&6H_%R)95?$IW![":E_C: M-3"HN^ARC4"/OLB5VC#@GP<35PZ/*8 V[O"R3/Z)6($IN^)S4V?JBO+<;'EV MHZG,+IA\UU3E V+<49A-,C]4A%"YCL _,OK6@VVR9<=SV%L\:I;DT0]H_>6D M*=5 _X,B\3:B$EN>^6MD)<.IH '1:3:#^R$<]*PY8 OCO&S.'+3R<=R?3>/9 M>,(_C^'GT;_?JP<7MQ=CZ:QO#5Y_Z'HP-X:!*+ZNM! M<,_.!V L]!]/O/CZXBQB Q3W\XBX>C"1D;B]DPGHZ&?B,^V'*=62R) MDO>^TJ,>-KE/,;8Z[J3/F8%;"]2KLIN.7I*]\9-2=9T.++B$P M]^*_XFM"W:5Q0FBA!*\.>OXF GG[FLJY7709B!4"8 D^FQF MQJK7=;;>:LFH,/MT+W!]IO(!]XC"P&OE,XJ)K)C21GJ*.T'.DX(E6FE-K.&^ M*)$C2_4)[RAE4YIZ7 ])4*7U]=+G39&QQWFF=%,'^U?C&&W, 4\JMOC.M)VQ M[R:)_1QMBY"5HEZ+PJHX:^'N)2[1@MCK(I/]!L 1X/HXTL1HS94]GEX'M?6*G:GT3<7]=&>4\#,;;B@+@!BZI+IZM>QW"#)6Z6*^K6T2L&= MZF#P1U(TQ3;G ".H*&VM-7Z+STW:/G=TB7!A/3C)*1\-2JP'??H@\:TV;N\F MAV0[G1Q[V%'Z[2W>>;#2D/+^ MA0L=C[]QHFBTA6%DJGA"<(:,VA4.5D=[-OU_04\$#/KMQ&"FQN'20S#Q%,C_$SR4:7 M#@-2ITC'X6C#R3^K9 HD.8=I02Z3>U2'%:JORU,7;2HJJB$=4>8HM6-.F MGU2;T<)18>YC>E&LUYP+MT)S@W)464?.Z#PHCX=%3PK[#S;P%G-!_BF'XJ,D MKP*(4:=@.FMM MCMF>D.OO+_>'U>P?;G5VNREN,-9\RZAG,45?;[V14I2W22X-3^&O"%"%YBK/ M^BY--GO.M^9, /^B&=,IR#Z+,E^9QM_1FZLAT=*! P!_>?OW[R[?OKJF#4 6 M(%;M.MGBO"D?EY$.B]LRV3*&+=(A@KNUI\KX/7#=!U+4[^&NHRGC(?*QVQOU M%^4^9W?LC%^6&0=]\(+DZ::1HOE2%+EK:C[\UGOJ3WZPVZ<:?=UN7E2[9)G^ MQQ](EI1?TC^PHW7B'*V=X]I"/($+;/Y*H9+)E>]04SCZ08[HBK**648A2*_/ M&%.$T8J[J/CXG ?#8NS6#%@>_X2A"]>#]NV;#PX*CL,6>)SAM(@WWY=8A &, M#9$&D%JVCGDW\>X9Q8*;NS#MN:X\=+HN;(0"SO2SL>UXXX[0[JQF_XC$7J&Z%<^(SF[-!N3(M&UK_(OIN?7*(E^#%#1C40)JU MKCGNE,.LKOW=[^A,]/PY&.)H]@'<>?^/3\F]*Y(!5CE9+.+9;$A,$]CGT.0% M_(P55(2@0O5@9]-A/!OTSV:S>#I=F-&136%G#"J!/(.'YM.X/Q_!3\/1,)Y/ MQ_Y9MV,QV&&@%@'?'X_G\60Z@:>GZ-*<--R8'GI3+F1U=CZ>#.+^F%R7BP%\ MPOHN8;7L6QS&B\4LG@S'.)/Y.)XOS#9\_/3ZY8N@GV8^*6YR)YA/.H/X_[()$R\R;YBS(Q,\%JR)XH62J'?<AUX\[GS N!09]KW?P[']9KQ(7T#_N\ MX$G]V3>MQWPVZQ[^[%W'Z1/JOFRKRY\YUMJ"4/=*OX'J^O3@>=J\Z?C6VVG8 M5F(;S>AS._%;L,/W;[.$@!ENUH-'(_ T.QC*KM;,Z&S?IWK6\D:QNG%$1:YYVM/?I(!-39K]L<&M?*X] MU_HGK:,UR#%(HI#RWVA%=*=G:M4Y7K[\=.?DNWN^U>J=\7Z M&+);3/REO N](&(TJVQBT121ZBR)+COAYT9=)_4+;C'1;?J/9'G0E!NVE;\@ MV]^3JG2Q+RZH;ALU+SI./>3X$Z[%P>K_PP4LQ?>BYNE1I&^-J(6I<"EJ89A6#DG&P\6@'8TG(NT2$;DF$37H'DIEYBPRF@CF#*!2>L-R%?-DR!O@=QLS$EKGE3"8 MVUZ@;@B[0KAEO6Z7,N1-R;7I^4?!_>;HOC%:LYM1^EE;I.W'V7B/]"WK^3;9Y?^],_>P[=?PK=-^()F MAO_QC)#*Z:R6]BB1^/F :M)R+2\::B*E[?;[DAR+3',(NO"S: :X"2>C;S3 M >SB]IMW-I'W!QCK!ADP&L[BT=R\^9GPWIK;VY@_JK@RV 24Y_E\#K\9#4?Q M8& X^:7G;(]S+O[4&4BX?E_S?MG_$OSJ^$QQF_IN:F!DR.3HU_7Y_3Z$]U0# MZ_]"ZAN"U >CC7X[&(SCZ6C\%.H;3>&$)F>CZ2CN+R:_COK&0S"Q9@/XS1C, MP]EP\3^)^G1R].OZ_()#5,0ULH:&CKB$I?1C5M NFJ7:NVJB)5PU+&6,6:?,N M;MX&!@.'9"B-7JA"^QEKJ;. //G$Y.8R'3I9O>DW7ZR+#96NMC XK_6W&\<> MZ]C%,J0'&.]&V[917J5J D^8O'C(K;_@&V+=IK=&*\E2@DW8Z@?N+EQI[O(S MI0J5J-:XY\0HY;=\?#"9^*\/1LR/PJ\?M2_*5%M ?CEL]%UL75FPK;@ MFXOX#^X]J5G$=R6MS6R2@[4EIB8JLY9.P91 M)-ZU%17;V5NO%@$:!V$3< $-0DMN@PG"5+2PH<9]Q1$(E]@F*37:E<)74CT Q=Q2T(AP#DH#/B,#&!L&.PANDOO*1(NVV%O,ASGY60TH.,A8 M[_5NK_AL,J:6UJU)W@!*S2I7U"^A'@68=\3#>'D8&=)/XT(OJ,69KW/MUAPD MH@L&VP%$F ]'@7'&.H?8IC,)N/K='6N*1A-2H+CZC9U==H MF W_Q.=V<])!G)X<.J#6:]/>0O/=7+%]PO5@0:A9$Z&^I:+>>W",SX#3M+6? M9M#?TT4AN6>.JSD^TK@W3_T&#! MT"8P/,IZUCQ,4SC+N<2&'W+%#Y&3X/V0FH!!*P\\I8L/>JGZ@ECIMZCYGV'> MJ:E=,ZN6^!>.LV).C0OJZ#[JDI49EYG%=SUVBV&N.FAQ6#;A'OUD;^(K"XK (S+%"+)DBPDGYNN6&_ MCXN%@$+2_%_H-8H%1AO8%[Y*9"D%:MKCGGL'8 2:RRZ#*K8$1,U#E34:QRLB M4$:,F22P,C(4GT13=]+$P%Q0BRH= DYCP"G94A]$6%C;/%5H4_>".PD?89^M M&CB?Z7S%R-H"O7!8W5*'0.P)>$$Q"O,2\#.Y7X&4BYTPL)?2H!,;^'OB@@; M#M?*NH/E4*IVU^"V-2E4%#/E18)879>%)M7$05;7W'!=_+$!* ['IVW%4VI< M\841^CQABJJ?:>,@ Z7TO=?VJ%BS0I:!H E,Q,L 1(9U27WU1$7O9]Y C79((19%+-& 'SW(I7D)-B,A?0E5)51!UTSJ/K)00W6)E OIY\0-QV 9-MFLH4S[0.@W^C^6(!3KQGC&TIRR"5B.,@2@U!B%R%H&G@-X,Y@BR R,T \YLZ\.[C"X*P,?"3RZ9UCU78*;Z1&I3#4F1*GIPCV](YRTJETG81,6G52S5%M54AEXC M8/4JO=FW_>ZQBDH?A,6G3:I<2Y%S4*?$2M,D;BF"J!4K-4 +%A?_8\N9<>5 M.8=@*]G^P,>+I_G =QKQ%(D-95O.J\7_VH^\H]J@RHU-BB4L$%'UD-[>O;N* M21&Y5=F++\M;P4B7MV:.L39Z? !E,D6PP%(0#3P^8*#+?,@M^$L-2EZR=QN% MY78JOKQ$L>KMODO+2-(V+E9E\ME@Z%L(Q_S.LT'?MA5>?4&> MN*JG*$OYD U[U6<;EG\BB=,T^,MAY'6[%:KB]Y[XJ-\Y;5OF^N3)]TBP*M4X M;'14EC:I=/VAS$Z#IF93KO533#L.(:M-,U;/H'J)Z2:B@L 5E+*@I%**[=YP M[_^T]TN=UVURRYZ-8"C#3)]&ZU/G+ER@\$PNB"K49V/;#OZ MYFC8XSTY;1G&_C6#2N7X MV_\IFX$ N>1ZQAX#MG3IM+WAX+IT[EEY37>+TQ@^9;OTXBNH*U6A N>V&8].!+2_2'E&FXBEJ\LV MDL]/]>@:)-:'DU"L;Q&_'O;ZM[Z->@5\2:PU&O#Z2ZVK0T7&+:KM&W,\2@,V ME"%_K+5CP8I;;$.C?1_:_-_]WK11^$QST2)-3NC]X(#]!VV(BC55*/>]7(XJ M0=&E/N94%MW-=H';^;[WOS!W==WIW-I)I!]$K.O]?FP'N4R5M%)"HB>OZWU6 MI=R7:L6PD+HS$]LIQBL']6+SV@D,S0D4>7/F<2V/J![ Z(W=ZZ MT[/*GV&:YY?/D7B]9@?;=?[R>1!&Q<>^/H_\NIXF?K>8->;"83[7J2&6Q?&8 M,9+,^<-SZD:/"%O">1IG+0SGV/ZY'D-X.(ETH1,/-+KP[;$>NT8(*)V&8(R6,TB6%XCN'/<'UD)N@V'M,]I@/HY5\/<@R M8WMU.'G)/R#;[<'4Y AO'C#&1%^!SRCHS=_2!Y2XE3C8'A']\!IE'1<1XQ([ MUX.KS/N:+@^D)2V37;)D[*]#ON$T$G)C.(30O:HV>E[$]2G$]GTIE@NC36N6) YR0R;2HXV,:5M6[L0Y[F MRP-* 0SA4A,4A\>^#HS-#EE/-4S:O)09FQ&J5%]*S0W(\W#')1 :J:H4]F-9 M'$K?DL3NG]]=BDD8[.)C+ +L&KAQ GLBR[' +; _U!6I'DWM=H$XA(U@3K3X MFK^I&U\RCE9J&(2J+DAVJX]UC^!=/U)XJ,"PW$(2!.IM@4M41Y YB:>8'Y@B MD+(#R9G^.A1%7;GI:""4U=#2Q F6CQ;LIUN![%XPVYMJ*:0\G?,CC+9#,7#G M5L.OJ4U?9HVZ21AK)TA:@LI<[8SK[Q@4ZO')^?Z-3YF=W!J):;,'* FU^JSZ MOU"A.?MHB"*)?@!^#?](%1)P@_X 3/SS9'T:(VA[-? BPY5_"Q^B0G@\QX\E M9JK 05YSKX"')W_R[<>6=SW;:9.M)S)E9/WFOIKO\^N[/@KSF$^ M]41ME4\2I31A9*!OTBTROK]PV;INTCN6@3&,>G]74-;E/:J'/_7^UJ,-SU89 M*#L6J(BN=3>/5&UF[9IEJM9Q7!&JO&#HT$U#*:N%_W1E*9$98^%-*WOATW L MT =G.[6&%8ZY9<.\2M,_5-,ZXE\U/OMY-IN"ZXMLZDZK]_\XA];&%QN-_;MH MI_0EN8PHVNE1B]5D=3/HD&"B.9[X]C%U!\[ZI@""7%)MN+.J\;6VZ*SST1[# M]XYKVRCCM6#\6@1CUC/:_^8DIFM?A!$]G)]D,4C&YI[35 PPM@\HBWS@E%BO MUOL>8M:;D+0;'UF1=GP[M^D%2%:OQL/C*9-]@S8VCY?< M>><\I%'1"I=<%#Z:_P+]_L(&-WQWCPMQG)'>?'O5S5\Z=QN!@W=;2=6A,WBB2M! M,?^HU?E><9D1[H\&;;"*=SX:Q\/^\/G9^70\C,?S20.<]:?<'Y+!8)W&PP&\ M,)W"J_-X/)O$\]GX^,M*5B%%G9T/QHMX-A_!0,/^.!Y-1F88.8/$,U8L*)[% MH_XHGHP79_-X,)O%P[E!38#;]2)Z?83#/-3RT7U?/_CR(!Y.N&_% $N=PXX4 M\W@R&=-W%_%H,0Z_VYQJ=0=KYRPRD2@(+C0?3>/I8();'D\7B'4Q/[I@GXJF M@V AU@SFMAB-^>?^()Z8TNXPR:LYBRY#I9YLZUV^11W\_Q$7-T9L'L@#9J*? M@V%@4516G,#U/_%FAH403[O11U0*3QS_)V[Y*1.+@QH*T[8"Z^O'4^VC(C^= M=(L=Y!7VB EPE/$.72Z79>IZLKG]89;;PFX)$7^,+&@X1&28>#B#W.&/5V?V(D(]W&J+U_Y$L-H!3]0#OCKH-PDI?S,7#*AHP_ M98>.^<@HT?QIZ"N?:;H=:'1/ ZH[!EEW6=O*IR[-7U.DM4%_%D^)[D9PPV;C M&5'C< KR9#@WOS7UL(863B+OP7 4+\;3,X1)G\':!B#C%S/]9^>ZNN3Z< J" M:7PV(=&$8A/_$\HI7-AP,H?Q:6&3?CQ93&AA$Q22]+/\MIY">8T]?!$*!8SL M/Q.V2K,7>MLSWP0),G>IFG9(\7?(P :9IM0=H:=#:6P3K"9::JPNC56*)1/J MD;FBWA:746T\33;<)<:*? ;V^ %*P^EA3FH:2."5? 5I,6.H=TR&<1P$"4' M4*$13'+U/0PTZ7_C0,-@H-FW#C,*AL'[,QG/OVVH<=BX6G]9>\M['-UWZPU& M'_\R\NT<,^?I&QT1U5-KL)IM/@:3QTCHY:DD-.DW2:AKG>#^WG))%?BP$17EHHEMFFH62_ 6AE_1S20?G+:E M@ZPS J^UJ46"/M@=SB8S5_IBX5@YQ1^)1!R%F:T.&I:3EX]+D^G$J87+N,9# M.G814<.HXC'8S@_+?4%),*Y+@,5O0?,:/7J*TN@:P?!(.+]9/ "S<3Z9F3D3 MFKB9=XQ'D#3>YDH]#K2. [I[;QV?M>02\71B,;P.1 3Z;-$;>'\DN7*E5(U* M'F055([IW3[SD:,E%Z467WC$OBZT(B8M]'N%TZN]^#IY(*L[! MJL?3KH'J4%;?"C@"'9YXT;K.]:-6/O[,(?H >ZK5Z;/<%)4<'[FMPTK&D,3U M2FL" ,7D](OLI =9C?@@LX4A 3/$GZN0B.&-SP4PC8*.Z*7@EF5L,! M1A"P*Q\E@J1?TW))L98T%"0HKR.DV* M(12WE*%QE*<&D "48MG,B)3#1!!\.Q)Z'9N_IXOBXM]TTX0=JQ#!Z;BE<#MKW+;-)G6 MU6RI1XN ML/\?-:ILLV_U1C>^SB4FMCD@'X9O:QN&1ESZ&W9:)(_F'+K MW+&'5OM/$@8<'0:C+42P" TX,VC0%AUN5ZH7WO.L]OHFWX=IH7V8[-IJ.2^$#_N4P(P4CM'&]I<'SB.&\'X-TZ39NJU)*< M5%JYJDWAPQ9>M?6%B4GF[4_\=DLX');#Q!#,QM2.89F_PGYN;,A44@_01+CD MM([!8C3B6BC_T!$- 245D"!Y1P_H7-WMI-V1P_2G#*'2HC19E0)2,UX)5+I4V^0I5KJ/7I?UR MQ') U'RY-GNUEW1.P!Q1UI]C5!3WOMZE7 M#5OYT=-! >R2OU;8U/ZWNIRBR:=!;3U?DS^XM7_$7_[A>1CS#L& 12P2]3D[ MX-'9:#:>?DC;#M,4I5&LC,,>2?F,*KS^IC[1WM^I\&:'?!:;VI(?(ML;/J')&85V M'/BZ#ZB.+F2XK%?P)>!#1@'!II-?*0_:^R!D*O:@J))8-4G6U&M@.X8=&'N6 M4$?:MA9IQF/A+69N1XZ?XDD7]K3]:NY,KVXT$SX4RU?JL722 K)L*"Z!J>6Q#Q+)J=R>I;5_5%DQVE.\:4LLT&8TYTP2'1E@_ M28W*/6BES8NKX^K-!4M/.!F9F[5GQL.)/I3:I@%H++!O92Q?H90U3X M58>;,^>]J0?FV&O%B4_)3<'@+*9P'OU9%VB-\X*8+ XF).S95VW,YAF.))B0 M59&!*A?T-\U8_18D3\4+J[#=30NH 6-<-,8(6CPH3F!3-/R=*NYCJ@]!7>C M%G)[ D:KW/,.:#Q]* M2.ZQO3N[U7U/G^UN4W NT_J0"T3'DZ/)#BXN"N_, M8WMP\P/9H"%8^'@SB^1A7L!B,XO$4P[E3N)NCOD'E MEK L-H^H:DY,\?7-V[/,PR@/A7_$U>4]E$0=\H6W.18Y(#7CMP+CGA[#WWHG M\H>CL9]')I'D/LJC;:&:2A:!)%FKV7,G-R%*@Z\)CA9F-XX' PS3#W5T9GF@ M0R79)G%H?>I6;OE0J )IC^79K]KZV6E;/ZMM_:7W0X][,V>PJH6"[A,?*^M> M%P_;M6.#13^>3^??L%\Z[F?[3U\C6M^%_EPB-4Z5N6Z8QUUPY[M;I<*@O346V#?D7CQ4U"R:-?TV M6Y!\ ^A]RM98)"2X>ZZ#FM?YK7U9-R':!K;H1Q1JVRF&.M^;GJ[2? .C*5PF M ,1Y 3PP4;#SG%/9L=\@@O%BQ:NH4^ZXZ4O.18\R@''15>UZ?"(.8HSC12M? M-/; ?C.)]N INV(WU"]"JB.I.X_1+NS2\7U\N[ M@B+F.\53I1K,;;%*-S6-PB#-N=9]&O#!_Z%@SV?K;+#-3>'_UJET+&/_@R"R ML\ K4@8[U>G7G]=Z)'.#ZBX/_C5*3O2S+NM2EG7IE_7B1!7HM6;Z?RDP6YWRTJ:3WGCRQ[/IL#<:PW^F MO?D<_C/HC> _S1>U[#IZR-+-ZJS?Z_?_V/*_7M_)JE\NUK@'82+KL#><_1'^ M=S;%_YTL\'_'L[8O4OSD/)/;\_QLTEN<@4I6C+,1- WW2=VR0/& MT77 IK.D;">'QE2R+=?"RIR=W@!_QI:U$7;LJ XP*0RJ7@#_T;A^6CGTD19E+K\"SG(_L=I G0AI"#7KCH;W?*KS/!]-I/)W. MGL,3MG'I&Q8-^,2H/\!:&GS"-K?[<#0/;AKW)[-XNACQS&9GL]XA=Z8U!?&(!?#!8_J5I A[KA(EP(^^9Y;^YHT+TG% M(N0G*A+W?T+=F%&N Z-)U\# @)\[TI8;,_R52H)?9N_J%N#P[ FU?[[A\+CQR)N#SLQR2ER&F)+:?V ME!2;W_$DNR=/OHF$7 $F.58^WBGNN'A@,8ELRN*O%>0PQ'\?"EG(^\OK5Y?_ M];0,"XN6+4GM)@K;UC;VR,:HX^TW)?3*^8&Z/RR.27,3>O6 $>K5\'O4Q-YY M$(73GGIJ.937\C%*->B[,%7[\#7-A_ET'&V#MN>^:89<0I)96T1CT7XM-3@6 M1)/(-NQF1WZ!!A3V;R+R5_PC4]&[2;*MP;K 5"32XP2 QPQ=1TK-!!ZO.2C\ M]E!*N9OH@R2>^%L(R4,A:76E'5C[X+P$TSO-ORW!2FP=Z+(( IP5P^O>P>[> MUL* ;W-B!H5$^=HYV7W!:M$_O#:BX!#8P2;;PP"'DJ)=5]AS]0K7#@SL+4:RB@S;C"6D<\%G?]@4 M>["BHR^];L"?.,+&*)M>C,HNIIKT\)I-+Z[^0YMG;8_Q-'^HB= MH*N[8^^-Q_.Y]K<+M\.@U?+.,#07V$R'O6.Z0[[J4_JRPYOETJ5IO9W@ASSZ M*UP*]$;;I&<\2CBR\.LV:FX"5<):)&2SVR#M9NMUI8<71MN)(^(C2H5M?XOR M9.M3+_(5A0O^GI8'_L:6EN2*?FX*#/46:W/F@9IV7,RZU+/'1_4(;,>'/+HT M.+WTEA"B@(O?2OX"NOQO*Y&C)$3<1V]*='"S*HM.K SN,$)(@4&SIWYY2 #L MI$=Q>0." AD[:LGR:D5]EIBYFLV 3E"3]CT1)8BWGT4A,[KTQ5 MV;ODGJF,Q:2@LQK\2[Z+^/6$'>\';D^&4HM-L<[R+5&$V^LC':01=A%)OR326*-M"2?OQ2/G7A5Z^'S.KTJPC/8I#%5B6J >N2/( MJSOL#), ^X35H_HE"4]7=UFZ1M^,Y(1^8+Z'\\0[(L5!R^)B7;!>P#O"K @_ M^@96W\Z$,=_%L&7I+$T*S^1.E&AJ3*.M#HD06# MOO*/PXK28(E)D$AV=WI75/L+"YUL.$OC E/$2:A%[S$YEFOW7U44^'37V'F3 MWD)2Z#A+)6=<_2KCRIQ@'\WZ\'R_C?T^PM],9K#_&E&F8VBR6_\2?D94XH2J M1WEIBKV<(?DI>\K0VU4H_XX_@ZCI:<5TH 4ZMLUHX?,\5#7H9#^5/P^_D>*M M<.JNJ(56K(F3%Z^-0AIF;EH!%TKEP/? M=5<468%ILG'=6.O$;_!=D9O"M83OL!3SA).PMJJ!H?<'@.FNOQ7:G2 M])>*X=#)IUUB\[2UQ;L&_KOD0N-.-P-[S%?)-KEE/UYU6Y2W 7[N-S-REU,< M"CM7\=P&:+EQ1H9=2+*'$X*)5G]FC#FZB:YD;S"V>$L-4<"\)\_U;QRH!]F;I5R,2-0$!IW!_N%>;V+;V2;(:UI7H&7+1!>=VK+(++'I@$&A ME9.ML=]F)AW%4/35LL.01VO0W@^J]"QCJLW$B1Z)CA_TU-""0UBA4:C"4(=@ M/;<"H'*J0LT!-%7&D97:KU@L,PUVQMS#VCE1V PYZB'MO1H?J[K0(Q=8+:P M%>6AHGSX ,:?-6Q,@=H_6%<[L@K0G#;<#5YBHRY@\\I]NJ<-$I!+"9"TG-:R M+*KJ@G>7,R@X1/H0@1IPJY"AE\ +-ZZUAZ+QL_>27KI+DU(*>2@!;J#%U1 _-V@I%?79Q>;B:8CA3M_VUY-@&*D:"!8DCVM[1 (AW97%#4?U*&[G&@UP M8![^$+@6EB[5MYDD;3PZ;^I%IY2%NY'7<07ZMKBR*,=H>9=S:UWJ2V'PFW>* MWZP0#^7*PX6+$D0N$%3@)T&[E[5L)G9PC<+P+RQYB(8TA[) M':>D*-[..=;P-AJ:6_K$[:^%[U,?1-1Z0VOXD4$R6A!4]REQ?I<8PE1U%2$-C4Q[* );N('-N+4.HPQ@=;6& M"IZX8/P^HHLMLTQ7ES-/?L;!:+!46M01PJ1M;:%\[.-[HZB!+_6MQXTJV MR>MO,WOQ2?A;"$XBO_3M?"BM"JQ]S@2JH>G2['66*E-M/@8G*-'M'TW^2$6= M@S]&Z%> :WI!'!K+SO>E1!;P%=2V=5V8W@$[*2.*5BC;B2:[3@B=LG1,XDT2 MR^W"%W[!<@A*IY;QH.N5?BD[T%2<90UJ1\XN:&W+@M-S> L_?G:EF*2)>95" MW.=Y>L_':L$7(GB/:0F=ZY6FO7IHCH*WF<14BK@+N6:Z$AE8)F5 2B4+F#37 MXH9. MZ")=RG".L6W?).W$VT?1^ ?/EL1^=$F@TYI[IL>K3V)7BP?S/"]D.(#WVE*M M&EC6J->RDHO%P+;T'+_2/DNB8_QS&T/#C=^;0C/L[A$D(0J%JZO'?Z)M^1Y@ MFDIH*VPU#7>LGJ#QLP=KT1:71PKH!5C,XZ.Z&VHW!U4^2L"LMQ7WK:M=@8A MPB=AR:#(X]L#B,9\F0JT)N@E B'"][@\;-(+Z?GF] ."*47+Z),H*-><.(B[ M?[M5D? .7^?C843E_93)BU?L.B=+<>^GJ M?SM/* C^^:BT/W.!B@_R0&D>HH9K%FBL0!^L@F$;>F0[Y]Z*1J7G("?UG)VU MVG0>%P[C]-K5!X5G0V+@!\D>QD;WF1/$'I+3"PE,,Y-I8C8I9P 5C G &R(% M$B5WAEN7S/6 63K8)DX9.6@[O:$):*7CO<=&\XMF>2I*@3=*Y5X@/$E3^2H M0Z;(L[ 9!RK'JQ2LHRIS<&A!=KE9"W=]EZX*1E;GX M9T[./:QVI&3A9(*1 HY9"6KFQ M,$7AI5[HFE(J.-SOF-BOX[Q^330*4F9@9ZT=8AZ4:' ;6:U-$ M_?9@PC5-R7%?P@.$:Y.I9;LK#Q2<02+8;1*6O50!"9+8FY%V,6IL6572^0PP M4;9TKI#@+.D7;9N'NTU.2YR$Y7"1=CY00&<%'0K')J% W>KP"%KO@"I><)I[ M1'?'&T=-K_8:T0K%<,)*CUVB. GV=V5QN,4BR_Y$B3VHR*9N*F3H2VT])07! MXU/W;OB'0:US,5=D[?EFVFWJ_-I?BGLDBF9V)SQN>AB@G/O*U!_HR=2#Q,$ M..JAQ >7'F3FS')K2S8-(3BP"JN^Q+?N(FHP '0(JQ)!3%#L^KS( M+VB"?A+\"%GAGSM]Q:Y9EAX7,7G)!:3.=BT;):"F[DNUSEK'OG?^T]^> X-> M^FH[^5;;>8@T$YKG8H(.6>HW M7Y0;^AR7,FWF.&"S*;=L'V^ FWX&6,3)=J M'.G9:.I_4T_@#)U"#F*2)<6SP=BTUJ:Q@*:G76,Y3%,M34/;;,;N \)X *4/>_!F>TIH:M.D:R1"5XU^]PW;BM6 ?N*= MYWKRC+4/KXC?8KVFJ "3&4TRI#5+5==7T>=BERVC&0(98Z2OS&Y2-M>\CPXS MZ*L[AJ19A<"B>^YEZPFXK8V6':L^ NX/$TPAL=0]Z&TYE]H$%0K\>^.Y@ 5B MCFJP!I$%Y+$%R7D!VLJ.L6VJ2O)T\**F]8]R3*XJO#=&S5-V.%V8-<21N@>6 M+L8H!7>DRZ4Y^[QCVXU.(U79UN.>(E08D,RA5%VZ3'(;T+8F=\T;+6FMSH-L M%\/N4@^YAE5*5,0H_C#U$ $[SF[OL'>F9$'"08:OLC* QBL]@)%*2A0DO23; M*OPXJ@/!V);$:-9 $9O,J;^&35AX%K)P.:[$1F;*W15WN\V#*[P!HCI0E$)9 M7-V;R#CE^*NV\J_LMVBZ\?MBJ;SU"[H!'72-0;F]63BN$C%6SN?C03R?#I_C MSX.X/YO%L]%4_C6(I]L2"?\%/PSG_S0.O[&N>6/E4S!QM[;97?H_-KA:+ M>#(3?KR8#[#=&+S^_&S>CT?S:=MH*XR#^1+NLQ%,A4Z75S3% M,YB9A6J5)4T;3V\(6S> W>R/AF?GPR'OZ@!^F,P,Q,V5V\D6A>,,AYG'_>G( M?6@03R>#>+ 8-3_]MGD)S^6PD6J&DW@PG3$QC?K#>#P@TD*PEBG!X9QC.[%Y M/)XN_#'!Q3!Q#;C#16[S'^M2M4L;M9$?*DI\XHUMN8V!A/6;\*HY@Q='+^<; MN1:/R7W8H#G5R"Z&4\0.BA=P(?NVR\WU26K9&7:JFQ-HTA#.<0)T8:IKWPCU M/JJ%Z#5!=0#(#(AQ$(]'<_QQ H-.!O/FH *Y9A3:VBC#N+^8N_^Z]TGEN"$8 M[QO@&P.X@'WY7PO5%)9$A4//X@E<,_F/&=A:,%AG@,UY9OWI&5R3A;WEUQTX M6F>SR2*>SR9G4WAC;$NFZ2(R\_-3N8:IP#V8].=G"]BOP>+H\^HP.AN-X>Z/ MST:C>#[V C1#YCJT4;S./WA>(1M"8'LX,9.L:>9?_'O+;8%BNFVH7X&3&.*#1>GP-OMS^8[JK_YJ/_9.= GD"LN:3)>(&.U;0>++Z!PH9^BV%_L M$; SAN$RSDB#H['))KB$=P4A3:F8(YW1LB\QZL0WB<#Y%MHJS@8&G MN%&/;C!AHDUGXWA(0!E8.Q_V<2-7>?C>EJ/M'JW:1*6^*0>ACE/XJ]GJ$_H$ MOG.]()N;$][^>3P94:])_*F_B!>#R1.'>>PF?J8Z]LV1H8A]3V;]>##I\\]P M/V>3)RS,1V(#?G(^7RCYS\=C'/+YB?.RS?S\**0&\CB-! _8D7?(-/ M?%./L<'0K;$YHM^QEPEB!B#') &%-96:%,@]-ZI [2=5"LG:O2&>P :8@0=P ML..%R UJGK+MU8M>91OZ4#"=Q^>AEL6OF(E!$1"D!2X*NN6"!X[M411DLX&/ M;[A"PX=8PI%]#O;1;\B"CXTDSGT'*88H@!2TJ#](5?BHA+LV$:Z\MEB'J /Q MD?)0% W:<,/'2K0@'K&]%,B@43\M6)YM1=71*W:Z89*Q.]OP\"O?!3JF378[ M0DG4LDVV-;?@0(CO^,9GFF4E1]+([VX"M]);8)]=Z'B]Z%H:>E81^_87;+N3 M$^#@TJNY"N+X41W-"UL=*HSS7:>WOGK*M^YY:X*AEV3*J[9'Y1P8'MW#)?VP M$TCEEN2RW_@#W\9Q1B9M[?0)):=,J"-X[0I;6<^66,5]83++*IG!"WQKBU=" M/+ !,.DKD[OIW#SZM RAEY$LIS=7PSCZ^.GURP\?KC^S1E4>R#\N;VE'2^EM MBD-V?K'M P)CD_*X+CF3B[4T0S3(.26D-V"%E).)GSB4]+-MWH@(%L8:).?7 MA7Z>4D%[T<^I=\C)!:73RI<>ET]?<4$=;^C 5-$[@KF"157IQRG(5?N>H S+ M)<-H@Q_%8^OFJ\!9U(L^8*D"UUU]>/6C2_B"*?R8 M[9=WF*Y[;:H6?NR]ZL5TQY]8F1=@G-8)VIC6?ZYTIGBUL*&@;@",?9L6MV6R MNP-RAP-*OL47YE.H \CC=B@<]U W6LYIOC&]G;#[YWC2S^687IR=OT4)5!PJ M6%_UO/Y/8R/H7<&VK/&P/R;'!KI8T#:?4Q/7\X'Q9'3>(.PX/9_#D^<#-)C( M"!A.\+^C>+$8!A^5A$=J4CW&1\B;0Y8/*7[G\W@P-*_@),#*'[+;#LRCQ4P< M> -U[,&?1\96L?.EA"AKD"&J"]71B,,0OKY 9P1ZM)X1N-B4()H7,Z-@ORR3 M?V8;="4MO/LJ_%?] Y=EDGY0-9 M>I_ZUD; '%T.BYBUW&;/P_!?F?Q@ER7NXP85X[KUQ$A2;Z%,SVET^,7&G!Q: MJE]-;MZR_XUJ,//)JH/_:P^O5W&T7-0.4U$O74]Q[KNH%H^U%[N!.M(*%KBG>:E=]@F0M!M(2 M(2Q7G/ZSB"FLAD%%5W3*2E\PQ_\SLQOV53LA:/;_.=LV'*CI!A,C.Q;CG1NN M!2F RDQ2"O;RZ""-,/3*0E(3WIJ4@',GEJ@UOIX.C9D+$5]N :F79_2L6US50!! M^R,79!%$9DQ++I-[0N25T M28BQN@I,3/D&2X#ID^BPEN4Q,.B,N"?A7_N]A6F,("697(EHMX""[R3UPZQR MW\_9IUNPXZCJ7KBDEV=4>?Q+2HNEKH!EB?>8<]T<\K*6=%/-E60'8$K]WG43 M2,S^U8DHP*3B=':5[28YPY6780(&5\8Z_'^M=#*0\7H24LU3%]@O$TEH_\A: M">_.^<=BDRT?&FY:]_3./'V2*^1S=P! 4TV>6HQ(U<)O\V7/V;7W::S5R_(; M4&CKOSI4]=_@0/HKV5PUE/W=([W".\QF4*,/JLV*0$G FM8"G=BT$AJ/N:W9U70"[*;Q"CKGW9;+@GT9 2X M18ONT7T E%'I,M>!_PNB8OX/:0?%9^'SGIV0>>4=O3C(I:E\\>[**VV)H8Y# MK,8@/ 3OUL%TVL4RTKRH@O4#T2N@*=Q+.N0W\QLGWW&O?YV4XE(Z"KQ#[B 0G@H'VI62)/S,:">= M-ZUK/FIG!>@U)FSG19,$K9#S$>2!GO^2>! 7'*DS"M&Y7*0 M?H/C8XD$WW+"PIZX7FV%*$?\^_,0)H8JU TS1C6-E$[_RG-?86=;Z:(F)LV8 M_ 2"3-[2\TUSD7T/G)6CH\[08-.I\]'+5$%ZY7W0CX(Z*"14=(7/VO6X;QDX M>F%T-9( OM2?Q3NW#:; +L%E4"(\7SCJ5:S)[!GC=/W.ZEX @7,*EV !;O3T M*@ 4I++HNP))I[A'46C7$V,;5! 3'Y/RE^CC70(TMDP/>PQCP=\"]?;RH]=S M<-P32DU.>LQ)_?9)GE9D'_E7K?/'Y]'U MJ_>]EW]Y%;@@7>5EKL)2F4PX.P2:@AICL0$650K$,F$3LM;SAE)NC:QEC_+7A:"T S])2M)/(@0 MCF7CW/FNVBK-;Y-;7K=#K6Z#M'8N&U=;R*#6=WQ^2PZ(T-A2;W\UU#-&!;;8 M?H>_<<7Z_+L__=M@-O[>W3QXPFV+XD0^ G5N"B3257-'DN@F*W;!=3>%9LN# MQH]; M?,%Y\<".]%/Q8^9:;N5;*QI%_9!XTR4 *MU_IEF[+J4QJ6J)PFB!IO M@92Y$G.6W9.:L22*S/$LQ&]1'OP]#4 XR*U*6J/I?>"]\S@GZS[16%/96!!> MDKS0+*M"'9&%D ME8-Z9Q_R5NT&(3/KS@#=:W\0-P5W7>;(VQULSVUA(@=I]P%0&8=)MM.\ ZLN/X;#FJ2V5.QQ^?!]&@IJ-E+ MQSV4A/3\ETK;1[HDDQM8I^M. UNQ3KX4G+\'.F@!/*]J5F(E\-32=9M[-I1N M&8S=![>W,;YTKW'3=F8LH>>PX6TP*W"O23E&7K6$Q3/(".>V6,@]QD9 >!#* M%@4S O83$?O@G'<'C@$3OEZ4W,"U0P^\ :)U+:MDI82MQAC_N*DEUZK2]#_? M22_.P,^+:Z,:2+\]7)9Z;SS9'Q* M72HJ83ZLB/'>BRR_D$*BL)J]9:/CDPZM0(<'JU*P8^BX28..00-70)UZ:EA& MA20[UJ_O@KFW:N1MVTV=TR3TA!S@=Z2"=C:BZ@QO.'?2@-._[=IQ5[HE^MFC M:J;O2M&ZT[AHWFASAJ?=-]>9FFHD;UK3123!2C-X!"W,)"(QU=WL_\77C#?= MK4#@IJFO)!E&G',%7_#PEQZ9RY6$,PZF!VQS'EN?SF!DGZS4=!_WX4O?EQKU M'6K\K(TO"7-68ZH$.BY ,HAX1UYXFR!6DTANJJ[7X+=L!?XOX^A7/HXV#561% %Y$L"F'?&Y^7U2V=]MCY_92/;SEMT[0.(C#DP M'_I&4C0WZO8:_6CG1AFD/@(5B\84A)0E;,WMQ@P>&4//[RO7-O6Y &;D](J'H>;@&7 M[ASV-L+FLY+#-NOH$ [-$2FP0&I/B9$BU&KA "/^B>ZV=6"'>5 )!1CIV;WM M_';K=T-,/ 02SG+.46A!QJ/>FM:)[%WTY$YNAB9-R,)SM]\.//BT<)&:ZBPM M3=R2$S\+TJ>===L(9YC=\B4LT:BU=F7=<3=K(26J3!8&*LFM$A_Y+8H:N=$F MML=J29XUOP3>Z])I18@+A'D0ZO': DXM: $>HBE6=[ &+MOS_GIVPP=[&.R M(T];\X?,DFT\EZDI M8WD-UZ4A>3NY%S5F+]JK=+Y-*A^8(YU(T ?KEB4F&\ET).823$(;/.A8%O]F M66;H%4N,50$:0JN!VMC %@NUL:!V.[3-<&6,#:G#XYK'DOH<8Q4?>1I#FIT)Q[VJJ\%17JR-7W1G42LL6&Z +,6719;#)FB<@7MRAYYSY\$B25R;8QET MI4[VEO>2@:%0W^2X8,N\7M!4])@]0UUMFP> M\VQ-@F\Z1AOLX$3G:).-O' (R"$'(^=+DVMMZ6+?%@5Y.X\R+U8:Q=SEGMKI M>D.II7N)W7H^#2][G"F7#4P6CLM0P;8ITG@VU>0\#KL7E6.I=>#U.@HG1E.8 MHCCW-=M[5DWQ$.[ Y'U_7&#XZ;%'<#=\AEQ](T/_Z TW5&V7"7KWR"XC)1H= M)YEDO&8*EXNHV#=2.EW=9:Z%!_UBE6*I#J/T>LU"[P@F?^ K.S(VVZ3;-:V( M@:Z\7N/Z?='O&RBK$AEF=$P)J1"Y:RHT+Y 4-C1M/2R/JXBFW97'>^U\=_^P MP^#9YH'EGHW@'O)#1;T\Q!KFI=VD#^A?'H"1L4+] .U422[!Q0JNH''3.^5T MS,JI]XI8==X#XPI^.WVM1GQ"_)*,8:C=K$Q!U9AJ4F*!7SB;PJ?)\S'3J3B5 M+39'DU&4)_O2=BY(*>2!L5P]Y-L)?Y+TV'"F7,O$2I_+=W:KTHM#$ELH7KS\ M)NNZ8VAG\K4!#X>G[W*GO?I9BQQ:FU1LWZ"Q0$:ZEFL")+"M]LL6A]G@T=94 M+[K1F/F.M,BN$W?! WB[JBJ6IIT3_KUC'XCO@AGR1=L<>FNO>_.X>,]DC^.S M3LZ[5,RG;)BW84E)VSPPU8F3H*JTEE#OMA.Y3)=\VW!>=Z#=%26%N/4J(B<' MDL8:-W]#/KI2(53VF!7XZXT;;,]'T1+LTY[AXM,$:H1>M'R35E5=S^:F_#_5W=MS6T M2+(B2G953N6!)$ *,0@P "A9*?_X]&6N.S.["U+'21YL@<#.96>Z>[I[NK_> M8RVNC5$60F0YZ:0E4N%15O#93\H>-S73QGH0E;M"7WG_.PY84U03<7( >#+4\K3NC%Z$X@":"I&7 RYKOPXE;7(M5*[E;[[>'Z(&]X5[O%*?H+O\E55C?&^T[.C-1>B)6W5N6QR?[PL)"$;Y-[A]([ MT4EJ6O:=")V-=E4EB3X8NB$+OKH,Q[6WD+U#*IA;C:Q4-9PDEB24X.C6<8 3 M^+K=_2YOQY4<<),X=/(<] DL=I_EJ?1BG3PG@TPW!_R-]V?_3Y<'<%WAG>K MN:SLP@O"0^>XRJ0?3E81Z$8PJ[%BZ9:$M?'[9OMUTRF[0C' >R[3X8[E M1\?5AQ57=L39D_ST50>3O6K9:DU-7U];H/X$PBINOQ7\K53-I$ _HHGI?, !0@0UTJ5AM4RRBF 36L!EX;8@OM)3- M! %8RC-M1#-==^KXZ"1!M:!&B2W?G&AMD9'9W2R;H?&F@_0][.C&8(WT28;@ M'CV^2=(%]WQY[FMA+%37_*>H::/=)4-K6K::%K'V]0,QC0 $WZ@0=/R%2J[& M7%0" 0#0E7:Z1O>/*&HC[PTE,I;DIC-9W$=62>][':O\WFIS_T!B4< _[Q^N M_E/<6JH"(IT<"[-BC"/8U+&*H3;R2V>E)!88:ZU?J*RV*GZ+_K/3&XQ74Y>1 M.[Y4Z>IX\\47O*?!&]=1M&$\;Y/#C\"IE)%)#A'-(I=& R$=3'DP=WZF^_C5 MG>*. %?X@PP?EUS$]].!PH\'3U%(_]J8#3J\@M5I]\HQ:, B*47^1L2+25^H M&8#OW!4B-+NBP1'E'[LI-W*9=+J3JJ) %A8%SUTS22X94(.$ES]TQ[[B,B^N M=^8KHG>=CU.,LA3E+,=B%AN9ZY:$&"Y5VL 'D5ZHE3Z'KYR?A>:TO^R#R?(_H# M;GRE0DFLR*:D@^K214C@RP*22;XBHRM65(62O=I=/]PA:B35JP+U^_9VN9.9 M_WI]A;_5Y' )@W,CLEY1*Q"O);PANKFLJ6:4>&(H9]!SD!KW1CCW]3?M>+G# M&P([U^-F37RNH2=MJ2.+ !L "9W\%I#Z@K;8_=%)U52VWV*YV1II(L9\)6*: MU(7E[N#63.@F7JZ9C:;D.Q-N5KO]X53XN%<:AB6>O#Y+8]_\@6NV][R4]BI> MLK;LV0\C**E#2:228T>>C!M"AY,N<[95#LO;G4BIL"PKFB)FI1O)SIJ4077 M"^TM1OD>/W>[&+R:]T=Y$\'5R![V2ST9JU\2K;Y^J?"ZQ4DL7/;6H69=\$U$ M-9TK LWB!YW*>6)NVA/I=&5RO;B,,G+_KT73I?01T[WL\C/H)K+.%EW7/DMT ML9NC? 2PYR2^90( XL:"]+;6[X 86ZBXV5?&I0$30Q5W2K- T,BX.KLRCRMU M?PF\]2@1&VH,\G0^@(X@Z^D)HT>YC84G.59^@9BN$L4AS&7+KFPH,PD\B]EJ M AI!78)K.1Q*298.A%[",>R[6-R4:H"V2ZVX.-NBQEK2*DJH!FKQFVH M:@I+5M8=L+%/Y-%=^.5:JA&KG4&JG8R0_=+)/%P8J:JD2/4E&G[TG ;"')'" M=G,0E@EC @K3+32F*$LHG/RB(N'%2M2=]92UM!. PY)9A#TY,A2;!4^6&+VN M#@$SWX@[^*4LF.QY)>OF7Q2G?I21%/MD <9# 1=\010SC3$C^4IC@-Q MSSE?R) H[W=;+O([/FYE=&]6&C^B4,&+%4:=XY737D>Q?KHG/X..7_VDXE>Q MEU/<*>N._,R^7SV31#^9LB%7)16G:U+YVZ\FYHQ9,,L7^63#N\DWZ=RP MQ0H]./2$I*' F**>M2!HUA5X>? .,J9"R_00QTJ <(9V^QOBRT"?NH*\6G51 MHE[8V,;UMR]XU@S7Y6ACO!Q=,M88:%,[$CSD3290>7H]CFN,A:D62Q\8CHU/[ J>E-TB!I_\ MVFME_%%A,;YCTIUS/3T=9J !]BFN2;OO+3 )LEL7#+4G N[%7_S4RJ@G9U\& M::^JSDE%E)41\;]FZ*?>3XZ$,")S"3>5"\88NV[NA:$%_[CW\:X-)?)Z>;5[ MP/,24^ ]@NCB$_URFF3QY,V27!=">C1%=C*1MT2&3Q*6&.]^ETLCE@F30,@9 MNKTY?>#:QTOAEX2'\7#7\:0D41#7CD=G!>NRH 'NA>,@< M$K72)",U'I+E_S6K8Y\*(:C-&RF?@.:)L"2CTBDCTMYE**-=I&[+$MPW/)^^ 5[9?3R^N88+V7N#RO0&IMN7#%$YD3,_6^( V M =!X>THM)Z'![2A(B2<,WQJ,R)-GK5=#/7MFWIXF7@)ZWD^_8K9TV.,B*93J $:\XN5R(]0(HD)+<0>(OS,9HX 4YB<0,YGBQ/8.N84=$-V>S$V MJ$J&N,>X?:"06ZGKDJ)@.DCY!-+*BPRCUO#N5)Z-+DDLG/.E*F3IT[>>IH]8 MNL,[)#+!;GVZ _+BA;DV!(OQFI9>4'&6)R<63@0]PG0D+AHL&@-%<66)84OF MFO A9JAZ%R6@>Q[O[4,71=!72M(COYY ZPYP!S#Q01_02F2AQB.) #76S<+X MYL#P]X(X]J!(;%0*4FA.1F A(QU(M5R;P=;$'62$S<+YSFA*%"KU=7.Y ^X! MD5OKEP30;%A!9F(V-DQ $_8DI!K+0&+ Z[=8 MEG8_.9W\O-TN6'K!HK$[DLA5D6U>)B>3YY,+E/^&O?H1[[Q1J*@.0"1CC9BE MJA/D$C5.0! U>Z^%;2LJ4;.U\H= *C%8_E:.0?=S:ARBQPZ<^&8I+O;(-EW) MI!@38YX[<&(>U"!7%%>+8DJ\:RLO:9N'4*W;'N,8M,.&NMYAH' MZUIH@50S_ JM1#J MW=7(OK6NN%5]1!,4YQ>0-C@-!WU5GK9P,C8$YP*>;%V M(]]2Q91T\B$)_=KHG#/].VD>ZO3A6U,86U_H=K(+EW]7G,*/>RO] MKT-3MIHO('$%^)%4W4.+P?>,QU@&;:]R+NZ1>5 ]F_#P*@:+I(6(G!&HCS2^ MY&\62#6), $>S/?#(5V%E@=3Q7JM=P]P%$D=7XR3S[_7*W/:F/0D%>1S"B&KJ&@OOMILEG#3; M;\NE*+W\@C;XO=C@$72&$]&!6-)2W$NR56SQ&OL34VGR/BT6\H!"0[W^WA]K/T._^EXB?&G$7:/\0&A&5N>D#JJ_^'#E M&(C#I:Q@>;F&DY8BU8R5E8_^TWTWF*6I>^T5ZA()#,UWX$[IG?,%E%K&DR*' M*JG&WEZX$<-B^T8MNS2?+O&8?SAPA4&06P(5XAXSR>2)H<*89)C)B %B2HC? M? L*"\D=W?"E[R8WZ+6$O-P+S=0R&2T-0\60L\MR[X\Y'4O5,Q15\X=;V*PA M886%K?PH*\JUD:%1J!%!)J]W<$!0Z+V$:>& 9WE2&8]^,!T7./O 4#-S0O+D MV(M@.K\;!%7@Q8+@5N&K[1?Z1/F@V)JA\86/0ODN36\]<6L 7H,S ;U*LNA" MY _(R$?=SV=@.W0A?;-?J=?)&RL7RRCG;3RL^K%8Z]'^>OB"9_O/XPL*3=)[ M'-I?/%T"0$<>0*#I1Q0=>Z<4S >KXIWTQKS0ZX?U33BS](VZ^WC!#M%1=\YN M'<^+U1^@$])-R*OATIRZ2J2:D_#'4I7%(JNHIOTSMU3D7-Q'[M5/>9RG+3VN M*V8R9]KI_!0AK)+M#>J.BB2G]EEJ=R.6R)Q9D_%06/TS+Q+[>:9\VVROLAPZ9J27(KN9XHZCM)SEHB8;?+ R1Z\DV>)0W4&CA%JUR0_AS9G+ M$)L/=DG,,PLQ%QV&G-_] 0/W0@QWID.2?KF9>+I^Y#[;T2B1&P3GV:.Y"U<$ MY%K$25W%=5'RYP(^F\52\7[AN1'_3+>\VX>KP\W#6D4C1=.\BF'4$_VAMP,= M&6NFY.L,]FB*A503K(&;UW&;)">];Q%C2 U//ZOC+"^)"]LZBZL\Z^'"A[L[ MM-!A8SK;I":+<4$OY=O*D?]20=@O$7FU\4,3ITEN";J=L):%MF2(Q:1LND^> M;F]NM.2<$N+L28_ TP-7<5JEX446AP=8;0@^:9:6'L M5QO.N"0C+H*'&CC4FAP^93D<)%6AGU5O'T]N,9P8-J\HFKBL2GBZ0KXM'5[5 M$8EB68"=BA).L(+XLTUA")-!J:HP,E 6MVT=EUF!,VF*N&F-95#EX1ED/_@Z M6)0YK>,T;[QOP8R*(S6"@#)@]"Q.\I''I3Y1/NV7R)5O"-P"-3;24)]Z;KZU MLH%1 ^.BW*72[M.$]4ZC6#254#<>SM7#9??9UP^[S8KL-BH.L_H#/^^CNJ=[ M!X1Y?2GRYU[)$?_"4T2-&8,!ZGT7$L1@9>5YKCX#/9ET"N;:9X0+7AE^GBAK M@%.:2OVKQBZ 1(!%8(;XJ03)GG2)WHQJ[ZU=3574FS(&NY\KJB=I7*2-P0]Z M>9?Z59EN\RR)FP29OTB*N"Q[#A=]9R/#X;%'=?42$GX_4]+ F72PSW4])^2S MPW+B]/M$@H_L$:.Y7LCH'4CL%]OM[P:L,LT'_]$+2N:'R>QJ@L)F)$_)#4\? M813,"O*B[CT:56@*^2-T9+K?J^&YX^24G16@@QNF@:^R;,\ M3E.#(N;Z."SV/JJ?Z:X3(F:&IQ58G+T=7=^%/Q. MAXJ+ETDUH6#SKV#SM9'DK@PEZ,ETI7T &?"YA^C^/U-?!M(#SG[Z-DT+T#&+ M8Z@/%*8V*:.\ CVL+9]&?44&)W6=PC<%:!EUUOY?HCXY.?K:F9^+SWAU"*N$ MG1J_?Z71I,I\:S1M'26-(@A4)O7.QA^= ^I,YVM)-R4>/TT.HBS)X"BJ"MC% MIG0LIT\;#0-N&$B@>Z;0H*J@:0/+6\9-7?0WEAFV-MXXV%H%J+1-#AUE(%CS M,C>Z$2MOP/;C20B",\GCLF@C,#M@9[/&T/;FB\5S'X"C$4UK(RU.]PKU]R1* MXZQD;TN*9[2UE#!:618T;AOG;6&/ZT[50,P5%0;0LFF ZNTQ"6/JQ9U]*;W MA35RKNP$.;^&N;7 ^?09=(C2T$G"5-Y3UUWYV_Y"XNZ9CMJLV (1I\R)Y;U8 MAKRHI--+?!I%O,K,1(>>9=LCZ< 9L%/5733-B QT%_Z>'$(%]X7#3KX/G6,\2:HK#94L3,"MH"7,@ MEKJH:6&S"B1"UAC?FIXF38BC=BH%':LMP((!D5C#NZ4@I=M:_AE\KY!DSL"^ M3XJH).&"@@__L24-OEA6@GW%+HDRBCKL=:)2V .6?E7+YN8"D[WVY"G^ J()Z*[(*M#X,F#^*JKAR"_R,BIS.$:+PA(& M7O4L:O! +*,"Q$A11FF%OM$D0N6^K4U2*%KTRJ%=5*1IW!3X!FV:@Y: 9 V M#[I:PF3@>/_G1@ED](3^(C[_C(A"R\7_]MY.^B;\?.3.OY*7>AHO**K*65'^ M$%79+"_@GVK6-/!/.LN;'SP-%RL,6H(M^[9:KA=1,DN2'SS_U]OL1R**LEE6 M_P#_KRO\?]GB_XO:-R(I(]/5AAU%)U$Y:Z-J!K)A5L-_IB/3NN3:BNV[Y>T# MDDAF+6FM,Q* R:PI^\MM_^+>.J (LQI<,;]E6W%7PT:9H$[/0L2F=% M9FXWSWXQF:85R/*J!F5B9CJ<@2=OEI1&/\U![P%; I\PO5*=V75RF$%E*^%, M;'.>61W5LP8_UV#AHH3J3H6OPIQN0*P5Z#$NJ1LX_JI9B69? 2=04_3X=04Z MU$="AQIY94U7 K*9/&8FTQ>,P=-M?;0W[*\^>#1 EH01P@4F%$!VX=,EZ;/) MM"G0;P^&(GR&XP#-Z;P2?V5U'E=H.L)?\"EK^#=]2ATZ"%MB*-)[*9)HN:#3 M2R(9@4W8MJ!OTH4!NCM:-)>(QBJT$ULXBN@[32$JO>-:7;$ST(> BHKTA;W] M[U24B3 Z>[?=G"ZX/!=2G*I>+UWDE"N$+K>J ).PAC.M0 ,6U"_ZPS,IQ/_5 M115,K#%:7U#XX70'-:EM4K3*H?E)!$R9&UYHH[<%*GY:\$72%;3]'J;D"1:$_"[&P& M%]B7> K<"WE6N,/QC##J(CR5<8?N^7P 8\][6?.U8 KB$9ULJQRF$H(,EJ:_P7[0G=.0?IG!+H)94I66K"?:'>I%,0GB<0"1 2FF M(,P;_ A&0%Q:%YT2/T-4\].W])U>0,2WC?I7M1=U;Q=4=60/!%B3F5MW3%R9 MUL/PC';78+8#DXE_C(X1(43NV(XNX(#'07O.T/MI\'@(F3.JRS9NZA*T.%A7 M\UPE-F31IZ=R 5,!+BB3)FKQ0JCM?5Y"G$2@RN=I$>5@D!>&TL1>;0^0'TX_ M*W+TW0'9 ;]6Z '1#7_U(,Y1Q(6GJVD+9RZY6$$B Z/F>"R8KBQTH/L:@IAL M*Y!U11J!<0#"",R0+, H1C34%S 5+"T7:%!62O&^)S.BO:0D+ M7*%0Q=E QQ4NU. "D_E8U068_@E_;MN1X6".J!3W,6>Z3CDLO152\?T$YQ%^ MPS=&,;'NZ]O\W<1E3BY7_)2T<9N61W8SQ&M\&['NZ8H$=%DG<5HF_!DXL"Z/ M>#'MZ+,DQK1I)8$W18%=GHRO:E&:( MS9SR9Z24IRJ1H ;L#ZMK,-M4!&I(\S;#+L1@(,UE?M?38Q5MT"4_V))Z*(S' M-$[EEB\,,Y_BJ7DBM,#GT?2?6$>?EHTO3=D(*E^#T6TI2F*2+EF9<#Q"FUF#[F"]47U&7WF! MCY"22"*5Z&3:Q* X&B&9, E0'S*V!D#NMK6P"U)I+\#/>>X+XA29#J:D_[0A M^Y(TF#W[%5O476W M8GT<@XC08RK_U:<]T//GR?P&BXA$61'5($ZR/,?.S:#%?U_=75U>?5U&)8C@ M'#J "1;87=,]&3" /2M+(U ),"[H/Y?+EY.IL\<#DPSR_)T@ QWMY<; MX4>.*0%(X;\1R5E#H&UG/[QEHXN9V*_" 1*BYJ# M3[]=;59W#W?!W\^,ND[=WW(N)N5T>?E';Y>R"-7H^/[CZ.BCKFRYG:Q1$$W2 M$<]DO<^\H6?RT5-^2N[!J+=T F1=9'>1(M#]P0YO'?U&(\+XC8F/ZY8C\?E0 MU]; 1]205__U,," WJ!_AQ:]H?K.D@Q%[KL!'-TF$/<8N4"/&X@,U$ X[_Y'2D2G-\Q-/90AD'W^9:\_][%$FN5MD," MZ"EK-:ZO1R^']^T>ET'A%6D(^8H>L+>, >RGNJSF'/N 7/C[PWHF#9PF\,Q; M3"651I!X1@((NOUM9LHZ&M%?$^JH;U!\\=Y.!R8)=IPSR="SKY=7L(A-[PN= M"=Q7;\WKS;(;DO43>_E *Q'M@H>I11,(@AUC7AY^=WGK,'>:^N@M+7W?JGL@ M(TOWSTEH#7PT&YISY1VO+GS?LADHJ4F_'D?X(RG8[(4@JD(XW:5?5TK];V^BP+4K"9?>3$:]CY1DZW M5F).<&HBL\A/&VXND2-"9*QTZ UZEO:8O)Z>G;=3=E1^BJ7R#-A?H/_ H8.1 M@)[DFM[-$[.ER&Q':HE4GL=,>, &+?T]BTRD1ZU!;]N!Z>3^Z>ADISGY*#E! MZ)A)C>AA8&JU?VH]9.DA@5'X.J=,TGBW/4P^;CETL<>(&GK[ MX[.V1BT3-SY%2;APN^@52R/R8.*)=]J> U[1YKR'%$>-*'-ZV.\QLHOSS6)I M==/?2R ]9>3K!EOW#ZK2;A=?#9=;1& F1!T+N_A5R=%(]R%!&O287@AGR26 M/>'6BQWH?*JB7] >>Z^,9*[MNE(EHB6RKZ..U%Z[]3W#OJJ2?1CHH,I'"%0O M!3QJLR.Y881 -OI0K!4RM'Z\AFI?L^'V2>EJNK6IT;F\(H M4GN-YRFPW8###G"F$JCCL*OOO<3/Q52Q]24H%XB!#T?0WL.IK=^@_2"QF>[$ M\JU7\,5"2"%GQ/5R<;OL\9>@T"+S /$Y&1SI1L&\^4/T?U(1".OMY:9SFW,4 M$@]75 Q[37*-;28Z NV/P)<A,O1SSJST0;?EO?#006E(0'U3-WWNSES/1OWH7"20V!.WI8[ Y*O4UM_R_4XN# 5QQTIC!AUA MNT/9$19OJE8FE[+#-$MJ'#I?U//J2=1P-;P^Z,V]>BX!]5*5S>!0\_T](H&? MB;CWT-F$66*D1<@9!>5/7@7,($H]H_G33/BXO8-G130\];C@"SBPM5AU&QY/ MKM6OO\W?]^C_N5=9^%DDJ]Y;JA)W];!#NC\PA.YAY4;#M+6ORW/)+IWW5FZ MTX]RX5"G]_5V+XH<]TW"3C[]RGV&Y0K%N$_F/5G25C%#38):_G!)L7H)B_"1ELPW_^X$\P, MK'%.##,QQQIDKDO_(6JU^9R"\R=FZ TUY7-A*7-DO0>TR$T.WWC=B^JILAL" M8F?&0RQZD1W,M.6= ?. *U^,0BH^Y/)8B *1D?V(]J)6TPW!2JMB=Q[E3^9> M\8)\(H_!],/%)]C7X)US-V.KQWTY;@2P!!%M;/[^_>3M M19JT)1E>Z*H]H^?Q2I:1.'YN.II$:"4KKW@X)\PYZ=MUS'#?(^M0"$H38%S"GY!ZQ O MD\=35%B==A_] M+9%PI$;K7CYA$^$,8CO8P+)^65>>+\O6\V7A-@^AK3B. M:E'=)DUD?EI6>*]V*G\@BFS?R.9IYFTNGVO5<\U0R@C0?3]D3P\M/@;G900] M>CT2G1!H3; A/X$1!NU_1$M+H2AV@%!>F,5[Q;W=GP$N3KRZ][T$.= M>R="+9$C7W^+)SMY%7D//U'8%68.Z! 0R-%/O%DON?>&V8,@XI#/&E2:#6NU,I0 M9Q]VDX3A9ASM0Z3R$GH%&S,8?A6*[A40.V-_A^W,DBQ#WVJ6Y/4Q[8P@PK#! MV)=(9_\Z=B9.JQ'SL$GS./RSD6D)(T#'_&]R!(B8HU /080Y'.Z' 3ME_*]P M]_U@7^%V'5@OAUW[X+CZ]_!)R%BCMO3H7OLS4D9"7_EIY-A6HZ&M3@E3)M3< M!;'R/V^#5@TZ/T.== &JND\$,:!&2.P0YI/#(7Z$I^!U&)*#00//7:H=Q'5R M^W;#]%WB].(V#;[-.@@/]Y-$!0H*4=J@X(FF(+T&^/8IP$RC^+8/ FGDL\'8 M!B+T\"'SW6&$1N,%C5H9"483UD8L')_P8^H%PRG($MG'<@F/[V#0!7A<=UHO M?%Q[;^#F<5U8W'-<4XF]\\CFG=#7(Z?][OSCJY>3^8?YB\FKM^&ULU99;:]LP%,>_BE#&:&'4=M*D=+4-6Z$PV$:A>=A;46S9 M%NCBR7+F]--/%]_BT5VR;B0OT=$Y.O_ST\61PDKM*'XH,%:@8917$2R4*M]Z M7I44F*'J0I28ZT@F)$-*=V7N5:7$**U,$J/>W/=7'D.$PSCD-;MCJ@*)J+F* MX&7O B[_5J0X@H]GK[_60MV\ JZ=O9G-_,?SFZG_S ;.(7 :']((!JM+Z/V^ MZ(7_O*Z.3:27STBWP[52ESE)7/T9TT^0)L)71MAK5S4.,\&'Q5U Y]"5$<-@ MBV@$;Q$E&TE,5H88H3OGGAM'(JB00.E=U62!\51/+ARXGMGP5H<1+J2M[2JX MWTT[?!+H>@:04-H#SJ%SQ&&)E,*2W^F.'6R=/X1 :Z]WI2;,)=H%\R4<$FRC MBVR$3+'LRP2P<\4AQ9G!D20O3*M$Z9F@4H)I(R4H%QQ9ABZC-;1L@BE],%_# MEVQ/N\F &V.VQ(? 4'2FGG5K#KOF6^2QFM,>RQZF"TJR%>I]K:?#;=\<'7PO M<48:VV^R'D"KH[*DNW>4Y)QA-YE?%@P.+!B'J*L#"B')D]8S1R71#BPAV&*I M2#+V?).H7.-&=<>IR0YEGI\@\TNO!G\^ZB>W?@< EK>84V^J&[IZ]S4YRAFJI[,T4;C.!@?S3@P:H?M>XE M(CC8GW!*:G9M"PZOZ?@[4$L#!!0 ( +%JKTY)^=+YNP0 /\E / M>&PO=V]R:V)O;VLN>&ULQ9I+;]LX$(#_"J'+IH==6Z^T#>H":9-T#:2)$0?9 MXX*6QC81B4Q)*JG[ZW#+V?F7,O?A>5]K- MHJWW#R>3B2NV4$OWAWD C4?6QM;2XZ;=3-R#!5FZ+8"OJTDRG1Y/:JET]/'# MOJR%G80;QD/AE=&XL]UQI^#)_3S>;@J))SS"K5S-HFDD9./-A:H\V#/IX8LU MS8/2FUD41V*MK//+MN[NS%II5:L?4'9;;FN>_C16_3#:RVI96%-5W57M@>XB MK,$][[D#ZU4Q.-'+U8U$UEET/,4"'Y53*U4IOYM%W?\*(KR+27 ;73OL?_M& M/+'_I1G->JT*.#-%4X/V?3M:J-K:M=NJ!Q<)+6N81?M3Q*DNQ;GV2"/FNB\* MSVWO!:N>E_U]>6RQG[#"GB@\8.=EW(+S07XVN@3MH!3XSYE*E4Q 'O-" M?I)..6'68F'!X:DOQ_1; NTM+]JE^M:H$L--@/..P'G'BW,AE15WLFI ? 7I M&ML.!^\"N/<$W'M>N-.B, W2B!LH0#U*K%Q(W?6\ J\,@_24BM)3[M[6Q^-. MAF,6(37"[)$YC@"]:2L5I\ZA6;M6_&),^:2J*J2D/!(SB^0,5H-'2NDB9O;% MTIOB?FNJ$JS[39SCD!T,V)BR1,RLB>566O@=0UP7@VLLR?W2VRA!Q/R&\)A9 MMLG5I9)=IJ<@C"@Q98:860US79@:Q*W\/F2BE! S.^$*R[TTSHD%6-$]WI", MLD/,K(>Y+AOG[4XL8=.)H8L<%TICP%-R$#HH3\3,HE@V*P??FK;+G3^^\%=" MJ2%A5\,KB8@X6F#>5.S>A)24'Q)F/XPD >+HME7NH#')B0:S(,AT8) ?)Y0[ M$F9WC*8#?7N&F)1&$F:-T$G!8'))V21AMDF;%>P[XF# 4!))F"4RIN!_04-, MRBL)LU="U[W:AI1:DD.J93B:*;4DS&H9B>!7TEK\^Q@N;U"B29E%,QK">] 0 MDS)->BC38$C'*!YB4J9)F4TSBKG$PLLFQ"07M9A-0PLQ7(M)*=.DS*:A,;,0 MDS)-RFP:&C,/,2GWI.QK6Z/I1:NB$)-R3\KL'@*S'40A)F6AE-E"!.8"CX28 ME(529@N1R=I EAEEH8S90C1F&) RRD(9LX7ZG'*O<'@CCL[ 2U4-DJ.,$E#V M/ZR%X7BV4"HO3C<6.@$]@X:8E( R9@'UF#?@5-G(2MR8G:S\[ADXQ"3?JS + MZ/76Q-'N 9.Z,#G** %ES )Z;=$QZ*8A)B6@[&"3GPXUQ*0$E#$+:!RSS35M MB$D)*&,6T#CF7Z VVQ"3$E#&O<(VBKELZCI\Z#DEH)Q90*^O/3\/HA"3$E#. M_D(FG)C_(J(0D[)0SFRA(68_1<,F[1_\]3K$I"R4,UMHB+E4&ZWP2HE]H.VI M)L2D+)2S+[@-,+N9)"9*UVMQ!FL( U).OM]GMA"]+A/F<#EEH9S;0B^7_(?C M*,2D+)1W%IKL/S@J8:TTE%=8AT'96NNNEV M.C<0@2&HD$2Q1]/>_:1L)I7:G%F@PR8H GU^5X\LFX>?Z5B70]?FYM#GQ=OI MV.9UU932_P@A;YITJO--UZ=V_&;7#:>ZC*_#/O3UYK7>IZ#+Y2H,TQG5X\-T MYN)YNZZ&YZU4BU_UL$]E786W8_C3#:^Y2:GDL@G0]2>I#-!QD]R.>#G!X4YX,B/6@U'[2B!]W.!]W2 M@^[F@^[H0??S0??T(%D"&9?\)(0U7VL!7 O?:P%@"U]L 60+WVP!: M?;0%L M"]]M 7 +7VX!= O?;@%X"U]O!7HK7V\%>NL5]MIHL\W76X'>RM=;@=[*UUN! MWLK76X'>RM=;@=[*UUN!WLK76X'>RM?;@-[&U]N WL;7VX#>=H6S$G18PM?; M@-[&U]N WL;7VX#>QM?;@-[&U]N WL;7VX#>QM?;@=[.U]N!WL[7VX'>SM?; M@=Y^A;-N=-C-U]N!WL[7VX'>SM?;@=[.U]N!WL[7VX'>SM<[ KTC7^\(](Y\ MO2/0._+UCD#OR-<[ KWC%>XJT64E7^\(](Y\O2/0._+UCA.]_4$L# M!!0 ( +%JKT[7)IR=W $ $ M,+;3G?-N-,\5LZ=71V&T:YLNS+,J1G?%6"@J:DW(K:,N59;6MR:F4[]BSA1K MLR(F)I,I*VP7J8OCV/?(%K,;6II-$T?7^^M]ZWEFG&OJPL3:=FS;E=^:CM\; MYIZ:84VH:A?.TH)L=+M+74*Z-L]2-63L%Q.^W]B?I_ONM^1]7=*?HMGELBZH MM,6F3;?DP7DR9:B(8MODH3*>RL?HZV[UGO?!^'AGVM28[1KV94%^NASQM:'# M 8;*,2?'M"WHT*BAL/_D_QKXL1L*ZVGL?*KZ6!]XO!3I(54#ZQ<>\Q&IWSHE ME;\:GEJ?[H=]L7X]?#_TPC^+@0V'_[WUX^40(#DD2 X%DD.#Y)B"Y#@'R7$! MDN,2) >?H 1!$96CD,I13.4HJ'(453D*JQS%58X"*T>15:#(*E!D%2BR"A19 M!8JL D56@2*K0)%5H,@J4&25*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4 M616*K I%5H4BJT*15:'(JE!D52BR*A19%8JL"D56C2*K1I%5H\BJ4635*+)J M%%DUBJSZA+(.Q[PU=?=3DF=KUQ_SV?#_D<4;4$L! A0#% @ L6JO3A\C MSP/ $P( L ( ! %]R96QS+RYR96QS4$L! A0# M% @ L6JO3B?HAPZ" L0 ! ( !Z0 &1O8U!R M;W!S+V%P<"YX;6Q02P$"% ,4 " "Q:J].MCR=[^\ K @ $0 M @ &9 0 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " "Q:J]. MF5R<(Q & "<)P $P @ &W @ >&PO=&AE;64O=&AE;64Q M+GAM;%!+ 0(4 Q0 ( +%JKTYB-+8]<0( -H( 8 " M ?@( !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3A3<$<,^ @ '@< !@ M ( !B1 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ L6JO3OC)2MR9! ^!0 !@ ( !NQX 'AL+W=O MM@$ -(# M 8 " 8HC !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3M!SL'2U M 0 T@, !@ ( !7R< 'AL+W=O&UL4$L! A0#% @ L6JO M3@<*I7VS 0 T@, !D ( !-BL 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3AH>_X&T 0 T@, M !D ( !]C 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3EZ5* ZU 0 T@, !D M ( !N#8 'AL+W=O>QW(+,! #2 P &0 @ &D. >&PO=V]R:W-H965T M&UL4$L! A0# M% @ L6JO3IY?0E&T 0 T@, !D ( !=CP 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3M*@ MF.O$ 0 -P0 !D ( !,D, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3@J3*7_5 0 G 0 !D M ( !)4D 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ L6JO3A1::U"T 0 T@, !D ( ! M14\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ L6JO3G03@ 0A @ [ 4 !D ( !3E8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3E*M[15- @ L0@ !D M ( !0&8 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ L6JO3F[;0;3P @ 3PP !D ( !Q&T M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ML6JO3E?+]KW1 @ I@H !D ( !UG@ 'AL+W=O>P >&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3LF+0C,A! M>!4 !D ( !_(, 'AL+W=O&PO=V]R:W-H965TP( -,( 9 " 4>+ !X;"]W;W)K&UL4$L! A0#% @ L6JO3H ,:K; @ CPH !D M ( !^8T 'AL+W=O0LX! V! &0 @ $+D0 >&PO=V]R:W-H M965T&UL4$L! M A0#% @ L6JO3L;/-L(G P @0L !D ( !,Y8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO M3HDP;]/W P 9A( !D ( !WY\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ L6JO3DGY MTOF[! _R4 \ ( !O4$! 'AL+W=O!( 0!;0V]N=&5N=%]4>7!E&UL 64$L%!@ !" $( !( .U* 0 $! end XML 71 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 239 302 1 false 74 0 false 7 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://verupharma.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://verupharma.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://verupharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements Of Operations Sheet http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements Of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements Of Stockholders??? Equity Sheet http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements Of Stockholders??? Equity Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Basis of Presentation Sheet http://verupharma.com/role/DisclosureBasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Liquidity Sheet http://verupharma.com/role/DisclosureLiquidity Liquidity Notes 8 false false R9.htm 10301 - Disclosure - Fair Value Measurements Sheet http://verupharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 9 false false R10.htm 10401 - Disclosure - Accounts Receivable and Concentration of Credit Risk Sheet http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk Accounts Receivable and Concentration of Credit Risk Notes 10 false false R11.htm 10501 - Disclosure - Balance Sheet Information Sheet http://verupharma.com/role/DisclosureBalanceSheetInformation Balance Sheet Information Notes 11 false false R12.htm 10601 - Disclosure - Intangible Assets and Goodwill Sheet http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill Intangible Assets and Goodwill Notes 12 false false R13.htm 10701 - Disclosure - Debt Sheet http://verupharma.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 10801 - Disclosure - Stockholders' Equity Sheet http://verupharma.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 10901 - Disclosure - Share-Based Compensation Sheet http://verupharma.com/role/DisclosureShareBasedCompensation Share-Based Compensation Notes 15 false false R16.htm 11001 - Disclosure - Contingent Liabilities Sheet http://verupharma.com/role/DisclosureContingentLiabilities Contingent Liabilities Notes 16 false false R17.htm 11101 - Disclosure - Income Taxes Sheet http://verupharma.com/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 11201 - Disclosure - Net Loss Per Share Sheet http://verupharma.com/role/DisclosureNetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 11301 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations Sheet http://verupharma.com/role/DisclosureIndustrySegmentsAndFinancialInformationAboutForeignAndDomesticOperations Industry Segments and Financial Information About Foreign and Domestic Operations Notes 19 false false R20.htm 11401 - Disclosure - Subsequent Events Sheet http://verupharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 20102 - Disclosure - Basis of Presentation (Policy) Sheet http://verupharma.com/role/DisclosureBasisOfPresentationPolicy Basis of Presentation (Policy) Policies 21 false false R22.htm 30303 - Disclosure - Fair Value Measurements (Tables) Sheet http://verupharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://verupharma.com/role/DisclosureFairValueMeasurements 22 false false R23.htm 30403 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Tables) Sheet http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables Accounts Receivable and Concentration of Credit Risk (Tables) Tables http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk 23 false false R24.htm 30503 - Disclosure - Balance Sheet Information (Tables) Sheet http://verupharma.com/role/DisclosureBalanceSheetInformationTables Balance Sheet Information (Tables) Tables http://verupharma.com/role/DisclosureBalanceSheetInformation 24 false false R25.htm 30603 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill 25 false false R26.htm 30703 - Disclosure - Debt (Tables) Sheet http://verupharma.com/role/DisclosureDebtTables Debt (Tables) Tables http://verupharma.com/role/DisclosureDebt 26 false false R27.htm 30903 - Disclosure - Share-Based Compensation (Tables) Sheet http://verupharma.com/role/DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://verupharma.com/role/DisclosureShareBasedCompensation 27 false false R28.htm 31103 - Disclosure - Income Taxes (Tables) Sheet http://verupharma.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://verupharma.com/role/DisclosureIncomeTaxes 28 false false R29.htm 31303 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations (Tables) Sheet http://verupharma.com/role/DisclosureIndustrySegmentsAndFinancialInformationAboutForeignAndDomesticOperationsTables Industry Segments and Financial Information About Foreign and Domestic Operations (Tables) Tables http://verupharma.com/role/DisclosureIndustrySegmentsAndFinancialInformationAboutForeignAndDomesticOperations 29 false false R30.htm 40101 - Disclosure - Basis of Presentation (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureBasisOfPresentationNarrativeDetails Basis of Presentation (Narrative) (Details) Details http://verupharma.com/role/DisclosureBasisOfPresentationPolicy 30 false false R31.htm 40301 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureFairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://verupharma.com/role/DisclosureFairValueMeasurementsTables 31 false false R32.htm 40302 - Disclosure - Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) Sheet http://verupharma.com/role/DisclosureFairValueMeasurementsReconciliationOfBeginningAndEndingLiabilityBalanceDetails Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) Details http://verupharma.com/role/DisclosureFairValueMeasurementsTables 32 false false R33.htm 40303 - Disclosure - Fair Value Measurements (Schedule of Qualitative Information) (Details) Sheet http://verupharma.com/role/DisclosureFairValueMeasurementsScheduleOfQualitativeInformationDetails Fair Value Measurements (Schedule of Qualitative Information) (Details) Details http://verupharma.com/role/DisclosureFairValueMeasurementsTables 33 false false R34.htm 40401 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskNarrativeDetails Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) Details http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables 34 false false R35.htm 40402 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Components Of Accounts Receivable) (Details) Sheet http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskComponentsOfAccountsReceivableDetails Accounts Receivable and Concentration of Credit Risk (Components Of Accounts Receivable) (Details) Details http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables 35 false false R36.htm 40403 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Summary Of Components Of Allowance For Doubtful Accounts) (Details) Sheet http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskSummaryOfComponentsOfAllowanceForDoubtfulAccountsDetails Accounts Receivable and Concentration of Credit Risk (Summary Of Components Of Allowance For Doubtful Accounts) (Details) Details http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables 36 false false R37.htm 40501 - Disclosure - Balance Sheet Information (Components Of Inventory) (Details) Sheet http://verupharma.com/role/DisclosureBalanceSheetInformationComponentsOfInventoryDetails Balance Sheet Information (Components Of Inventory) (Details) Details http://verupharma.com/role/DisclosureBalanceSheetInformationTables 37 false false R38.htm 40502 - Disclosure - Balance Sheet Information (Schedule of Estimated Useful Lives of Assets) (Details) Sheet http://verupharma.com/role/DisclosureBalanceSheetInformationScheduleOfEstimatedUsefulLivesOfAssetsDetails Balance Sheet Information (Schedule of Estimated Useful Lives of Assets) (Details) Details http://verupharma.com/role/DisclosureBalanceSheetInformationTables 38 false false R39.htm 40504 - Disclosure - Balance Sheet Information (Plant and Equipment) (Details) Sheet http://verupharma.com/role/DisclosureBalanceSheetInformationPlantAndEquipmentDetails Balance Sheet Information (Plant and Equipment) (Details) Details http://verupharma.com/role/DisclosureBalanceSheetInformationTables 39 false false R40.htm 40601 - Disclosure - Intangible Assets and Goodwill (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillNarrativeDetails Intangible Assets and Goodwill (Narrative) (Details) Details http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables 40 false false R41.htm 40604 - Disclosure - Intangible Assets and Goodwill (Gross Carrying Amounts of Finite Intangible Assets) (Details) Sheet http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillGrossCarryingAmountsOfFiniteIntangibleAssetsDetails Intangible Assets and Goodwill (Gross Carrying Amounts of Finite Intangible Assets) (Details) Details http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables 41 false false R42.htm 40701 - Disclosure - Debt (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureDebtNarrativeDetails Debt (Narrative) (Details) Details http://verupharma.com/role/DisclosureDebtTables 42 false false R43.htm 40702 - Disclosure - Debt (Credit Agreement) (Details) Sheet http://verupharma.com/role/DisclosureDebtCreditAgreementDetails Debt (Credit Agreement) (Details) Details http://verupharma.com/role/DisclosureDebtTables 43 false false R44.htm 40703 - Disclosure - Debt (Residual Royalty Agreement Liability) (Details) Sheet http://verupharma.com/role/DisclosureDebtResidualRoyaltyAgreementLiabilityDetails Debt (Residual Royalty Agreement Liability) (Details) Details http://verupharma.com/role/DisclosureDebtTables 44 false false R45.htm 40704 - Disclosure - Debt (Credit Agreement Interest Expense) (Details) Sheet http://verupharma.com/role/DisclosureDebtCreditAgreementInterestExpenseDetails Debt (Credit Agreement Interest Expense) (Details) Details http://verupharma.com/role/DisclosureDebtTables 45 false false R46.htm 40801 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://verupharma.com/role/DisclosureStockholdersEquity 46 false false R47.htm 40901 - Disclosure - Share-Based Compensation (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureShareBasedCompensationNarrativeDetails Share-Based Compensation (Narrative) (Details) Details http://verupharma.com/role/DisclosureShareBasedCompensationTables 47 false false R48.htm 40902 - Disclosure - Share-Based Compensation (Recorded Share-Based Compensation Expenses) (Details) Sheet http://verupharma.com/role/DisclosureShareBasedCompensationRecordedShareBasedCompensationExpensesDetails Share-Based Compensation (Recorded Share-Based Compensation Expenses) (Details) Details http://verupharma.com/role/DisclosureShareBasedCompensationTables 48 false false R49.htm 40903 - Disclosure - Share-Based Compensation (Weighted Average Assumptions For Options Granted) (Details) Sheet http://verupharma.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsForOptionsGrantedDetails Share-Based Compensation (Weighted Average Assumptions For Options Granted) (Details) Details http://verupharma.com/role/DisclosureShareBasedCompensationTables 49 false false R50.htm 40904 - Disclosure - Share-Based Compensation (Summary Of Stock Options Outstanding And Exercisable) (Details) Sheet http://verupharma.com/role/DisclosureShareBasedCompensationSummaryOfStockOptionsOutstandingAndExercisableDetails Share-Based Compensation (Summary Of Stock Options Outstanding And Exercisable) (Details) Details http://verupharma.com/role/DisclosureShareBasedCompensationTables 50 false false R51.htm 41001 - Disclosure - Contingent Liabilities (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureContingentLiabilitiesNarrativeDetails Contingent Liabilities (Narrative) (Details) Details http://verupharma.com/role/DisclosureContingentLiabilities 51 false false R52.htm 41101 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://verupharma.com/role/DisclosureIncomeTaxesTables 52 false false R53.htm 41102 - Disclosure - Income Taxes (Reconciliation Of Income Tax Expense (Benefit)) (Details) Sheet http://verupharma.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpenseBenefitDetails Income Taxes (Reconciliation Of Income Tax Expense (Benefit)) (Details) Details http://verupharma.com/role/DisclosureIncomeTaxesTables 53 false false R54.htm 41104 - Disclosure - Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) Sheet http://verupharma.com/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) Details http://verupharma.com/role/DisclosureIncomeTaxesTables 54 false false R55.htm 41105 - Disclosure - Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) Sheet http://verupharma.com/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAmountsClassifiedInBalanceSheetsDetails Income Taxes (Schedule Of Deferred Tax Amounts Classified In Balance Sheets) (Details) Details http://verupharma.com/role/DisclosureIncomeTaxesTables 55 false false R56.htm 41302 - Disclosure - Industry Segments and Financial Information About Foreign and Domestic Operations (Schedule of Segment Reporting Information) (Details) Sheet http://verupharma.com/role/DisclosureIndustrySegmentsAndFinancialInformationAboutForeignAndDomesticOperationsScheduleOfSegmentReportingInformationDetails Industry Segments and Financial Information About Foreign and Domestic Operations (Schedule of Segment Reporting Information) (Details) Details http://verupharma.com/role/DisclosureIndustrySegmentsAndFinancialInformationAboutForeignAndDomesticOperationsTables 56 false false R57.htm 41401 - Disclosure - Subsequent Events (Narrative) (Details) Sheet http://verupharma.com/role/DisclosureSubsequentEventsNarrativeDetails Subsequent Events (Narrative) (Details) Details http://verupharma.com/role/DisclosureSubsequentEvents 57 false false All Reports Book All Reports veru-20190331.xml veru-20190331.xsd veru-20190331_cal.xml veru-20190331_def.xml veru-20190331_lab.xml veru-20190331_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 75 0000863894-19-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000863894-19-000007-xbrl.zip M4$L#!!0 ( +%JKTY_PT+'>6D! +8)&0 1 =F5R=2TR,#$Y,#,S,2YX M;6SL?=ERXTB2X/..V?P#5M,]765&*7D?RJI:4RI3-9K.0RME=N_TBPP"@B0Z M08"%0TKVUZ^[1P00( &2($$2I##3526)("+";_?PXY?_\V-B:\_,\RW7^?6L M<5$_TYACN*;EC'X]"_USW36[YANW[H,>V3[N@C1@]V+YK]B_I%0SL_%R]ZI_OP1=?1 MZ(W-BT;TR;5XJ>M<:ITWC(/_GCR; VV[OB_GHV# M8'KYYLW+R\L%_OG"]4;PI7KKC>7X@>X8[(P_>6E;SO=? M6O1T8S 8O*%/HT?A1:85/:N^M_N&?R@?-=G<^-9G:^'KZV]ACPU_/<.?G MQ]Z.G[VV'EL/"*4 M'K^Z\'-+_")P\WAMZ[[_9?AWW?-T)_CBW5NC<7#UP_(?<0./L) ?V@&PY@/S MGBV#^>))_Q.;/#&/GPV6!IZS@IGX#7ZW3/S+T&*>1F=F"3A+8%W?_O7LMSK\ M7[_;Z@_:O[R)OQ:_RFXU)%'.\R\WAG MO^'Y+E>=[Y\!VGS&R?<#I (O"/Z M:_0@<\S$8ZT&OMI4'OKEC?+R7]X(W"\AA$9=H826H(3!(W#1XT, [\5C_,[< MD:=/QY:AVT0%@IP?W]V7%=6P_\O,_9_])@YP^>Y^Q[ALU-? Y>"\WBH"ERU@ MY1B5XF?$Y+WNC!AA#G_[I/^P)N&$'S3F>8^95G"C&Y8-QXN9_>'E.__H:N0Q M N?<%R,P/QC,T6'#RG?%7YKEE@M(+!&(SG[#7Q,P6D4CN63/ IB%T,F"BT15P/7F:7<][^'JF;B^]83DI\YQ/3\3H$#WOK3,/@ MZVS*8HJ8__3.:Y=;EI)"^:H "E2\F3!5%!E?J"> M4C1R?7I-C4>^9GK=5?"QHM?-Z'4=7Z+,]%6(2W!,N-S(*KIGOF6&NGWOSG0; M/C@1VVCYL4[ 0KKR'[\,%8ZM;K$/2&P^.&/ M$/9U[4ZFK@._^H1C^=17C[3:["%PC>_'@=FE!SO[33Z6MA/.UJ%_B3ZKTQ0B? RW;[3+?/6N=:G5J"7W"'(20=+SU@1 MQ!Q!&$8X"6U,[/P2C)F'CWELC*!_9K>.X4[8:1''NN<]04))^'']2G*42'+T MUR.(_BX\^T:S(HE2DL1: 0)XK%DD2?02)-&K2*)$)-%;CR1Z19%$ ?8%_'GB M.J?G;"RHZ-,O^B1.WX6^ MY3#?OS( 1#[9/O&EP94_M3QV5'9>QGG$+4'*@K*8.=7!L5= M VV'Q'L6Z$#WY@?=FOB,?UPIXK*RLT^5<16X?C]A..+1OC&7G*E M6HO!8N0 'P2+E6X]'5Q6RO5D,5MIU[UKUX(QOG/,[/MH@\=6O;(;#FDWU ?G MK?IAD%B9#2>#RLIJ.%7$5D;# 8R& A"^::9;I5D+0V)Q@;1*LQY8LQX.E95F M/57$5IKU$)JUP&!WWNR02K46@\5>H4&5O%BL=.OIX+)2KB>+V4J[[EV[%HSQ M,@6["SF:C,%4=L.A[(8" VF5V7!8L^& J*RLAE-%;&4T',!H*##87=7G[:E> MHS0)A!4&BXB*'3"3HT)@$0@\X(5AA16+>>>T.$KED//IU^8MZ(>7-?^FH%-OLRO'5,ZYFZ[\9?^3"9VNZ,'4ED M85=TDVE["Y8-7*]BJ6-E*?EQ$I.O MGJONF1]XEA&(+K_?'"OP[Q^^51IJ-3LM!=TILU*EG4K 1R>EF5XM*YVL5LH* MX:=SCQ0FA/TO4T3+4=-SYGF.)60?B[L[6W<^ZQ-E,M;7%_?KV U]W3&O'/.! M/<,6&7-XW.;6,7#'SPR_=QPX5$\H!$'>(Y8WAI$'K;"GV0=T"4X.FVN=[%B0 MV*^0>! D%G*EUENX4:L$[&$%;.^\WMN!@-W 32@['G=AO)A>E]8WK-3ML[&;RSP8#.*)G@+O2,L>ZS4YO0N>* )Q!I MVO&M8ME)H"QI%Z>'^8VB]J^57/+LH= @_,G3:?$W2T=*H\=Y2714])GJ"?M> M0*/,7=LRZ;G;@$V2V:9?8"&=#P*GLPKK@KX:)7;^SMR1IT_'EJ&F H@RL= ! MW+*2FUUPG,MT2,14F@&*(N@3E\^$IJ#.-'">H ^_+Q(U")*SQW_\O:+)36A2 MP._R'W^OB' )$2[D]DL5))]+$N-518SKU1*D@5$ARJN**+>6C-\>*F+<1C)^ M>ZB(<&LB?'=?$>$V1/CNOB+"K8GPZD-%A-L0X=6'DR+"]%A/Y4P?!U$>QIDN M1SRR\J9+2I1[\J:/G@HK=_H$W>FCI\K*GSX!?_J54&'E4)?:H7XE5%AYU*7V MJ ]S.SV7OELYU,=!DX=RJ/>;>+Q?$JW\Z2/QIX^;""MW^B3=Z>,FRLJ;/@EO M^C408>7&E-R-*4-Q6N7'' =1'L:/.5!9W;YHM')DCL*1.7HJK#R9$_1DCIXJ M*U?F!%R95T*%E2]3:E]F/U28U?,HKM"\UOWQE4/_P9Y.S[J-T$[_:^REW#%O MZ'H3W3'8.].FC7U_<5TI(>19?#6ZE*?%Z M\-YUCD%C#3J/'GL%=#[VCJ5Q_JE0>@SQBM8K#7Z1HZNQ1D6>GL@FFSDI.5SEYSZ6_#:KELQ^9[K.Q:YNWDZGG/C,EO>8DL"P?7G+.LB-X M,1Y:\7+Y>+F0.:Z;H;KBY7WP\I8(CJS#GF(<]A(9H)_T?[K>=>@'[H1Y2G[= M YM8CEYN1'*3;G[_\EI#.<"NKZUZZUUE] HQ])N/S5YT;Z7\5F&S"&SVSAO- M\V9O%3:CQXHUF*.L8#&MB\_:B9->/39DGL=,^OB!8459N]Q87:C_F#^9S&S- M/MKQV4H5&O>+QAW-L\^%QBM^V-8IXC%YMK+S8S&(;)XP(INO"9&-$T9DXU@0 MR8W4P=\=/1+C M4&7*N+7D)#@/SI,CM??P MH1]8!F\>.JMD7U2LG :82N*5A0Q/3;.AZ[WHGD(E M5W; / =\G&-ZS%KY"1$ MW;'C,.U,)X>X5"5U[)C;2/.6(6;WV(BZ7>YQ2C'IU6MW,F&>894]VG4UZ4Q?>4Y%P@20\!]2*7+/)]142W%&AN_ AV96!^&H,Q/(T M%JDLQ%.@X+)8B*^,KBL3\%[\.,9J],Q,*%TR%,Q..>E5U9 MB*4BX/)8B*^)K"L#\>@-Q*,FUU=(<$>%[@--O*X,Q,*%T_X-Q*.?0%Q9B*6B MX+)8B*^,KBL3\%[]2T@@49@XUO@QD8(%/72=&=@0[<8G[0 M/0> 57+$+_!ZVME4?95VN)---6@T(YZOB."01+#F74(?N\SNC@C*U41@WS!) M#9=4;'%8MCA<""5BBUY%! ?S'UCHW?UKI:-W]Q4=K4-'IT8>)XRQA>E@X1-L]%N )[28?^L\PXY<3T'> MG<>>7-<_$I0M.T_<>E4Y4-E;/6Z"LAOC2-H=KX&MZ"QE1U3*M*Z*M\I:$+XY MRBK>.@"B%H5@W(7GH_7,S%L'WCVRGFQVY?LL\-_-^, JZBB:N"X)QLR;?_HX M$)KSR,I]2O:9CT^H5H@O.^*+ZM715N+ W8@.JF%Z183R $?M]>*YW2WZ J]S MO5WA=H3H)(LD[Z2'"61'+L/ M854"H#0"8/<>6\77Y>/K'87/*KXN(U\7/? FI='!/1R?$5K)I^.]E MHFV?_4:^G+KO$["T-L"<_N,X,:?N^P0PEV4X76%#\Z^S*4N(T ^3J>W.&*/A M6E^FQ]/D.W&<6$AFGJ>\QL^ZKF^%P&-GS05,=]7Y;R5+3^RNFYY8P/RWM2V" MB.P_,=T//;*";IUI&"SPQ?P#[RV?FXY-/_'#E*/OW/J7%)A9)]1),[CXU6U ,A_F736I*X M-C1\\MD?(7SP 3->%\S^N<_+;>GOK!(ES^(9$%5F\:6!=->]&CKGC=8:H1[^ MV&[S6:JZI^,/ZV5%W+-P>\]\RPQU^]Z=Z39\<"(87GZLX]'T%?KVB[X=E7E4 MDO5D.*Y"V<&Y;,WV8]>N8\"6^+/WEO_]W>P=^)TUIW6;^/0.;+V2? MV;'@<\7I%+,V[7@GVX)L SH@OO[J!N!_&N1[ K0,9CWK3W;);U#6)P9B]:5G M/ 'CMUB*X#EPUZ'G'8^07X\.4DY68;_2"R='!TL[\%5D<#@R.%P7OA1#OS(/ M#FX>K%_[N4U^5[$449D'IX#]2B^41R_LIP*23E=YOF4,4Q+#UAVE'86 M->8JE#I^:/-!&-ZS93#_U#"Z_'R[#:1W]I8V3,C\$@8^ /@;UHR:]&S)L;@B MUX@PF'FHLO/BNBEA%>I*='V5Y+K##\F8[\Y;%%$>OH8L88#NX\KQUC'<"8MH M]J-KZ)%-&KF-S+9!5_S.'.8!*3OFE3FQ',LGG^R9B5EV)6?-N*=?YH$53S+/ MB4_J8G)K8CGBP9*Y2.30=B:6"K=L2_=<62$4:F.XT/Z M\H2'2G>46W<QPWUA>3):L4G'+@NIC4R+2X],&O M\4H7%+L+.FR3"Q@\*^A#CK@'C? MT42#@Y]T3T;N_SX_QQQ9[8$9"(WS<_[G$/^&8,(/E8S-"6^&S<6.(431+V_D MG_D"^.6TUW337V/K+WYH!>N^I9/^%BM@DW5?T5YX!4;NOT_3/<^< Y45JT/X&:TMQFKG XOK8/51=MI-S M69#S_S>Y(+XQ7N<#*8UKAJ6Z-DY.__%7-E-INY%S055)92ZPL'YGZ;'T"(CO"RSG-?@C$.']0=!5@@O#87!$M6F-_&C64S[QK(9>1Z"5RU2;;AC,1MW 3(U>K&XGL=+\-N[9B*XIG>"S/E&)%$1[OGW\[">)A-GEQ;/6H[YWIH6_#U M$J\4NDV.B1*],>[T&3;&$+(Z7K8QO^R\PS#'"$V5$^IGO[6:S6Z]U06-N'3! MO)MJI6TJ/ON*334[S4ZCV]QL4W$7$> J[6XJ[D5M]?N%+,M$ /&/#8[_51L;A(!67:4<["^>QW4&?659XFWN>I4GYER MDF9]2V89])K=5@I=)M;+N:7M6*5=;_::K:787V]+"TS<;';2=K9!+'(5UANK ML1YO<).C#/:!]FWVMP\:R-J?QU!+B0P2A>M;J_3G7'1^E4SO-7O]Q!83"Z^] MK+N#YZJ M;]9&7&O0[S0;O3T>_$LP!N<.7$R/C?%:Z)GQ)+2/:&NQX,OPJ_Y#L5C;VR$6 M+,I&!\,O&^ZDL&-LAZ:"CV&:E/FEVW>Z9=XZ(N%+W6ZJE; VU >=]J#;J:L" M(7W)W/MJ;@7&1KW3[78'[5;NC?T3[$XD:_^KF_$-0D.\U59_53BBJ(S#%6?N M=Y+V[KI'F8< K!_ ?IP1IH/Z=ZYM&;.O<+AWMFM\C\_=G??@5L8F_M,.WIK6 M\W^.@K>:^%GS@YG-?CV;Z!B6.K?9,+BL3X.WXG^\ ]\ZU_L4FO @]&+Z$WXH7R9:?E3 M6Y]=:I9C V(2;_QJ39BO?68OVKT[T1WEI?C.MPB#?<(SV I*U/.E]%&^M(I=6K]5N[QDZO4R&V<0A;S<:_79_ST?H M9-+\#DHR5UEYO?W3=^:=\%Y*E5=11+^>"-KO!2(KX@M[J_1?Y0!WF_6$H[(7 MAL]Y5;G*W6JTVMV](SA?^LF.6;[3:]7W#8!\62C[9GK@P%9][S#9,%BZ=[9' M+=_:-\OT,EEFDYAK>P"B:[!O/9])]#OH^;8*A[W>OLV<;N9%U5YZ(:X*]33J M];VK@4Q5MN=6HJM3%]K- O3\B^X8[,;UWKOA4S ,4P;*+%RY=I;?"?=6FBB MUU9RYVOOHJ #I&:SK.V1M+J->2=\WP?8+IZ-1N*!#[!=XDZ!!U N?[X,;RP' M7B-#8T_3E6F)WYJ/MPQ\B9 MYKR*DIK=3K_9/\!!FBMB93E3+QKU7C>1$E+ .6Z=0'=&%B@!/BU-2=5;F:>3 MCRL:K5ZWUJ-9[[1SKMJO+UUUQX"JKPVHQ=J#>NK.UZ8K@'&B]U0A0F.UPYS$?P$B06"=G85]'H2?%EF\^W-R\ M+=WF,&5%!T*C;!(DM=#10Q/9&Q[#E),)DIN)01H3?_)=VS*IG&S(+1[=AO<+ MH<%S3?X&DD*[=8P+[:<86]=O7U@M_O7]6TW]S V][ ]#/_LS7"OQH;>FRJ>W"@:>CYH0[P$BDV7F@#H#$7QF,CS &D;!J@ M-OSP@1FA9P66>.+##V,,FI+R8 M@F2')F$=GG9"6#X5P1&T\#F@&\_$^(;V8@5C^ET(K*D'+[2FN,$1CRO"&EB, M..6413#D:D3C>B0)KF\7#Q?:[U=7=UE8BXD2X.A.K #>5--T.QB[X6BLIDC! M\[;%GF&%8*P'](D*@8EN @=XF)G%_@BQ#!@ /-&_,WI2!2( 3P/6CH#OP
3[I-C../&0LP!Q!@>I@] U/YG*=,D#_/B"?/G1#DER&.'S76%AGG5#!= M1%:BH?MC;6B[+_$+\I]XQ4(;@!#E!W*[PPSF^[IGD40U+8-N4*3.D.F90./ ML)@1:A!TB<]GVC ,0"QHO/L*BK4,ZD:J*H!4\K]B \A<<$WL//G3\MD^I3?, MN++EV@>Y!UAR._.,ZP=4:58PX^HAUC=""Z%*E!HCTH7,#ZP)J6GD0MWWP\F4 M\S$I57TX!%H61(YB&C:@3WA #C:NJ5K/UX?!X]/2,2LT%A@ST'G!5_A^P88D8?E7V 2DBRL$%J MU[3@W!Z7EV!X^ JJ:^ M'KD79L1K4@D(2I1K,+.BL'4WMZ(^Y"[V5;@$$N0C<>7H@9!.,:KR:\)+Q2\& M$SG7"PS7=KW+_^ A-/XZCX'D09>!#&;A?G [&IZVL;W5,[.%C+> TOSPR;=, M"VP31H16)M?\(OF2W+!%7;F.\N.NF)0F4AL07A#1"*:7L8O<[KZ@/Z/"K*9= M^: IM#O=^Z[=C740"P8+ XR/PF>+X8ZKNSG?%5? C=XP$"A,^R^&SFKDI'ZT M)A9W8==Y+.G)I>\9G-+L]_ST[:\_:U/;T'Y:N=:*'+OUXH MFTO 9M6IY1K;'_O3S]K#^\\7[_[KO?;3_ X_@4L&'K">M4LP D!A^-;(L8: M=HP.H_(1:DG#9D:^;@A)CE:2I+$X:L%LB[KI,>FJQZ+F0@,YA"S"@T_X5EX) M+%7"%R-PR7SG;DH7WA]5+BX>!LA/4TH;DZ0(;\3/P?6*@B78F0I>CL9:%F#E M1J+.6 [L%=Y32_QUK)O\K !'C(V@%>N:(5B'$E#,&8%F)PB Y/_.4-_64-^' M0P ?M\(0?B:FH%E/(>ECG:"%?0ZU,<>I@4Z7>#??PLUU

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end